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ABSTRACT 
Background: Hospital administrative data have been used to evaluate population-level surgical outcome in the UK. However, these data do not account for harm recorded outside of the hospital setting, nor pertain to health status as health status is under-represented by conventional diagnostic coding. A systematic review of the literature identified studies reporting on changes in quality of life associated with surgical adverse events (SAEs). The evaluated studies demonstrated a significant correlation between short-term surgical harm and long-term physical and mental well-being. Interactions between harm and health status have not previously been studied using population-level data.  Hypothesis: Patient-level linkage of multiple routine databases can improve our understanding, measurement and risk adjustment of harm in gastrointestinal surgery.  Methods: Almost a tenth of primary care patients in England with linkage of Clinical Practice Research Datalink, Hospital Episodes Statistics, National Cancer Intelligence Network, Office of National Statistics and Index of Multiple Deprivation databases were studied. Nine gastrointestinal surgical procedures were evaluated to measure short-term harm (technical SAEs, systemic SAEs) and long-term health status (postoperative psychiatric morbidity, postoperative symptoms). Risk factors derived from linked databases were evaluated against outcome including 30-day mortality, readmission, prolonged hospital stay, technical SAEs, systemic SAEs, one-year mortality, postoperative psychiatric morbidity and postoperative symptoms by binary logistic regression analysis. Predictive performance was compared between models with predictor covariates derived from linked databases and those derived from hospital data only by assessing discrimination.  Results: 
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Overall, 73655 patients who underwent 75854 procedures between April 2000 and March 2011 were evaluated. At least one SAE within 30 days of surgery was recorded in 10.7% of procedures. Of all recorded SAEs, 28% were identified in primary care data only. The proportion of post-discharge SAEs was 42.5%. Within twelve months after surgery, postoperative psychiatric morbidity was recorded in 11.4% of procedures and postoperative symptoms in 16.9% of procedures. Regression analysis revealed that technical SAEs were associated with increased risk of poor postoperative health status. When adjusted for SAEs, new onset postoperative psychiatric morbidity was associated with significantly increased risk of one-year mortality (OR=1.48, p<0.001). Postoperative mental health status therefore had a significant impact on survival, and this association was particularly strong in patients undergoing surgery for upper gastrointestinal malignancy. Prospective studies must therefore explore the role of early recognition and development of interventions to reduce the impact of this type of harm. Linked databases improved the performance of prediction models for all outcome. However, this was though to be of clinical value in models predicting postoperative psychiatric morbidity only.  Conclusions: Linked routine databases characterized the overall burden of surgical harm and poor health status in gastrointestinal surgery. Using this important information resource, interactions between short and long-term outcome were identified. Prediction of poor health status improved to a level that could inform policy. Further development of analytical methods and validation of data may pave the way for large-scale evaluations of quality within integrated health systems using linked routine databases.   
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1. CHAPTER ONE – INTRODUCTION 
Surgical harm 
What is harm?  Surgery should achieve positive effects on patients. With improving standards of care, focus is increasingly placed on reducing morbidity and mortality. However, harm is an all-encompassing concept that may include a wide range of markers that may have not traditionally been evaluated in surgery. Researchers have endeavoured to achieve consensus on what is inferred by different terms that describe harm such as complications, adverse events, morbidity and misadventure.[Clavien 2009, Low 2015] The following terms that describe the harmful impact of surgery will be considered in this thesis: Harm: The World Health Organization defines harm as injury caused by medical intervention.[World Health Organization 2005] It is synonymous with the term complications, which has been traditionally used to describe harm related to surgical intervention. The term morbidity is also used although often to reflect the lasting impact of harm on patients.[Kazaryan 2013] Classification systems such as the Clavien-Dindo grading have emerged to help categorize harm, in this instance according to the level of subsequent treatment needed.[Clavien 2009] While harm often arises from error, harm can also occur in the absence of error (Figure 1-1).[Bosma 2011] For example, in surgery, while high rates of anastomotic leakage, wound infection and venous thromboembolism may indicate error and poor quality, these events may not be entirely mitigated and so there can be an ‘acceptable’ level of harm. In gastrointestinal surgery, although conversion and stoma formation may incur some level of harm to patients, they are often carefully considered and intended surgical decisions. In some circumstances, certain levels of harm may be accepted to achieve a clinical goal. Adjuvant axillary radiotherapy in breast surgery may be harmful as it often causes lymphoedema of the upper limb, however, it is still delivered to achieve 
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better long-term survival in breast cancer patients.[Das 2015] For the purposes of this investigation, harm will be defined according to the literature as an all-encompassing term for injury to patients resulting from medical intervention, whether intended or not.  Error: Error is defined as the failure of a planned action to be completed as intended or the use of a wrong plan to achieve an aim.[World Health Organization 2005] These may be cognitive (judgmental errors) or result from deviations from standard protocol (violations).[C. Vincent 1998] When assessing safety in healthcare, harm resulting from error should by definition be modifiable, allowing for the potential to reduce harm through understanding and prevention.[Nabhan 2012] There are also errors that lead to no harm (near misses). While great strides have been made in reducing near-misses in the aviation industry, in healthcare the current approach is to learn from errors that have lead to actual harm to prevent them from happening in the future.[Mattioli 2012]  Adverse events: Adverse events are defined as harm caused by error.[World Health Organization 2005] This term is most popular when describing human error in healthcare. There is growing recognition of the importance of preventing adverse events to improve safety in surgery.[The Royal College of Surgeons of England 2009] Adverse events related to healthcare intervention have been shown to affect up to 25% of hospitalized patients.[Landrigan 2010] Recent publicity of unsafe practice has reiterated the importance of detecting and preventing hospital adverse events, placing the safety agenda to the forefront of service and research initiatives.[Francis 2010] Considerable resources have been invested in monitoring and reducing the rates of adverse events.[Hall 2009] Delivering good quality care by reducing the rates of adverse events has been shown to be cost effective in the United States (US). Actively monitoring safety in detail seems to reduce adverse events in some circumstances.[Chassin 1996] Despite this, adverse events are underestimated and there has been little reduction in overall rates over recent years.[Landrigan 2010] This may be due to the difficulty in gaining a comprehensive picture of all types of adverse events that can influence patients in the surgical setting.  
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  Figure 1-1. Overlap between harm and error to delineate different types of safety events  
 
Why measure harm?  
‘We can only be sure to improve what we can actually measure’ 
 
        [Darzi 2008]    With increasing complexity of medical treatments and growing emphasis on safety, there is a need to monitor harm more accurately to guide effective investment in quality improvement. This requires population-level data. A national prospective quality-dedicated registry, the American College of Surgeons National Surgical Quality Improvement Project (NSQIP) in the US measures short-term adverse events in general and vascular surgery. These include anastomotic leakage, prolonged postoperative ileus, superficial and deep surgical site infection (SSI), pneumonia, unplanned intubation, venous thromboembolism, renal failure, urinary tract infection, stroke, peripheral nerve injury, myocardial infarction, haemorrhage, sepsis and shock, unplanned reoperation and unplanned readmission. In the 
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United Kingdom (UK), most data on safety and quality have come from the Hospital Episodes Statistics (HES).  In surgery, great strides have been made to reduce perioperative mortality. Although the focus has often been rightly placed on avoidable death, most patients who come to harm following surgical intervention do not die in the perioperative period. Softer indicators of harm can affect a greater number of patients and may be more useful indicators of quality than survival.[Landrigan 2010] In this light, further work is needed to capture all types of harm in the UK. Such knowledge may facilitate the development of strategies to improve quality on a national scale.  The direct impact of harm is difficult to quantify in patients who do not die. Some studies have used quality of life (QOL) as an alternative endpoint to mortality when evaluating outcome from surgery. QOL is one domain of health status that can be measured using questionnaires. The literature exploring change in QOL associated with harm will be worthy of evaluation to develop a utility for measuring levels of harm in patients. Better understanding of how harm interacts with health status will justify the proposed population-level analysis of surgical outcome.  
Systematic review of how surgical harm and affects quality of life  
Background  Quality of healthcare is increasingly judged by how better health status can be achieved.[Chow 2009] Although the advantages of new treatments in achieving better QOL postoperatively are extensively reported, negative results are less frequently discussed. Nevertheless, QOL scores are increasingly incorporated into cost-utility analyses of surgical outcome.[Park 2012]  To study the impact of surgical outcome on QOL, it would be important to understand the methods used to evaluate QOL. QOL is defined as an individual’s perception of their position in life in the context of the culture and value systems in which they live and in relation to 
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their goals, expectations, standards and concerns.[World Health Organization 1997] It is therefore a very broad concept dependent on the patient’s physical, psychological and social status, as well as their environment. Health-related QOL is the aspect of QOL that affects physical or mental health, which is increasingly recognized as an important and measurable health outcome.[Centers for Disease Control and Prevention 2000] However, health-related QOL models differ in what they measure, making it challenging to aggregate data and influence policy.[Bakas 2012] Methods of assessing QOL using questionnaires are broadly categorized into disease-specific and generic instruments according to what they have been designed to capture.   This literature review will explore whether QOL is a surrogate for severity of harm, which can reflect the significance of the impact on patients’ lives. In addition to physical function, QOL questionnaires often assess symptoms and mental status. All of these factors are important domains of long-term health status that may be markers of harm. The impact of adverse events on QOL has not previously been reviewed across subspecialty procedures. Synthesis of the evidence may help quantify the relationship between adverse events and health status represented by well-being. This may determine the economic and societal burden of harm through calculation of quality adjusted life years (QALYs). QOL scores can be used to quantify the burden of individual adverse events on patients. Adverse events that are significantly correlated with changes in QOL should be the focus of initiatives to reduce harm and improve quality and safety in surgery.   
Aim To evaluate studies that report on the association between adverse events and QOL in gastrointestinal surgery.  
Methods A systematic literature review of studies that report on QOL scores following gastrointestinal surgery was performed to compare QOL scores between patients who have and have not suffered adverse events. The primary outcome measure was the difference in 
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QOL scores between patients who suffered adverse events and those who did not. For the purpose of the proposed investigation, the term surgical adverse events (SAEs) will be used to encompass all types of short-term surgical harm akin to error. Literature search: The research protocol was registered (National Institute for Health Research, University of York, www.crd.york.ac.uk/prospero, CRD42013003888). The study was conducted in accordance with the guidelines for the ‘Preferred Reporting Items for Systematic reviews and Meta-Analyses’.[Moher 2010] A literature search was performed using MEDLINE (1946 to date), EMBASE (1947 to date) and the Cochrane Database of Systematic reviews by combining MESH and all-field search terms for (quality of life) AND (surgical procedure) AND (adverse event). The full texts of original articles and relevant reviews were obtained. Reference lists from included articles were hand searched for other possible data. Corresponding authors were consulted on their views on study design and other sources of data by e-mail. The grey literature was searched using Google. The search terms used for the main search conducted on Ovid® (Wolters Kluwer Health) search engine are presented in Table 1-1.    
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Quality of Life/ OR Health-Related Quality of Life/ 
AND 
cholecystectomy/ OR cholecystitis/su OR pancreatectomy/ OR pancreas resection/ OR pancreas/su 
OR pancreas neoplasms/su OR hepatectomy/ OR liver resection/ OR liver/su OR liver neoplasms/su 
OR oesophagectomy/ OR esophagus resection/ OR esophagus/su OR esophagus neoplasms/su OR 
total gastrectomy/ OR gastrectomy/ OR gastric resection/ OR stomach neoplasms/su OR 
colectomy/ OR proctectomy/ OR proctocolectomy/ OR rectum surgery/ OR colon surgery/ OR 
colorectal neoplasms/su OR colonic neoplasms/su OR rectal neoplasms/su OR colon 
diverticulosis/su OR laparotomy/ OR laparoscopy/ OR inguinal hernia/su OR incisional hernia/su OR 
antireflux surgery/ OR fundoplication/ OR hiatus hernia/su OR esophageal achalasia/su OR gastric 
bypass/ OR obesity surgery/ OR ulcerative colitis/su OR crohn’s disease/su OR appendicectomy/ OR 
appendicitis/su OR anal canal/su OR digestive system surgical procedures/  
AND 
postoperative complications/ OR intraoperative complications/ OR morbidity/ OR adverse 
effects.af OR adverse events.af OR / intensive care unit/ OR reoperation/ OR second-look surgery/ 
OR harm.af OR safety incident.af OR patient safety/ 
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Study selection: Studies in gastrointestinal surgery were evaluated to identify both procedure-specific and universal SAEs encountered in ten separate gastrointestinal procedures. In accordance with the Clavien-Dindo classification of surgical complications (Table 1-2), evaluated SAEs were defined as any deviation from the normal postoperative course.[Clavien 2009] Articles using both generic and disease-specific QOL instruments were included. Only articles written in English language were selected for further review.  
 
Table 1-2. SAEs evaluated in the systematic review categorized according to the Clavien-Dindo 





Definition SAE Included in review  I  Any deviation from normal postoperative course without the need for intervention except for antiemetics, antipyretics, analgesics, diuretics, electrolytes, physiotherapy 
 Pain Nausea and vomiting Ileus Oedema 
 No 
 II  Any deviation from normal postoperative course requiring pharmacological intervention other than such allowed for grade I 
 Wound infection (requiring antibiotics) Venous thromboembolism Bleeding (requiring transfusion) 
 Yes 
 III  Any deviation from normal postoperative course requiring surgical, endoscopic or radiological intervention under anaesthesia 
 Anastomotic leakage Anastomotic stenosis Organ injury Obstruction Collection Reoperation  
 Yes 
 IV  Life-threatening deviation from normal postoperative course requiring organ support 
 Admission to ICU Respiratory failure Acute kidney injury Cardiac event Cerebrovascular event Systemic sepsis  
 Yes 
 V  Deviation from normal postoperative course leading to death  Death  No 
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SAEs that are natural sequelae of disease or surgery that were attributable to the patients’ underlying condition or incurred through treatment were excluded.[Nabhan 2012] SAEs defined purely based on postoperative symptoms were excluded due to complexities in assessing postoperative symptoms. For example, studies evaluating QOL changes in gastroesophageal reflux vary according to whether pH monitoring, contrast series, endoscopy or questionnaires were used for diagnosis, as well as whether patients with functional reflux were included in the analysis.[Irvine 2004] Symptoms are also often features assessed directly by QOL questionnaires and therefore to include them in the systematic review may skew the analysis. QOL and symptoms assessed by QOL questionnaires are important domains of health status worthy of measurement at population level. However, studies using symptom severity scores only (corresponding to Clavien-Dindo grade I) to assess QOL were not included for the literature review. Only studies using tools that evaluate overall well-being were included. Abstracts, conference articles, opinions and case studies were excluded from the review. Two trained reviewers independently selected potentially relevant articles by reviewing the titles of abstracts identified by the search engine. Articles were included if they reported on QOL scores following SAEs. Any discrepancies between the reviewers were referred to a third reviewer to make a final decision on inclusion of a particular study. When studies reported on the same cohort of patients, the most recent study with the longest follow-up length was evaluated.   Study quality assessment: The quality of the studies included in the systematic review was assessed using criteria adopted from the literature. A scoring system was devised based on two previous reviews of QOL studies. Nine items were adopted from Mols et al who reviewed ten studies assessing QOL in breast cancer survivors.[Mols 2005] Two of these items were also part of criteria set by Noyez et al who reviewed 29 studies that measured QOL following cardiac surgery.[Noyez 2011] Two further items were criteria set only by Noyez et al making a total of eleven items to assess study quality (Table 1-3). The sum of 
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positive responses to items derived a study quality score (range 0-11), the higher score representing higher study quality.   Table 1-3. Items scored for assessment of study quality adopted from Mols et al Noyez et al.  
 





Quality of life is compared between groups 
 
2 The point of follow-up is defined prospectively 
3 Response rates >75% 
4 Characteristics of non-responders given 
5 Validated quality of life instrument 
6 Mean values reported 
7 Consent or ethical approval is described 
8 Pre- and post-operative QOL measured  
 
9 Missing data imputation stated 
10 Accounts for confounding factors  
 
11 Selection criteria are formulated  Data collection and analysis: Data items collected included author, publication year, study design, study size, SAEs, QOL instruments, QOL components, response rates, follow-up, analytical methods and mean QOL scores in SAE and no-SAE groups. Reported QOL scores derived the mean difference in postoperative QOL between SAE and no-SAE groups for each type of SAE. Mean QOL scores from different studies were combined to calculate the average effect of SAEs on postoperative QOL. Different QOL instruments were scaled down to a common zero to one score before the scores were combined. For this, QOL scores in each study were divided by the maximum for the instrument used. Global QOL scores were 
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combined where numerical values were reported. If not, the averages of the reported component scores were used. Scores were combined irrespective of whether significant differences were demonstrated in a particular study. Physical and mental component scores were analyzed where data were available. Time trends were observed in studies that reported on postoperative QOL scores at multiple time points. 
Results Out of 3193 potentially relevant titles, 3065 were excluded following abstract review (Figure 1-2). Full texts were reviewed for the remaining 127 studies. Thirty studies were included in the final list of articles for further analysis.[Farouk 1998, Boerma 2001, Melton 2002, Voitk 2002, Anthony 2003, Delaney 2003, Matsushita 2004, Moore 2004, Avery 2006, Cense 2006, Constantinides 2006, Lim 2006, Boer 2007, Rea 2007, Sharma 2007, Bitzer 2008, Chessin 2008, Kasparek 2008, Parviainen 2008, Bloemen 2009, Scarpa 2009, Scarpa 2010, Katuchova 2011, Riss 2011, Derogar 2012, Kiely 2012, Mbah 2012, Mennigen 2012, Polese 2012, Kellokumpu 2013] The inter-rater agreement between reviewers for inclusion of studies was 90%.     
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Initial Search  EMBASE 1858 MEDLINE 1335 COCHRANE LIBRARY 0 
Full texts 127 
Articles selected by one or both reviewers 33 
Excluded by 3rd reviewer 1 
Final list 30 
Prospective studies 13 
Abstracts 3193 Conference abstracts    220 Not primary research (eg letters, comments) 794                     Not gastrointestinal surgery      984 Symptom score instead of QOL    277 No reporting of comparative groups  476 Not SAE by definition     315                    No data on SAE vs no SAE   80 Preoperative quality of life only   14            
3 articles from same cohort (2 excluded) 
Retrospective studies 17 
Lower GI surgery 5 
Upper GI surgery 8 
Lower GI surgery 11 Upper GI surgery 6 
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 Study quality: The mean study quality score for the 30 studies was six (range two to ten). Only one study scored two[Farouk 1998], two studies scored three[Melton 2002, Polese 2012], four studies scored four[Moore 2004, Chessin 2008, Kellokumpu 2013], five studies scored five [Constantinides 2006, Lim 2006, Praviainen 2008, Bloemen 2009, Mennigen 2012], seven studies scored six [Boerma 2001, Votik 2002, Kasparek 2008, Scarpa 2009, Katuchova 2011, Riss 2011, Kiely 2012],  five studies scored seven [Avery 2006, Boer 2007, Rea 2007, Derogar 2012, Mbah 2012], two studies scored eight [Matsushita 2004, Sharma 2007], three studies scored nine [Delaney 2003, Cense 2006, Bitzer 2008] and one study scored ten [Anthony 2003].  Study characteristics: Out of the 30 studies evaluated, 13 were prospective and 17 were retrospective studies. Prospective studies stated a set length of time after surgery when QOL was measured in each patient, and combined the effects of different types of SAEs together. Eight out of thirteen prospective studies measured both preoperative and postoperative QOL. The remaining five prospective studies measured postoperative QOL only. Most studies were retrospective. Retrospective studies measured postoperative QOL at a single time point (different follow-up for each patient), and addressed the impacts of rare SAEs such as common bile duct injury. The median follow-up for prospective and retrospective studies was 6 months (IQR 3-12) and 61 months (IQR 40-89) respectively. The average number of patients in each study was lower for prospective studies (140.6 patients) compared with retrospective studies (430.8 patients).  The most frequently used QOL instrument was the SF36 in nine studies.[Boerma 2001, Voitk 2002, Moore 2004, Constantinides 2006, Rea 2007, Bitzer 2008, Kasparek 2008, Polese 2012, Kellokumpu 2013] Generic instruments were used in twenty studies (SF36, SF12, EQ-D5, EQ-VAS, SF20, CGQL, City of Hope, 15D, KPS), disease-specific instruments in eleven studies (FACT-C, QLQ-C30, GIQLI, Stoma-QOL) and the type of QOL instrument was unspecified in one study. Two studies used both generic and disease-specific 
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instruments.[Sharma 2007, Katuchova 2011] The characteristics of the studies included in the systematic review are summarized in Table 1-4.  
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Table 1-4. Summary of studies selected in systematic review  






SAE QOL Components with  Response 
      QOL   (months)   (%) Instrument significant difference (%) 
Oesophagectomy Derogar Prospective No 153 60 All types 33 QLQ-C30 Dyspnoea, fatigue 92 
  Avery Prospective No 139 3 Within 30 days 27 QLQ-C30 P, R, S, G, F, N, P 86 
  Cense Prospective Yes 104 3 Prolonged ICU stay 17 SF20 PF 88 
Colorectal resection Sharma Prospective Yes 110 1.5 Within 30 days 39 FACT-C, EQ-5D FW 95 
  Anthony Prospective Yes 71 12 Within 30 days 27 FACT-C Total score 88 
  Riss Retrospective No 21 107 Anastomotic leak 7 SF12 None 76 
  Bloemen Retrospective No 170 36 Unspecified 27 QLQ-C30 PF 71 
  Lim Retrospective No 112 26 Anastomotic leak 17 QLQ-C30 Total score 83 
  Constantinides Retrospective No 203 68 Within 30 days 20 SF36 RP, BP, PF 88 
  Polese Retrospective No 198 58 Anastomotic stenosis 13 SF36 RP, RE, EW, SF, BP, GH 75 
Crohn's resection Delaney Retrospective Yes 82 1 Within 30 days 23 CGQL Total score 80 
  Scarpa Prospective No 47 3 Obstruction 6 CGQL  Total score - 
  Kasparek Retrospective No 132 41 All types 19 SF36 PF 75 
Gastric bypass Rea Prospective Yes 423 24 All types 22 SF36 RP, BP, GH, V, SF, MH 56 
Cholecystectomy Bitzer* Prospective Yes 205 6 All types 34 SF36 RP, BP 86 
  Melton Retrospective No 89 48 CBD injury - City of Hope PR 61 
  Moore Retrospective No 86 62 CBD injury - SF36 All 58 
  Boerma Retrospective No 89 70 CBD injury - SF36 All 92 
Emergency laparotomy Boer Prospective No 155 6 Within 6  months 26 EQ-VAS None 85 
Ileal pouch Mennigen Prospective No 130 12 Pelvic sepsis 9 GIQLI None 72 
  Chessin Retrospective No 817 102 Pelvic sepsis 16 CGQL None 46 
  Kiely Retrospective No 3224 84 Pelvic sepsis 5 CGQL Total score 86 
  Farouk Retrospective No 1508 72 Pelvic sepsis 5 Unspecified Domestic, recreation - 
  Scarpa Retrospective No 44 25 Parastomal hernia 7 Stoma-QOL Total score - 
Pancreatectomy Katuchova Prospective Yes 90 76 Within 30 days 21 KPS, QLQ-C30 None 72 
  Mbah Prospective Yes 90 6 All types 29 QLQ-C30 None 91 
  Pravainen Retrospective No 27 110 All types 36 15D None 93 
Antireflux Votik Retrospective No 90 60 All types 35 SF36 None 44 
  Kellokumpu Retrospective No 139 120 All types 25 SF36 PF, RF, P, GH, E 85 
Gastrectomy Matsushita Prospective Yes 111 6 All types 48 QLQ-C30 PF 89 
 
* Patient-reported outcome 
34  
Association between SAEs and QOL: Data were evaluated from a total of 8859 patients in thirty studies. In 14 studies, although statistically significant differences in QOL between SAE and no SAE groups were reported, no numerical values for the differences in mean QOL between the two groups were given.[Farouk 1998, Boerma 2001, Matsushita 2004, Constantinides 2006, Lim 2006, Sharma 2007, Bitzer 2008, Kasparek 2008, Parviainen 2008, Scarpa 2009, Scarpa 2010, Riss 2011, Mbah 2012, Kellokumpu 2013] Instead, results were either illustrated graphically,[Constantinides 2006, Lim 2006, Kasparek 2008, Kellokumpu 2013] summarized in words,[Farouk 1998, Matsushita 2004, Bitzer 2008, Parviainen 2008, Mbah 2012] reported as medians,[Boerma 2001, Riss 2011] or only the odds ratio were presented.[Sharma 2007, Scarpa 2009, Scarpa 2010] In one study, although the difference in mean QOL was reported, QOL scores in each group were not given.[Derogar 2012]  Multiple studies demonstrated significant negative associations between SAEs and QOL in colorectal resection, oesophagectomy, Crohn’s resection and cholecystectomy. Patients undergoing Crohn’s resection and oesophagectomy had the worse QOL scores even without SAEs. A single study showed significant negative QOL change associated with SAEs in gastric bypass. Studies evaluating ileal pouch formation and anti-reflux surgery showed conflicting results. SAEs were not associated with QOL change in emergency laparotomy and pancreatectomy. Out of the studies that reported on component scores, only the physical components significantly decreased in six studies,[Anthony 2003, Moore 2004, Avery 2006, Cense 2006, Bloemen 2009, Kellokumpu 2013] and only the mental component in one study.[Melton 2002] Both physical and mental components significantly decreased in two studies.[Rea 2007, Polese 2012] Multivariate analysis was performed in 16 studies.[Boerma 2001, Anthony 2003, Delaney 2003, Matsushita 2004, Moore 2004, Avery 2006, Boer 2007, Rea 2007, Sharma 2007, Bitzer 2008, Bloemen 2009, Scarpa 2009, Scarpa 2010, Derogar 2012, Kiely 2012, Polese 2012]  
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QOL in SAE 
group 
QOL in no 
SAE group 
Mean Difference 
SAE vs no SAE 
Morbidity 
(%) 
Number of Studies 
QOL Instrument 
  Significant 
Not 
significant 
Oesophagectomy ICU admission 0.220 0.430 0.210 17.0 1 0 SF20 
Colorectal resection Anastomotic stenosis 0.700 0.875 0.175 13.0 1 0 SF36 
Oesophagectomy All types 0.41.4 0.554 0.140 30.0 2 0 QLQ-C30 
Crohn's resection All types 0.030 0.140 0.110 21.0 2 0 CGQL, SF36 
Colorectal resection All types 0.672 0.761 0.089 28.3 4 0 FACT-C, QLQ-C30, SF36 
Gastric bypass All types 0.450 0.535 0.085 22.0 1 0 SF36 
Cholecystectomy Common bile duct injury 0.578 0.650 0.073 - 3 0 SF36, City of Hope 
Emergency laparotomy All types - - 0.064 26.0 0 1 EQ-VAS 
Ileal pouch Pelvic sepsis 0.732 0.782 0.050 8.8 2 2 CGQL, GIQLI 
Pancreatectomy All types 0.920 0.940 0.020 28.7 0 3 QLQ-C30, KPS 
Anti-reflux surgery All types 0.570 0.580 0.010 30.0 1 1 SF36 
 
FACT-C adjusted from 0-136 
GIQLI adjusted from 0-144 
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Change in QOL Over Time: Seven studies examined postoperative QOL at multiple time points (Table 1-5).[Matsushita 2004, Cense 2006, Rea 2007, Bitzer 2008, Derogar 2012, Kiely 2012, Mbah 2012] All except one study demonstrated significant associations with SAEs at one or more time points.[Mbah 2012] One study combined QOL scores from different time points together to derive the mean postoperative QOL.[Kiely 2012] Two studies demonstrated a significant difference in QOL between groups but did not perform longitudinal analysis of QOL scores.[Rea 2007, Bitzer 2008] Three studies evaluated time interactions of change in QOL during follow-up.[Matsushita 2004, Cense 2006, Derogar 2012] These studies singled out QOL components with significant group-time interactions including decline in physical functioning three months after prolonged ICU stay after oesophagectomy, increased sleeping difficulties five years after SAEs in oesophagectomy, and decreased physical functioning six months after SAEs in gastrectomy. Time trends were also observed when separate studies used the same QOL instrument to scrutinize the effects of SAEs. Two studies in laparoscopic cholecystectomy fulfilled this criterion.[Boerma 2001, Moore 2004] They confirmed that the impact of common bile duct injury was prolonged and persistent (0.229 at 62 months and 0.276 at 70 months), and that the proportional changes in physical and mental component scores were similar in the two studies. This analysis was not possible in other procedures due to heterogeneity of QOL instruments used and differences in the way follow-up data were aggregated in different studies.  
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Oesophagectomy Cense Physical function 0, 1, 3*, 6, 9, 12, 18, 24, 30, 36 -0.12, 0.09, 0.21*, 0.16, -0.07, -0.11, 0.02, 0.05, 0.10, -0.02  Yes 
Oesophagectomy Derogar Sleep difficulty 6, 36, 60* 0.03, 0.06, 0.15* Yes 
Cholecystectomy Bitzer Role physical, bodily pain 0, 0.5, 6* - No 
Gastric bypass Rea Total score 12, 24* 0.02, 0.07* No 
Ileal pouch Kiely Total score 3, 12, 36, 60, 120 0.05* (all time points together) No 
Gastrectomy Matsushita Physical function 0, 1, 6* - Yes 
Pancreatectomy Mbah Total score 0. 1.5, 3, 6 - No 





*p<0.05   
38  
Discussion This review demonstrated significantly negative associations between SAEs and QOL in a range of gastrointestinal surgical procedures. The impact on QOL was significant for many of the SAEs evaluated, and ranged between 0.01 and 0.21 (Table 1-5). In some circumstances, suffering an SAE meant that patients only achieved a QOL score of 20% compared with those without SAE. Surgical harm was therefore significantly correlated with patients’ well-being. The SAEs identified in this literature review are important determinants of health status and worthy of measurement in clinical trials and population-level analyses.   Short-term harm incurred through SAEs was associated with poor longer-term QOL. In one of the studies, patients undergoing oesophagectomy experienced sleep disturbance at five years after surgery.[Derogar 2012] This means that long-term health status is significantly correlated with perioperative errors. These data suggest that QOL may be an important utility to evaluate the economic and societal burden of SAEs. Such measures may help define the threshold for safe surgical practice. Limitations of this review included the potential for publication bias excluding QOL studies that did not demonstrate a QOL change. Furthermore, there was heterogeneity of analytical methods described in evaluated studies. Similar to other reviews of QOL studies, it was found that study design, QOL instruments used, length of follow-up, recording of preoperative QOL score and methods for statistical analysis were variable.[Mols 2005, Angriman 2010, Noyez 2011] These findings suggest that further work is necessary to improve the standard of research in this area, and achieve uniformity on analytical methods and QOL questionnaires used for assessing the changes related to the occurrence of adverse events.   In the evaluated studies, the physical component of QOL was significantly affected in eight out of the nine studies that reported on component scores. However, a third of these studies also reported significant impact on mental component scores.[Melton 
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2002, Rea 2007, Polese 2012] Significant psychological stress is therefore associated with SAEs, and may be an important aspect of long-term outcome.  The literature suggests that QOL analysis often incorporates postoperative symptoms as determinants of health status. In gastrointestinal surgery, symptoms related to organ function may determine the long-term efficacy of surgical procedures. However, postoperative symptoms are rarely reported on a population-wide scale.  Understanding how health status is evaluated in patients undergoing gastrointestinal surgery has been essential for the development of this thesis. While demonstrating insights into how harm affects QOL, this systematic review has also summarised the methods used to measure QOL in patients undergoing gastrointestinal surgery. Overall, QOL was evaluated in many different ways. The short-form 36 (SF36) was the most commonly used QOL instrument, and often used where disease-specific instruments were lacking. As this questionnaire has been extensively validated at population level, it suitable for the comparison of QOL scores across procedures. The SF36 demonstrated that bariatric surgery was associated with poor QOL before and after surgery compared to colorectal surgery, where SAEs had a greater impact on QOL (Table 1-5). While generic instruments such as the SF36 are most likely to identify an unexpected disease impact, they may not be sensitive enough to quantify clinically important change in function.[Borgaonkar 2000] It is therefore generally considered to be of value to include both generic and disease-specific assessments in studies of QOL.  The most commonly used disease-specific instrument was the cancer specific QLQ C-30, which was first developed in 1988 and is a core generic questionnaire associated with different disease specific modules. This instrument has been translated to 81 languages and used in over 3000 studies worldwide.[European Organization for Research and Treatment of Cancer 2014] Studies have validated outcome using QLQ-C30 through comparison with the SF36.[Apolone 1998] Both of these instruments measure QOL as well as other domains of health status such as symptoms and disability. The SF36 
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consists of eight domains of health status of which two measure QOL (well-being), two measure symptoms (pain and fatigue), two measure impairment and two measure disability (role limitation).[Ware 1992]  The QLQ-C30 consists of 15 domains including five measures of function, nine symptoms and one measure of well-being.[European Organization for Research and Treatment of Cancer 2014] In addition to health status determined by physical well-being, psychological or mental well-being accounts for two of the domains in both SF36 and QLQ-C30. Mental QOL can be influenced by factors such as psychiatric illness as well as functional and role limitations due to emotional problems. This systematic review has identified that mental well-being is an important component of health status, which deserves further exploration in this thesis.  Overall, this systematic review identified that surgical harm manifesting as adverse events was significantly associated with QOL. This justifies the proposed exploration of using linked national databases to evaluate surgical harm and its interactions with health status. The literature also suggests that parameters of longer-term health status including impairment, disability and symptoms are closely related to physical and mental well-being, and are worthy of further assessment in surgical patients. .      
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2. CHAPTER TWO – PROPOSED RESEARCH 
Introduction 
Increasing public awareness of unsafe practice has meant that there is growing emphasis on patient safety and monitoring levels of harm within healthcare systems.[Kohn 2000, Francis 2010] Outside of prospective studies, population-level information on the quality of healthcare delivery is captured in databases, aggregated centrally, and made available for use by researchers and those evaluating services. In England, the NHS Health and Social Care Information Centre (HSCIC) offers a combination of routinely collected information such as hospital administrative data and patient reported outcome linked to population statistics derived from Census data. While many of these databases comprise of routinely collected information, there are other healthcare databases such as incident reporting systems that have no pre-defined variables as they contain qualitative data.  This chapter will provide an overview of the methods by which harm can be measured within healthcare systems. By reviewing the literature, previous large-scale evaluations of adverse events in surgery will be described, and the advantages of using certain types of data presented. This will help chose the appropriate resources for the proposed exploration of harm data in gastrointestinal surgery. By doing so, the rationale for the proposed research, as well as the aims and objectives to address the hypothesis will be discussed.   
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Methods of identifying harm  
Previously described methods of identifying harm are considered in descending order of granularity and ascending order of population coverage (Table 2-1).   
Table 2-1. Methods of identifying surgical harm 





Global Trigger Tool (US) 
Institute of Healthcare 
Improvement 
Qualitative No Yes 
Avoidable mortality tool 
(UK) 
London school of hygiene and 
tropical medicine 
Qualitative No Yes 
Incident 
reporting 
National Reporting and 
Learning System (UK) 
The National Patient Safety 
Agency 
Qualitative No Yes 
Confidential Reporting 
System for Surgery (UK) 
Royal College of Surgeons of 
England 
Qualitative No Yes 
Strategic Executive 
Information System (UK) 
The National Patient Safety 
Agency 
Qualitative No Yes 
Central Alerting System 
(UK) 
Medicines and Healthcare 
Products Regulatory Agency 




Patient Reported Outcome 
Measures (UK) 
Health and Social Care 
Information Centre 
Quantitative Yes No 
National Bowel Cancer 
Audit Programme (UK) 
Association of Coloproctology 
of Great Britain and Ireland 
Quantitative Yes No 
National Oesophagogastric 
Cancer Audit (UK) 
Royal College of Surgeons of 
England 
Quantitative  Yes No 
National Bariatric Surgery 
Registry (UK) 
The British Obesity and 
Metabolic Surgery Society 
Quantitative Yes No 
National Cancer Registry 
Database (UK) 
The National Cancer 
Intelligence Network 
Quantitative Yes No 
The National Surgical 
Quality Improvement 
Program (US) 
The American College of 
Surgeons 




Insurance databases (US) 
Medicare, Medicaid and 
Veterans Association 
Quantitative Yes No 
Hospital Episodes Statistics 
(UK) 
Health and Social Care 
Information Centre 





Egerton Medical Information 
System 
Quantitative Yes No 
Clinical Practice Research 
Datalink (UK) 
Medicines and Healthcare 
Products Regulatory Agency 
Quantitative Yes No 
Population 
statistics 
Death certificate data (UK) Office of National Statistics Quantitative Yes No 
 




Case notes review Performed by clinicians or trained non-clinical staff, these methods are currently the gold standard for root-cause analysis. Holistic (implicit) and criterion-based (explicit) methods exist.[Hutchinson 2010] The Global Trigger Tool developed by the Institute for Healthcare Improvement is an example of an explicit method that has led to the detection of a higher number of adverse events than previously thought.[Classen 2011] Implicit methods have previously been used for detailed analyses of adult preventable deaths in England.[Hogan 2012] Studies have shown that about half of adverse events related to hospital care are preventable.[C. Vincent 2001] However, case notes review is costly and time-consuming, so it is not a suitable tool for population-level analyses.[C. Vincent 2001] Due to the depth of analysis that can be undertaken, this method of evaluating safety is increasingly recognized as an important aspect of service evaluation. The ‘Saving 1000 Lives Campaign’ in Wales has previously utilized implicit methods of case notes review on a large scale as part of an initiative to improve patient safety.[NHS Wales 2010]  
Incident reporting The World Health Organisation acknowledges the role of incident reporting in improving patient safety.[WHO 2005] The National Reporting and Learning System (NRLS) in the UK, is the largest database of incident reports in any system and reporting rates have steadily increased over time since data collection began in January 2003.[C. A. Vincent 2006, Hutchinson 2009] Over 10 million incidents have been stored on the NRLS database since 2005.[The National Patient Safety Agency 2006] Incident reporting systems are unique in that they draw information on adverse events from reports submitted by healthcare professionals, paralleling methods used in the airline industry. Although individual reports offer information from the reporter’s perspective in detail, the number of adverse events detected per hospital is small compared to other methods.[Sari 2007] In addition to all-purpose reporting systems such as the NRLS, 
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specialty-specific reporting systems also exist. An example is the Confidential Reporting System for Surgery, which gives more detailed technical information on SAEs as case-reports that help inform targeted audiences.[Royal College of Surgeons of England 2012] The reporting of serious incidents otherwise known as ‘never events’ has become mandatory since 2009, and records are stored in the Strategic Executive Information System database.[National Patient Safety Agency 2010] The Medicines and Healthcare products Regulatory Agency (MHRA) regularly feeds drug and device alerts to the Central Alerting System, which sends out national alerts online. Incident reporting tools promote learning and feedback, while offering detail and insight into types of harm not captured in other databases.[Wallace 2009] While incident reporting improves learning at local level,[Howell 2013] it is not a reliable way of quantifying harm, nor is there any evidence in its value as a measure of quality of care due to lack of validation through linkage with other datasets or case-notes.[Hutchinson 2009] Incident reporting data are not considered as routine due to its free-text nature meaning that variables have not been pre-defined.[Effective Healthcare Program 2014]  
Clinical registries Registries require prospective data entry into dedicated specialty-specific databases.[Polygenis 2013] Databases are often maintained through collaboration with academic societies. A previous Health Technology Assessment identified that clinical and disease-specific registries account for over half of all healthcare databases that can help evaluate quality.[Raftery 2005] Examples include the National Bowel Cancer Audit Programme, the Inflammatory Bowel Disease Registry, the National Oesophagogastric Cancer Audit, the National Bariatric Surgery Registry and the National Cancer Intelligence Network (NCIN). An example from the US is the Surveillance, Epidemiology and End Results Program for cancer registry data. In most registries, although headline figures from consolidation of registry data are available in the public domain, the raw patient-level data are not widely available for research and service evaluation. Overall, 
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clinical registries have detailed information for disease-specific groups but are associated with high running costs. NSQIP is a dedicated prospective registry designed to measure surgical quality. It has collected data on over 250 variables including risk factors and SAEs since October 2002. NSQIP data have been used to demonstrate improving trends in rates of SAEs in participating hospitals.[Hall 2009] NSQIP hospitals have reported reductions of up to 50 complications per hospital per year, translating to significant financial gains. It costs $35000 per hospital per hospital per year to be part of NSQIP. It is therefore more expensive than other resources such as those derived from routine data.[Raftery 2005] Although the number of enrolled hospitals has increased to 374 in 2012, this represents a fraction (10-20%) of surgical patients in the US. It is therefore a sampling technique and doesn’t offer population-wide coverage. It also doesn’t cover all general and vascular surgical procedures. Follow-up in NSQIP is limited to 30days after surgery, so it cannot address long-term impact of surgery on health status.  Patient-reported outcome is another type of prospective registry. Quality of healthcare is increasingly framed by patient reported outcome including QOL.[Chow 2009] This allows for the assessment of health status and patient satisfaction. The Patient Reported Outcome Measures (PROMS) database in England uses patient surveys to record outcome from the patients’ perspective including QOL at three months after surgery using the EQD5 method. Currently, data are available for inguinal hernia repair, varicose veins surgery, total hip replacement and total knee replacement.[Neuburger 2013] This database started in April 2009 and is routinely linked to hospital administrative data in England.[HSCIC 2014] QOL is therefore assessed on an unprecedented large scale. 
Hospital administrative data Hospital databases offer the greatest population coverage to allow for evaluation of harm on a large scale. A previous study found hospital administrative databases to be more cost-effective than clinical registries when evaluating outcome on a large scale.[Raftery 
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2005] Healthcare insurance data in the US is offered by organisations such as Medicare, Medicaid and the Veterans Administration, who hold large administrative datasets that have been used for population-level analyses of outcome. Other administrative databases such as the California Patient Discharge Data also exist.[White 2004] Some initiatives such as the Healthcare Cost and Utilization Project combine information from multiple administrative databases to allow for comprehensive valuation of healthcare.[Bernard 2005] In these databases, clinical diagnoses are recorded using the International Classification of Diseases (ICD). While administrative data in the US use ICD version 9 (ICD-9 CM), HES uses ICD version 10 (ICD-10) and has done so since 1987. Additionally, operative coding systems allow for the precise evaluation of type and timing of surgical procedures. For this, a clinical modification of ICD-9 CM is used in the US whereas the Classification of Interventions and Procedures from the Office of Population Census and Surveys (OPCS) is used in the UK. There have been several iterations of OPCS. The current version is OPCS version 4.6. In surgery, routine hospital data have helped derive observed-to-expected ratios and failure-to-rescue rates to compare performance between hospitals.[Silber 2010, Ghaferi 2011] In addition, the Agency of Healthcare Research and Quality (AHRQ) have developed several quality indicators to assess outcome and safety in the US.[McDonald 2002] In England, HES data have been recorded since April 1987.[Appleby 2012] This database contains data inputted by clinical coders reviewing case notes of hospitalized patients upon discharge. This has allowed for the demonstration of variation in rates of mortality amongst hospitals in England.[Aylin 2013] One study found that SAEs affect up to 5% of patients undergoing, oesophagogastric cancer resection using this database.[Almoudaris 2011] Using HES reoperation has emerged as a process measure serving as a surrogate for SAEs affecting 6.5% of patients undergoing colorectal surgery.[EM Burns 2011] Medical comorbidity has been found to affect a third of elderly patients within one year of colorectal surgery.[Mamidanna 2012] AHRQ patient safety indicators (PSIs) have been translated 
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into ICD10 and OPCS codes for HES,[Raleigh 2008, Bottle 2009].  While the accuracy of coding for PSIs has been validated in the US, no validation study has been undertaken in the UK for these specific indicators.[Rosen 2012, Tsang 2012]   
Population statistics Population statistics collected nationally are considered to be routinely collected data that may be relevant to healthcare. Death certificate data from population statistics can offer information on date and cause of death. Some SAEs may be recorded through diagnostic coding using the ICD-10 system as cause of death. In the UK, the Office for National Statistics (ONS) has collected details of death, together with birth and marriage information from local registry offices since 1837. These data have been previously used to validate both in-hospital and out-of-hospital deaths recorded in other healthcare databases.[Mamidanna 2012] Such information is essential when evaluating the impact of SAEs and processes on mortality at population level. Mortality is best assessed using linked ONS data to identify deaths occurring outside of hospital.[Slavin 2012] In addition to information on death, population statistics are used to derive socioeconomic data according to geographical information derived from the Census survey in the UK.[Smallwood 2011]  
Primary care electronic health records Another source of routine data in the UK is primary care electronic health records. A recent literature review concluded that primary care databases are an important source of information for evaluating patient safety.[Tsang 2012] Overall, 98% of General Practitioners (GPs) use electronic medical records in the UK.[Bates 2003] Several software systems are used to record clinical and other data, which are uploaded onto different databases specified by the system in use. The Read clinical coding system, a dedicated coding system for primary care developed in the 1980s by Dr James Read has superseded the OXMIS (Oxford Medical Information System), which was originally developed in the 1970s by translating ICD version 8.[Preece 1971, Read 1986] Read 
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coding is now widely accepted as the standard nomenclature for clinical coding in primary care, and a predecessor to the new internationally unified coding system SNOMED CT, developed by the International Health Terminology Standards Development Organisation. [IHTSDO 2014] Out of the electronic medical record systems available in primary care, the Egerton Medical Information System® (EMIS) has over half of the market share and supports the largest primary care database called Q-Research® covering about 50% of the UK population.[EMIS Group 2013] Other databases include The Health Improvement Network (CSD Research®, INPS software®), Secure Anonymised Information Linkage System (Welsh National Institute for Social Care and Health Research) and the Clinical Practice Research Datalink (CPRD, Vision software system®), all of which have a smaller market share. CPRD, formally known as the General Practice Research Database (GPRD), is the oldest database of primary care electronic health records in the UK having been first introduced in 1987.[Tyrer 1996] Although it covers a smaller percentage of the UK population (currently 8%, 4.4 million active patients) than EMIS, it has generated the highest number of peer-review publications out of any of the primary care databases in the UK.[Y. C. Chen 2011] One review found that 749 studies were published between 1995 and 2009 from either CPRD or GPRD.[Y. C. Chen 2011] Important clinical insights have been gained using these resources. These data have previously been used to demonstrate the correlation between proton pump inhibitor use and community-acquired Clostridium difficile infection.[Dial 2005] CPRD has the added advantage of having the highest number of patients linked to HES making it a useful platform to evaluate patient care across integrated health systems. Comparison of CPRD to UK Census data has previously shown that CPRD is geographically representative of the UK population in terms of patient demographics and death rates.[Campbell J 2013]  Most research using CPRD has been in pharmacoepidemiology, but studies evaluating clinical harm are emerging.[Bodmer 2009, Bolland 2011, Huerta 2011, Humes 2011, 
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Khan 2011] A recent study showed that wound infection and postoperative pain are frequently coded in primary care data.[Tsang 2010, Tsang 2013] Primary care data have previously been used to determine the rate of venous thromboembolism (VTE) related to hospital treatment.[Walker 2013, Walker 2014] In addition to diagnoses coding for SAEs, primary care data contain information on comorbidity, body mass index (BMI) and prescriptions making this databases well-suited for the purposes of preoperative risk assessment.[Khan 2010, H. P. Booth 2013] Studies have used these data to demonstrate a significant proportion of VTE recorded in primary care following hospitalisation in pregnant women and in patients with colorectal cancer.[Abdul Sultan 2013, Walker 2014] In these studies, linkage of data to hospital records and the longitudinal nature of the recorded data meant that it was possible to demonstrate that VTE risk was increased for longer after hospitalisation than previously thought. Whether primary care data can help identify other SAEs that manifest after the patient has been discharged from hospital has not been previously explored. This may allow for the quantification of overall rates of SAEs in UK patients by combining information from hospital and primary care data.  
Population-level analysis of surgical outcome using routine data 
Population-level data offer large numbers of patients for evaluation of healthcare. Early reports of outcome date back to Florence Nightingale’s accounts of the dangers of London hospitals based on mortality statistics in 1861.[Nightingale 1863] It is not until the 1980s that data from insurance companies in the US helped reveal meaningful insights into variations in quality of care.[Cromwell 1987] Greater emphasis on achieving high standards have encouraged an expansion in the number of indicators that may help identify poor quality.[Darzi 2008] Demand for granularity has also been driven by growing emphasis on improving hospital safety.[Kohn 2000] This has lead to an 
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abundance of metrics in multiple data sources making service evaluation more challenging than ever before. Amongst the different ways of evaluating quality, routinely collected population-level data offer the highest numbers of patients. Routine databases are considered as those that have continuous data collection of defined variables with aggregation at national or regional levels, and use standardized definitions for covariates for the population covered.[Effective Healthcare Program 2014] They allow for large-scale statistical analyses of variations in institutional outcome. The term ‘routine data’ is commonly used in Europe, while ‘administrative data’ is used in the US, which includes data collected for a primary purpose other than research such as health insurance. Insurance databases helped develop the concept of risk-adjusted outcome.[Iezzoni 1997] The AHRQ have used these data to broadly classify quality indicators for prevention (14 items), inpatient care (34 items), patient safety (18 items) and pediatrics (20 items).[Agency for Health and Research Quality 2013] Importantly, most quality indicators are those that are associated with negative effects on patients, reflecting the emphasis on the need to prevent harm to maintain high standards (Table 2-2).  Disease or procedure-specific clinical registries are designed for the primary purpose of audit. Other examples of routine databases that may reflect healthcare include primary care electronic health records, prescription data and population statistics including socioeconomic area and death registries. There is a wide range of routine databases that may offer insight into quality. One review in the UK identified 270 different routine datasets that could be evaluated.[Raftery 2005] Although some of these databases have been criticised for their lack of clinical information relevant for quality assessment, the abundance of metrics forms a rich pool of information from which research and service questions could be answered.[Smeets 2011] Since the emergence of multiple indicators of poor outcome, composite measures have been shown to better reflect institutional variation than individual indicators.[Werner 2006, Almoudaris 2013] There are also 
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increasing accounts of pooling of multiple resources together to gain a complete picture such as the Healthcare Cost and utilisation project in the US, which combines different types of insurance data, and the Clinical Practice Research Datalink (CPRD) in the UK, which combines primary and secondary care databases as well as population statistics and clinical registries. Data synthesis represents the future of increasingly complex evaluations of quality scrutinised by service providers, purchasers and users.  
  
Table 2-2. AHRQ quality indicators relevant to adult general surgery [Agency for Health and 
Research Quality 2013] 
Prevention In-patient Safety 
   
Perforated appendicitis Oesophageal resection volume Retained surgical item 
Pancreatic resection volume Perioperative haemorrhage 
 
Oesophageal resection mortality Postoperative physiological derangement 
 
Pancreatic resection mortality Postoperative respiratory failure 
 
Proportion of laparoscopic cholecystectomy Postoperative venous thromboembolism 
 
Incidental appendicectomy in elderly Postoperative sepsis 
  
Postoperative wound dehiscence 
  
Accidental puncture or laceration     
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In surgery, hospital administrative data have demonstrated institutional variations in morbidity and mortality in the US.[Birkmeyer 2001, Dimick 2013] This has lead to the recognition of quality indicators such as reoperation and failure-to-rescue that may better reflect variations in performance.[Merkow 2009, Ghaferi 2011] The demand for a more targeted approach has lead to the emergence of a quality-specific prospective registry in general and vascular surgery. NSQIP records SAEs related to surgery as primary endpoints to help identify under-performing hospitals.[Hall 2009]  HES uses discharge coding for the entire population of England to inform national ‘payment-by-results’ tariffs. This database was recently used to measure mortality according to day of week, leading to proposals for increasing services over weekends.[Aylin 2013, Hunt 2015] Outcome has been reported in most surgical specialties including general, gastrointestinal, urological, vascular, breast and orthopedic surgery.[Nuttall 2005, EM Burns 2011, Johal 2012, Almoudaris 2013, El-Dhuwaib 2013, Jameson 2013, Neuburger 2013] Aggregate outcome data from HES is available in the public domain at the Health and Social Care Information Centre (HSCIC) website. The use of routine data for healthcare evaluation is not limited to hospitals. The UK has one of the largest numbers of primary care electronic medical records in the world.[Majeed 2004] This has lead to initiatives such as Care.Data programme that have sought to drive the integration of healthcare data within the English National health Service (NHS).[NHS England 2014] Care.Data was not implemented successfully due to public perception of dangers related to confidentiality within a government-lead initiative.[Crooks 2012, McEwan 2015]  Consequently, there is currently a lack of research-quality data to evaluate clinical processes across integrated health systems. Some studies have closed this gap. For example, outcome in surgical patients have previously been evaluated using primary care data.[Humes 2013, Walker 2014] In this context, measures of comorbidity have also been described, which may help assess 
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surgical risk.[Khan 2010, T. Williams 2012] Whether primary care data can help evaluate surgical risk using these parameters has not previously been studied.   While routine data have helped evaluate surgical outcome, using this information to improve quality remains a challenge. Further developments in data synthesis, clinical relevance of recorded information and comprehensiveness are likely to stimulate data-driven approaches to improving quality in surgery.   
Database linkage as a platform for quality research 
Due to the abundance of healthcare data available, linked database analysis has come to the forefront of clinical and basic scientific research. The idea of record linkage from multiple sources of information dates back to 1969 when two mathematicians proved that the probabilistic decision-making was optimal when the comparison attributes were conditionally independent.[Fellegi I 1969] The use of existing databases is recommended to avoid the cost of developing new databases.[Raftery 2005] Examples from bio-banks and health informatics have lead the way in linking clinical and tissue information from multiple resources to gain in-depth knowledge of the molecular mechanisms under-pinning disease processes and the effects of interventions. Roden et al developed links between a DNA biobank and phenotypic data derived directly from electronic medical record systems in the US to study the genetic susceptibility to disease at population level. [Roden 2008] In the UK, the suitability of primary care data in conducting studies with linkages to disease registries and genetic data repositories has previously been assessed.[Leppenwell 2012] In this review, challenges with linking data such as the variation in recording of coding amongst the available database software systems have been identified as potential areas for improvement.  In the clinical arena, important studies have been conducted using linked registry data. Berger et al linked multiple regional disease registries to observe important clinical features specific to paediatric pulmonary hypertension that were not previously 
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apparent using adult registries or single datasets.[Berger 2012] Linked hospital and primary care data in the UK have also been used effectively to evaluate processes that transgress boundaries within integrated health systems. One study correlated BMI data in primary care to risk of revisional hip or knee replacement surgery.[Culliford 2013] Another study identified that over a third of recorded gastrointestinal bleeding in primary care were not referred to hospital for investigation.[Crooks 2012] The UK has a unique system where GPs act as the ‘gatekeeper’ for hospital services and the majority of patients are referred through this route. This integrated health system is a suitable platform to evaluate the interaction between primary and secondary care services from a database perspective. Data on harm in gastrointestinal surgery using these databases is currently lacking.  Linkage of information from different databases provides a powerful way of expanding the application of available covariates, and validating data items.[Hammill 2009] Linkage between HES and ONS data has been available from April 1998. In surgery, this has allowed for the evaluation of out-of-hospital mortality and morbidity related to admission for elective and emergency procedures.[Sweetland 2009, Mamidanna 2012] ONS linkage to HES has also facilitated survival analyses following cancer resection.[Mamidanna 2012, Mamidanna 2013] Others have linked data to clinical registries to undertake more detailed evaluation of outcome. Fotheringham et al linked the UK Renal Registry to HES and ONS to demonstrate variations in dialysis rates amongst English hospitals.[Fotheringham 2012] Morris et al linked HES and ONS to the NCIN database to demonstrated variations in cancer site and stage-adjusted rates of abdomino-perineal resection across England.[E. Morris 2008] Other studies have linked information from different clinical registries to gain insights into rates and causes of harm in urological and orthopaedic surgery.[Santos 2014, Holleyman 2015]  As there are so many different markers of harm, there may be overlap between information captured in different databases. No single database has been shown to 
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capture all harm.[Naessens 2009] It is therefore logical that combining information from multiple databases increases the detection of harm and may help reflect overall impact of surgery more precisely than from single databases. Linkage of healthcare databases offers a platform to study increasingly complex clinical processes that overarch in-hospital, out-of-hospital and specialist services. For this, accurate patient-level linkage of data is needed.  In March 2011, the Department of Health in collaboration with the MHRA, launched CPRD as an initiative to promote the use electronic health records for the purposes of health research and service evaluation.[Department of Health 2011] The focus of MHRA was to offer linkage to other databases to enhance the granularity of patient level information. Linkage of CPRD to HES, ONS, NCIN, Myocardial Ischaemia National Audit Project and socioeconomic data using the Index of Multiple Deprivation (IMD) is commercially available upon request and the provision of adequate academic justification. In light of delays in government-lead linkage schemes such as Care.Data seen in recent years, CPRD is currently the largest database of primary care electronic health records linked to hospital data available for research use. This database allows for the evaluation of the interface between primary care and hospital care, which is increasingly recognized as an important aspect of the patient journey where adverse events can arise.[Kripalani 2007] These data operate longitudinally across the patient’s entire health journey allowing for the detailed evaluation of factors affecting referral and post-discharge care. One disadvantage of database linkage is that it invariably leads to smaller patient numbers through exclusion of patients at each step of the linkage process. Strict criteria are applied to qualify data for linkage in order to maintain uniformity and quality of data. The greater the number of databases linked, the greater the potential for the need to exclude patients due to them not fulfilling the required criteria or incomplete information. This means that linked databases always have less patients than the 
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smallest of the component databases, unless there a high proportion of missing data is accepted. Although the majority of linked healthcare databases are currently used for research purposes, efforts to increase data quality and achieve greater patient numbers may facilitate the use of these resources for the purposes of service evaluation in the future. Studies in surgical patients are lacking. Database linkage offers the opportunity to scrutinize quality from multiple perspectives, which may be of value in surgical patients in light of growing interest in long-term outcome. Different databases can identify covariates of different types. For example, while hospital administrative data may capture out-of-hospital harm through recording of readmission, primary care data may be more reflective of harm that may present to primary care more frequently than to hospitals.  
How primary care data can help evaluate surgical harm 
Post-discharge harm Historically, outcome research in surgery has focused on mortality and in-hospital harm. More recently, there has been greater recognition of the impact of harm occurring following hospital discharge.[Kazaure 2012] Pouw et al demonstrated in 60 Dutch hospitals that standardized mortality ratios were influenced by ‘discharge bias’ and therefore, post-discharge harm is an essential part of hospital outcome evaluation.[Pouw 2013] For harm other than mortality, most studies using hospital administrative data have reported on in-hospital harm. This is because hospital administrative data only capture information during hospital stay, so harm that occurs outside of the hospital setting that do not lead to readmission are not captured by hospital databases. Trends towards enhanced recovery, early discharge, day-case surgery and reduced follow-up mean that harm may increasingly arise in the community. Resources other than hospital administrative databases may capture this type of harm.  One study evaluating case notes found that adverse events are detected in up to 19% of patients following 
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discharge from a period hospitalisation.[Forster 2003] In this study, authors found that 30% of adverse events detected in the post-discharge setting were preventable, allowing the potential for prevention and improving outcome. Another study evaluating discharge records identified that 12% of adverse events recorded in hospitalised patients were in the outpatient setting, out of which 44% were preventable.[Woods 2007] In surgery, NSQIP data have previously been used to quantify post-discharge SAEs in patients undergoing general and vascular surgical procedures. Using this database, Kazure et al found that 41.5% of complications in general surgery occurred in the post-discharge setting, and that these SAEs significantly increased the risk of poor outcome including reoperation and mortality.[Kazaure 2012] However, this database is limited in its follow-up of patients to up to 30 days postoperatively, making it impossible to detect harm beyond the immediate postoperative setting. Another study using NSQIP found that following cancer surgery, over a third of postoperative VTE events occurred following hospital discharge.[Merkow 2011] These findings are reflected by drives towards stricter adherence to post-discharge thromboprophylaxis to prevent harm from VTE beyond hospital stay.[Bergqvist 2002]  In the UK, there is an established integration of health systems where primary care and hospital services work closely in partnership. Overall, 98% of the population in the UK is registered with GPs, who are handed over the care of patients following hospital discharge.[The King's Fund 2009] The drive to transfer skills from secondary to primary care has meant that GPs and other health professionals in primary care are well-placed to detect adverse effects related to hospital treatment that may arise in the community.[Darzi 2008] GPs have recently expressed their desire to increase awareness of adverse events related to hospital care as well as those that occur primarily as a result of care given in the primary care setting.[Vinegar 2013] The aspect of the patient journey immediately after discharge from hospitals has previously been highlighted as a key area where medication error can lead to significant patient harm.[Royal Pharmaceutical 
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Society 2012] Studies have identified that poor communication and discharge planning are factors that lead to poor outcome in this setting.[Kripalani 2007] Primary care databases may therefore be an important resource from which the impact of post-discharge surgical harm can be quantified from the perspective of the service user and purchaser. This may lead to greater understanding of the overall rates of harm related to surgery across integrated health systems and throughout patients’ entire health journeys.  
Assessing surgical risk Risk adjustment is important for performing accurate surgical risk stratification and case-mix adjustment for outcome. For comorbid illness, risk adjustment was first performed to improve the fairness of reimbursement for diagnosis related groups using health insurance data in the US.[Iezzoni 1988] Since then, case-mix adjustment has been an integral part of evaluating hospital outcome and demonstrating variability in the quality of patients receiving treatment. Today, many variables are used to predict risk for different types of outcome. This may include demographic characteristics such as age, gender and socioeconomic status. Furthermore, other patient characteristics including BMI, comorbidity, nutritional status, American Society of Anaesthesiology grading and even biochemical parameters such as albumin have been explored as potential predictors of harm.[Dimick 2010] Some have performed objective assessments of fitness for surgery by testing for physiological reserve through cardiopulmonary exercise testing. [Levett 2015] However, mathematical risk prediction models for hospital procedures are usually based on information obtained at the point of preoperative evaluation by hospitals. Health status assessed over a longer preoperative phase is likely to better reflect patients’ normal physiological status and ability to withstand the insult of surgery. Indicators of day-to-day activity such as frailty are emerging as important predictors of surgical outcome.[Robinson 2013, Velanovich 2013] This parameter may be best evaluated in primary care where the patients’ health needs can be tracked 
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several years before surgery. Clinical coding for psychological well-being may also reflect preoperative health status. Psychiatric morbidity has previously been explored as a determinant of survival in oesophagogastrectomy.[Wikman 2015] To date, whether psychiatric morbidity can influence outcome across different surgical procedures has not previously been explored.  For population-level quantification of observed-to-expected ratios of outcome, administrative data can offer large-scale information on demographics and comorbidities. In the UK, this has been done using HES data. However, there are some limitations to HES such as the lack of present-on-admission flags, which means that comorbidities such as previous cerebrovascular accident and myocardial infarction recorded during hospital admission cannot be differentiated from acute events that occurred during hospital stay.[Bottle 2014] Linkage of hospital and primary care data may clarify whether such comorbid illness existed before surgery, and facilitate the accurate evaluation of risk. Other predictor covariates may also be identified in primary care data. Lifestyle measures such as smoking and BMI have previously been shown to increase surgical risk, but are not routinely captured by hospital databases.[Leroy 2005, Jin 2015] While BMI is not routinely calculated to assess surgical risk in primary care, measurements of weight and height are frequent, and BMI is recorded annually in over half of obese patients in primary care.[H. P. Booth 2013] These data have previously been used to evaluate outcome following bariatric surgery.[H. Booth 2014]  Overall, different parameters of preoperative risk as determined by patient characteristics and health status measured in primary care data may reflect the case-mix of patients being referred to secondary care. These data are likely to be of value to service users, purchasers and providers. .  
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The impact of surgery on health status Improvement in perioperative care has lead to the reduction of short-term morbidity and mortality in surgery. This has lead to a growth in interest for evaluating the impact of surgery on domains of health status such as QOL.[Djarv 2008]  The Constitution of the World Health Organization includes a definition of health as a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity. [World Health Organization 1946] Health status can reduce through impairment defined as loss or abnormality of psychological, physiological, or anatomical structure or function.[World Health Organization 1980] Impairment is based on objective clinical measures. If this results in poor functional status, this is defined as disability. Disability that impacts on the individual’s role within society is handicap. In addition to impairment and functional status, health-related QOL is also another domain of health status. Health-related QOL is the individual’s perception of their health within the context of day-to-day living.[World Health Organization 1997] Finally, symptoms are an increasingly recognized and important domain of health status.[Stewart 2008]  The role of psychological functioning in determining the overall health status of an individual has previously been recognized.[Emmons 2012] Psychiatric morbidity may be considered as a set of symptoms indicating psychological impairment that impacts on the individual’s function. It has previously been explored as an important determinant of mortality in patients with cancer.[Satin 2009] Surgical intervention seems to increase the psychological impact of disease as observed by the increased rates of psychiatric diagnoses postoperatively.[Liberzon 2006] Using data from the Swedish National Registry, Wikman et al demonstrated that postoperative psychiatric morbidity significantly impacts on two-year mortality following  oesophagogastric resection for cancer.[Wikman 2015] However, population-level analysis of psychiatric morbidity across different types of gastrointestinal surgical procedures has not been possible due to the lack of resources that record surgical and psychiatric outcome together. Primary 
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care electronic records have previously been used to evaluate psychiatric morbidity in the UK population.[Hardoon 2013, Reed 2013] Whether these resources can evaluate psychiatric morbidity in the perioperative setting has not previously been explored.  Health status is also represented by symptoms other than those that are psychiatric in nature. When considered together with postoperative psychiatric morbidity, these markers of postoperative health status may be important determinants of long-term outcome in gastrointestinal surgery.  
Rationale for proposed research 
Although a lot of knowledge has been gained about healthcare quality from hospital administrative data, there are limits to what they can capture as activity is recorded only during hospital stay, readmission or visits to the outpatient clinic. The large number of interactions between patients and healthcare professionals in primary care are not represented in hospital data, which are therefore unlikely to offer a complete overview of healthcare processes in increasingly integrated health systems. Surgical harm manifesting as SAEs and poor postoperative health status recorded outside of the hospital setting that do not lead to hospital readmission or re-referral are not captured by hospital databases. In light of decreasing tendencies in hospital follow-up, linkage of primary care data to hospital administrative data may be an important way of evaluating outcome across the transition of care from hospital to the community. While studies using primary care data have identified harm previously, exactly what proportion of harm is captured in primary care is not known. Increasing trends towards early hospital discharge, shorter hospital stay, day-case operating and enhanced recovery mean that harm may increasingly arise when patients are away from the hospital in which they underwent surgery in the post-discharge setting. GPs are often the first point of contact if problems arise after hospital discharge, and are therefore well placed to observe the effects of hospital treatment during recuperation from surgery.  
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In addition to detecting more harm, evaluating linked hospital and primary care databases may be a useful way of assessing risk. Primary care data has additional features that may be beneficial for the purposes assessing patients that are referred for treatment. For example, the coding system is purpose-built and has extensive codes for lifestyle factors and health status. The data are recorded longitudinally allowing for precise assessments of diagnoses and clinical events over time. Prescription data offer information on disease-specific treatments and trends in dosage and adverse effects. These resources offer highly granular patient-level information that may be useful when stratifying risk. Furthermore, linkage of CPRD to other databases for population statistics (ONS), cancer registry (NCIN) and socioeconomic status (IMD) means that this particular system offers high quality research data.  The main disadvantage of primary care data is that it is segmented across different software systems used in the UK. Furthermore, linkage to hospital data is limited depending on the system. Consequently, while HES covers the entire population, CPRD with the highest number of patients linked to HES covers less than 10% of the population. This means that primary care data cannot be used, in its current form to evaluate variation in performance across the nation. Furthermore, although there have been many studies using linked primary care data, there is lack of validation for many of the codes used to define clinical events. Nevertheless, the high granularity of data available from CPRD makes it a suitable platform for the detailed evaluation of health processes. In particular, surgical patients who interact with different parts of the system within the NHS may have relevant information recorded in multiple routine databases. Database linkage offers an opportunity to evaluate population-level outcome in greater detail than has been possible before outside of the setting of prospective studies.  Recent studies have explored the wide range of harm that can impact on patients undergoing gastrointestinal surgery.[Low 2015] It would therefore be important for population-level analyses to capture all types of harm. No previous analysis has 
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evaluated SAEs and long-term health status in the same database. This thesis will explore the use of linked routine population-level databases to evaluate surgical harm and effect on long-term health status in patients undergoing gastrointestinal surgery in England. This may unearth new knowledge by increasing our understanding of risk associated with harm and its impact on outcome. Linked data would also be an ideal platform to assess the value of using multiple database covariates to predict outcome. A schematic representation of the proposed investigation is presented as a flow chart in Figure 2-1.     
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Figure 2-1. Flow diagram of project overview       
  
 
   
 
 Linked routine population-level database including CPRD, HES, ONS, IMD and NCIN 
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 Demonstration of impact of harm on quality of life in gastrointestinal surgery serving as the rationale for the proposed research 
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Patient-level linkage of multiple routine population-level databases can improve our understanding, measurement and risk adjustment of harm in gastrointestinal surgery. 
Aims 
This thesis will address the following aims: 1. To measure harm in gastrointestinal surgery using linked routine databases 2. To develop prediction models for surgical outcome using linked database covariates 3. To assess predictive performance of regression models developed from linked data 4. To understand the relationship between short-term surgical harm and long-term health status  
Objectives 
The aims will be achieved by addressing the following objectives using linked routine national databases:  1. Identify a suitable linked dataset  2. Describe the study cohort using linked database covariates 3. Measure overall rates of surgical adverse events  4. Measure preoperative and postoperative health status 5. Perform logistic regression analysis for short and long-term outcome 6. Determine the risk factors for harm and poor health status 7. Evaluate the performance of prediction models using HES and linked database covariates 8. Demonstrate correlations between short-term harm and long-term health status 
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Thesis structure 
Different types of data analysis will be presented to explore the hypothesis and address the objectives. The Chapter subsequent to this introductory Chapter will outline the main methods by describing database procurement, covariate development and statistical analysis. Each chapter after the methods chapter will present a component of data analysis together with detailed methods on how covariates were derived and evaluated. The analysis will be broadly separated into five parts: description of cohort characteristics, identification of short-term harm (SAEs), measurement of health status (frailty, psychiatric morbidity, symptoms), development of regression models for outcome and evaluation of prediction model performance using different types of data. The first three components of data analysis will be separate Chapters and include introduction, methods, results and discussion so that appropriate conclusions are drawn from each Chapter. The last two data Chapters will incorporate regression analysis and assessment of predictive performance together. The regression analysis will be done at two levels, one for predicting harm from patient and surgery characteristics and one for predicting outcome using all variables including those describing harm and health status. This structure of presenting the data analysis in this thesis reflects the sequence of data analysis undertaken, where conclusions drawn from each step influenced the development of subsequent analytical methods. An alternative approach would have been to present the results from all analyses together, which would have been difficult to follow. After the presentation of data, a final discussion Chapter will consider the results from all data Chapters together.  
67  
3. CHAPTER THREE - METHODS 
Introduction 
The systematic review of the literature demonstrated the association between surgical harm and QOL in patients undergoing gastrointestinal surgery.[Bouras 2014] By impacting on both mental and physical QOL, surgical harm was demonstrated to correlate with long-term outcome. Some of these effects have previously been evaluated in prospective studies through close follow-up and detailed questioning of patients. Such methods are associated with high costs. Population-level routine databases can offer an overview of harm related to hospital care. Patient-level linkage to other databases may help elucidate types of surgical harm and poor health status that are not identified in hospital databases, and offer a wide range of predictor covariates. In the context of gastrointestinal surgery, key pieces of information that can be gained from primary care data include lifestyle factors such as smoking and obesity, as well as preoperative and postoperative health status. Factors reflecting health status such as frailty and psychiatric morbidity are increasingly recognized as important determinants of outcome, however under-represented in hospital databases.[Saxton 2011, Wikman 2015] There has also been increasing emphasis on cancer specific variables such as stage that can also influence outcome, which can be derived from linkage to cancer registry data.[Merkow 2013] Linkage of multiple routine databases may allow for detailed evaluation of surgical harm and correlation with outcome. To evaluate whether linked routine databases can achieve greater granularity of information and help model surgical risk more precisely, commercially available data with patient-level linkage of hospital, primary care, cancer registry, population statistics and socioeconomic databases will be obtained for patients undergoing gastrointestinal surgery in the English NHS. This chapter will describe the methods used to identify the surgical study cohort and the 
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covariates that describe risk, rate and outcome to test the proposed hypothesis. Variables will be broadly categorized as follows:  1. Patient and surgery characteristics 2. Surgical adverse events 3. Health status 4. Outcome The way in which individual covariates in each of these categories will be derived from linked population-level data will be described here, before assessing the value of these covariates in identifying and predicting outcome in subsequent chapters.  
Aim 
 To describe the methods used to derive covariates from linked routine population-level databases 
Objectives 
1. To describe where and how the data were obtained 2. To describe the identification of the study cohort  3. To describe how covariates will be derived from linked databases   
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Obtaining the dataset 
CPRD was chosen as the platform for analysis as it offers the greatest linkage of primary care data to other databases. Each individual database was routinely collected offering high numbers of patients in each of the linked databases. CPRD is an observational data research service, jointly funded by the NHS National Institute for Health Research (NIHR) and the MHRA, designed to maximize the use of primary care clinical data through linkage to other databases. Their aim is to create opportunities for observational research to deliver outputs that are beneficial to the public. Since 1987 when the earlier version GPRD was founded, over 600 GP practices in the UK are registered with CPRD. GPs in these practices use the Vision Clinical System® software (In Practices Systems Ltd) to maintain electronic health records for patients and record information during consultations in real-time. From this system, anonymised patient information is automatically uploaded to the CPRD database, which is updated monthly and made available to subscribers through the online server (CPRD-GOLD). There is an opt-out clause for patients in consenting practices to withdraw permission to upload their individual information. Linkage is performed centrally using a common variable, the National Health Service (NHS) number, which is assigned to every patient who registers with services provided by the NHS.[Eaton 2008] Data were downloaded as comma separated values (.csv) files from the CPRD website and converted to Statistical Package for Social Sciences (SPSS) data files for further analysis.  
Population coverage This database of primary care electronic health records, has recorded patient data since April 1997. Up to April 2015, 686 practices are part of CPRD encompassing 4.4 million active patients who are alive and currently registered.[Herrett 2015] One feature of the database is that patients who move practices are given a new unique patient identifier and so may be double-counted in retrospective studies. The number of patients with more than one identifier in CPRD is not known. However, CPRD quote that the 
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population coverage of their database to be roughly 8% of the UK population. This includes data from all four countries in the UK, and the CPRD population distribution has been shown to be geographically representative of the UK population through comparisons with demographic and mortality data from ONS.[Campbell J 2013]  
Database linkage CPRD offers linkage to the Index of Social Deprivation (IMD) that specifies socioeconomic status as a score. About 50% of practices in CPRD have opted for linkage to the HES database. This equates to 5.2 million patients with records including those that are inactive in the CPRD database with available linked HES variables. At present, this includes in-patient HES data that contains information on episodes of hospital care during admission including diagnosis and procedures amongst other covariates that describe process.  HES is a suitable database to identify surgical patients as there have been studies validating this type of data for accuracy of coding for surgical procedures. One systematic review of 32 studies identified that while reported coding accuracy for OPCS codes ranged between 52.6% and 85%, discharge coding improved over time when compared with case notes.[E. M. Burns 2012] There are on-going efforts to link other types of HES data such as outpatient, accident and emergency and critical care data with CPRD. Additionally, 95% of HES-linked practices also have ONS linkage to death certificate information. Out of the patients with CPRD, HES and ONS linkage, 90% of cancer patients have linkage to cancer registry data, which is available upon request and agreement with the NCIN. Additional linkages are available to other registries including the Myocardial Ischaemia National Audit Project and the Mother Baby link. Further linkages to hospital pharmacy records and the National Joint Registry are underway. Linkage is performed at the patient level centrally using the NHS number,[Eaton 2008] which is then converted to a new unique patient identifier to minimize the use of identifiable data on the system. While CPRD is a coded database, information in free-text form is also available upon 
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request. This includes data from discharge summaries and directly from written medical records of patients. These records are used for verification of data submitted by practices. 
 
Data quality control CPRD ensures the quality of their data using rigorous checking. This includes algorithms for assessing continuity and completeness of data when received from participating practices. Practice level quality checks help assess whether individual practices are providing data of acceptable research standards. Additionally, recording guidelines are provided by CPRD to help GPs with data input to meet the needs of researchers and those evaluating service. Regular feedback is provided to each practice on completeness and consistency of data, together with instructions and support on how to improve. If a practice fails to address shortcomings, it will no longer be part of CPRD and researchers and other users of the database will be made aware of the potential for inaccuracies. In addition to practice-level quality control, patient-level parameters are screened for patients that do not meet up-to-standard criteria for data quality. These criteria filter out patients by identifying discrepancies in registration details and periods of missing data. By placing emphasis on data quality that exceeds that of its competitors, CPRD is considered as the standard for studies of primary care data aiming to achieve results that are generalisable to the population.   




Ethical approval All studies using the CPRD database need to be approved by the Independent Scientific Advisory Committee (ISAC) before publication, who are consulted to ensure studies undertaken are of an appropriately high scientific standard. ISAC approval was obtained for this thesis on the 21st of September 2013 (Appendix 1). Ethical approval was obtained locally from the research ethics committee London Westminster (Ref 13/LO/1374, Protocol STDA3106) and approved on the 30th of September 2013 (Appendix 2). 
Variables in linked databases  Database linkage allows for a high number of variables to be obtained for each patient (Figure 3-1). Variables derived from multiple databases include CPRD (patient, practice, staff, consultation, clinical, additional clinical, referral, immunisation, test and therapy), HES (patient, hospital, episodes, diagnosis and procedures), ONS (date of death and cause of death), NCIN (diagnosis, cancer type, stage and adjuvant therapy) and area-based deprivation (socioeconomic status). Part of the CPRD dataset is prescription data, which is coded by British National Formulary codes. Prescription data will be used to identify patients on medications that signify a particular diagnosis such as anticoagulation therapy for VTE and medication to treat psychiatric illness. A comprehensive list of variables included in linked databases is presented in Appendix 3.   
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Figure 3-1. Database linkage for linked CPRD, HES, ONS, IMD and NCIN databases.
 
Identifying the surgical study cohort  
Patients undergoing gastrointestinal surgery will be evaluated for the following reasons: 1. Most hospitals offer gastrointestinal surgical services with a range of procedures within subspecialties encompassing varying degrees of risk in both emergency and elective settings.  2. Gastrointestinal surgery has been included in previous quality improvement programs such as NSQIP.  3. The systematic review identified significant effects of harm on QOL in gastrointestinal surgery. 
Definition of gastrointestinal surgery Definitions for the type of surgery that will be evaluated will be based on the operative procedure coding system used in HES (OPCS). Excluding oral surgery, there are three categories of surgical procedures on the human gastrointestinal tract: lower digestive 
74  
tract, upper digestive tract and other abdominal organs – principally digestive.[Connecting for Health 2009] The term gastrointestinal surgery is therefore synonymous with digestive surgery, which includes the organs forming the gastrointestinal tract as well as accessory organs of digestion such as the liver and pancreas.[US National Library of Medicine 2015] In the UK, surgery of the gastrointestinal or digestive system is usually performed by general surgeons with subspecialist interests in upper gastrointestinal, lower gastrointestinal or hepatopancreaticobiliary surgery. Oesophageal surgery is increasingly performed by upper gastrointestinal surgeons rather than thoracic surgeons reflecting increasing rates of gastroesophageal junction adenocarcinoma. Gastrointestinal surgery also includes less major procedures such as appendicectomy and cholecystectomy, which may not necessarily be considered as sub-specialty surgery. Nevertheless, all procedures involving surgery to the digestive system within the remit of general surgical subspecialties will be considered in this thesis. Oral surgery will be excluded as this is not considered as a sub-specialization within general surgery. Abdominal wall surgery will not be included as although performed by general surgeons, there is no surgery to the digestive system in most patients.  To identify the relevant procedures, operations recorded nationally were identified in aggregate HES data from HSCIC. Nine of the most common procedures involving surgery to the gastrointestinal system were selected for evaluation. These procedures will include surgery to the gastrointestinal tract and the wider digestive system in patients with both cancer and benign disease, in elective and emergency settings and associated with variable risk of both short and long-term poor outcome.  
Selection of index procedures in hospital data To select surgical patients, HES data will be used to define surgical procedures as most population-based studies in the UK have used this database to evaluate surgical outcome. Coding in HES for surgical procedures has previously been validated against case 
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Table 3-1. OPCS and ICD-10 codes to identify index gastrointestinal surgical procedures in 
HES 
 








Small bowel resection 
 
G58, G59, G69, G70 
 




H06, H07, H08, H09, H10, H335, 
H041, H043, H048, H049, H05, H11, 
H331, H332, H333, H334, H336, 
H337, H338, H339 
 
C18, C19, C20, C21, C26, K50, 





J02, J031, J035, J18, J27, J55, J56, 
J57, J58 
 
C17, 18, C19, C20, C22, C23, 
















G281, G282, G283, G284, G285, 
G288, G289, G301, G302, G303, 
G304, G308, G309, G311, G312, 
G313, G314, G315, G316, G318, 
G319, G310, G320, G321, G322, 
G323, G324, G325, G328, G329, 
G330, G331, G332, G333, G335, 












H51, H52, H53 I84       
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Inclusion and exclusion criteria Only patients who were registered at an up-to-standard linked primary care practice for at least one day during the study period of 1st April 1997 to 31st March 2012 were included in the study. Only patients with linked HES, CPRD and ONS data were evaluated. IMD and NCIN data were included for those with available data. Patients were selected if they fulfilled the OPCS and ICD-10 criteria for admission for surgery within the specified study period. Only adults aged 18 or over were eligible.  Patients with no linkage of HES-CPRD-ONS data to allow for at least three years preoperative and one-year postoperative evaluation were excluded from the analysis. Patients who left their primary care practice were identified using the ‘transfer out date’ code (tod) in CPRD. Patients were excluded if they transferred out of their practice within a year of hospital discharge unless the reason was for death. 
Database coverage The maximum period of database coverage that was available at the time of approval of the application for the proposed research was requested. Given the period of database coverage, index procedures performed between1st April 2000 to 31st March 2011 were selected to allow for three-years preoperative and one-year postoperative data for risk-outcome analyses. These periods were selected based on previous studies evaluating preoperative risk and long-term outcome in gastrointestinal surgery.[Sundararajan 2007, Mamidanna 2012] 
Deriving the covariates  
Clinically plausible variables derived from linked databases will be categorized as patient characteristics, surgery characteristics, SAEs, health status and outcome (Table 3-2). Patient and surgery characteristics will be derived from HES, CPRD, NCIN and IMD data recorded preoperatively. SAEs will be measured in HES and CPRD within 30 days of surgery. The diagnosis coding will be ICD-10 in HES and Medcode in CPRD. Medcode is a 
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direct translation of the Read coding system for use in CPRD data. Over 55000 different Medcodes are used in the database.  As the focus of this exploration was to evaluate long-term outcome, it would be important to adjust for short-term harm adequately for the purposes of regression analysis. This will help demonstrate the effects of long-term poor health status when adjusted for short-term harm. In HES, ICD-10 coding does not encompass all types of surgical harm. Instead, reoperation determined through OPCS coding has previously been reported to be a useful surrogate for SAEs in gastrointestinal surgery.[EM Burns 2011, Almoudaris 2013] Reoperation will be evaluated together with technical and systemic SAEs measured in CPRD and HES using diagnosis coding. Similarly, preoperative and postoperative health status will be measured between 36 months before and up to twelve months after the index surgical procedure. Psychiatric morbidity will be measured both preoperatively and postoperatively as it would be important to adjust for preoperative psychiatric morbidity when evaluating risk of postoperative psychiatric morbidity.[Scholtz 2007, Wikman 2015] Frailty was measured only in the preoperative setting as a predictor of outcome. It was felt that twelve months after surgery was too short to evaluate frailty reliably. Symptoms were only measured postoperatively, as preoperative symptoms were thought to vary according to the condition for which patients were undergoing surgery, and not be reflective of health status. Frailty and postoperative symptoms will be measured entirely in CPRD, as HES contains no information on these parameters. Psychiatric morbidity will be measured in CPRD and HES, as psychiatric morbidity that leading to hospital admission has previously been demonstrated to be significantly associated with mortality.[Wikman 2015]     
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Table 3-2. Covariates derived from linked databases  
 
  





















HES and CPRD 
HES and CPRD 
CPRD 
CPRD 






















HES and CPRD 






30-day technical SAEs 
30-day systemic SAEs 











Postoperative psychiatric morbidity 




Surgery characteristics HES codes for method of admission and determines whether surgery was undertaken as emergency or electively. For this, the admission method variable will be used to identify emergency admissions (admimeth=21, 22, 23, 24 or 28). The remainder of admissions will be considered as elective (admimeth=11, 12 or 13). Inter-hospital transfers from other hospitals (admimeth=2A, 2B, 2C or 28) will be included if patients were originally admitted for the purpose of undergoing the index surgical procedure (first position of OPCS and ICD-10 codes). Surgical approach (minimally invasive or open) will also be determined from HES. For this, OPCS codes in the same episode as the one coding for the index surgical procedure will be searched for codes specifying laparoscopic approach (Y751, Y752, Y758, Y759, Y508) or thoracoscopic approach (Y536, Y74) as previously described.[Mamidanna 2012, El-Dhuwaib 2013] All procedures without codes denoting minimally invasive approach will be considered as open surgical procedures.  
 Patient characteristics Demographics: The variables age and gender are available both in HES and CPRD databases. Age will be specified at the time of admission for the index surgical procedure. Gender will be specified as male or female. Demographic data will be derived from HES unless they are missing, in which case they will be derived from CPRD instead. Socioeconomic status: Linkage to IMD data will be requested from CPRD for the proposed surgical cohort. IMD denotes the index of multiple deprivation, which is determined by the seven aspects of deprivation including income, employment, health deprivation and disability, education skills and training, barriers to housing and services, crime and living environment. The greater the composite score, the lower the socioeconomic status. The IMD captures a wider range of factors compared with other socioeconomic scores such as the Townsend and Carstairs indices, and therefore offers greater differentiation of deprivation amongst geographical areas.[Office of National Statistics 2012] Patients will be categorized into quintiles according to the average 
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deprivation score of their local authority derived from general population data in England.[Public Health England 2012] The level of socioeconomic status will be incorporated as a continuous variable in subsequent regression analyses.  BMI: BMI data will be derived from height and weight recordings in CPRD. Some patients had BMI directly recorded in these data fields. BMI recordings closet to but before the time of surgery will be used as surrogates for preoperative BMI. Only BMI recordings of 12-75 will be considered valid to exclude extreme out-lying values. Only data within three years before surgery will be used as recordings of preoperative BMI. This is known as the last observation carried forwards method, which has previously been used to estimate BMI from CPRD data.[H. P. Booth 2014] BMI data were found to be missing in up to 16% of patients in this study. Smoking: Smoking will be measured using Medcodes in CPRD (Table 3-3). Any recording of a code for smoking within the 36 months before surgery will be considered as history of smoking.   





















Very heavy smoker 
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Comorbidity: There are several methods of evaluating surgical risk from comorbid illness using hospital administrative data such as HES.[Armitage 2010] The most commonly used measure of comorbidity is the Charlson index, although other composite measures such as the Elixhauser exist. [Sharabiani 2012] Fifteen different comorbidities will be evaluated in linked databases. This excludes cancer and metastatic disease, which although normally part of the Charlson index, will be represented in cancer registry data. The remaining comorbidities will be measured in HES and CPRD to capture all recordings of comorbidity within 36 months before surgery. Previous studies have demonstrated that comorbidity recorded within 36 months before surgery was most significantly associated with outcome.[Stukenborg 2001] Components of the Charlson index have previously been translated from ICD-10 coding to Read coding to measure chronic illnesses in primary care.[Khan 2010] This study showed that there were 1481 different Read codes for the 15 comorbidities of the Charlson score (Table 3-4). The corresponding medcodes will be specified and used to identify comorbidities in CPRD. The date of recording of a medcode for comorbidity will be referenced against the date of the index surgical procedure in HES.  In HES, comorbidities will be identified using ICD-10 codes recorded during the admission for the index surgical procedure or previous hospital admission within 36 months before surgery (Table 3-5). Codes recorded in any of the diagnosis positions apart from the primary diagnosis code (diag_2 to diag_20) will signify comorbidity.[Bottle 2011] Multiple recordings of the same comorbidity in the same database will be considered as a single recording of that type of comorbidity. For the purposes of predicting outcome, the effect of individual comorbidities will be tested rather than using the Charlson score. This is because the Charlson score has only previously been validated for mortality but not for other outcome. It was felt that rather than using a composite score that has not previously been validated in this dataset, the risk incurred by each of the components of the Charlson index should be evaluated 
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separately. When evaluating the overall impact of comorbidity on outcome, the presence of one or more comorbidity will be considered as a risk factor as previously described.[Armitage 2010]  The concordance between HES and CPRD for recording comorbidity will be assessed by determining the number of comorbidities recorded in each database. The proportion of comorbidities recorded by both databases out of the total number of comorbidities recorded in each database will be calculated to evaluate overlap between HES and CPRD.  
84  




8281, 23770, 23951, 27641, 27853, 36294, 37006, 44303, 44617, 47632, 50076, 51708, 53636, 58859, 62854, 62891, 65117, 66368, 67575, 69766, 69767, 70528, 70869, 71450, 83845, 96751, 100769, 
101836, 102117, 102252, 104134, 105324 
Myocardial infarction 241, 1204, 1677, 2491, 3704, 4017, 5387, 8935, 9507, 10562, 12139, 12229, 14658, 14898, 16408, 17464, 17689, 17872, 29643, 30421, 34803, 46017, 50372 
Heart failure  398, 884, 1223, 2062, 2906, 4024, 5141, 5255, 9913, 10079, 11424, 12590, 15058, 17278, 21837, 23707, 24503, 27884, 27964, 30779, 32671, 32898, 32945, 46912, 66306, 74131, 75877 
Cerebrovascular 
accident 
504, 1298, 1469, 1786, 1895, 2418, 3535, 5051, 5871, 6116, 6155, 6253, 6960, 7017, 7780, 8181, 8443, 9696, 10062, 10792, 12555, 12833, 13564, 13577, 15788, 16956, 17322, 17326, 18604, 18689, 
18912, 19201, 19260, 19280, 19354, 19412, 20284, 23361, 23580, 27975, 28314, 28807, 29939, 30202, 31060, 33499, 34117, 34135, 37493, 38304, 40053, 41577, 41910, 42331, 44740, 45781, 48149, 
51138, 51311, 51326, 51767, 53810, 54744, 56007, 57315, 58545, 60692, 63830, 65745, 71274, 71585, 73901, 74318, 74457, 83663, 84221, 84955, 87389, 90572, 92036, 96630, 96717, 98642 
Dementia 1350, 1916, 4357, 4693, 5931, 6578, 7323, 7664, 8195, 8634, 8934, 9565, 11175, 11379, 12621, 15165, 19393, 19477, 25386, 25704, 26270, 27759, 29386, 30706, 31016, 34944, 38438, 38678, 42279, 
42602, 43089, 43292, 43346, 46488, 49263, 55313, 55467, 55838, 56912, 60059, 64267, 76213, 79014 
Pulmonary disease 78, 148, 185, 233, 719, 794, 1208, 1555, 2195, 3018, 3163, 3243, 3366, 3458, 3480, 3540, 3665, 4442, 4606, 4892, 5005, 5267, 5627, 5798, 5867, 5909, 6707, 7058, 7146, 7191, 7229, 7416, 7731, 
8303, 8335, 8355, 10980, 11150, 11312, 11370, 11833, 12987, 13065, 13066, 14777, 14798, 15157, 15248, 15588, 15626, 16410, 16717, 17359, 18207, 18323, 19492, 19519, 20113, 20364, 21232, 
22536, 22752,  22905, 23446, 23461, 23492, 24248, 24884, 25181, 25603, 25796, 26306, 26442, 26501, 26503, 26504, 27345, 27819, 29325, 30235, 30815, 31167, 31225, 31423, 31447, 32679, 
33450, 34001, 36240, 37247, 37365, 37959, 38144, 38146, 38639, 39478, 39570, 40159, 40788, 40823, 41017, 41020, 41491, 41694, 42824, 44525, 45073, 45089, 45427, 45782, 46460, 46529, 46578, 
46977, 47684, 47782, 49194, 51410, 51858, 53095, 54822, 54893, 55552, 55758, 56652, 56860, 58196, 58791, 60188, 60805, 61118, 61513, 62200, 63216, 63479, 63912, 64721, 65376, 66043, 66058, 
67709, 68066, 70787, 74025, 74205, 74285, 74295, 74458, 74630, 74717, 78034, 88717, 89206, 90583, 92955, 93206, 93353, 93577, 94894 
Peripheral vascular 
disease 
1517, 1735, 1736, 1867, 2760, 3530, 4325, 4970, 5414, 5702, 5943, 6853, 6872, 9204, 9759, 11430, 11680, 12735, 13572, 15304, 16034, 16521, 16800, 16993, 17220, 17345, 17767, 23532, 23672, 
26232, 27563, 28109, 31053, 32556, 37750, 38907, 39949, 40068, 40787, 45521, 51057, 51166, 51634, 53634, 59534, 63408, 63920, 73961, 74334, 92925, 102719, 102725 
Connective tissue 
disease 
844, 1029, 1408, 3670, 6916, 7871, 8350, 9707, 9954, 10919, 11920, 12019, 15205, 15511, 17085, 20007, 21358, 22205, 23552, 27603, 28417, 28853, 29353, 29472, 29519, 31209, 31564, 31724, 
33474, 35759, 35937, 36942, 41941, 42299, 42719, 42940, 43816, 44141, 45284, 46436, 47672, 48832, 49067, 50863, 51238, 51239, 55601, 56202, 56838, 57675, 58706, 59738, 62401, 63198, 63365, 
68277, 70221, 70658, 71763, 71784 73619, 74564, 76073, 77143, 79947, 79981, 81274, 82815, 93715, 93927, 94996, 96456, 99414, 100776, 100914, 104629 
Peptic ulcer 352, 657, 670, 1262, 1295, 3101, 3462, 4643, 4741, 5521, 5928, 6333, 6865, 9853, 11104, 11124, 14671, 15175, 15403, 15821, 15979, 18001, 18027, 18324, 18625, 18654, 19928, 20677, 22918, 
23082, 23688, 24021, 24040, 24342, 26261, 28366, 29317, 29771, 30054, 32856, 33438, 33914, 36461, 36583, 37620, 40997, 41271, 42274, 44073, 44284, 44309, 44324, 44335, 44637, 45184, 45304, 
48730, 48946, 50048, 50497, 51406, 52138, 52313, 52323, 53081, 53126, 53336, 53669, 53797, 53822, 57958, 60249, 60346, 63001, 63482, 63582, 63718, 64014, 64111, 64165, 64556, 64710, 64913, 
65737, 66092, 67082, 67356, 67711, 68661, 69663, 70005, 70390, 70456, 71150, 71403, 71881, 71897, 71904, 73338, 73417, 73697, 74496, 74848, 75673, 79977, 82405, 84227, 90899, 92695, 93436, 
94104, 94397, 96090, 96622, 96628, 99430, 99670, 102177 
Diabetes 506, 711, 758, 1038, 1407, 1549, 1647, 1682, 2378, 4513, 5884, 6125, 6791, 6813, 7059, 8403, 8842, 9013, 10098, 10692, 12213, 12455, 12736, 13071, 14803, 14889, 15690, 17858, 17859, 18143, 
18219, 18264, 18278, 18390, 18505, 18683, 21482 22023, 22487, 22884, 24363, 24423, 24458, 24490, 24693, 25627, 26054, 26108, 26855, 28769, 29979, 30294, 30323, 32403, 32627, 33343, 33807, 
33969, 34152, 34912, 35288, 35399, 36633, 36695, 37648, 37806, 38617, 38986, 39070, 40023, 40401, 40682, 40837, 41686, 42505, 42567, 42729, 43139, 43785, 43857, 43921, 43951, 44440, 44443, 
45491, 45913, 45914, 46850, 46917, 47315, 47954, 49074, 49869, 50609, 50960, 50972, 51261, 51697, 51756, 51957, 52212, 52236, 53200, 54600, 54856, 54899, 55075, 55431, 56268, 56803, 59253, 
59288, 59991, 60107, 60499, 60699, 60796, 61071, 61122, 62107, 62146, 62209, 63017, 63357, 63371, 63762, 64283, 64357, 64446, 64668, 65025, 65062, 65704, 66145, 66675, 69124, 69676, 69993, 
70448, 70766, 70821, 72345, 72702, 93468 
Diabetes complications 1323, 2340, 2342, 2475, 2986, 3286, 3837, 5002, 6509, 7795, 9835, 10099, 10418, 10659, 10755, 11129, 11433, 11626, 12640, 13099, 13101, 13103, 13279, 16230, 16491, 17262, 17545, 18209, 
18230, 18425, 18496, 18777, 21983, 22573, 24694, 24836, 30477, 33254, 34268, 34283, 35107, 35385, 37315, 38161, 39317, 39420, 40962, 41049, 41389, 41716, 42762, 42831, 44260, 44779, 44982, 
45467, 45499, 45919, 46301, 46963, 47321, 47328, 47377, 47409, 47582, 47649, 47816, 48192, 49146, 49276, 49554, 49655, 50225, 50429, 50527, 50813, 52041, 52283, 52303, 55239, 55842, 57278, 
57621, 58604, 59365, 59725, 59903, 61344, 61523, 61829, 62674, 63555, 63690, 64571, 65463, 65616, 66872, 66965, 67905, 68105, 69278, 69748, 70316, 72320, 93922, 99231, 102201 
Renal disease 350, 512, 2773, 4669, 4850, 6712, 6842, 7804, 8828, 10647, 10809, 11875, 12465, 12479, 12566, 12585, 12586, 15097, 21989, 25582, 25980, 29013, 29638, 30310, 31369, 33580, 34637, 34648, 
35235, 36342, 41676, 41881, 45867, 46242, 50728, 50804, 53940, 53945, 56893, 56939, 57168, 57568, 60857, 61494, 61930, 63615, 64482, 65064, 65400, 66062, 67193, 67460, 67995, 68114, 73026, 
94350, 97758, 99631, 99644, 103532 
Paraplegia 1749, 3063, 3293, 3514, 8492, 8933, 9375, 20122, 22135, 36133, 37160, 39085, 46175, 99040, 
Liver disease 899, 1638, 1754, 1755, 3450, 4743, 5638, 6015, 6863, 7602, 8206, 9029, 9494, 15424, 15489, 16455, 16725, 18739, 19512, 22841, 23578, 27438, 40963, 44120, 44676, 47257, 53480, 53704, 53877, 
55454, 58630, 68376, 69204, 69313, 100253 
Severe liver disease 1641, 5129, 8363, 10636, 10797, 23511, 24989, 26319, 30655, 44424, 47214, 48102, 62582, 73139, 89587, 96756, 105611 
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Table 3-5. ICD-10 codes for comorbidity in HES adopted from Bottle et al. 
Comorbidity ICD-10 codes 
Myocardial infarction  I21, I22, I23, I252, I258  
Cerebral vascular accident  
G450, G451, G452, G454, G458, G459, G46, 
I60-I69  
Heart failure  I50  
Connective tissue disorder  
M05, M060, M063, M069, M32, M332, M34, 
M353  
Dementia  F00, F01, F02, F03, F051  
Diabetes  
E101, E105, E106, E108, E109, E111, E115, 
E116, E118, E119, E131, E131, E136, E138, 
E139, E141, E145, E146, E148, E149  
Liver disease  K702, K703, K717, K73, K74  
Peptic ulcer  K25, K26, K27, K28  
Peripheral vascular disease  I71, I739, I790, R02, Z958, Z959  
Pulmonary disease  J40-J47, J60-J76  
Diabetes complications  
E102, E103, E104, E107, E112, E113, E114, 
E117, E132, E133, E134, E137, E142, E143, 
E144, E147  
Paraplegia G041, G81, G820, G821, G822  
Renal disease  
I12, I13, N01, N03, N052-N056, N072-N074, 
N18, N19, N25  
Severe liver disease  K721, K729, K766, K767  
Human immunodeficiency virus 
 
B20, B21, B22, B23, B24 
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Cancer specific variables: Cancer diagnosis will be determined in HES. This is because the indication for surgery is recorded together with the index surgical procedure in HES, and patients will be selected for analysis based on these two parameters. In patients undergoing surgery for cancer, as cancer stage is not recorded in HES (except for the presence of metastatic disease), this data will be derived from NCIN data.. For this, cancer stage will be categorized according to the TNM classification system with stage grouping I-IV.[Sobin 2009] Pathological stage will be used where data are available. If no pathological data is available, clinical or radiological staging will be used instead. Those undergoing surgery for cancer but with no cancer stage data will be categorized as cancer of unknown stage in regression analyses.  
Surgical adverse events Definition: The term SAE will be used to describe a range of markers or surrogates of surgical harm that are indicative of errors. In accordance with the Clavien-Dindo Classification, SAEs will be defined as any deviation from the normal postoperative course that is not unavoidable or intended.[Disclosure Working Group 2008, Clavien 2009] Complications that are natural sequelae of disease or surgery that are attributable to the patients’ underlying condition or incurred through treatment will not be considered as SAEs. SAEs will be recorded within 30 days of surgery to signify short-term surgical harm, as opposed to longer-term harm assessed through markers of health status.  Types of SAEs: A previous study evaluating primary care data identified adverse events using three categories of Read codes – injury and poisoning (Read Code Chapter S), cause of injury and poisoning (Read Code Chapter T) and external causes of morbidity and mortality (Read code Chapter U).[Tsang 2013] The most commonly identified adverse events in this study by Tsang et al was postoperative infection. The systematic review identified SAEs that were reported to be significantly associated with QOL. These SAEs will be the focus of analysis. Most studies evaluated the effect of all types of SAEs 
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Table 3-6. SAEs that impact on QOL evaluated in studies included in systematic review 
Type of SAE Examples 
Technical 
Organ injury 
Bile duct injury[Boerma 2001, Melton 2002, Delaney 2003, Moore 2004] 
Perforation[Constantinides 2006] 
Collection 
Anastomotic leakage[Anthony 2003, Delaney 2003, Constantinides 2006, Lim 2006, 
Rea 2007, Bloemen 2009, Scarpa 2009, Katuchova 2011, Riss 2011, Derogar 2012] 
Pelvic sepsis[Farouk 1998, Anthony 2003, Chessin 2008, Kiely 2012, Mennigen 2012] 




Superficial surgical site[Anthony 2003, Bitzer 2008, Bloemen 2009] [Delaney 
2003]infection[Farouk 1998, Anthony 2003, Sharma 2007, Kasparek 2008, Grosse 
Frie 2012, Mbah 2012] 
Dehiscence[Boer 2007] 
Seroma[Bitzer 2008] 
Deep infection[Boer 2007] 
Bleeding[Delaney 2003, Parviainen 2008, Grosse Frie 2012] 
Fistula[Constantinides 2006, Parviainen 2008] 
Obstruction 
Paralytic ileus[Anthony 2003, Kasparek 2008, Bloemen 2009, Mbah 2012] 
Anastomotic stenosis[Voitk 2002, Rea 2007, Polese 2012] 
Mechanical obstruction[Scarpa 2009] 
Parastomal hernia[Scurtu 2005, Scarpa 2010] 
Bleeding Haemorrhage[Delaney 2003, Rea 2007, Derogar 2012, Mbah 2012] 
Systemic 
Respiratory 
Venous thromboembolism[Rea 2007, Kasparek 2008, Derogar 2012] 
Pneumonia[Avery 2006, Constantinides 2006, Sharma 2007, Kasparek 2008, Derogar 
2012, Mbah 2012] 
Cardiovascular 
Myocardial infarction[Anthony 2003, Derogar 2012, Mbah 2012] 
Atrial fibrillation[Anthony 2003] 
Stroke[Anthony 2003, Derogar 2012] 
Renal 
Acute kidney injury[Delaney 2003, Boer 2007, Derogar 2012, Mbah 2012] 
Urinary retention[Anthony 2003] 
Sepsis 
Urinary tract infection[Anthony 2003, Kasparek 2008, Bloemen 2009] 
Clostridium difficile colitis[Anthony 2003, Mbah 2012] 
Process 
Prolonged or unexpected ICU stay [Avery 2006, Cense 2006] 
Reoperation[Voitk 2002, Anthony 2003, Bloemen 2009, Scarpa 2009]  
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Measuring SAEs: Guided by the findings of the systematic review, technical and systemic SAEs will be measured in HES and CPRD. The recording of diagnosis (ICD-10) coding for technical SAEs in HES including bleeding, organ injury and wound-related SAEs has previously been described. [El-Dhuwaib 2013] The recording of systemic SAEs in HES including VTE, pneumonia, acute renal failure, cerebrovascular accident and myocardial infarction using ICD-10 codes has previously been reported.[Mamidanna 2012, Almoudaris 2013, Dyer 2013] In HES, recording of technical and systemic SAEs during hospital admission for the index surgical procedure, or during subsequent admissions within 30 days of surgery will be considered as SAE.  Compared with HES, there are fewer studies of SAEs using CPRD data. Systemic and technical SAEs will be identified in CPRD using medcodes from the day after surgery to 30 days after surgery (Table 3-7). The validity of diagnosis codes in CPRD has been previously  found to be acceptable for the purposes of studying health outcome.[Herrett 2010] The NHS Information Authority Clinical Terminology Browser will be used to identify terms describing SAEs.[NHS information Authority 2009] Medcodes for a broad range of terms for SAEs will be searched for using the CPRD Medical Dictionary.  Overall SAE rates will be presented as the number of procedures in patients affected by SAEs in the study cohort. Patients will be considered to have SAEs if they are affected with at least one type of technical or systemic SAE. Multiple recordings of SAEs more than once in each database will not be counted as separate events to avoid double-counting of the same patient. Rates of SAEs identified in HES and CPRD will be compared, as well as the overlap between databases. The proportion of SAEs identified in CPRD data in addition to HES data will be calculated for each type of SAE to evaluate the value of incorporating CPRD data to measure SAEs.      
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Table 3-7. SAEs that will be measured in linked HES and CPRD 
 










Wound infection HES or CPRD 
Wound dehiscence HES or CPRD 
Bleeding HES or CPRD 
Organ injury 
 






HES or CPRD 
Pneumonia HES or CPRD 
Acute renal failure HES or CPRD 
Cerebrovascular accident HES or CPRD 
Myocardial infarction 
 
HES or CPRD 
   Time to SAE: The longitudinal nature of the CPRD database allows for the assessment of date of occurrence of SAEs relative to the index surgical procedure date. This allows for the assessment of timing between harm events. The time from surgery to SAE will be calculated as the number of days to the date of the first recording of SAE in either database. In CPRD, the event date will signify the day of recording of diagnosis by medcode. All dates in CPRD data are referenced against the first primary care registration date in each patient. In HES, time to SAE will be the discharge date as it is not possible to specify the date of the recording of SAEs in the available data. Recordings of SAE in patients who were in hospital for longer than 30 days will not be included. For SAEs recorded during hospital readmission, time to SAE will be the time from date of surgery to date of readmission.  
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Post-discharge SAE: Post-discharge SAEs will be defined as those SAEs recorded in CPRD within 30-days of surgery where the date of the medcode event was greater than the discharge date in HES. In HES, SAEs recorded during readmission within 30 days of surgery will be counted as post-discharge SAE. The proportion of SAEs recorded after hospital discharge will be calculated for each type of SAE, and presented as the percentage of post-discharge SAE over the total number of SAE.  Reoperation: Reoperation will be measured in HES using OPCS codes as previously described[E. M. Burns 2011, Almoudaris 2013] The reason for reoperation will be specified for each reoperation (Table 3-8). Re-entering the abdomen (OPCS=T301) and thorax (OPCS=T032) on the same day as the index surgical procedure will be counted as reoperation. All other OPCS codes on the same day will be considered as coding for the index procedure. Any OPCS code for a surgical procedure between the first and the 30th postoperative day will also be counted as reoperation. The reasons for reoperation will be broadly categorized as wound-related problems, bleeding, small bowel obstruction, organ resection (proctocolectomy, oesophagogastrectomy, hepatopancreatobiliary resection, cholecystectomy and appendicectomy), peritoneal washout and formation or attention to stoma according to OPCS coding. Reoperation codes that do not fit into these categories will be classified as reoperations for ‘other’ reasons.  Wound-related SAEs: Codes for wound-related SAEs will account for diagnoses described by terms including the words ‘wound’, ‘abscess’, ‘infection’, ‘dehiscence’ or a combination (Table 3-9). In HES, ICD-10 codes for wound-related SAEs will be adopted from a previous study (T857=infective reaction to implant, T814=infection following a procedure not elsewhere classified, T813=disruption of operation wound not elsewhere classified).[El-Dhuwaib 2013] As previously described in the literature, the codes T857 and T814 will be considered as codes for wound infection as other infective complications such as pneumonia are specifically coded for in HES.  
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Table 3-8. OPCS codes for reoperation in HES 
 
Reason for 
reoperation Description OPCS codes 
Wound related SAEs Surgery to skin S608 S068 S069 S089 S242 S571 S573 S572 S574 S575 S577 S578 S579 S472 S474 S478 S434 S438 S476 S352 S358 S359 S628 S132 S152 
  Repair of dehiscence  T282 T283 S424 S428 T288 T289 S421 S422 S423 S429 T313 T315 T316 T318 T774 T963  
Bleeding Re-entering of thorax or abdomen T032 T301 
Small bowel 
obstruction Division of adhesions T412 T413 T415 T423 
  Relief of small bowel obstruction G611 G618 G692 G693 G694 G698 G711 G714G718  G721 G723 G725 G731 G733 G768 G784 G786 G788 G822 G589 G638 T374 G488 G674 G535 G538 G591 G634 G715 G699 G702 G712 G713 G734 G738 G762 G763 G828 G513 G584 G588 G728 G781 G782 G824 
Organ resection Appendicectomy H011 H012 H018 H019 H021 H023 H024 H028 H029 H031 H032 H038 H039 
  Oesophagogastric resection G011 G012 G013 G018 G019 G021 G022 G023 G024 G025 G028 G029 G031 G032 G033 G034 G035 G038 G039 G271 G272 G273 G274 G275 G278 G279 G281 G282 G283 G284 G285 G288 G289 
  Proctocolectomy 
H041 H051 H053 H058 H059 H068 H071 H072 H073 H074 H083 H084 H085 H088 H091 H098 H099 H101 H102 H103 H109 H298 H305 H308 H331 H336 
H338 H339 H111 H112 H119 H122 H131 H135 H193 H161 H138 G722 H176 H178 T412 T413 T415 T423 H061 H063 H062 H064 H078 H079 H081 H082 H092 
H093 H094 H095 H104 H105 H089 H108 H332 H333 H334 H335 H113 H114 H115 H118 H198 H199 H624 H628 H192 H478 H479 H299 
      
  Hepatopancreatobiliary resection J021 J022 J023 J024 J026 J028 J029 J181 J182 J183 J183 J185 J188 J189 J271 J272 J273 J274 J275 J276 J277 J278 J279  J18 J551 J552 J553 J558 J559 J561 J562 J563 J564 J568 J569 J571 J572 J573 J574 J575 J576 J578 J579 
Peritoneal washout Open drainage of peritoneum T341 T342 T343 T348 T349 H625 
  Drainage of peritoneal cavity T461 T462 T463 T468 T469 
Stoma Formation of or attention to ileostomy G733 G739 G741 G742 G743 G748 G749 G751 G752 G753 G754 G755 G758 G759 
  Formation of or attention to colostomy H141 H142 H148 H149 H151 H152 H153 H155 H156 H158 H159 
  Formation or attention to jejunostomy G601 G602 G608 
Other Re-entering of thorax or abdomen T033 T034 T111 T112 T118 T119 T302 T303 T304 T308 T309 Y32 
  Attention to anastomosis G311 G312 G313 G314 G315 G316 G318 G319 G321 G322 G323 G324 G325 G328 G329 G320 G332 G335 G336 J301 J302 J303 J304 J305 J308 J309  273 J274 J291 J292 J321 J322 J328 J329 J378 J379 J595 J596 
  Repair of organ 
G332 M372M062 M151 M131 M132 M138 M168 M212 M218 M162 M193 M221 M264 M359 M373 M378 M379 M202 M258 M274 M335 M021 M025 
M651 M763 M764 M191 M228 M136 M292 P253 P258J021 J022 J023 J024 J025 J026 J027 J028 J029 J031 J032 J033 J034 J035 J038 J039 J041 J042 J043 
J048 J049 J051 J052 J053 J058 J059 J041 J042 J043 J048 J049 J724 J728 T891 T893 T898 T899 
  Incision of organ G385 H168 T554  J212 J241  
  Perforation of organ G351 G362 G532 G633 
  Manipulation of organ G251 G252G253 G258 G259 G387 G401 G402 G403 G404 G405 G406 G408 G409 H622 
  Operations on omentum  T361 T362 T365 T368 T369  
  Incision or examination of peritoneum T331 T411 T414 T418 T419  T428 T431 T432 T488  
  Splenectomy J691 J692 J693 J698 J699  
  Repair of abdominal hernia G231 G232 G233 G234 G238 G239 T252 T253 T259 T262 T272 T273 T278 T279 T312 
  Operations on mesentry T384 T388 T398  
  Perineal operation N242 N248 N249 P111 P131 P138 H531 H558 H581 H582 H583 H588 H589 H412 H418 H419 H464 H468 H469 H541 H568 H444 H448 Q552 
OPCS = Office of Population Census Survey Classification of Interventions and Procedures version 4.4 
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Table 3-9. Read codes and medcodes for wound-related SAEs in CPRD 
Wound-related SAE Read code Medcode Description 
Wound infection SP25500 2364 Postoperative wound infection, unspecified 
  SP25100 5613 Postoperative wound abscess 
  SP25800 8833 MRSA infection of postoperative wound 
  SP25700 16222 Postoperative wound infection superficial 
  SP25600 51854 Postoperative wound infection deep 
  SP25000 3866 Postoperative stitch abscess 
  SP28.00 17156 Postoperative wound sinus 
  SP23200 20875 Surgical wound necrosis 
  22L4.00 14822 O/E - wound infected 
  L443.12 12278 Infection - perineal wound 
Wound dehiscence SP23011 26430 Postoperative wound breakdown 
  SP23000 9766 Operation wound dehiscence 
  7H19211 25090 Suture of dehiscence of anterior abdominal wound 
  SP23.00 17140 Operation wound disruption 
  SP23100 23406 Operation wound rupture 
  SP23011 26430 Postoperative wound breakdown 
  SP23300 62668 Burst abdomen NEC   Bleeding and organ injury: Codes used to identify bleeding and organ injury will be adopted from previous studies of HES data (T812=organ injury, T810=bleeding).[El-Dhuwaib 2013] Additionally, the CPRD database will also be evaluated for recording of medcodes for postoperative bleeding and organ injury (Table 3-10).    
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Table 3-10. Read codes and medcodes used to identify bleeding and organ injury in CPRD  
 
Read code Medcode Description 
Bleeding SP21.12 17825 Haemorrhage - postoperative 
  SP21.11 8775 Haematoma - postoperative 
  SP21.00 20857 Perioperative haemorrhage or haematoma 
  SP21000 28652 Intraoperative haemorrhage 
  SP21200 31521 Postoperative haematoma formation 
  SP21100 9571 Postoperative haemorrhage 
  TA0..11 27956 Accidental haemorrhage during medical care 
  L443.11 42967 Haematoma – perineal wound 
 Organ injury SP22000 50195 Injury to blood vessel during surgery 
  SP22z00 65063 Perioperative injury NOS 
 
SP22.00 38311 Perioperative injury 
  SP22212 28397 Accidental laceration during procedure 
  SP22211 40465 Accidental bladder perforation during operation 
  SP22.12 31910 Accidental puncture during a procedure 
  SP22100 28214 Injury to nerve during surgery 
  SP22200 23475 Accidental organ perforation during a procedure 
  TA00.00 29599 Acci cut/punct/perf/haem – surgical operation 
 
TA05z12 30080 Acci cut/punct/perf/haem – procedure NOS 
  TA0..12 29897 Accidental cut during medical care 
  TA0..00 18838 Accidental cut/punct/perf/haem – medical care 
  TQ0..13 50397 Accidental perforation during medical care 
 
TA0z.00 51629 Acci cut/punct/perf/haem – medical care NOS 
TA0y.00 71205 Acci cut/punct/perf/haem – other medical care 
 TA0..14 68382 Accidental puncture during medical care 
 U610.00 43775 Unint cut/punct/perf/haem during surg/med care 
 U610000 67165 Unint cut/punct/perf/haem during surgical opn 
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Systemic SAEs: Theses postoperative events are diagnoses recorded using ICD-10 codes in HES and CPRD. The postoperative SAEs involving major organ-systems will include cardiac events, respiratory failure, renal failure and cerebrovascular events. Systemic SAEs will be recorded in HES if they are recorded during hospital admission for the index procedure and hospital stay was less than 30 days, or recorded during readmission and the readmission date was within 30 days of surgery.  In CPRD, medcodes for deep vein thrombosis (DVT) and pulmonary embolism (PE) have previously been described in the literature.[Vinogradova 2014] Validation against hospital correspondence and GP questionnaires found them to be 84% accurate.[Lawrenson 2000] VTE will be defined as a code for DVT or PE in HES or CPRD with evidence of anticoagulation between 15 days before and 90 days after the event, or death within 30 days of the event, as previously described.[Walker 2013, Walker 2014] Patients treated by anticoagulation will be identified in prescription data using prodcodes, which are codes used to record medication in CPRD. Prodcodes for oral and parenteral anticoagulation are described in Table 3-11. Only the earliest recording of VTE in either database will be counted in each patient to avoid double counting of the same patient.   Similar to VTE, diagnosis codes will be used to identify pneumonia, myocardial infarction, acute renal failure and cerebrovascular accident in CPRD and HES (Table 3-12). These SAEs will therefore be identified purely based on diagnosis coding with no criteria for using prescription records.  
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Table 3-11. Prodcodes used to identify anticoagulation therapy in CPRD 
Warfarin Heparin/Unfractionated heparin 
45, 61, 1781, 6262, 8466, 8467, 13348, 
17965, 23078, 31511, 33711, 31937, 34019, 
34758, 34864, 30203, 34299, 30202, 43408, 
34087, 34095, 43407,  34417, 34086, 833, 
36099, 43409, 44866, 40143, 34088, 48869, 
38041, 34526, 38044, 34418, 34517, 34416, 
34576, 10560, 39866, 34691, 34918, 20754,  
43655, 47944, 48070, 50000, 51484, 51496, 
51509 
 
29318, 24896, 26146, 28506, 9605, 14891, 
10170, 10194, 6695, 10044, 19486, 10002, 9593, 
9140, 22428, 49578, 48673, 10240, 14308, 
14110, 14851, 14212, 9610, 9640, 17004, 19989, 
17007, 15709, 29317, 30895, 32511, 7199, 
20154, 13270, 4995, 13210, 20153, 6478, 14138, 
13058,  37086, 7307, 7371, 7154, 2677, 13097, 
10004, 14341, 17664, 14099, 12974, 36172, 
51642, 51006, 13663, 19280, 14788, 17049, 
17592,  17484, 16061, 21233, 18634, 17791, 
18732, 21316, 27325, 18635, 29207, 2676, 
16476, 6860, 16530, 5526, 10072, 18209, 2675, 
5747,  5998, 25155, 36989, 36911, 50391, 51350, 
52004, 8664, 10532, 3895, 12681, 135568, 
35033, 20029, 20024, 14794, 20028, 47646,  
19337, 21365, 21490, 21518, 13716, 30108, 
37616,  36196, 33307, 37678, 20010, 36142, 
30396, 25287, 37131, 37613, 47633, 35941, 
35955, 15293, 37704, 28593, 31541, 42106, 
25195, 27035, 42853, 52841,  32645, 32844, 
33558, 44491, 47397, 8664, 10936, 3895, 35033, 
17216, 10449, 12681, 13568, 13716, 30108, 
37616, 36196, 33307, 37678,  36142, 37131, 
37613, 35941, 15293, 28 593, 29318, 31541, 
24896, 25195, 42853, 52841, 26146, 28506, 
32645, 53350, 44491, 47397, 50994, 32577, 

















       
CPRD medcode 1224, 824, 428, 
3392, 9255, 22038, 
25478, 3576, 
32002, 42158, 









































       
HES ICD-10 I801, I802, I260, 
I269 
I21, I22 J13, J14, J15, 
J16, J17, J18, 
J69, 
I60, I61, I62, I63, N17 
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Health status Health status can be described through the domains of impairment, disability (poor function), symptoms and physical and mental well-being. Preoperative health status including psychiatric morbidity and frailty will be measured in the 36 months before surgery. Postoperative health status including postoperative psychiatric morbidity and postoperative symptoms will be measured over twelve months after surgery. These domains of health status are a mixture of impairments, disabilities and symptoms that were selected as they have previously been described in the surgical literature.  Frailty: A mixture of impairments, symptoms and disability (poor functionality) often comprise the components of what is described as frailty.[Young J 2014]Terms describing frailty components will be searched for using the NHS terminology browser to identify medcodes describing frailty (Table 3-13).[NHS information Authority 2009] Recording of codes for ten components of frailty including cognitive impairment, incontinence, disability, history of falls, gait abnormalities, involvement of geriatrician, hearing impairment, social isolation, poor nutritional status and visual impairment will be identified in the 36 months before surgery. Although depression is recognized as a component of frailty, this will not be included as part of frailty diagnosis as psychiatric illness will be represented as a separate covariate. Recording of the same component of frailty in the same patient will be considered as a single recording of that particular frailty component. Some patients will consequently have recordings of multiple frailty components. The overall rate of frailty will be defined as the overall proportion of procedures in patients with at least one recording frailty in the 36 months before surgery. The relationship between frailty and age will be explored graphically by dividing the cohort into seven age category groups. Then demographic predictors of frailty including age group, gender and socioeconomic status will be evaluated by logistic regression analysis.  
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Table 3-13. Medcodes for frailty components in CPRD 











1694 10514 38041 1437 298 38048 52063 384 26432 52432 405 13133 38067 70317 108 10115 25943 38099 401 30206 207 654 296 
1713 10571 38060 3283 470 38052 52219 1634 28793 52452 1512 17696 38077 91940 110 10378 27678 38104 412 30208 400 1855 299 
1916 11105 38084 3381 1900 38059 52220 1759 28885 52466 2042 17877 38078 92342 117 10993 27698 50994 416 30394 968 8869 300 
1917 11106 51379 5196 3972 38069 52444 4859 29821 53082 2495 18175 38079 95586 464 11099 28609 51380 466 31962 1693 12398 555 
1993 11107 51682 6161 6544 38071 52445 6008 33529 53385 2537 19233 38080 95587 465 11419 28654 52012 467 38044 2955 12655 567 
2908 11379 51724 12727 7617 38072 52463 6815 33887 55553 2538 19724 38082 95777 1147 11634 28706 52711 536 38055 11228 12656 690 
3991 12353 51739 13421 9137 38075 52547 7970 36402 58988 2539 19725 38083 95802 1399 12077 29020 55596 686 38056 11251 29047 746 
4033 12583 52394 13422 9343 38087 52989 8694 38029 60003 2645 25953 38086 97495 1404 12078 29200 59548 1397 38085 12076 32559 1714 
5188 15165 52800 13424 24775 38088 58779 8730 38031 64722 3054 27613 38103 98558 1511 13059 30858 59653 3912 38090 13357 36455 1806 
5777 16225 52801 13426 24969 38091 58781 9951 38057 67903 4346 28112 50892 100593 1856 13060 31242 60058 4035 38092 24976 36951 2746 
5931 16797 52804 13429 24973 38093 63968 10419 38065 68579 4623 30129 51699 102945 2777 13061 31243 62418 5581 51200 26195 36995 7203 
6387 18192 52805 15400 24985 38095 66067 11307 38068 68591 7557 30131 51730 103953 3001 13202 32561 65170 5967 51744 38051 37937 19646 
6542 18636 53014 15555 24986 50884 68429 11308 38070 68600 7570 32032 54437 105471 3284 13203 32993 65412 10112 52245 53992 38024 20256 
7664 19297 53016 15918 24987 51203 69942 11709 38076 68613 9074 36256 54438 
 
4062 13284 32994 65413 10170 58602 54380 38025 51546 
8195 19565 53125 17320 25009 51228 70318 15112 38096 69762 9305 36996 54565 
 
4347 13359 32995 65425 10479 71293 96338 38054 51612 
9786 25220 53978 17620 25942 51229 91945 15745 38097 72474 9638 38030 55875 
 
4600 13360 34490 68924 10975 
  
38063 52013 
10493 25704 59122 17637 26114 51390 92049 17167 38098 93454 9990 38033 57096 
 





31256 26225 51462 92301 17638 38100 98315 11097 38034 58780 
 





38058 38028 51467 92343 17728 38101 98713 11448 38035 59521 
 
5814 13561 34791 72377 17407 
  
55220   
30706 26421 
 
38073 38039 51470 97402 18007 38102 
 
12060 38036 60130 
 
6038 15147 35323 100956 18008 
  
56315   
32057 26434 
 
38081 38040 51475 98311 19299 51427 
 
13127 38037 60785 
 




72615   
38027 27677 
 
38094 38042 51544 98448 19751 51669 
 
13128 38047 63199 
 




102563   
29386 27759 
 
52763 38043 51693 101352 21081 51851 
 
13129 38050 63322 
 
7235 20829 38049 
 
19417 




100658 38045 51765 101751 21349 52290 
 
13130 38062 66091 
 
8093 21561 38053 
 
19666 








13131 38064 67937 
 
8094 22916 38061 
 
22170 

























   
30033 
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Psychiatric morbidity: This will be identified by diagnosis codes for psychiatric illness in CPRD and HES, and prescription codes for treatment for psychiatric illness.  Codes for the diagnoses of depression, psychosis (bipolar disorder and schizophrenia) and anxiety will be measured in CPRD (Table 3-14). In HES, ICD-10 codes recorded in the first position of a hospital episode (signifying the main condition treated) for the diagnoses of depression, mania, bipolar affective disorder, delusional disorder and neurotic disorder will be identified in hospital admissions other than the hospital admission for the index surgical procedure. Prescription data will be analysed for codes for commonly used medications for psychiatric illness including antidepressants (Fluoxetine, Paroxetine, Sertraline, Citalopram, Es-Citalopram, Mitrazapine, and Venlafaxine), antipsychotics (Quetiapine, Risperidone, Olanzapine), mood stabilizers (Lithium) and anxiolytics (Diazepam and Lorazepam). Patients will be considered to have preoperative psychiatric morbidity if they had a diagnosis code in CPRD or HES, or a prescription code within 36 months before surgery. Postoperative psychiatric morbidity will be identified from the day after surgery to twelve months after surgery, and the time to the first recording of psychiatric morbidity will be recorded in each patient. For this, the date of recording of a psychiatric diagnosis will be evaluated from the date of the medcode event in CPRD, the date of admission to hospital in HES and the date of the first prescription to treat psychiatric illness in prescription data. This value will be compared to time to postoperative symptoms to evaluate whether one aspect of health status correlates with another.    
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Depression Psychosis Anxiety disorder 
            
CPRD Diagnostic 
coding 
Medcode 655, 543, 1131, 9796, 5987, 6950, 595, 5879, 
1055, 324, 6546, 10667, 7604, 15220, 7749, 
9183, 7737, 17770, 22806, 100977, 11329, 
98252, 98414, 24112, 18510, 23731, 28248, 
10720, 98346, 29527, 24117, 4639, 9211, 
2970, 10610, 11717, 11913, 10438, 9667, 
3291, 9055, 15155, 16506, 2560, 1533, 
12099, 7011, 16632, 6854, 15219, 8584, 
8478, 34390 
854, 1494, 8407, 9422, 2117, 34236, 
15733, 16764, 17281, 576, 32222, 21986, 
11055, 37681, 30619, 9281, 25546, 33410, 
39316, 10575, 18053, 35848, 6874, 14784, 
8567, 31316, 16808, 9521, 33751, 4677, 
3702, 16562, 27986, 31535, 63583, 28277, 
6710, 1531, 14728, 12173, 20110, 37070, 
12831, 17385, 19967, 60178, 26227, 4678, 
13024, 21065 
636, 4534, 4659, 6939, 10344, 9386, 5385, 
25638, 962, 23838, 9944, 50191, 35825, 









19183, 34294, 34456, 45224, 34288, 42107, 
45316, 45329, 34202, 33410, 45247, 19470, 
30258, 34216, 34856, 42803, 34849, 22, 
2548, 4075, 38890, 36893, 42499, 32401, 
42387, 44944,  488,  727, 45915, 7328, 
49519, 31168, 47966, 40160, 47945, 43239, 
33337 
 
10107, 5283, 5039, 9794, 5040, 7039, 
38885, 38912, 38906, 38840, 40779, 
40932, 44024, 45839, 46764, 46871, 
49696, 51178, 53552, 2787, 302, 2786, 
1320, 1321, 5219, 16489, 46677, 47832, 
667, 6373, 11828, 16434, 16425, 7382, 
35141, 35589, 51240 
 
34876, 28347, 34681, 3205, 34561, 20968, 
53461, 10274, 51985, 46, 46966, 45313, 47, 
34677, 46913, 45218, 12849, 41607, 9065, 
34335, 34635, 34482, 41632, 45244, 34807, 
42503, 32296, 34524, 51335, 34340, 34045, 
34338, 34033, 33672, 29945, 34615, 2352, 
53566, 34892, 3870, 45135, 9045, 9111, 
34293, 32853, 1400, 9430, 33086, 35932, 
39284, 42814, 14417, 1088, 41391, 10409, 





ICD-10 F32, F33 F20-F29, F30, F31 F40-F48 
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Postoperative symptoms: The recording of postoperative symptoms in CPRD from the day after surgery to twelve months after surgery will signify the presentation of patients to primary care with poor postoperative health status. Postoperative symptoms will be identified by the recording of medcodes, and categorized into gastrointestinal symptoms and symptoms reflecting general health status. Symptoms related to the digestive system that may affect different types of gastrointestinal surgical procedures will be measured including reflux, dysphagia, dyspepsia, vomiting, nausea, dumping, steatorrhoea, diarrhea and faecal incontinence (Table 3-15). Symptoms that are not related to the gastrointestinal tract but may also be reflective of health status following surgery include fatigue and postoperative pain (Table 3-16). The time to earliest presentation of postoperative symptoms will be calculated in each patient, by subtracting the date of surgery from the date of the occurrence of the medcode event.   
Table 3-15. Medcodes used to identify postoperative gastrointestinal symptoms in CPRD 




    
 
    
2535 1241 52278 192 257 176 10203 1437 491 
984 4281 60172 5134 43233 3992 21565 5196 5843 






























6016  37602 
   19470 
  
5039  6752 
     
  
17017  24284 
     
   
 25834 
     
   
 6101 
     
   
 17600 
     
   
 35707 
            40410       
103  
Table 3-16. Medcodes used to identify general postoperative symptoms in CPRD 












  1147 
  7235 
  29292 
  
Outcome measures While SAEs and health status may be influenced by surgery, other outcome will also be evaluated to see if they can be predicted in models incorporating SAEs and health status as predictors. Outcome measures for regression will be categorized into short-term outcome (within 30 days of surgery – mortality, readmission, prolonged hospital stay and SAEs) and long-term outcome (within twelve months of surgery – mortality, postoperative psychiatric morbidity and postoperative symptoms).  Mortality: Date and cause of death will be derived from ONS data. 30-day mortality is the most commonly reported outcome measure in surgery, and will be the primary endpoint of the analysis of short-term harm (SAEs). There is emerging evidence that there is significant variation in long-term outcome in patients undergoing gastrointestinal surgery.[Mamidanna 2012] Whether long-term harm (postoperative psychiatric morbidity and postoperative symptoms) impact on long-term mortality will be evaluated up to twelve months after surgery. As psychiatric morbidity will be assessed, the 
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proportion of deaths that were attributable to suicide will be determined using ICD-10 codes for self harm recorded in death certificates.  Readmission: Readmission rates have previously been reported in gastrointestinal surgery.[Ozturk 2009] Whether harm identified in primary care impact on readmission rates is not known. Readmission rates will be calculated using the discharge date of the index surgical admission and the admission date of any subsequent hospital admissions within 30 days of the index surgical procedure. The reason for readmission was not specified in this part of the analysis so any hospital admission 30 days from the index operation were considered as readmission.  Prolonged hospital stay: Length of stay will be calculated from the admission date and discharge date variables for the index hospital admission in HES. Length of stay will be converted into a binary outcome by considering patients in the upper quartile (25%) of length of stay in each of the nine index surgical procedures to have prolonged length of stay as previously described.[T. C. Collins 1999]  
Statistical analysis 
SPSS version 22.0 (SPSS for Windows, Chicago, Illinois) will be used to manage the databases. The primary endpoint of the proposed investigation will be the overall number of patients affected by surgical harm (SAEs) and poor health status (postoperative psychiatric morbidity and postoperative symptoms) as measured using CPRD and HES. Focus will be placed on post-discharge surgical harm not identified by HES. Rates of recording of codes for predictor and outcome covariates will be described as the proportion of procedures in patients with recording of specified codes. Time to event for long-term outcome will be compared between symptoms and psychiatric morbidity using the unpaired student t-test.  
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Binary logistic regression modelling For the purposes of modelling risk of harm, preoperative covariates will be derived from CPRD, HES, NCIN and IMD. In addition to patient and surgery characteristics, preoperative health status (preoperative psychiatric morbidity and frailty) will also be incorporated into regression models to predict outcome.  Binary logistic regression modelling will evaluate the effect of preoperative characteristics, SAEs and health status on short and long-term outcome. For these analyses, age, BMI and socioeconomic status will be considered as continuous variables. The remainder of the variables will be categorical. Any predictor variable that is not associated with at least one recording of the dependent parameter will be excluded from regression models. Collinearity between predictor covariates will be tested by deriving the variance inflation factor (VIF) for each variable in regression analyses. VIF will be recalculated for each regression analysis when new predictor covariates are entered into prediction models for outcome. A p<0.05 will be considered as significant for the predictive ability of variables included in regression analyses. After evaluating prediction models for outcome, regression analyses for the most commonly performed procedures will be undertaken to assess risk in individual surgical procedures.  
Assessing predictive performance of regression models The value of incorporating predictor covariates from linked databases to model surgical risk will be assessed by comparing the predictive performance of regression models derived from linked database covariates to those derived from HES covariates only. The predictive performance of regression models for 30-day mortality, readmission, prolonged stay, technical SAEs, systemic SAEs, one-year mortality, postoperative psychiatric morbidity and postoperative symptoms will assessed by discrimination. For this, the area under the receiver operating characteristic (ROC) curve will represent the discriminating ability of prediction models. This will be taken as a surrogate for 
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predictive performance. The ROC has previously been demonstrated to be a useful descriptive tool for evaluating whether a new predictor might be of clinical relevance, although other methods such as the likelihood ratio and Wald test also exist. [Vickers 2011] ROC values range between 0.5 (random prediction) to 1.0 (perfect discrimination). Threshold value for ROC will be set a priori so that meaningful conclusion can be drawn at the end of the analysis.  To derive the ROC, the surgical cohort will be split into two for the purposes of cross-validation.[Steyerberg 2010] Patients from the South of England (South East, South West, East Anglia). will comprise the training dataset and patients from the North of England (Midlands, North West, North East) will be in the test dataset. Geographical location will be derived from the Region variable in primary care data. Regression models will be fitted to South patients. The regression coefficients derived for each of the predictor covariates from South patients will be used to calculate the predictive probability for outcome in each North patient. Predicted outcome and true outcome will be compared in North patients to derive the ROC of prediction models.  Previous studies have reported on the clinical usefulness of models with ROC values ranging between 0.75 and 0.85.[Hannan 1992, Grover 1995, Schneeweiss 2001] In surgery, ROC values of 0.76-0.78 for morbidity and 0.91-0.93 for mortality have previously been reported from NSQIP.[Dimick 2010] It is generally considered that an ROC of less than 0.6 has no clinical value whereas an ROC of greater than 0.8 has discrimination adequate for genuine clinical utility.[Ohman 2000]  ROC values will be compared between models using HES predictor covariates only and adding in predictor covariates from linked databases, including variables for harm and health status. The difference in predictive performance between the HES model and the linked database model will be expressed as a percentage (ROC change of 0.001 corresponding to 0.2%). Previous studies have reported on prediction models of surgical harm with percentage change in the ROC of models ranging between 1.7% and 22% 
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when new covariates have been included.[Grover 1995, Schneeweiss 2001, Dimick 2012] However, what change in ROC may be of benefit is variable and must be considered separately for each clinical scenario.[Stukenborg 2001] For the purposes of this investigation, the percentage change in ROC will be assessed to compare predictive performance of models based on the HES and linked database models. However, what change in performance of models is clinically meaningful is not known. For the purposes of this investigation, the improvement in performance of prediction models following the inclusion of linked database covariates that will be accepted will be defined a priori. This will be considered as an improvement in ROC from below to above the threshold of 0.8, which will be considered as important from a clinical and policy perspective.  
Evaluation of time trends Prediction models will be used to evaluate overall trends in risk-adjusted rates of harm and poor health status in the integrated health system represented by the linked database. Patterns of outcome will be evaluated over the time-frame of the obtained dataset spanning over a decade. By identifying significant changes in outcome, insights will be gained into potential areas for improvement.  
Individual procedure analysis While regression analysis of the whole cohort allows for the comparison of risk amongst surgical procedures, subgroup analysis will focus on individual surgical procedures. The most commonly performed procedures will be scrutinized to identify patient, surgery, harm and health status characteristics derived from linked databases that may be important determinants of outcome.  
Missing data Missing numerical data of less than 10% will be addressed by imputing the mean value for the cohort for patients with missing data fields. If the proportion of missing data is greater than 10%, multiple imputation will model the missing values against known predictors and available data fields. Previous studies have demonstrated that in data 
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with 10-60% of missing values, multiple imputation is the best method for addressing the lack of data.[Barzi 2004] However, it has also been demonstrated that no imputation method is suitable for data with over 60% missing values. This threshold for an acceptable rate of missing values will be set a prior, so any covariate with over 60% missing data will be excluded from the analysis. Missing data for categorical variables will be addressed by creating a separate category for patients with unknown status.    
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4. CHAPTER FOUR - COHORT CHARACTERISTICS 
Introduction 
Surgical risk is estimated by evaluating the effect of individual risk factors on outcome. Extensive work has been done using NSQIP to derive risk-adjusted probability of harm.[Berenguer 2010] Variation in adjusted mortality risk has been demonstrated to be as high as five-fold when comparing low-volume hospitals with high-volume hospitals.[Ghaferi 2011] Hospitals in the NSQIP programme have demonstrated decreasing rates of SAEs suggesting an association between participation and quality improvement.[Hall 2009] Measuring the rate of SAEs may therefore be worthwhile as this has previously lead to observations of reduced harm. No such dedicated surgical quality registry in surgery exists in the UK.  Database linkage may facilitate the evaluation of risk by offering a greater number of predictor covariates than using HES only. BMI is recorded in primary care data and is known to be an important determinant of surgical risk.[Yasunaga 2013, Amri 2014] There is also growing emphasis on the incorporation of cancer-related variables such as disease type and stage into prediction models of risk.[Merkow 2013] Socioeconomic status has previously been reported to influence outcome, including cancer-specific survival in those undergoing surgery for malignancy.[Wu 2014] Whether such covariates lead to better prediction of risk has not been evaluated before on one platform. To understand the effects of surgical harm on patients, first, accurate regression models incorporating clinically plausible predictor covariates are needed to model risk reliably.  While NSQIP offers important insights into performance, routine data may be a more cost effective way of evaluating healthcare process on a wider scale. HES covers the entire population of England but linked data offer the potential to overcome limitations in HES such as lack of information on out-of-hospital harm and health status. If 
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regression models derived from linked data can predict risk of surgical harm better than using only HES data, there would be a case for increasing population coverage to achieve high granularity of data across the nation. To evaluate whether predictor covariates identified in linked databases can predict surgical risk accurately, patient and surgery characteristics of the study cohort must first be described. These covariates will be used in subsequent chapters to predict outcome. Outside of the setting of a prospective registry, these resources may be the most effective way of obtaining population-level information on short and long-term harm, and their impact on patients. In this chapter, the surgical cohort will be selected using HES data by the methods described in Chapter Three. Patient and surgery characteristics, including demographics, type of surgery, BMI, smoking, comorbidities, cancer stage and socioeconomic status will be derived for patients undergoing gastrointestinal surgery. These characteristics will form the bases of regression models for outcome in subsequent Chapters.  
Aim 
1. To describe patient and surgery characteristics of the study cohort  2. To quantify risk factors identified in HES and those identified in the entire linked database    
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Methods 
Recording of index surgical procedures in HES defined by procedure (OPCS) and diagnosis (ICD-10) codes allowed for the identification of the study cohort. Patients who underwent one of nine index gastrointestinal surgical procedures between 1st April 2000 and 31st March 2011 were included in the analysis. Preoperative and operative covariates for patient and surgery characteristics were defined from multiple linked databases. Surgery characteristics including surgical procedure, surgical approach (minimally invasive or open) and emergency admission were defined in HES as described in Chapter Three. Patient characteristics including demographic data (age, gender and socioeconomic status), lifestyle measures (BMI and smoking), cancer specific variables (cancer diagnosis and cancer stage) and comorbidities were derived using a combination of variables from CPRD, HES, NCIN and IMD databases. Predictor covariates were evaluated for each of the nine surgical procedure groups selected in HES. While each predictor covariate was described in its respective database of capture, comorbidities were measured by combining coding from HES and CPRD. 
Surgery characteristics 
Overall, 75854 procedures performed in 73655 patients were recorded between 1st April 2000 and 31st March 2011. This meant that 2199 procedures were performed in patients who had another index procedure performed at least 30 days apart. Each index procedure, regardless of whether it was in the same patient, was considered as separate. Overall, 2.9% (2171/73655) of patients had two index surgical procedures and no patients had more than two recorded procedures. These data were derived from patients who were identified in 364 primary care practices that were part of the CPRD database.    
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Table 4-1. Procedures and indications for surgery in 75854 gastrointestinal surgical 
procedures performed between 1st April 2000 and 31st March 2011 
    
Index Surgical procedure 
Surgical procedure  
n (%) 




Gastrectomy 683 (40.6) 
Oesophagectomy 1001 (59.4) 
 
Gastric cancer 944 (56.1) 
Oesophagus cancer 740 (43.9) 
 
Small bowel resection 
 
Jejunectomy 122 (8.8) 
Iliectomy 1260 (91.2) 
 
Small bowel cancer 161 (11.6) 
Crohn’s disease 230 (16.6) 
Bowel ischaemia 388 (28.1) 
Adhesional obstruction 548 (39.7) 




Colectomy 8707 (57.1) 
Proctectomy 6550 (32.9) 
 
Colorectal cancer 11742 (77) 
Inflammatory bowel disease  1485 (9.7) 





Hepatectomy 681 (56.3) 
Bile duct excision 85 (7.0) 
Pancreatectomy 444 (36.7) 
 
Colorectal cancer 628 (51.9) 
Primary liver/bilary cancer 285 (23.5) 




Appendicectomy  10814 (100.0) 
 




Fundoplication 1003 (100.0) 
 




Partial gastrectomy 93 (8.2) 
Manipulation of stomach 539 (47.7) 
Anastomosis of stomach to small bowel 498 (44.1) 
 




Cholecystectomy 29596 (100.0) 
 
Cholelithiasis 25557 (86.4) 




Haemorrhoidal surgery 13778 (100.0) Haemorrhoids 13778 (100.0) 
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HES data determined surgical procedure and indication for surgery (Table 4-1). Amongst the nine procedure groups, the highest number of patients was in cholecystectomy (n=29596) and the lowest number was in antireflux surgery (n=1003). For oesophagogastectomy, there were proportionally more oesophageal resections than gastric resections, although there were proportionally more gastric cancers than oesophageal cancers recorded. Most small bowel resections were of the ileum, and the commonest reasons for resection were ischaemia and adhesional obstruction. There were proportionally more colonic resections carried out than resections of the rectum, and the highest number of patients underwent surgery for malignancy. Over half of hepatopancreatobiliary resections were for secondary liver metastases. As there were no specific codes for bariatric procedures, they were derived from codes for gastric surgery with a primary ICD10 code of obesity as previously described.[E. M. Burns 2010] In the nine surgical procedure groups, the number of emergency procedures was lowest in antireflux surgery (6% - 6/1003) and highest in appendicectomy (98.8% - 10690/10814) (Table 4-2). The majority of small bowel resections were performed as emergency. The proportion of procedures performed by minimally invasive approach was lowest for haemorrhoidectomy (0% - 1/13778) and highest for cholecystectomy (89.7% - 26547/29596). Antireflux surgery and bariatric surgery were also performed by laparoscopy in most cases.   
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Table 4-2. Surgery characteristics in patients who underwent gastrointestinal surgery 
 
    
Procedure 
Patients Emergency surgery 
Minimally invasive 
approach 
n n (%) n (%) 
    
Antireflux surgery 1003 6 (0.6) 811 (80.9) 
Appendicectomy 10814 10690 (98.8) 2413 (22.3) 
Bariatric surgery 1130 2 (0.2) 904 (80.0) 
Cholecystectomy 29596 3088 (10.4) 26547 (89.7) 
Colorectal resection 15257 4221 (27.6) 1883 (12.3) 
Haemorrhoidectomy 13778 724 (5.3) 1 (0.0) 
Hepatopancreatobiliary resection 1210 60 (5.0) 106 (8.8) 
Oesophagogastric resection 1684 116 (6.9) 174 (10.3) 
Small bowel resection 1382 1109 (80.2) 59 (4.3) 
Total 75854 20016 (26.3) 37028 (32.7) 
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Patient characteristics 
Demographics After including data from both HES and CPRD, there were no missing data for age and gender. Overall, the median patient age was 55 years (IQR 40-68) (Table 4-3). The youngest patients were those who underwent appendicectomy, and the oldest patients were those who underwent colorectal resection. Overall, 58.2% (44180/75854) of patients were female. The highest proportion of female patients was in bariatric surgery, closely followed by cholecystectomy. The highest proportion of male patients was in hepatopancreatobiliary resection.  
Body mass index Overall, 56.7% (42973/75854) of patients had recorded BMI in the three years before surgery. The recording of preoperative BMI ranged between 45.8% in appendicectomy and 87.9% in bariatric surgery. The lowest mean BMI was observed in small bowel resection (BMI=25.2) while the highest was in bariatric surgery (BMI=49.1). Previous studies have shown that data on BMI may be missing in up to 50% of non-diabetes individuals. This data is missing at random and how the data is missing is dependent on whether patients are diabetic.[Taylor 2013] As the proportion of missing data rate is high, multiple imputation of missing values by chained equations was used to model BMI against age, sex, socioeconomic status, and diabetes.[Azur 2011]. The mean BMI of the surgical cohort before imputation was 28.6 (SD 6.6) and after imputation was 28.4 (SD 6.5).      
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Table 4-3. Demographics and BMI in patients who underwent gastrointestinal surgery 
      
 










      
Antireflux surgery 1003 47 (38-57) 446 (44.5) 27.6 (4.4) 560 (55.8) 
Appendicectomy 10814 36 (24-49) 4951 (45.8) 26.4 (5.3) 4948 (45.8) 
Bariatric surgery 1130 44 (37-52) 893 (79.0) 49.1 (8.1) 993 (87.9) 
Cholecystectomy 29596 53 (40-65) 22461 (75.9) 29.5 (5.9) 17983 (60.8) 
Colorectal resection 15257 69 (59-77) 7207 (47.2) 26.7 (5.1) 8779 (57.5) 
Haemorrhoidectomy 13778 52 (42-64) 6421 (46.6) 27.3 (5.3) 7201 (52.3) 
Hepatopancreatobiliary resection 1210 65 (57-72) 518 (42.8) 26.9 (4.7) 735 (60.7) 
Oesophagogastric resection 1684 68 (59-74) 795 (57.5) 26.5 (4.8) 1025 (60.9) 
Small bowel resection 1382 65 (48-76) 446 (44.5) 25.2 (5.6) 560 (55.8) 
Total 75854 55 (40-68) 44180 (58.2) 28.4 (6.5) 42973 (56.7) 
 
  
Socioeconomic status Socioeconomic status groups were assigned according to the IMD score derived from data linked to CPRD. The most affluent group with the lowest deprivation scores were designated as Class I whereas the least affluent group with the highest deprivation scores were designated as Class V. The number of missing data fields for this variable was small. Overall, 0.5% (407/75854) procedures were undertaken in patients with unknown IMD score. These patients were assigned to the middle IMD group (class III). In most of the nine surgical procedures, the largest proportion of patients was IMD group II while the smallest proportion of patients was IMD group V (Table 4-4). All procedures conformed to this pattern, except for bariatric surgery where IMD IV and V were the two groups with the largest proportion of patients. 
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Table 4-4. Socioeceonomic status as determined by the IMD 2007 score (quintiles) in patients who underwent gastrointestinal surgery 
Procedure n Class I (%) Class II (%) Class III (%) Class IV (%) Class V (%) Missing data (%) 
   
     
Antireflux surgery 1003 198 (19.7) 246 (24.5) 216 (21.5) 189 (18.8) 151 (15.1) 3 (0.3) 
Appendicectomy 10814 2494 (23.1) 2488 (23.0) 2147 (19.9) 2039 (18.9) 1551 (14.3) 95 (0.9) 
Bariatric surgery 1130 169 (15.0) 228 (20.2) 192 (17.0) 286 (25.3) 244 (21.6) 11 (1.0) 
Cholecystectomy 29596 5989 (20.2) 6863 (23.2) 6050 (20.4) 6026 (20.4) 4507 (15.2) 161 (0.5) 
Colorectal resection 15257 3525 (23.1) 3857 (25.3) 3129 (20.5) 2765 (18.1) 1921 (12.6) 60 (0.4) 
Haemorrhoidectomy 13778 2823 (20.5) 3234 (23.5) 2641 (19.2) 2703 (19.6) 2309 (16.8) 68 (0.5) 
Hepatopancreatobiliary resection 1210 308 (25.5) 308 (25.5) 272 (22.5) 194 (16.0) 127 (10.5) 1 (0.1) 
Esophagogastric resection 1684 299 (17.8) 429 (25.5) 345 (20.5) 340 (20.2) 266 (15.8) 5 (0.3) 
Small bowel resection 1382 307 (22.2) 331 (24.0) 290 (21.0) 241 (17.4) 210 (15.2) 3 (0.2) 
Total 75854 16112 (21.2) 17984 (23.7) 15282 (20.1) 14783 (19.5) 11286 (14.9) 407 (0.5) 
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Smoking The overall proportion of patients with a history of smoking in the 36 months prior to surgery was 23.8% (18087/75854). From lowest to highest, the proportion of procedures undertaken in patients with a history of smoking was 19.5% (2976/15257) in colorectal resection, 21.3% (128/1210) in hepatopancreatobiliary resection, 24.0% (3300/13778) in haemorrhoidectomy, 24.7% (2675/10814) in appendicectomy, 25.3% (7472/29596) in cholecystectomy, 25.4% (255/1003) in antireflux surgery, 25.4% (427/1684) in oesophagogastrectomy, 27.4% (379/1382) in small bowel resection and 30.5% (345/1130) in bariatric surgery.  
Cancer stage Patients who underwent surgery for indications other than malignancy were not expected to have cancer stage data. Out of the four procedures with patients undergoing surgery for cancer (colorectal resection, oesophagogastric resection, hepatopancreatobiliary resection, small bowel resection), 25.5% (3270/12823) of patients had no recorded cancer stage (Table 4-5). These patients were categorized as having cancer of unknown cancer stage. In order of increasing proportion of missing data, cancer stage was recorded in 87.4% (10264/11742) of patients undergoing colorectal resection, 56.4% (682/1210) of patients undergoing hepatopancreatobiliary resection, 33.1% (558/1684) of patients undergoing oesophagogastric resection and 14.3% (23/161) of patients undergoing small bowel resection. The most common cancer stage was stage III in all procedures except for hepatopancreatobiliary resection where stage IV was the most common stage. This is reflective of the increasing numbers of hepatectomy performed for liver metastasis from colorectal cancer.  
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Cancer stage IV 
(%) 
 
Cancer stage unknown 
(%) 
   
     
Colorectal resection 15257 11742 (77.0) 1816 (15.5) 3937 (33.5) 4039 (34.4) 472 (4.0) 1478 (12.6) 
Hepatopancreatobiliary resection 1210 1210 (100) 18 (1.5) 28 (2.3) 71 (5.9) 565 (46.7) 528 (43.6) 
Oesophagogastric resection 1684 1684 (100) 140 (8.3) 96 (5.7) 286 (17.0) 36 (2.1) 1126 (66.9) 
Small bowel resection 1382 161 (11.6) 0 (0.0) 7 (4.3) 9 (5.6) 7 (4.3) 138 (85.7) 
Total 19533 14797 (75.7) 1974 (13.3) 4068 (27.5) 4405 (29.8) 1080 (7.3) 3270 (22.1) 
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Comorbidities The overall proportion of patients with at least one comorbidity recorded in the 36 months prior to surgery in HES or CPRD was 27% (20503/75854) (Table 4-6). The overall proportion of patients with one or more comorbidities recorded in both HES and CPRD was 10.2% (7772/75854). Overall, HES recorded more comorbidities than CPRD (21% - 15918/75854 in HES, 17.4% - 13200/75854 in CPRD). Diabetes and pulmonary disease were the two most frequently recorded comorbidities in both databases. Negligible numbers of patients with HIV were identified in both databases. HES detected more diabetes, heart failure, CVA, dementia, HIV, MI, liver disease, pulmonary disease, PVD, peptic ulcer, connective tissue disease and paraplegia. CPRD identified more patients with diabetic complications and renal failure than HES. Overall, adding CPRD data to HES increased the number of procedures in patients with comorbidities by 28.8% (20503/15918). As for the concordance between HES and CPRD data, the proportion of comorbidities recorded in CPRD out of those noted in HES ranged between 0% (0/11) for HIV and 79% (3690/4670) for diabetes (Table 4-7). The proportion of comorbidities recorded in HES out of those recorded in CPRD ranged between 0% (0/0) for HIV to 81% (3690/4536) for diabetes. The proportion of HES recorded comorbidities out of those recorded in CPRD was greater than the proportion of CPRD recorded comorbidities out of those recorded in HES for eleven of the fifteen comorbidities evaluated. Overall, CPRD identified 49% (7772/15918) of patients with at least one comorbidity recorded in HES while HES identified 59% (7772/13200) of patients with at least one comorbidity recorded in CPRD. Roughly half of patients with comorbid illness identified in one database were therefore identified in the other database. 
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Table 4-6. Comorbidities recorded in HES and CPRD according to captured database in 
patients who underwent gastrointestinal surgery 
 
 





CPRD or HES 
(%) 
     
Diabetes 4670 (6.2) 4536 (6.0) 3690 (4.9) 5516 (7.3) 
Diabetic complications 309 (0.4) 546 (0.7) 106 (0.1) 749 (1.0) 
Heart failure 1099 (1.4) 526 (0.7) 264 (0.3) 1361 (1.8) 
CVA 767 (1.0) 775 (1.0) 278 (0.4) 1264 (1.7) 
Dementia 174 (0.2) 108 (0.1) 49 (0.1) 233 (0.3) 
HIV 11 (0.0) 0 (0.0) 0 (0.0) 11 (0.0) 
Myocardial infarction 1442 (1.9) 546 (0.7) 252 (0.3) 1736 (2.3) 
Liver disease 221 (0.3) 107 (0.1) 56 (0.1) 272 (0.4) 
Pulmonary disease 7707 (10.2) 4152 (5.5) 2423 (3.2) 9436 (12.4) 
Peripheral vascular disease 1009 (1.3) 690 (0.9) 316 (0.4) 1383 (1.8) 
Renal failure 1094 (1.4) 2296 (3.0) 426 (0.6) 2964 (3.9) 
Severe liver disease 120 (0.2) 28 (0.0) 14 (0.0) 134 (0.2) 
Peptic ulcer 1241 (1.6) 716 (0.9) 379 (0.5) 1578 (2.1) 
Connective tissue disease 941 (1.2) 911 (1.2) 385 (0.5) 1476 (1.9) 
Paraplegia 285 (0.4) 24 (0.0) 11 (0.0) 298 (0.4) 
*At least one recorded comorbidity 15918 (21.0) 13200 (17.4) 7772 (10.2) 20503 (27.0)  
*The sum of all comorbidities does not equal the number of patients with at least one 
comorbidity as some patients had more than one comorbidity recorded      
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Table 4-7. Concordance of comorbidity recording in HES and CPRD in patients who 
underwent gastrointestinal surgery 
 
 
*Comorbidities recorded in 
CPRD and HES / 
comorbidities recorded in 
HES (%) 
*Comorbidities recorded in 
CPRD and HES / 
comorbidities recorded in 
CPRD (%) 
   
Diabetes 3690/4670 (79) 3690/4536 (81) 
 Diabetic complications 106/309 (34) 106/546 (19) 
Heart failure 264/1099 (24) 264/526 (50) 
CVA 278/767 (36) 278/775 (36) 
Dementia 49/174 (28) 49/108 (45) 
HIV 0/11 (0)  0/0 (0) 
Myocardial infarction 252/1442 (17) 252/546 (46) 
Liver disease 56/221 (25) 56/107 (52) 
Pulmonary disease 2423/7707 (31) 2423/4152 (58) 
Peripheral vascular disease 316/1009 (31) 316/690 (46) 
Renal failure 426/1094 (39) 426/2296 (19) 
Severe liver disease 14/120 (12) 14/28 (50) 
Peptic ulcer 379/1241 (31) 379/716 (53) 
Connective tissue disease 385/941 (41)  385/911 (42) 
Paraplegia 11/285 (4) 11/24 (46) 
At least one recorded comorbidity 7772/15918 (49) 7772/13200 (59)  
*Concordance was defined as comorbidity recorded in one database (HES or CPRD) out of 
those recorded in the other database   
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When evaluating all comorbidities identified in CPRD or HES, the number of patients affected by at least one type of comorbidity was lowest in appendicectomy 15.3% (1654/10814) and highest in bariatric surgery 49.6% (561/1130) (Table 4-8 a and b). Bariatric surgery was associated with the highest rates of diabetes (31.1% - 351/1130), diabetic complications (5.6% - 63/1130), paraplegia (0.9% - 10/1130) and pulmonary disease (23.4% - 264/1130). Overall, HIV affected the smallest proportion of patients (0% - 11/75854) whereas pulmonary disease affected the largest proportion of patients (12.4% - 9436/75854). Out of those patients who had at least one comorbidity, 74% (15142/20474) had only one recorded comorbidity. The remaining patients had between two and eleven recorded comorbidities.   
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 Table 4-8 (a and b). Different types of comorbidity identified in HES or CPRD according to type of comorbidity in patients who underwent 
gastrointestinal surgery 
 














Procedure n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) 
  
         
Antireflux surgery 1003 12 (1.2) 9 (0.9) 5 (0.5) 0 (0.0) 197 (19.6) 9 (0.9) 0 (0.0) 2 (0.2) 
Appendicectomy 10814 68 (0.6) 96 (0.9) 84 (0.8) 7 (0.1) 1036 (9.6) 82 (0.8) 2 (0.0) 9 (0.1) 
Bariatric surgery 1130 18 (1.6) 17 (1.5) 16 (1.4) 0 (0.0) 264 (23.4) 20 (1.8) 0 (0.0) 6 (0.5) 
Cholecystectomy 29596 586 (2.0) 368 (1.2) 382 (1.3) 34 (0.3) 3902 (13.2) 567 (1.9) 6 (0.0) 120 (0.4) 
Colorectal resection 15257 576 (3.8) 553 (3.6) 455 (3.0) 127 (0.8) 2052 (13.4) 460 (3.0) 1 (0.0) 65 (0.4) 
Haemorrhoidectomy 13778 271 (2.0) 148 (1.1) 174 (1.3) 45 (0.3) 1384 (10.0) 195 (1.4) 2 (0.0) 31 (0.2) 
Hepatopancreatobiliary resection 1210 46 (3.8) 31 (2.6) 26 (2.1) 3 (0.2) 133 (11.0) 24 (2.0) 0 (0.0) 22 (1.8) 
Oesophagogastric resection 1684 95 (5.6) 74 (4.4) 71 (4.2) 5 (0.3) 260 (15.4) 51 (3.0) 0 (0.0) 8 (0.5) 
Small bowel resection 1382 64 (4.6) 87 (6.3) 51 (3.7) 12 (0.9) 208 (15.1) 59 (4.3) 0 (0.0) 9 (0.7) 






          
 n 
Renal 
failure Paraplegia Diabetes 
Heart 







with at least one 
comorbidity 




      
  
Antireflux surgery 1003 27 (2.7) 2 (0.2) 29 (2.9) 4 (0.4) 37 (3.7) 0 (0.0) 1 (0.1) 284 (28.3) 
Appendicectomy 10814 150 (1.4) 14 (0.1) 323 (3.0) 71 (0.7) 49 (0.5) 53 (0.5) 1 (0.0) 1659 (15.3) 
Bariatric surgery 1130 56 (5.0) 10 (0.9) 351 (31.1) 14 (1.2) 4 (0.4) 63 (5.6) 0 (0.0) 564 (49.9) 
Cholecystectomy 29596 944 (3.2) 86 (0.3) 1908 (6.4) 272 (0.9) 573 (1.9) 212 (0.7) 32 (0.1) 7689 (26.0) 
Colorectal resection 15257 1099 (7.2) 107 (0.7) 1727 (11.3) 669 (4.4) 373 (2.4) 242 (1.6) 55 (0.4) 5662 (37.1) 
Haemorrhoidectomy 13778 363 (2.6) 56 (0.4) 677 (4.9) 137 (1.0) 144 (1.0) 91 (0.7) 14 (0.1) 2839 (20.6) 
Hepatopancreatobiliary resection 1210 85 (7.0) 2 (0.2) 170 (14.0) 25 (2.1) 47 (3.9) 17 (1.4) 14 (1.2) 454 (37.5) 
Esophagogastric resection 1684 101 (6.0) 10 (0.6) 205 (12.2) 80 (4.8) 300 (17.8) 50 (3.0) 4 (0.2) 772 (45.8) 
Small bowel resection 1382 139 (10.1) 11 (0.8) 126 (9.1) 89 (6.4) 51 (3.7) 21 (1.5) 13 (0.9) 580 (42.0) 
Total 75854 2964 (3.9) 298 (0.4) 5516 (7.3) 1361 (1.8) 1578 (2.1) 749 (1.0) 134 (0.2) 20503 (27.0) 
 
(b) 




In this chapter, HES data were used to identify patients who undwent gastrointestinal surgery in linked databases. These patients had a high number of covariates for patient and surgery characteristics recorded in multiple databases. HES data offered information on age, gender comorbidities and surgery characteristics as predictor covariates. The addition of other databases increased the number of characteristics evaluated at patient-level.  HES data revealed that one quarter of patients had gastrointestinal surgery as emergency, while a third had minimally invasive surgery. Aylin et al reported similar emergency admission rates of 22.7% in the same database.[Aylin 2013]  Comorbidities identified in CPRD and not in HES made up over a quarter of all recorded comorbidities, thereby increasing the number of patients at risk. In particular, primary care data identified more patients with diabetic complications and renal failure than HES, highlighting the importance of these data when evaluating long-term conditions.  However, some conditions such as liver disease and paraplegia were poorly coded in CPRD compared with HES. As there were only eleven patients identified with HIV in either datasets, this comorbidity will be excluded from subsequent regression analyses.  It is challenging to compare the results of different studies evaluating comorbidity in routine data as analytical methods vary considerably. A previous study using HES data report on the proportion of patients with more than one comorbidity to range between 19% and 47% depending on surgical procedure.[Armitage 2010] In this study, comorbidity was measured in the year prior to surgery. In this Chapter, comorbidity was evaluated up to three years before surgery identifying 13%-50% of patients to have at least one comorbidity. Data from the Quality Outcome Framework have previously demonstrated that 58% of those aged 60 or over had at least one comorbidity while 25% had two or more comorbidities, much higher than in the presented analysis.[Department 
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of Health 2012] However, what is counted as comorbidity differs between studies. The Quality Outcome Framework includes hypertension, depression, atrial fibrillation and hypothyroidism as comorbidity that are not part of the Charlson index. Inclusion of these comorbidities would have increased overall comorbidity rates. Longitudinal data such as primary care data allow for the capture of comorbidity across a patient’s life-span. One previous study using CPRD studied all patients registered in primary care to evaluate how many had at least one recorded comorbidity in their entire health records. This study therefore looked at comorbidities over a longer timescale, and identified that 41% of patients had a comorbidity recording. This longer time frame meant that this value was higher than the value of 27% in surgical patients presented in this Chapter.[Crooks 2015] Variation in analytical methods can therefore lead to differences in comorbidity rates using similar databases.   While it is acknowledged that validation of the presented findings against other data is needed for the correct interpretation of results, this was beyond the scope of this thesis. In this thesis, it was not acceptable to use identifiable patient information to cross-reference against other data such as case notes. Generally, validation studies for the reporting of comorbidity in HES are lacking. Further work beyond the scope of this thesis should consider validation of the secondary coding for comorbidity in HES against other patient data.  For the purposes internal validation of the presented dataset, comorbidity rates were compared across different databases. This revealed that half of the patients identified as having comorbidity in HES were also identified in CPRD (Table 4-7). CPRD identified an additional 6% of patients with comorbidity (increased the overall comorbidity rate by 29% when compared to using HES data only). These data demonstrate that using the two databases together increase the number of patients with recorded comorbidity by just under a third. However, validation against HES may be of limited value as there is currently a lack of studies exploring the accuracy of comorbidity recording in HES.  
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BMI could also be considered as comorbidity, although it also reflects lifestyle. Over a half of patients had BMI recorded within 36 months before surgery, which is sufficient to perform multiple imputation of missing values. However, BMI is likely to have been recorded more often in patients with higher BMI and obesity-related complications, introducing some bias to the recording of this variable.[H. P. Booth 2013] Furthermore, it was not possible to standardize the recording of BMI in each patient. This was because BMI was recorded for different reasons in primary care. In those with recorded BMI, the recording closest to the time of surgery within three years before surgery was considered as preoperative BMI. Large-scale studies evaluating BMI changes are uncommon outside the setting of bariatric surgery. One longitudinal study demonstrated that BMI had a tendency to decrease with illness.[Stevens 2001] In gastrointestinal surgery, BMI may change depending on the condition for which patients are undergoing surgery. Due to limitations in the available data, the present analysis accepts that the recording of preoperative BMI is merely an estimate as the timing of recording varied amongst patients.  In terms of life-style variables, almost a quarter of patients admitted to smoking at some point in the 36 months before surgery. Evaluation of the UK population by survey reveals similar rates of about 20% of the population who admit to previous smoking.[HSCIC 2014] The reliable figures obtained from primary care data may be reflective of the extent of routine questioning in primary care as part of registration and health checks. Given these results, primary care may be a useful resource for identifying other lifestyle characteristics such as alcohol intake and exercise. While primary care data offered patient-specific variables, cancer registry data allowed for the determination of disease-specific variables. Overall, cancer stage was recorded in over three-quarters of patients undergoing surgery for cancer offering insight into prognosis and potential for other treatments in addition to surgery. Outcome may vary significantly depending on how advanced tumours are and whether the intention to treat 
129  
is palliative. However, recording of stage data was highly variable depending on type of cancer. The proportion of stage IV cancer in patients undergoing resectional surgery was 7.3%. Whether these patients originally underwent surgery for curative intent is not known. Socioeconomic data were recorded with a high degree of completeness, with very few patients with missing data. This confirmed that unlike other surgical patients, the majority of patients undergoing bariatric surgery were from poor socioeconomic backgrounds as previously reported in the UK.[Ahmad 2014]  Overall, linkage of patient–level data allowed for a dataset of patients with highly granular information that may be important when modeling risk of harm in gastrointestinal surgery. While NSQIP records a high number of preoperative variables to predict risk, important factors such as cancer stage are not routinely collected and therefore not part of prediction models. Furthermore, health status, which will be evaluated in a subsequent Chapter, is not part of the NSQIP dataset. By offering a greater number of preoperative covariates than using HES data alone, linked databases may be a useful resource of information to gain novel insights into risk factors associated with surgical outcome. This is despite the fact that these data are not purpose-built for assessing surgery, unlike NSQIP. Further research is necessary to standardise analytical methods and to determine the accuracy of diagnosis coding in each of the linked database components.  This will allow assessment of the potential for using these resources to monitor quality on a wider scale.  These data form the grounding for regression analysis of risk of surgical harm in the remainder of the proposed investigation. The detailed information obtained through routinely collected information may facilitate more accurate risk prediction than possible using hospital databases alone. Overall, more patients with preoperative risk factors were detected using the linked database approach. The effect of incorporating linked dataset variables into regression analyses will help judge the value of using these 
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resources to improve risk stratification models. This may serve as evidence to promote further database linkage and population coverage of this important dataset.  
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5. CHAPTER FIVE – SURGICAL ADVERSE EVENTS 
Introduction 
The systematic review revealed that SAE significantly impacts on QOL. This means that surgical harm can be associated with poor long-term health status. Having derived a panel of patient and surgery characteristics that may model risk precisely, focus will now be placed on determining the rates of measurable postoperative surgical harm. SAEs are recordings of short-term harm that may be modifiable and therefore worthy of measurement. Understanding the rates of SAEs may allow for identification of areas where harm is commonplace, thereby offering the opportunity for greater understanding and development of strategies to reduce harm. The number of different SAEs reported in the literature is high, but all harm must be measured to gain a complete picture of the burden on patients and services. Linked databases may offer the opportunity to observe SAEs from multiple perspectives across healthcare providers, and encompass all types of harm that may influence outcome.   Technical SAEs such as anastomotic leakage and wound infection have been studied as markers of surgical quality in prospective registries.[Health Protection Agency 2013, National Oesophagogastric Cancer Audit 2013] However, when using routine data, diagnosis coding may not be accurate for many technical SAEs. One study evaluating inguinal hernia repair in HES found wound infection rates to be 0.2% and 0.3% for laparoscopic and open inguinal hernia repair respectively.[El-Dhuwaib 2013] Reported rates in the literature are much higher, ranging between 1% and 2.7% depending on surgical approach.[Schmedt 2005] In this light, surveillance programs by the Health Protection Agency has evaluated wound infection rates across 17 different surgical 
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procedures.[Health Protection Agency 2013] However, not all gastrointestinal procedures are represented in these databases.  Important technical SAEs such as anastomotic leakage are not specifically coded for in HES. Instead, investigators have used surrogates such as reintervention to estimate rates of technical SAEs such as anastomotic leakage.[Buchberg 2011, Almoudaris 2013] The need for subsequent therapy means that SAEs that are treated by reintervention are at least grade III according to the Clavien-Dindo classification (Table 1-2), and are therefore associated with significant levels of harm.[Clavien 2009] To determine the overall rates of SAEs and to model the risk of harm accurately, the proposed analysis of routine data should incorporate such process measures that have been reported as important quality indicators in the past. Reoperation in particular was found to decrease QOL in the systematic review and deserves further attention [Voitk 2002, Anthony 2003, Bloemen 2009, Scarpa 2009]  Other technical SAEs that deserve consideration include bleeding and organ injury. A study using HES data to evaluate inguinal hernia repair for the entire English population reported rates of bleeding and organ injury to be 1% and 0.05% respectively.[El-Dhuwaib 2013] In this study, rates of organ injury were significantly higher following laparoscopic compared with open inguinal hernia repair. Reported rates in systematic reviews of prospective studies reveal rates to be much higher. Schmedt et al found bleeding rates to be lower for laparoscopic (8.6%) compared with open mesh (14.3%) repair.[Schmedt 2005] In light of this discrepancy between what is captured by hospital administrative data and what is observed in prospective studies, there may be a role for evaluating primary care data to assess technical SAEs, particularly for ambulatory surgery.  Surgery can also have significant effects on organ systems culminating in the need for organ support in the critical care setting.  Although focus has previously been placed on technical errors, the importance of negative physiological impact of surgery leading to 
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adverse postoperative outcome is increasingly recognized. Using hospital administrative data, Mamidanna et al found that medical morbidity including cardiac events, respiratory compromise, renal failure, stroke and VTE affected over a third of elderly patients undergoing emergency colorectal resection.[Mamidanna 2012] In upper gastrointestinal surgery systemic SAEs impacted on 22.6% of patients undergoing gastrectomy and 39% in patients undergoing oesophagectomy.[Mamidanna 2012, Mamidanna 2013] Systemic SAEs such as postoperative VTE can have devastating effects on patients. Increasing trends towards early hospital discharge mean that a significant proportion of VTE may present after hospital discharge and be treated in the ambulatory setting.[Merkow 2011, Kazaure 2012] Previous studies report that VTE risk persists up to 90 days after surgery and beyond hospital stay.[White 2003, Sweetland 2009] However, the post-discharge incidence of VTE in the general surgical population in England is difficult to estimate from hospital administrative data. Primary care data record SAEs encountered by GPs including VTE.[Tsang 2013, Walker 2014] The National Institute for Health and Care Excellence (NICE) suggest the need to scrutinise primary care data to gain a complete picture of postoperative VTE at population level and shape future thromboprophylaxis policy.[National Institute for Health and Care Excellence 2010] Linked primary care data have previously been used to measure VTE in hospitalized pregnant women and patients undergoing colorectal resection.[Abdul Sultan 2013, Walker 2014] In both studies, VTE events were recorded beyond the conventional period of thromboprophylaxis cover. Primary care data may help us gain new insights into other predisposing factors for longer-term VTE risk across different types of gastrointestinal surgical patients.    Thromboprophylaxis guidelines in the UK have originated from the THRIFT (Thromboembolic Risk Factors) Consensus Group recommendations, which were derived from in-patient data.[Thromboembolic Risk Factors (THRIFT) Consensus Group 1992] VTEs can occur in up to 80% of surgical patients if no thromboprophylaxis is given.[Geerts 2001] Rates decrease to 6-9% in early studies of surgical 
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thromboprophylaxis.[Clagett 1988, R. Collins 1988] In high-risk groups VTE may arise beyond hospital discharge and a meta-analysis confirms that cancer patients undergoing major abdominal or pelvic resection may benefit from extended thromboprophylaxis for up to 28 days after surgery.[Bottaro 2008] There is currently some debate about whether a tailored approach to post-discharge thromboprophylaxis would benefit some patients.[Bergqvist 2002] When using routine data, there remains uncertainty on whether systemic SAEs such as VTE are captured in its entirety in HES. One previous study has found low rates of SAEs such as VTE in HES. In this study, at twelve months follow-up, only 0.66% of patients undergoing urological surgery were found to have recorded VTE in HES. [Dyer 2013] For these reason, linking HES to other databases may offer more information on overall rates of VTE, as well as other systemic SAEs, justifying the proposed analysis of surgical harm using the presented linked database methodology.  Another difficulty with evaluating systemic SAEs using HES is lack of present-upon-admission flags for some SAEs. For example, it is not possible to differentiate coding for myocardial infarction and cerebrovascular accident during the index hospital admission due to lack of present-on-admission flags in HES. Primary care data may help elucidate what is the true rate of postoperative systemic SAEs. No previous study has evaluated primary care data for systemic SAEs across different surgical procedures. Although the accuracy of diagnosing medical conditions in primary care data has previously been validated, these codes have not previously been used to measure harm in the perioperative setting.[Khan 2010] The proposed investigation therefore aims to bridge this knowledge gap by offering a comprehensive overview of harm, including systemic SAEs that may be identified in the post-discharge setting. Only a few studies have recorded SAEs in primary care data. Tsang et al identified that over half of adverse events recorded in primary care data were either postoperative infection (including wound) or pain.[Tsang 2013] Walker et al demonstrated that VTE 
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risk in colorectal surgery continued to rise in the post-discharge setting particularly in those with advanced disease.[Walker 2014] Primary care data may be a valuable way of determining the overall rates of post-discharge SAEs, in addition to what has been reported in the literature already. In this chapter, whether linked databases can improve our understanding of overall rates of SAEs will be assessed. For this, the number of SAEs identified in HES and CPRD will be determined. As there is some overlap between the two databases, the number of additional SAEs identified when compared with using HES only will be quantified for each type of SAE. This will allow for the evaluation of the value of incorporating primary care data in the assessment of surgical harm using routinely collected information.  
Aims 
To measure the overall rates of SAEs using linked primary care and hospital databases  
Methods 
Technical and systemic SAEs were measured up to within 30 days of surgery from a combination of data from CPRD and HES. Technical SAEs included reoperation, wound-related SAEs, bleeding and organ injury. Systemic SAEs included VTE, myocardial infarction, cerebrovascular accident, pneumonia and acute renal failure.  While reoperation was derived from HES data only, all other SAEs were captured in varying proportion using a combination of data from HES and CPRD. These SAEs were captured by diagnosis coding in HES during the index hospital admission (during which time the index surgical procedure was performed) or if the patient was readmitted with the SAE coded in the first diagnosis position for that readmission (signifying the reason for readmission). The time of reoperation in HES was specified by the operation date for reoperation. This was irrespective of whether reoperation was during the index 
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admission or during readmission as long as it took place within 30 days of surgery. For all other SAEs, it was not possible to determine the time of recording of SAE in HES. If the SAE was recorded during the index hospital admission, the time of recording of SAE was defined as the discharge date (if the discharge date was within 30 days of surgery). If the patient was readmitted with a recording of SAE in HES, the time of recording of SAE was specified as the admission date for that readmission (within 30 days of the index surgical procedure). In CPRD, SAEs were identified by medcodes recorded together with the dates when the diagnoses were made relative to the index surgical procedure. For the analysis of post-discharge SAEs, both SAEs identified in CPRD as well as those identified in HES by readmission were evaluated to derive the total number of post-discharge SAEs recorded. This included reoperations that took place within 30 days of surgery if it was recorded during readmission.  
 
Rates of technical surgical adverse events 
Reoperation Procedure coding (OPCS) was used to identify reoperation as a surrogate for in-hospital technical SAEs. The overall number of reoperations within 30 days of the index surgical procedure identified in the study cohort was 2643. The proportion of procedures that were associated with a recording reoperation within 30 days of the index operation was 2.7% (2072/75854) (Table 5-1). The least frequently recorded reason for reoperation was bleeding (0.2% - 119/75854) and most frequently recorded reason for reoperation was organ resection (1.7% - 1302/75854). The reason for reoperation did not fit into one of the six predefined categories for reoperation in only a small proportion of patients (0.2% - 168/75854) who were categorized as having ‘other’ reasons for reoperation. The lowest reoperation rate was observed in haemorrhoidectomy (0.5% - 73/13778) and highest rate in small bowel resection (9.5% - 131/1382). Procedures associated with a 
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low reoperation rate (<2.5%) included cholecystectomy, antireflux surgery, appendicectomy, haemorrhoidectomy and bariatric surgery. The remaining four procedures were major organ resections including resections for cancer and were all associated with high (>5%) reoperation rates.  In these procedures, oesophagogastric resection was associated with the highest rates of organ re-resection, hepatopancreatobiliary resection was associated with the highest rates of bleeding, small bowel resection was associated with the highest rates of wound-related SAEs and colorectal resection was associated with the highest rates of stoma-related surgery and small bowel obstruction. The median time to reoperation within the 30-day time frame was 8 days (IQR= 3-14). Reoperation was therefore observed during the early postoperative phase.  In this analysis, HES data were used to demonstrate variation in reoperation rates amongst the evaluated gastrointestinal surgical procedures. There were also clear differences in reasons for reoperation for the nine procedures evaluated. While procedure-specific analyses exist, this was the first time reoperation rates were compared across different surgical procedures using HES data. Reoperation rates were similar to previous accounts. Burns et al reported the overall reoperation rate in colorectal surgery to be 6.5%.[EM Burns 2011] This was evaluated at 28 days after surgery, leading to a slightly lower rate than the 7.1% observed in the present analysis. The figures are plausibly similar, demonstrating the representativeness of the current cohort of surgical patients in HES based on previous studies.    
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Table 5-1. Reoperation rates according to reason for reoperation in patients who underwent gastrointestinal surgery  



















        
 
 
Antireflux surgery 1003 11 (1.1) 2 (0.2) 1 (0.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 8 (0.8) 
Appendicectomy 10814 221 (2.0) 2 (0.0) 14 (0.1) 24 (0.2) 1 (0.0) 178 (1.6) 16 (0.1) 3 (0.0) 
Bariatric surgery 1130 25 (2.2) 1 (0.1) 1 (0.1) 1 (0.1) 1 (0.1) 6 (0.5) 2 (0.2) 15 (1.3) 
Cholecystectomy 29596 338 (1.1) 27 (0.1) 18 (0.1) 20 (0.1) 3 (0.0) 274 (0.9) 10 (0.0) 1 (0.0) 
Colorectal resection 15257 1080 (7.1) 56 (0.4) 123 (0.8) 184 (1.2) 383 (2.5) 712 (4.7) 87 (0.6) 18 (0.1) 
Haemorrhoidectomy 13778 73 (0.5) 0 (0.0) 0 (0.0) 2 (0.0) 0 (0.0) 1 (0.0) 0 (0.0) 70 (0.5) 
Hepatopancreatobiliary resection 1210 69 (5.7) 12 (1.0) 4 (0.3) 12 (1.0) 4 (0.3) 39 (3.2) 4 (0.3) 3 (0.2) 
Oesophagogastric resection 1684 124 (7.4) 14 (0.8) 11 (0.7) 14 (0.8) 29 (1.7) 81 (4.8) 4 (0.2) 6 (0.4) 
Small bowel resection 1382 131 (9.5) 5 (0.4) 34 (2.5) 26 (1.9) 17 (1.2) 11 (0.8) 4 (0.3) 44 (3.2) 
Total 75854 2072 (2.7) 119 (0.2) 206 (0.3) 283 (0.4) 438 (0.6) 1302 (1.7) 127 (0.2) 168 (0.2) 
 
*The sum of all types of reoperation does not equal the total number of patients with at least one recorded reoperation as some patients had more 
than one type of reoperation recorded
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Wound-related adverse events Wound-related SAEs were captured in both CPRD and HES.  The total number of wound-related SAEs recorded was 4234. Overall, 5.4% (4093/75854) of procedures were associated with a recording of wound-related SAE in HES or CPRD databases within 30-days of surgery. The highest rate was in small bowel resection (9.6% - 133/1382) whereas the lowest rate was in haemorrhoidectomy  (0.6% - 78/13778).  Wound infection was most frequently recorded in hepatopancreatobiliary resection (8.3% - 101/1210) and least frequently recorded in haemorrhoidectomy (0.5% - 75/13778). The median number of days to wound infection was 14 (IQR 9-20). CPRD increased the detection of wound infection by 102% (1899/1869) when compared to using HES data only (Table 5-2).  Table 5-2. Thirty-day wound infection captured in HES and CPRD in patients who underwent 
gastrointestinal surgery 
 
n HES (%) CPRD (%) 
HES and 
CPRD (%) 
HES or CPRD 
(%) 
      
Antireflux surgery 1003 2 (0.2) 19 (1.9) 0 (0.0) 21 (2.1) 
Appendicectomy 10814 424 (3.9) 457 (4.2) 91 (0.8) 790 (7.3) 
Bariatric surgery 1130 13 (1.2) 47 (4.2) 4 (0.4) 56 (5.0) 
Cholecystectomy 29596 360 (1.2) 979 (3.3) 56 (0.2) 1283 (4.3) 
Colorectal resection 15257 842 (5.5) 440 (2.9) 60 (0.4) 1222 (8.0) 
Haemorrhoidectomy 13778 16 (0.1) 63 (0.5) 4 (0.0) 75 (0.5) 
Hepatopancreatobiliary resection 1210 66 (5.5) 39 (3.2) 4 (0.3) 101 (8.3) 
Oesophagogastric resection 1684 78 (4.6) 46 (2.7) 6 (0.4) 118 (7.0) 
Small bowel resection 1382 68 (4.9) 38 (2.7) 4 (0.3) 102 (7.4) 
Total 75854 1869 (1.7) 2128 (1.9) 229 (0.2) 3768 (3.3)    
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Wound dehiscence was most frequently recorded in small bowel resection (2.8% - 39/1382) and least frequently recorded in haemorrhoidectomy (0.02% - 3/13778). The median number of days from the index surgical procedure to wound dehiscence was 16 (IQR 11-22) when taking into account all data from HES and CPRD. CPRD identified an additional 12.6% (52/414) more procedures associated with wound dehiscence compared to HES data only (Table 5-3).    Table 5-3. Thirty-day wound dehiscence captured in HES and CPRD in patients who 
underwent gastrointestinal surgery 
 





      
Antireflux surgery 1003 1 (0.10) 0 (0) 0 (0) 1 (0.09) 
Appendicectomy 10814 52 (0.48) 11 (0.10) 5 (0.04) 58 (0.53) 
Bariatric surgery 1130 7 (0.62) 0 (0) 0 (0) 7 (0.61) 
Cholecystectomy 29596 45 (0.15) 20 (0.06) 1 (0.00) 64 (0.21) 
Colorectal resection 15257 248 (1.63) 28 (0.18) 10 (0.06) 266 (1.74) 
Haemorrhoidectomy 13778 1 (0.01) 2 (0.01) 0 (0) 3 (0.02) 
Hepatopancreatobiliary resection 1210 14 (1.16) 1 (0.08) 0 (0) 15 (1.23) 
Oesophagogastric resection 1684 12 (0.71) 1 (0.05) 0 (0) 13 (0.77) 
Small bowel resection 1382 34 (2.46) 9 (0.65) 4 (0.28) 39 (2.82) 
Total 113182 414 (0.37) 72 (0.06) 20 (0.01) 466 (0.41)  
 
Bleeding  Bleeding was postoperative if it was recorded in CPRD or recorded during readmission in HES. However, it was not possible to determine whether bleeding was intraoperative or postoperative if it was recorded during the index hospital admission in HES. 
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Nevertheless, the overall incidence of bleeding was derived using a combination of data from both CPRD and HES databases.  Overall, the number of recordings of bleeding was 754. Bleeding was recorded in 1% (740/75854) of procedures in HES or CPRD databases within 30-days of surgery (Table 5-4). The lowest rate was in appendicectomy (0.5% - 58/10814) and the highest rate was in hepatopancreatobiliary resection (3.2% – 39/1210). When compared with capture in HES only, CPRD helped identify 4.8% (34/706) more episodes of bleeding. The median number of days from surgery to recording of bleeding was 9 (IQR 6-14). These results suggest that while most bleeding that occurs is recorded as in-patient or during readmission, a small proportion present to and are treated entirely in the primary care setting.   
 
Table 5-4. Bleeding according to captured database in patients who underwent 
gastrointestinal surgery 
      
 





      
Antireflux surgery 1003 6 (0.6) 1 (0.1) 0 (0.0) 7 (0.7) 
Appendicectomy 10814 51 (0.5) 9 (0.1) 2 (0.0) 58 (0.5) 
Bariatric surgery 1130 10 (0.9) 2 (0.2) 0 (0.0) 12 (1.1) 
Cholecystectomy 29596 238 (0.8) 21 (0.1) 7 (0.0) 252 (0.9) 
Colorectal resection 15257 215 (1.4) 7 (0.0) 2 (0.0) 220 (1.4) 
Haemorrhoidectomy 13778 102 (0.7) 4 (0.0) 1 (0.0) 105 (0.8) 
Hepatopancreatobiliary resection 1210 39 (3.2) 2 (0.2) 2 (0.2) 39 (3.2) 
Oesophagogastric resection 1684 32 (1.9) 0 (0.0) 0 (0.0) 32 (1.9) 
Small bowel resection 1382 13 (0.9) 2 (0.1) 0 (0.0) 15 (1.1) 
Total 75854 706 (0.9) 48 (0.1) 14 (0.0) 740 (1.0) 
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Organ injury The total number of injury to organ recorded in both databases was 477. In one procedure, organ injury was recorded in both CPRD and HES databases. In all other procedures, organ injury was recorded in either HES or CPRD databases. Overall, 0.6% (476/75854) of procedures were associated with a recording of organ injury in HES or CPRD within 30-days of surgery (Table 5-5). The lowest rate was in haemorrhoidectomy (0.0% - 1/13778) and the highest rate was in oesophagogastrectomy (1.3% - 22/1662). When compared with capture in HES only, CPRD helped identify 0.4% (2/474) more episodes of organ injury. The median time to the recording of organ injury was 13 days (IQR 6-24) after surgery. The data demonstrates that organ injury occurs predominantly in hospitals instead of in the primary care setting.   
Table 5-5. Organ injury according to captured database in patients who underwent 
gastrointestinal surgery 
      
 





      
Antireflux surgery 1003 9 (0.9) 0 (0.0) 0 (0.0) 9 (0.9) 
Appendicectomy 10814 22 (0.2) 1 (0.0) 1 (0.0) 22 (0.2) 
Bariatric surgery 1130 6 (0.5) 1 (0.1) 0 (0.0) 7 (0.6) 
Cholecystectomy 29596 199 (0.7) 1 (0.0) 0 (0.0) 200 (0.7) 
Colorectal resection 15257 197 (1.3) 0 (0.0) 0 (0.0) 197 (1.3) 
Haemorrhoidectomy 13778 1 (0.0) 0 (0.0) 0 (0.0) 1 (0.0) 
Hepatopancreatobiliary resection 1210 5 (0.4) 0 (0.0) 0 (0.0) 5 (0.4) 
Oesophagogastric resection 1684 22 (1.3) 0 (0.0) 0 (0.0) 22 (1.3) 
Small bowel resection 1382 13 (0.9) 0 (0.0) 0 (0.0) 13 (0.9) 
Total 75854 474 (0.6) 3 (0.0) 1 (0.0) 476 (0.6) 
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Rates of systemic surgical adverse events 
Venous thromboembolism The total number of recorded VTE in both databases was 390. Overall, 0.4% (336/75854) of procedures were associated with a recording of VTE in HES or CPRD within 30-days of surgery (Table 5-6). The lowest rate VTE was in haemorrhoidectomy (0.0% - 5/13778), while the highest rate was in oesophagogastrectomy (1.8% - 30/1684). The addition of CPRD data helped increase the number of captured VTE by 30.2% (78/258). The median time to VTE in the two databases were 14.8 days (SD 8.2) in CPRD and 15.6 days (SD 7.9) in HES.  Table 5-6. Thirty-day VTE captured in HES and CPRD in patients who underwent 
gastrointestinal surgery 








CPRD (%)       Antireflux surgery 1003 4 (0.4) 1 (0.1) 0 (0) 4 (0.4) Appendicectomy 10814 20 (0.2) 27 (0.2) 1 (0) 35 (0.3) Bariatric surgery 1130 2 (0.2) 1 (0.1) 1 (0.1) 3 (0.3) Cholecystectomy 29596 20 (0.1) 37 (0.1) 12 (0) 49 (0.2) Colorectal resection 15257 67 (0.4) 143 (0.9) 28 (0.2) 182 (1.2) Haemorrhoidectomy 13778 2 (0) 3 (0) 0 (0) 5 (0) Hepatopancreatobiliary resection 1210 5 (0.4) 9 (0.7) 3 (0.2) 11 (0.9) Oesophagogastric resection 1684 7 (0.4) 23 (1.4) 0 (0) 30 (1.8) Small bowel resection 1382 5 (0.4) 14 (1) 2 (0.1) 17 (1.2) 
Total 75854 132 (0.2) 258 (0.3) 47 (0.1) 336 (0.4) 
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Myocardial infarction The total number of myocardial infarction recorded in both databases was 588. Overall, 0.7% (539/75854) of procedures were associated with a recording of myocardial infarction within 30-days of primary surgery in either HES or CPRD databases (Table 5-7). The addition of CPRD data helped increase the number of captured postoperative myocardial infarction by 134% (309/230). The lowest rate of myocardial infarction was in antireflux surgery (0.2% - 2/1003) while the highest rate was in small bowel resection (1.8% - 25/1382). The mean time to recording of myocardial infarction was 12.0 days (SD 8.5) in HES and 14.5 days (SD 8.7) in CPRD.  
 
Table 5-7. Thirty-day myocardial infarction captured in HES and CPRD in patients who 
underwent gastrointestinal surgery 
      





      
Antireflux 1003 2 (0.2) 1 (0.1) 1 (0.1) 2 (0.2) 
Appendicectomy 10814 85 (0.8) 6 (0.1) 2 (0) 89 (0.8) 
Bariatric 1130 3 (0.3) 0 (0) 0 (0) 3 (0.3) 
Cholecystectomy 29596 164 (0.6) 31 (0.1) 9 (0) 186 (0.6) 
Colorectal 15257 61 (0.4) 146 (1) 31 (0.2) 176 (1.2) 
Haemorrhoidectomy 13778 30 (0.2) 7 (0.1) 2 (0) 35 (0.3) 
Hepatopancreatobiliary resection 1210 3 (0.2) 4 (0.3) 1 (0.1) 6 (0.5) 
Oesophagogastrectomy 1684 3 (0.2) 15 (0.9) 1 (0.1) 17 (1.0) 
Small bowel resection 1382 7 (0.5) 20 (1.4) 2 (0.1) 25 (1.8) 
Total 75854 358 (0.5) 230 (0.3) 49 (0.1) 539 (0.7) 
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Pneumonia The total number of pneumonia recorded in both databases was 1231. Overall, 1.5% (1143/75854) of procedures were associated with a recording of pneumonia within 30-days of surgery in either CPRD or HES databases (Table 5-8). The addition of CPRD data helped increase the number of captured pneumonia by 4.7% (51/1092). The lowest rate of pneumonia was in haemorrhoidectomy 0.1% (10/13778) while the highest rate was in oesophagogastrectomy 8.4% (141/1684) The median time to recording of pneumonia was 14.7 days (SD 9.4) in HES and 11.6 days (SD 8.8) in CPRD.   
Table 5-8. Thirty-day pneumonia captured in HES and CPRD in patients who underwent 
gastrointestinal surgery 
      





      
Antireflux 1003 1 (0.1) 11 (1.1) 0 (0.0) 12 (1.2) 
Appendicectomy 10814 14 (0.1) 76 (0.7) 8 (0.1) 82 (0.8) 
Bariatric 1130 1 (0.1) 9 (0.8) 0 (0.0) 10 (0.9) 
Cholecystectomy 29596 25 (0.1) 180 (0.6) 17 (0.1) 188 (0.6) 
Colorectal 15257 70 (0.5) 543 (3.6) 48 (0.3) 565 (3.7) 
Haemorrhoidectomy 13778 2 (0.0) 8 (0.1) 0 (0.0) 10 (0.1) 
Hepatopancreatobiliary resection 1210 1 (0.1) 49 (4.0) 1 (0.1) 49 (4.0) 
Oesophagogastrectomy 1684 14 (0.8) 135 (8.0) 8 (0.5) 141 (8.4) 
Small bowel resection 1382 11 (0.8) 81 (5.9) 6 (0.4) 86 (6.2) 
Total 75854 139 (0.2) 1092 (1.4) 88 (0.1) 1143 (1.5)   
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Cerebrovascular accident The total number of cerebrovascular accident recorded in both databases was 70. Overall, 0.1% (61/75854) of procedures were associated with a recording of cerebrovascular accident within 30-days of surgery in CPRD or HES databases (Table 5-9). The lowest rate of cerebrovascular accident was in antireflux surgery (0.0% - 0/1003) and bariatric surgery (0.0% - 0/1130) where no cases of cerebrovascular accident were recorded. The highest rate of cerebrovascular accident was in small bowel resection (0.6% - 8/1382). The median time to cerebrovascular accident was 14.8 days (SD 9.7) in HES and 16.9 days (SD 9.9) in CPRD. The addition of CPRD data helped increase the number of captured cerebrovascular accidents by 38.6% (17/44).  
 
Table 5-9. Thirty-day cerebrovascular accident captured in HES and CPRD in patients who underwent gastrointestinal surgery 
      
Procedure n CPRD (%) HES (%) 
HES and 
CPRD (%) 
HES or CPRD 
(%) 
      
Antireflux 1003 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
Appendicectomy 10814 0 (0.0) 1 (0.0) 0 (0.0) 1 (0.0) 
Bariatric 1130 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
Cholecystectomy 29596 6 (0.0) 9 (0.0) 2 (0.0) 13 (0.0) 
Colorectal 15257 14 (0.1) 22 (0.1) 5 (0.0) 31 (0.2) 
Haemorrhoidectomy 13778 1 (0.0) 3 (0.0) 1 (0.0) 3 (0.0) 
Hepatopancreatobiliary resection 1210 1 (0.1) 0 (0.0) 0 (0.0) 1 (0.1) 
Oesophagogastrectomy 1684 2 (0.1) 3 (0.2) 1 (0.1) 4 (0.2) 
Small bowel resection 1382 2 (0.1) 6 (0.4) 0 (0.0) 8 (0.6) 
Total 75854 26 (0.0) 44 (0.1) 9 (0.0) 61 (0.1)   
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Acute renal failure The total number of acute renal failure recorded in both databases was 354. Overall, 0.4% (328/75854) of procedures were associated with a recording of acute renal failure within 30-days of primary surgery in HES or CPRD databases (Table 5-10). The lowest rate of acute renal failure was in antireflux surgery (0.2% - 2/1003) while the highest rate was in small bowel resection (1.8% - 25/1382). The median time to recording of acute renal failure was 14.7 days (SD 8.4) in HES and 13.7 days (SD 9.5) in CPRD. The addition of CPRD data helped increase the number of captured acute renal failure by 9.3% (28/300).  
 
 
Table 5-10. Thirty-day acute renal failure captured in HES and CPRD in patients who 
underwent gastrointestinal surgery 
      
Procedure n CPRD (%) HES (%) 
HES and 
CPRD (%) 
HES or CPRD 
(%) 
      
Antireflux 1003 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
Appendicectomy 10814 4 (0.0) 13 (0.1) 3 (0.0) 14 (0.1) 
Bariatric 1130 0 (0.0) 1 (0.1) 0 (0.0) 1 (0.1) 
Cholecystectomy 29596 11 (0.0) 29 (0.1) 2 (0.0) 38 (0.1) 
Colorectal 15257 33 (0.2) 183 (1.2) 18 (0.1) 198 (1.3) 
Haemorrhoidectomy 13778 2 (0.0) 5 (0.0) 2 (0.0) 5 (0.0) 
Hepatopancreatobiliary resection 1210 1 (0.1) 11 (0.9) 0 (0.0) 12 (1.0) 
Oesophagogastrectomy 1684 1 (0.1) 8 (0.5) 0 (0.0) 9 (0.5) 
Small bowel resection 1382 2 (0.1) 50 (3.6) 1 (0.1) 51 (3.7) 
Total 75854 54 (0.1) 300 (0.4) 26 (0.0) 328 (0.4)   
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Total rates of surgical adverse events 
The total number of technical SAEs recorded was 8093 and the total number of systemic SAEs recorded was 2407. The overall proportion of procedures with at least one type of technical SAE recorded within 30 days of surgery was 8.4% (6379/75854). The rate of technical SAEs was lowest in haemorrhoidectomy (1.7% - 229/13778) and highest in small bowel resection (18.2% - 251/1382). The overall proportion of procedures with at least one type of systemic SAE recorded within 30 days of surgery was 2.9% (2236/75854). The rate of systemic SAEs was lowest in haemorrhoidectomy (0.4% - 56/13778) and highest in small bowel resection (11.5% - 159/1382).  The total number of SAEs recorded in HES or CPRD was 10500. When evaluating results according to database of capture, the proportion of procedures with SAEs captured in HES was 7.7% (5833 /75854) while the proportion of procedures with SAEs captured in CPRD was 3.8% (2904/75854). The proportion of procedures with SAEs recorded in either database was 10.7% (8106/75854), while the proportion of procedures with SAEs recorded in both databases was 0.8% (631/75854). The addition of CPRD data to HES meant that an additional 3.0% (2273/75854) of procedures had a recording of SAEs. This equated to an additional 28.0% (2273/8106) of procedures associated with SAEs identified by CPRD but not by HES. This means that over a quarter of harm recorded was identified in primary care data only.  The overall proportion of procedures with either technical or systemic SAE was 10.7% (8106/75854) (Table 5-11). In terms of type of SAE, the proportion of procedures with both technical and systemic SAEs recorded was 0.7% (509/75853). Of the procedures with at least one recording of SAE, 81.7% (6644/8106) had only one type of SAE recorded (Table 5-12). Of those procedures with multiple SAEs recorded, 79.5% (1162/1462) had two types of SAEs recorded, 16.8% (246/1462) had three types of SAEs recorded and 3.7% (54/1462) had four or more types of SAEs recorded. Multiple SAEs were most common in procedures that included patients undergoing organ 
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resection for malignancy. The rate of more than one SAE recorded in the same procedure was highest in small bowel resection (7.0% - 97/1382) followed by oesophagogastrectomy (4.6% - 78/1684), colorectal resection (4.5% - 692/15257) and hepatopancreatobilary resection (4.5% - 54/1210). These procedures are therefore associated with multiple recordings of harm. Whether multiple harm impacts on outcome will be evaluated in subsequent regression analyses.  
 
Table 5-11. The overall rate of SAEs in patients who underwent gastrointestinal surgery 
Procedure n Technical SAE (%) Systemic SAE (%) *Any SAE (%) 
     
Antireflux 1003 44 (4.4) 17 (1.7) 59 (5.9) 
Appendicectomy 10814 949 (8.8) 213 (2.0) 1119 (10.3) 
Bariatric 1130 93 (8.2) 15 (1.3) 105 (9.3) 
Cholecystectomy 29596 1917 (6.5) 447 (1.5) 2282 (7.7) 
Colorectal 15257 2448 (16.0) 1066 (7.0) 3246 (21.3) 
Haemorrhoidectomy 13778 229 (1.7) 56 (0.4) 280 (2.0) 
Hepatopancreatobiliary resection 1210 181 (15.0) 75 (6.2) 233 (19.3) 
Oesophagogastrectomy 1684 267 (15.9) 188 (11.2) 415 (24.6) 
Small bowel resection 1382 251 (18.2) 159 (11.5) 367 (26.6) 
Total 75854 6379 (8.4) 2236 (2.9) 8106 (10.7) 
 
* The sum of procedures affected by technical and systemic SAEs does not equal the total 
number of procedures affected by SAEs as some procedures had both technical and systemic 
SAEs recorded   
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Table 5-12. The number of SAEs recorded per procedure in patients who underwent gastrointestinal surgery     
Number of SAEs n 0 (%) 1 (%) 2 (%) 3 (%) 4 (%) 5 (%) 6 (%) 
   
      
Antireflux surgery 1003 944 (94.1) 52 (5.2) 6 (0.6) 1 (0.1) 0 (0.0) 0 (0.0) 0 (0.0) 
Appendicectomy 10814 9695 (89.7) 907 (8.4) 176 (1.6) 34 (0.3) 1 (0.0) 1 (0.0) 0 (0.0) 
Bariatric surgery 1130 1025 (90.7) 87 (7.7) 17 (1.5) 1 (0.1) 0 (0.0) 0 (0.0) 0 (0.0) 
Cholecystectomy 29596 27314 (92.3) 2010 (6.8) 225 (0.8) 39 (0.1) 7 (0.0) 0 (0.0) 1 (0.0) 
Colorectal resection 15257 12011 (78.7) 2554 (16.7) 528 (3.5) 133 (0.9) 28 (0.2) 2 (0.0) 1 (0.0) 
Haemorrhoidectomy 13778 13498 (98.0) 248 (1.8) 29 (0.2) 3 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
Hepatopancreatobiliary resection 1210 977 (80.7) 179 (14.8) 38 (3.1) 11 (0.9) 5 (0.4) 0 (0.0) 0 (0.0) 
Oesophagogastric resection 1684 1269 (75.4) 337 (20.0) 65 (3.9) 9 (0.5) 4 (0.2) 0 (0.0) 0 (0.0) 
Small bowel resection 1382 1015 (73.4) 270 (19.5) 78 (5.6) 15 (1.1) 4 (0.3) 0 (0.0) 0 (0.0) 




Post-discharge surgical adverse events 
The total number of post-discharge technical SAEs recorded was 3709. Overall, 4.4% (3313/75854) of procedures were associated with a recording of post-discharge technical SAE. Of all the technical SAEs recorded, 51.9% (3313/6379) were post-discharge technical SAEs (Table 5-13). Reoperation followed readmission in 27.1% (562/2072) of those that required reoperation. All other reoperations were during hospital admission for the index surgical procedure. Postoperative wound infection was recorded after hospital discharge in 71.4% (2690/3768) of procedures, post-discharge wound dehiscence in 44% (205/466), post-discharge bleeding in 31.4% (232/740) and post-discharge organ injury in 4.2% (20/476). The procedure with the lowest proportion of post-discharge technical SAEs of all technical SAEs was oesophagogastrectomy (24% - 64/267) whereas the highest proportion of post-discharge technical SAE of all technical SAEs was observed in haemorrhoidectomy (83% - 190/229).  The total number of post-discharge systemic SAEs recorded was 753. Overall, 1.0% (726/75854) of procedures were associated with a recording of post-discharge systemic SAE. Of the systemic SAEs recorded, 32.5% (726/2236) were post-discharge systemic SAEs (Table 5-14). Amongst the systemic SAEs evaluated, the proportion of SAEs diagnosed after hospital discharge of all systemic SAEs was lowest for pneumonia (17.5% - 200/1143) and highest for myocardial infarction (55.7% - 300/539). The procedure with the lowest proportion of post-discharge systemic SAEs of all systemic SAEs was small bowel resection (13.2% - 21/159) and the procedure with the highest proportion was haemorrhoidectomy (75% -  42/56).    
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Table 5-13. Post-discharge technical SAEs in the study cohort (% denotes proportion of post-discharge SAEs out of all SAEs) 






















At least one post-
discharge 
technical SAE  
    (%) 
      
 
Antireflux surgery 5 (45.5) 21 (100.) 0 (0.0) 2 (28.6) 0 (0.0) 26 (59.1) 
Appendicectomy 134 (60.6) 621 (78.6) 36 (62.1) 34 (58.6) 2 (9.1) 705 (74.3) 
Bariatric surgery 12 (48.0) 53 (94.6) 6 (85.7) 5 (41.7) 0 (0.0) 68 (73.1) 
Cholecystectomy 177 (52.4) 1162 (90.6) 44 (68.8) 87 (34.5) 13 (6.5) 1374 (71.7) 
Colorectal resection 147 (13.6) 599 (49.0) 91 (34.2) 25 (11.4) 5 (2.5) 752 (30.7) 
Haemorrhoidectomy 58 (79.5) 71 (94.7) 3 (100.0) 74 (70.5) 0 (0.0) 190 (83.0) 
Hepatopancreatobiliary resection 7 (10.1) 52 (51.5) 6 (40.0) 3 (7.7) 0 (0.0) 62 (34.3) 
Oesophagogastric resection 9 (7.3) 53 (44.9) 5 (38.5) 2 (6.3) 0 (0.0) 64 (24.0) 
Small bowel resection 13 (9.9) 58 (56.9) 14 (35.9) 0 (0.0) 0 (0.0) 72 (28.7) 




Table 5-14. Post-discharge systemic SAEs in patients who underwent gastrointestinal surgery (% denotes proportion of post-discharge SAEs out of all 
SAEs) 






















At least one post-
discharge 
systemic SAE  
(%) 
      
 
Antireflux surgery 3 (75.0) 1 (50.0) 5 (41.7) 0 (0.0) 0 (0.0) 8 (47.1) 
Appendicectomy 16 (45.7) 77 (86.5) 24 (29.3) 0 (0.0) 3 (21.4) 119 (55.9) 
Bariatric surgery 2 (66.7) 3 (100.) 4 (40.0) 0 (0.0) 1 (100.) 8 (53.3) 
Cholecystectomy 31 (63.3) 159 (85.5) 67 (35.6) 8 (61.5) 9 (23.7) 268 (60.0) 
Colorectal resection 74 (40.7) 26 (14.8) 62 (11.0) 12 (38.7) 59 (29.8) 217 (20.4) 
Haemorrhoidectomy 3 (60.0) 31 (88.6) 6 (60.0) 2 (66.7) 1 (20.0) 42 (75.0) 
Hepatopancreatobiliary resection 4 (36.4) 1 (16.7) 8 (16.3) 1 (100.) 0 (0.0) 14 (18.7) 
Oesophagogastric resection 14 (46.7) 0 (0.0) 14 (9.9) 1 (25.0) 0 (0.0) 29 (15.4) 
Small bowel resection 3 (17.6) 2 (8.0) 10 (11.6) 0 (0.0) 6 (11.8) 21 (13.2) 




When considering technical and systemic SAEs together, the total number of SAEs recorded after the discharge date of the hospital admission for the index surgical procedure in both databases was 4462. Overall, 5.2% (3936/75854) of procedures were associated with at least one recording of post-discharge technical or systemic SAE in either HES or CPRD databases (Table 5-15). Of all SAEs recorded, 42.5% (4462/10500) were post-discharge SAEs. CPRD captured a higher number of post-discharge SAE compared with HES. Of the procedures with post-discharge SAEs, 66.6% (2624/3936) were identified through recording in CPRD. The addition of CPRD data to HES increased the detection of post-discharge SAEs by 61% (1246/1508). Out of all post-discharge SAEs identified, 31.7% (1246/3936) were detected in CPRD data only.   
Table 5-15. Post-discharge SAEs captured in HES and CPRD databases in patients who 
underwent gastrointestinal surgery 
      
Procedure n CPRD (%) HES (%) 
HES and 
CPRD (%) 
HES or CPRD 
(%) 
      
Antireflux 1003 23 (2.3) 9 (0.9) 1 (0.1) 34 (3.4) 
Appendicectomy 10814 555 (5.1) 342 (3.2) 125 (1.2) 808 (7.5) 
Bariatric 1130 53 (4.7) 22 (1.9) 6 (0.5) 75 (6.6) 
Cholecystectomy 29596 1186 (4.0) 440 (1.5) 103 (0.3) 1607 (5.4) 
Colorectal 15257 553 (3.6) 474 (3.1) 146 (1.0) 933 (6.1) 
Haemorrhoidectomy 13778 101 (0.7) 94 (0.7) 10 (0.1) 228 (1.7) 
Hepatopancreatobiliary resection 1210 44 (3.6) 35 (2.9) 8 (0.7) 74 (6.1) 
Oesophagogastrectomy 1684 56 (3.3) 45 (2.7) 16 (1.0) 91 (5.4) 
Small bowel resection 1382 53 (3.8) 47 (3.4) 16 (1.2) 86 (6.2) 
Total 75854 2624 (3.5) 1508 (2.0) 431 (0.6) 3936 (5.2) 
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Discussion 
In this chapter, overall number of SAEs identified within 30-days of surgery using the linked database methodology was 10500. The proportion of procedures affected by at least one type of SAE recorded in HES or CPRD was 10.7% (8106/75854). Over a tenth of patients undergoing gastrointestinal surgery were therefore affected by SAEs. Most procedures with recorded SAE had only one type of SAE recorded. The addition of CPRD data increased the number of all recorded SAEs except for reoperation (which was not coded in CPRD). CPRD allowed for the identification of a significant number of post-discharge SAEs. Almost half of all SAEs identified by the linked database methodology were recorded after patients were discharged from hospital. SAEs that occur after hospital discharge must therefore be taken into account to gain a comprehensive understanding of overall rates of postoperative SAEs in gastrointestinal surgery.  When evaluating SAEs that occurred after hospital discharge, post-discharge SAEs accounted for a higher proportion of the total number of SAEs in ambulatory procedures when compared with procedures that are associated with a significant length of hospital stay. The highest proportions of post-discharge technical (Table 5-13) and systemic (Table 5-14) SAEs were observed in haemorrhoidecotmy, bariatric surgery, antireflux surgery, cholecystectomy and appendicectomy. The lowest proportions of post-discharge technical and systemic SAEs were observed in major organ resections (small bowel resection, oesophagogastrectomy, colorectal resection and hepatopancreaticobiliary resection). These data demonstrate that with drives to undertake surgery with short hospital stay, primary care data may be an important resource to identify harm following ambulatory surgery.  Of the technical SAEs, reoperation, bleeding, wound dehiscence and organ injury were less frequently recorded after hospital discharge than as in-patient, meaning that these SAEs occurred predominantly during admission for the index operation. Although bleeding was recorded mainly in HES, there is some suggestion that bleeding may be 
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treated entirely in the primary care setting. Wound infection was the most commonly recorded SAE and was recorded more frequently in CPRD data than HES. Wound infection rates observed in linked databases were comparable to what has been reported in the literature. Studies evaluating NSQIP have reported on wound infection rates of 9.7-10.5% in colorectal surgery compared with 8% observed in the current investigation.[Berenguer 2010] In the UK, prospective audits have revealed the rate of wound infections to be 7%, 2.8%, 10.3% and 6.8% for hepatopancreatobiliary resection, cholecystectomy, colorectal resection and small bowel resection respectively.[Health Protection Agency 2013] These figures compare to 8.3%, 4.3%, 9.3% and 7.4% in linked data in the same procedure groups. For wound dehiscence, it was not possible to determine whether dehiscence was superficial or deep. It is probable that wound dehiscences identified in HES were deep and those identified in CPRD were superficial, although it was not possible to confirm this with the available data.  For systemic SAEs, the overall number of SAEs detected by linked databases was lower than for technical SAEs. Myocardial infarction occurred more frequently after hospital discharge. Almost a third of systemic SAEs were recorded in the post-discharge setting and may cause significant out-of-hospital harm. Longitudinal evaluation of timing of SAEs revealed that time to pneumonia and acute renal failure was longer when recorded in HES compared to CPRD. This suggests that patients who developed these types of SAEs were likely to have longer hospital stay (as time to SAE was the discharge date in HES data). Conversely, myocardial infarction and cerebrovascular accident had the highest numbers recorded after hospital discharge and the time to recording of these events was longer in primary care data. This suggests that there may be a delay in onset of cardiac and cerebrovascular events after surgery that manifests in the primary care setting. There should be greater awareness about the need to treat and refer these types of systemic SAEs in the post-discharge setting.  
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Overall, almost two-thirds of post-discharge SAEs were identified in CPRD data. The number of SAEs identified in addition to those identified in HES ranged between 0.4% and 134% depending on type of SAE. For some SAEs such as wound infection and myocardial infarction, there were over double the number of SAEs identified through the addition of primary care data. The proportion of SAEs detected in primary care data only was almost a third, indicating that these SAEs did not lead to readmission and were treated entirely in the primary care setting.  Of the nine types of gastrointestinal procedures examined, the four major organ resections that included patients undergoing resection for cancer (colorectal, oesophagogastric, hepatopancreatobiliary, small bowel) had the highest rates of both technical and systemic SAEs. Of these, small bowel resection was associated with the highest rates of both technical and systemic SAEs, most likely due to the high proportion of operations in this group performed as emergency and the fact that almost a quarter of these patients had ischaemic bowel, which is associated with significant physiological insult, vascular comorbidity and poor outcome. Linked database analysis therefore demonstrated that small bowel resection is associated with significant levels of harm when compared with other types of gastrointestinal surgical procedures. These findings suggest the need to reduce harm particularly in small bowel resection.  Overall, post-discharge SAEs accounted for a greater proportion of overall SAEs in procedures  associated with shorter hospital stay including haemorrhoidectomy, bariatric surgery, antireflux surgery, appendicectomy and cholecystectomy. Functional procedures such as antireflux and bariatric surgery were also associated with a greater proportion of post-discharge SAEs, although the overall rates of SAEs in these procedures were relatively low. These findings suggest that primary care data may be particularly useful when evaluating harm related to procedures with short hospital stay.  One limitation of the presented method was that it was necessary for patients to present to primary care for postoperative SAEs to be recorded in this database. The accuracy of 
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the presented method is therefore reliant on the accuracy of diagnosis by GPs. Further studies are necessary to validate the diagnostic accuracy of primary care data. The true rates of events, including those that did not lead to the patient seeking medical attention is not known. However, SAEs that are considered to be severe enough to warrant medical attention by patients by going to their doctors are represented in these results.  Linked primary care and hospital databases were used to quantify the overall rates of technical and systemic SAEs within 30 days of gastrointestinal surgery. In light of increasing trends towards early hospital discharge, primary care data may be a useful way of determining surgical harm that occurs that is not captured by hospitals. These data will be combined with covariates describing patient and surgery characteristics presented in the previous chapter, to derive regression models for assessment of the influence of short-term surgical harm on outcome.    
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6. CHAPTER SIX –HEALTH STATUS 
Introduction 
Previous evaluations of routine data have typically focused on measurable surgical outcome including perioperative mortality, morbidity and survival. There is also growing emphasis on technical failures that may be implicated in patient safety. However, there is an increasing recognition of the importance of the impact of surgery on overall health status. Metrics of health status such as QOL are being incorporated into health economic analyses.[Chow 2009] Some argue that QOL is the most important outcome in surgery. Consequently, there are population-level analyses of patient-reported outcome including QOL in some commonly performed surgical procedures as part of the PROMS project.[HSCIC 2015] The systematic review presented in Chapter One demonstrated that SAEs are significantly associated with QOL. In many of the studies, the effects on QOL lasted for several months after surgery. Both physical and mental components of QOL were affected by SAEs, signifying the longer-term effects of surgery and related harm on both physical and mental aspects of health status. There is also growing evidence that preoperative QOL predicts outcome.[Blazeby 2005] While analysis of adverse symptoms was excluded from the systematic review, symptoms are an integral part of assessing health status. Many disease-specific QOL tools such as the QLQ-C30 (EuroQol) incorporate postoperative symptoms as measures of health status following surgery. Domains of health status that represent impairment, disability, symptoms and well-being may therefore be worthy of measurement in the proposed linked database methodology, as markers of both preoperative risk as well as postoperative outcome.  The psychological impact of disease and surgery has previously been studied in prospective studies. A previous meta-analysis showed that mental illness can be prevalent in up to one third of patients with cancer in acute care hospitals.[Singer 2010] 
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A study of 1615 patients from the Swedish National Database found that 2.5% and 4.2% of patients were treated for psychiatric illnesses in in-patient and outpatient settings respectively following oesophagogastric cancer resection [Wikman 2015] In this study, the authors reported on increased mortality risk associated with in-patient psychiatric care (OR=1.65), outpatient psychiatric care (OR=1.93) and psychotropic medication (OR=2.77). Primary care data have previously been used to assess psychiatric morbidity associated with illness, in one example between asthma and depression.[Walters 2011] No previous study has evaluated psychiatric morbidity in surgical patients using primary care and hospital data together. Furthermore, no previous study has reported on the frequency of both preoperative and postoperative psychiatric morbidity in one sitting.   Other measures of health status such as frailty are also emerging as determinants of outcome.[Robinson 2013]. There is growing recognition of the importance of primary care data in evaluating frailty.[Drubbel 2014] Studies have previously shown that preoperative frailty correlates with morbidity and mortality in surgery.[Velanovich 2013] Frailty captures a range of components that indicate poor health status. Some components, such as cognitive impairment may overlap with comorbidity coding for dementia. Other frailty indicators include comorbidities such as incontinence and gait abnormality, but they are not part of the Charlson index and therefore not routinely evaluated in population-level analyses. Markers of frailty also include process metrics such as involvement of geriatric services indicating the need for specialist input. These components of frailty have been reported extensively in the literature and fall into twelve major groups.[Drubbel 2014, Young J 2014] Of these, emergency admission and psychiatric morbidity are represented by other covariates in the proposed linked databases. To avoid excessive interaction between variables, these will be excluded as frailty components. The ten remaining components of frailty identified in the literature will be measured in primary care data to evaluate their rate and impact on surgical harm and outcome.  
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Some studies have used primary care data to evaluate other aspects of health status after surgery. Using CPRD, Booth et al demonstrated a reduction in clinical diabetes following bariatric surgery, as a marker of metabolic function.[H. Booth 2014] Primary care data have also been used to evaluate symptoms in gastrointestinal disease. One study demonstrated that the absence of presentations with symptoms in primary care is associated with poor cancer survival.[Dregan 2013] These data indicate that primary care data is a useful resource for assessing symptoms leading to diagnosis, and this concept may be extrapolated to the postoperative setting to assess health status. This type of analysis has not previously been undertaken.  Health status has not been previously evaluated in surgical patients at population level using routinely collected information. This may be because hospital administrative data lack information on health status. Furthermore, quality registries such as NSQIP focus on short-term outcome due to high running costs associated with longer-term follow-up. By incorporating all influencing variables in one database, the proposed investigation aims to evaluate longer-term health status in patients, together with short-term harm and patient and surgery characteristics derived from linked databases. In this Chapter, frailty, psychiatric morbidity, and postoperative symptoms will be measured to gain a better understanding of health status before and after gastrointestinal surgery.   
Aims 
• To assess preoperative and postoperative health status in gastrointestinal surgery  
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Methods 
Recording of markers of preoperative and postoperative health status were identified in linked databases from 36 months before surgery to twelve months after surgery. Any recording on the day of surgery was considered as preoperative. Measures of preoperative health status included frailty and preoperative psychiatric morbidity, while measures of postoperative health status included postoperative psychiatric morbidity and symptoms. Frailty and symptoms were derived entirely from CPRD data, while psychiatric morbidity was derived from a combination of data from CPRD and HES. Medcodes for frailty, symptoms and psychiatric diagnoses were identified in CPRD, while ICD-10 codes were used to identify psychiatric diagnoses that lead to readmission in HES. Additionally, prescription data were used to identify treatment for psychiatric illnesses. Prescription data linked to CPRD have previously been used to evaluate the use of psychiatric medication in England.[Hassan 2014] Those with postoperative psychiatric morbidity with no history of preoperative psychiatric morbidity were considered as new onset postoperative psychiatric morbidity. The time to postoperative psychiatric morbidity was calculated as the time from surgery to recording of psychiatric morbidity in each of the three databases. The time to postoperative symptom was calculated as the time from surgery to time of recording of medcode in the CPRD database.  
Frailty 
There were 18703 recordings of frailty in patients undergoing gastrointestinal surgery. The overall proportion of procedures with at least one code for frailty recorded in the 36 months prior to surgery was 18.1 % (13752/75854) (Table 6-1). The number of procedures in patients with at least one previous recording of frailty was lowest in appendicectomy 10.5% (1331/10814) and highest in bariatric surgery 26% (294/1130). 
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Patients undergoing bariatric surgery had the highest rates of many components of frailty including isolation, poor nutrition, incontinence and disability. Of the different components of frailty recorded, poor nutrition was the least frequently recorded component of frailty 0.6% (489/75854) whereas involvement of a specialist geriatric service was the most commonly recorded component of frailty 6% (4556/75854). Of the 13752/75854 (18.1%) of patients who had at least one recording of frailty, 91.4% (5540/6062) had only one frailty component recorded only. The remaining patients with recorded frailty had between two and five different types of frailty recorded within 36 months before surgery.  
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Table 6-1. Preoperative frailty recorded within 36 months before surgery in patients who underwent gastrointestinal surgery  
Procedure n 

























             
Antireflux surgery 1003 137 (13.7) 21 (2.1) 15 (1.5) 17 (1.7) 3 (0.3) 13 (1.3) 5 (0.5) 12 (1.2) 3 (0.3) 19 (1.9) 53 (5.3) 
Appendicectomy 10814 1131 (10.5) 210 (1.9) 164 (1.5) 121 (1.1) 46 (0.4) 48 (0.4) 38 (0.4) 101 (0.9) 71 (0.7) 94 (0.9) 410 (3.8) 
Bariatric surgery 1130 294 (26.0) 59 (5.2) 24 (2.1) 42 (3.7) 31 (2.7) 27 (2.4) 7 (0.6) 23 (2.0) 24 (2.1) 50 (4.4) 83 (7.3) 
Cholecystectomy 29596 5234 (17.7) 1032 (3.5) 703 (2.4) 638 (2.2) 169 (0.6) 361 (1.2) 185 (0.6) 577 (1.9) 308 (1.0) 501 (1.7) 1750 (5.9) 
Colorectal resection 15257 3697 (24.2) 824 (5.4) 549 (3.6) 385 (2.5) 138 (0.9) 210 (1.4) 245 (1.6) 551 (3.6) 365 (2.4) 329 (2.2) 1221 (8.0) 
Haemorrhoidectomy 13778 2306 (16.7) 438 (3.2) 376 (2.7) 248 (1.8) 49 (0.4) 178 (1.3) 145 (1.1) 265 (1.9) 135 (1.0) 220 (1.6) 763 (5.5) 
Hepatopancreatobiliary resection 1210 229 (18.9) 36 (3.0) 34 (2.8) 17 (1.4) 10 (0.8) 10 (0.8) 12 (1.0) 27 (2.2) 14 (1.2) 45 (3.7) 68 (5.6) 
Oesophagogastric resection 1684 350 (20.8) 72 (4.3) 61 (3.6) 40 (2.4) 22 (1.3) 10 (0.6) 24 (1.4) 52 (3.1) 20 (1.2) 38 (2.3) 101 (6.0) 
Small bowel resection 1382 374 (27.1) 86 (6.2) 52 (3.8) 40 (2.9) 21 (1.5) 20 (1.4) 36 (2.6) 42 (3.0) 48 (3.5) 52 (3.8) 107 (7.7) 
Total 75854 13752 (18.1) 2778 (3.7) 1978 (2.6) 1548 (2.0) 489 (0.6) 877 (1.2) 697 (0.9) 1650 (2.2) 988 (1.3) 1348 (1.8) 4556 (6.0) 
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Age and frailty The overall rate of preoperative frailty increased with age. The proportion of procedures in patients with previously recorded frailty ranged between 9.6% (767/8004) in the 1-29 years age group, to 46.6% (2299/4936) in the over 79 years age group (Figure 6-1). Logistic regression analysis revealed that when adjusted for demographic factors including gender and socioeconomic status, age independently predicted the recording of preoperative frailty (Table 6-2). The odds ratio for preoperative frailty increased with increasing age group. Compared with the reference category of the youngest patients (18-29 years), the oldest patients (>79 years) had almost a nine-fold increase in risk of preoperative frailty (OR=8.81). When adjusted for age group, both female gender (OR=1.57) and poor socioeconomic status (OR=1.06) were independent predictors of preoperative frailty. These findings suggest that while coding for frailty in primary care electronic health records correlate with age, the evaluation of this parameter in regression models may clarify the relationship between age and health status, and how they lead to poor outcome.  
 Figure 6-1. Proportion of procedures with at least one preoperative recording of frailty 
according to age group in patients who underwent gastrointestinal surgery 
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Table 6-2. Predictors of preoperative frailty in patients who underwent gastrointestinal surgery 
   
Dependent variable = Preoperative 
frailty 
Odds ratio (95% CI) 














30-39 1.12 (1.01-1.23) 0.027 
40-49 1.48 (1.35-1.63) <0.001 
50-59 1.70 (1.56-1.86) <0.001 
60-69 2.16 (1.98-2.36) <0.001 
70-79 3.91 (3.59-4.26) <0.001 




When combining data from CPRD, HES and prescriptions, there were 29485 recordings of psychiatric morbidity between 36 months before surgery and twelve months after surgery (Figure 6-2). The total number of procedures affected by either preoperative or postoperative psychiatric morbidity was 22.8% (17292/75854). Out of these procedures, the total number affected by both preoperative and postoperative psychiatric morbidity was 31.2% (5507/17292). Overall, medication data identified the greatest number of patients with psychiatric morbidity while HES data identified the smallest number (Figure 6-2). The greatest overlap in recording of psychiatric morbidity 
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was seen between CPRD diagnosis data and prescription data (18.3% - 5409/29485). The overlap between prescription data and HES was 3.5% (1034/29485) while the overlap between CPRD diagnosis data and HES was 2.5% (733/29285). Only 1.7% (490/29485) recordings of psychiatric morbidity were identified in the same patient in all three databases.   
Figure 6-2. Overlap between databases in capturing psychiatric morbidity in linked HES, CPRD 
and prescription data.  
  
Preoperative psychiatric morbidity The total number of recordings of preoperative psychiatric morbidity in linked databases was 18943. Overall, 18.6% (14140/75854) of procedures were associated with preoperative psychiatric morbidity (Table 6-3). Recording of preoperative psychiatric morbidity was lowest in hepatopancreatobiliary resection (13.9% - 168/1210) and highest in bariatric surgery (41.1% - 464/1130). Procedures that were not for resection 
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of malignancy (cholecystectomy, haemorrhoidectomy, appendicectomy, antireflux surgery) were generally associated with high rates of preoperative psychiatric morbidity. Compared to these patients, those undergoing major organ resection for cancer had lower rates of preoperative psychiatric morbidity. Prescription data identified the greatest number of patients with preoperative psychiatric morbidity. HES identified the least number of patients with preoperative psychiatric morbidity.  
 
 
Table 6-3. Preoperative psychiatric morbidity recorded within 36 months before surgery 
according to captured database in patients who underwent gastrointestinal surgery 
 n HES (%) CPRD (%) 
Prescription 
(%) 
At least one 
recording  (%) 
      
Antireflux surgery 1003 25 (2.5) 115 (11.5) 185 (18.4) 243 (24.2) 
Appendicectomy 10814 106 (1.0) 972 (9.0) 1227 (11.3) 1718 (15.9) 
Bariatric surgery 1130 55 (4.9) 223 (19.7) 356 (31.5) 464 (41.1) 
Cholecystectomy 29596 545 (1.8) 3301 (11.2) 4542 (15.3) 6197 (20.9) 
Colorectal resection 15257 201 (1.3) 1019 (6.7) 1668 (10.9) 2212 (14.5) 
Haemorrhoidectomy 13778 196 (1.4) 1383 (10.0) 1946 (14.1) 2636 (19.1) 
Hepatopancreatobiliary resection 1210 10 (0.8) 77 (6.4) 140 (11.6) 168 (13.9) 
Oesophagogastrectomy 1684 42 (2.5) 101 (6.0) 153 (9.1) 240 (14.3) 
Small bowel resection 1382 33 (2.4) 133 (9.6) 189 (13.7) 262 (19.0) 
Total 75854 1213 (1.6) 7324 (9.7) 10406 (13.7) 14140 (18.6) 
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Three different types of preoperative psychiatric morbidity were recorded in linked databases (Table 6-4). Overall, depression (12.9% - 9761/75854) was the most common type of preoperative psychiatric morbidity recorded in patients who underwent gastrointestinal surgery. Psychosis (1% - 724/75854) was the least frequently recorded type of preoperative psychiatric morbidity. Bariatric surgery was associated with the highest rates of all three types of psychiatric morbidity. Appendicectomy was associated with the lowest rates of preoperative anxiety whereas hepatopancreatobiliary resection was associated with the lowest rates of preoperative depression. Appendicectomy, oesophagogastrectomy and hepatopancreatobiliary resection were associated with the lowest rates of preoperative psychosis. 
 
Table 6-4. Preoperative psychiatric morbidity recorded within 36 months before surgery 
according to type of psychiatric illness in patients who underwent gastrointestinal surgery 







At least one 
recording (%) 
      
Antireflux surgery 1003 102 (10.2) 175 (17.4) 12 (1.2) 243 (24.2) 
Appendicectomy 10814 674 (6.2) 1258 (11.6) 81 (0.7) 1718 (15.9) 
Bariatric surgery 1130 178 (15.8) 384 (34.0) 27 (2.4) 464 (41.1) 
Cholecystectomy 29596 2741 (9.3) 4395 (14.8) 318 (1.1) 6197 (20.9) 
Colorectal resection 15257 1157 (7.6) 1306 (8.6) 118 (0.8) 2212 (14.5) 
Haemorrhoidectomy 13778 1218 (8.8) 1827 (13.3) 131 (1.0) 2636 (19.1) 
Hepatopancreatobiliary resection 1210 99 (8.2) 97 (8.0) 8 (0.7) 168 (13.9) 
Oesophagogastrectomy 1684 133 (7.9) 136 (8.1) 11 (0.7) 240 (14.3) 
Small bowel resection 1382 119 (8.6) 183 (13.2) 18 (1.3) 262 (19.0) 
Total 75854 6421 (8.5) 9761 (12.9) 724 (1.0) 14140 (18.6)   
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Postoperative psychiatric morbidity The total number of recordings of postoperative psychiatric morbidity in linked databases was 10542. Overall, 11.4% (8659/75854) of procedures were associated with postoperative psychiatric morbidity (Table 6-5). Recording of postoperative psychiatric morbidity was lowest in appendicectomy (9% - 969/10814) and highest in bariatric surgery (22.1% - 250/1130). Excluding patients who underwent bariatric surgery, patients who underwent oesophagogastrectomy and hepatopancreatobiliary resection had the highest rates of postoperative psychiatric morbidity. Prescription data identified the greatest number of patients with postoperative psychiatric morbidity. HES identified the least number of patients with postoperative psychiatric morbidity.  
 
Table 6-5. Postoperative psychiatric morbidity recorded within twelve months after surgery 
according to captured database in patients who underwent gastrointestinal surgery 
 n HES (%) CPRD (%) 
Prescription 
(%) 
At least one 
recording (%) 
      
Antireflux surgery 1003 13 (1.3) 57 (5.7) 104 (10.4) 142 (14.2) 
Appendicectomy 10814 85 (0.8) 411 (3.8) 701 (6.5) 969 (9.0) 
Bariatric surgery 1130 38 (3.4) 61 (5.4) 207 (18.3) 250 (22.1) 
Cholecystectomy 29596 266 (0.9) 1350 (4.6) 2787 (9.4) 3600 (12.2) 
Colorectal resection 15257 197 (1.3) 515 (3.4) 1164 (7.6) 1550 (10.2) 
Haemorrhoidectomy 13778 115 (0.8) 588 (4.3) 1249 (9.1) 1614 (11.7) 
Hepatopancreatobiliary resection 1210 22 (1.8) 52 (4.3) 123 (10.2) 163 (13.5) 
Oesophagogastrectomy 1684 37 (2.2) 79 (4.7) 160 (9.5) 234 (13.9) 
Small bowel resection 1382 24 (1.7) 37 (2.7) 100 (7.2) 137 (9.9) 
Total 75854 797 (1.1) 3150 (4.2) 6595 (8.7) 8659 (11.4) 
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When considering the different types of postoperative psychiatric morbidity, depression (7.8% - 5926/75854) was the most common type of post-operative psychiatric morbidity affecting patients undergoing gastrointestinal surgery (Table 6-6). Psychosis (0.7% - 567/75854) was the least frequently recorded type of postoperative psychiatric morbidity. Oesophagogastrectomy was associated with the highest number of recordings for postoperative anxiety. Postoperative depression and psychosis was most frequently recorded following bariatric surgery. Appendicectomy was associated with the lowest rates of postoperative anxiety and depression, while oesophagogastrecotmy was associated with the lowest rates of postoperative psychosis.  
 
Table 6-6. Postoperative psychiatric morbidity recorded within twelve months after surgery 
according to type of morbidity in patients who underwent gastrointestinal surgery 







At least one 
recording (%) 
      
Antireflux surgery 1003 51 (5.1) 97 (9.7) 10 (1.0) 142 (14.2) 
Appendicectomy 10814 335 (3.1) 709 (6.6) 71 (0.7) 969 (9.0) 
Bariatric surgery 1130 72 (6.4) 212 (18.8) 15 (1.3) 250 (22.1) 
Cholecystectomy 29596 1372 (4.6) 2507 (8.5) 229 (0.8) 3600 (12.2) 
Colorectal resection 15257 676 (4.4) 968 (6.3) 94 (0.6) 1550 (10.2) 
Haemorrhoidectomy 13778 621 (4.5) 1085 (7.9) 118 (0.9) 1614 (11.7) 
Hepatopancreatobiliary resection 1210 83 (6.9) 95 (7.9) 9 (0.7) 163 (13.5) 
Oesophagogastrectomy 1684 119 (7.1) 162 (9.6) 9 (0.5) 234 (13.9) 
Small bowel resection 1382 49 (3.5) 91 (6.6) 12 (0.9) 137 (9.9) 
Total 75854 3378 (4.5) 5926 (7.8) 567 (0.7) 8659 (11.4) 
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Postoperative psychiatric morbidity in patients without preoperative psychiatric 
morbidity The overall proportion of patient with a recording of both preoperative and postoperative psychiatric morbidity was 5507/75854 (7.3%) (Table 6-7). The procedure with the lowest proportion of patients with both preoperative and postoperative psychiatric morbidity recorded was in appendicectomy (586/10814 – 5.4%) and the highest proportion of patients with both preoperative and postoperative psychiatric morbidity recorded was in bariatric surgery (18.4% - 208/1130). Of all patients with preoperative psychiatric morbidity, the overall proportion of patients who also developed postoperative psychiatric morbidity was 38.9% (5507/14140). The lowest proportion of patients with preoperative psychiatric morbidity who developed postoperative psychiatric morbidity was seen in small bowel resection (29.4% - 77/262), while the highest proportion of patients with preoperative psychiatric morbidity who developed postoperative psychiatric morbidity was seen in bariatric surgery (44.8% - 208/464). Of all patients without preoperative psychiatric morbidity, the overall proportion of patients who developed new onset postoperative psychiatric morbidity was 5.1% (3152/61714). The lowest proportion of patients with preoperative psychiatric morbidity who developed new onset postoperative psychiatric morbidity was seen in appendicectomy (4.2% - 383/9096), while the highest proportion of patients with preoperative psychiatric morbidity who developed new onset postoperative psychiatric morbidity was in oesophagogastrectomy (9.5% - 137/1444). The two procedures with the highest rates of new onset postoperative psychiatric morbidity were oesophagogastrectomy and hepatopancreaticobiliary resection.   
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Table 6-7. Postoperative psychiatric morbidity recorded in patients with preoperative psychiatric morbidity and postoperative psychiatric morbidity 
recorded in patients without preoperative psychiatric morbidity (new-onset postoperative psychiatric morbidity) within twelve months after surgery 
in patients who underwent gastrointestinal surgery 
































      
Antireflux surgery 1003 94 (9.4) 48 (4.8) 94/243 (38.7) 48/761 (6.3) 
Appendicectomy 10814 586 (5.4) 383 (3.5) 586/1718 (34.1) 383/9096 (4.2) 
Bariatric surgery 1130 208 (18.4) 42 (3.7) 208/464 (44.8) 42/666 (6.3) 
Cholecystectomy 29596 2451 (8.3) 1149 (3.9) 2451/6197 (39.6) 1149/23399 (4.9) 
Colorectal resection 15257 839 (5.5) 711 (4.7) 839/2212 (37.9) 711/13045 (5.5) 
Haemorrhoidectomy 13778 1081 (7.8) 533 (3.9) 1081/2636 (41.0) 533/11142 (4.8) 
Hepatopancreatobiliary resection 1210 74 (6.1) 89 (7.4) 74/168  (44.0) 89/1042 (8.5) 
Oesophagogastrectomy 1684 97 (5.8) 137 (8.1) 97/240 (40.4) 137/1444 (9.5) 
Small bowel resection 1382 77 (5.6) 60 (4.3) 77/262 (29.4) 60/1120 (5.4) 
Total 75854 5507 (7.3) 3152 (4.2) 5507/14140 (38.9) 3152/61714 (5.1) 
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Postoperative symptoms 
There were 16447 recordings of postoperative symptoms in the twelve months following gastrointestinal surgery. The overall number of procedures with at least one recording of postoperative symptoms was 16.9% (12819/75854) (Table 6-8). The proportion of procedures affected by postoperative symptoms was lowest for appendicectomy (11.2% - 1207/10814) and highest for oesophagogastrectomy (38.5% - 649/1684). Of the eleven different postoperative symptoms evaluated, diarrhoea (6.2% - 4721/75854) affected the greatest number of procedures while steatorrhoea (0% - 16/75854) affected the smallest number of procedures.  When the frequency of each individual type of symptom was evaluated according to surgical procedure, postoperative reflux and dysphagia were found to be recorded at the highest rate after anti-reflux surgery and oesophagogastrectomy. Postoperative dyspepsia was also most frequently encountered following oesophagogastrecotmy together with cholecystectomy. Nausea, vomiting and steatorrhoea were most frequently encountered after oesophagogastrectomy and hepatopancreatobiliary resection. Dumping was most frequently encountered after oesophagogastrectomy. Interestingly, diarrhoea was most frequently encountered after oesophagogastrectomy and small bowel resection, although hepatopancreatobiliary and colorectal resections also demonstrated high rates. Faecal incontinence was most frequently encountered after colorectal and hepatopancreatobiliary resections.  In terms of general postoperative symptoms, fatigue was most frequently encountered after oesophagogastrectomy and bariatric surgery. Postoperative pain was most common after antireflux surgery and oesophagogastrecotmy. Overall, the highest rates of postoperative symptoms were observed in patients undergoing upper gastrointestinal surgery (oesophagogastrectomy, hepatopancreatobiliary resection, antireflux surgery).  
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Table 6-8. Postoperative symptoms recorded within twelve months of surgery in patients who underwent gastrointestinal surgery  
 n 
At least one 



















             
 
Antireflux surgery 1003 295 (29.4) 168 (16.7) 60 (6.0) 34 (3.4) 29 (2.9) 2 (0.2) 59 (5.9) 0 (0.0) 0 (0.0) 41 (4.1) 31 (3.1) 24 (2.4) 
Appendicectomy 10814 1207 (11.2) 146 (1.4) 18 (0.2) 174 (1.6) 195 (1.8) 1 (0.0) 402 (3.7) 1 (0.0) 1 (0.0) 162 (1.5) 291 (2.7) 92 (0.9) 
Bariatric surgery 1130 211 (18.7) 20 (1.8) 7 (0.6) 25 (2.2) 36 (3.2) 2 (0.2) 57 (5.0) 0 (0.0) 0 (0.0) 51 (4.5) 60 (5.3) 7 (0.6) 
Cholecystectomy 29596 5220 (17.6) 965 (3.3) 84 (0.3) 1195 (4.0) 566 (1.9) 3 (0.0) 1780 (6.0) 2 (0.0) 13 (0.0) 746 (2.5) 1004 (3.4) 241 (0.8) 
Colorectal resection 15257 3076 (20.2) 265 (1.7) 63 (0.4) 347 (2.3) 581 (3.8) 1 (0.0) 1445 (9.5) 2 (0.0) 23 (0.2) 643 (4.2) 465 (3.0) 111 (0.7) 
Haemorrhoidectomy 13778 1580 (11.5) 305 (2.2) 44 (0.3) 338 (2.5) 133 (1.0) 1 (0.0) 477 (3.5) 0 (0.0) 13 (0.1) 156 (1.1) 344 (2.5) 110 (0.8) 
Hepatopancreatobiliary resection 1210 307 (25.4) 32 (2.6) 10 (0.8) 40 (3.3) 76 (6.3) 1 (0.1) 125 (10.3) 8 (0.7) 3 (0.2) 89 (7.4) 31 (2.6) 10 (0.8) 
Oesophagogastric resection 1684 649 (38.5) 138 (8.2) 116 (6.9) 83 (4.9) 154 (9.1) 17 (1.0) 223 (13.2) 3 (0.2) 1 (0.1) 179 (10.6) 64 (3.8) 19 (1.1) 
Small bowel resection 1382 274 (19.8) 23 (1.7) 6 (0.4) 23 (1.7) 61 (4.4) 0 (0.0) 153 (11.1) 0 (0.0) 0 (0.0) 54 (3.9) 41 (3.0) 2 (0.1) 
              
Total 75854 12819 (16.9) 2062 (2.7) 408 (0.5) 2259 (3.0) 1831 (2.4) 28 (0.0) 4721 (6.2) 16 (0.0) 54 (0.1) 2121 (2.8) 2331 (3.1) 616 (0.8) 
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As some patients had more than one type of postoperative symptoms recorded, the numbers of recordings of different types of symptoms were evaluated. Most (11.4%) of patients had only one recording of postoperative symptoms within twelve months of surgery (Table 6-9).  The highest number of different types of postoperative symptoms recorded was five, which was recorded in eight patients. Multiple recordings of postoperative symptoms were most frequently observed following oesophagogastrectomy and hepatopancreatobiliary resection.  
 
Table 6-9. The numbers of recordings of different types of postoperative symptoms within 
twelve months after surgery in patients who underwent gastrointestinal surgery 
Number of postoperative 
symptoms n 0 (%) 1 (%) 2 (%) 3 (%) 4 (%) 5 (%) 
   
     
Antireflux surgery 1003 708 (71.3) 229 (23.3) 47 (4.4) 18 (1.0) 1 (0.0) 0 (0.0) 
Appendicectomy 10814 9607 (92.1) 1058 (7.3) 134 (0.6) 12 (0.0) 3 (0.0) 0 (0.0) 
Bariatric surgery 1130 919 (88.2) 169 (10.6) 35 (1.1) 7 (0.1) 0 (0.0) 0 (0.0) 
Cholecystectomy 29596 24379 (86.4) 4306 (12.0) 772 (1.5) 119 (0.2) 20 (0.0) 2 (0.0) 
Colorectal resection 15257 12185 (84.3) 2493 (13.9) 487 (1.6) 78 (0.1) 14 (0.0) 4 (0.0) 
Haemorrhoidectomy 13778 12198 (91.4) 1373 (7.8) 180 (0.7) 26 (0.1) 1 (0.0) 0 (0.0) 
Hepatopancreatobiliary resection 1210 903 (79.8) 221 (16.6) 63 (3.5) 22 (0.1) 1 (0.1) 0 (0.0) 
Oesophagogastric resection 1684 1038 (67.1) 414 (23.9) 176 (7.3) 47 (1.6) 9 (0.1) 2 (0.1) 
Small bowel resection 1382 1108 (83.2) 211 (14.5) 49 (2.2) 14 (0.1) 0 (0.0) 0 (0.0) 
Total 75854 63045 (86.9) 10474 (11.4) 1943 (1.4) 343 (0.2) 49 (0.0) 8 (0.0)     
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Time from surgery to recording of poor postoperative health status 
As there are multiple domains of health status, it is feasible that one domain of health status can influence another. For this, the interaction between postoperative psychiatric morbidity and symptoms will be tested by logistic regression. If one domain of health status is an independent predictor of the other, it can be concluded that there is a significant interaction between these two domains of health status. For this model, it is necessary to decide which of the domains will be entered into regression models as a predictor covariate. One way of assessing this is to determine which of the variables are recorded earlier by measuring the time to recording of postoperative psychiatric morbidity and postoperative symptoms from surgery.  
Time to postoperative psychiatric morbidity When calculating the time from surgery to the earliest recording of postoperative psychiatric morbidity in each of the three databases, prescription data had the shortest median time from surgery to earliest recording of psychiatric morbidity. Psychiatric diagnoses made for readmission in HES data were much later than in CPRD and prescription data (Table 6-10).   
Table 6-10. Median days from surgery to recording of postoperative psychiatric morbidity 
according to captured database  
Data source 
Median days from surgery to first 
recording of psychiatric morbidity 
(IQR) 
    
CPRD 135 (55-264) 





IQR = Interquartile range 
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Time to postoperative symptoms When performing longitudinal evaluation of time from surgery to postoperative symptoms, the median time to the first presentation of postoperative symptoms was 109 days. The shortest time to earliest onset of symptoms was for nausea while the longest time was for fatigue (Table 6-11). Nausea, vomit and pain presented early, whereas the remaining symptoms presented later.   
Table 6-11. Time from surgery to postoperative symptoms in patients who underwent 
gastrointestinal surgery  
Symptom 
 
Median days from surgery to first recording 
of postoperative symptom (IQR) 
    
Reflux 152 (61-257) 
Dysphagia 136 (61-254) 
Dyspepsia 151 (61-251) 
Dumping 135 (46-169) 
Vomit 108 (33-228) 
Diarrhoea 123 (45-233) 
Steatorrhoea 148 (69-225) 
Nausea 89 (29-204) 
Faecal incontinence 160 (48-237) 
Fatigue 168 (70-264) 
Postoperative pain 13 (6-25) 
 







Amongst the evaluated procedures, the highest rates of postoperative symptoms were observed in the first three months after surgery (Figure 6-3). The frequency of recording of symptoms in primary care decreased over time during follow-up. Oesophagogastrecotmy was associated with the highest rates of postoperative symptoms during the first nine months of follow-up, while appendicectomy and haemorrhoidectomy had the lowest rates.   
 
Figure 6-3. Proportion of procedures that presented to primary care with postoperative 









Figure 6-4. Proportion of procedures with postoperative symptoms and postoperative 




In this Chapter, linked routine databases were used to evaluate three aspects of health status in patients undergoing gastrointestinal surgery namely frailty, psychiatric morbidity and postoperative symptoms. For all of these domains, primary care data identified coding that signified poor health status. Overall, almost a fifth of patients undergoing surgical procedures had a recording of one of ten categories of frailty within the 36 months before surgery, similar to previous studies. In a prospective study, Robinson et al identified preoperative frailty in 28% patients undergoing elective cardiac and colorectal surgery.[Robinson 2013] Using linked database covariates, frailty was found to be associated with age, female gender and poor socioeconomic status. These 
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findings mirrored previous studies that demonstrated high rates of frailty in women of poor socioeconomic status.[Szanton 2010] Age grouping was an independent predictor of frailty, for which the risk increased incrementally with age. However, the recording of frailty was not limited to the elderly population. The evaluation of frailty as a predictor covariate of outcome after adjustment for age may therefore be of value. Importantly, the impact of frailty on harm in surgery has been under-explored.  CPRD allowed for the measurement of heterogeneous components of frailty including impairments, disabilities and symptoms that are commonly reported. Indicators of process such as specialist referral to geriatric services were also included as a measure of frailty, highlighting the versatility of this database in identifying different aspects of health status. Identifying patients with at least one frailty component may be useful when stratifying risk, however it should not be assumed that individual frailty components have equal weightings with regards to risk. Further studies are needed to determine how frailty components interact when predicting outcome.  While frailty was measured entirely in CPRD, it was possible to identify some patients with psychiatric morbidity in HES. These patients were admitted to hospital for the primary reason of treating psychiatric illness and therefore represented the severe spectrum of disease. However, the proportion of patients admitted to hospital for psychiatric illness was small. Most patients were identified using diagnosis codes in CPRD and prescription data. About a fifth of the study cohort had a recording of psychiatric morbidity within the 36 months before surgery. Data on preoperative psychiatric morbidity have seldom been reported outside of the context of prospective studies in bariatric surgery.[Gertler 1986] These findings therefore offer new insights into the incidence of preoperative psychiatric morbidity across gastrointestinal surgical procedures.   Just over a tenth of procedures were undertaken in patients with recorded postoperative psychiatric morbidity. Although this was a lower rate than before surgery, this was 
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observed over a shorter period of time. However, it is feasible that surgery is associated with a reduction in rates of psychiatric morbidity. Previous studies have demonstrated that bariatric surgery improves psychiatric morbidity in obesity.[Saenz-Herrero M 2015] Further evaluation of how illness affects mental status in the preoperative setting is needed to fully understand how psychiatric morbidity can arise during the course of illness and treatment. Patients undergoing surgery for cancer had the highest rates of new onset postoperative psychiatric morbidity. This meant that in general terms, younger patients undergoing functional (non-cancer resection) surgery had the lowest rates of new onset psychiatric morbidity following surgery, highlighting how operations aimed to improve function generally improve health status.  Postoperative psychiatric morbidity was diagnosed in 4.2% of patients in the primary care setting in the presented analysis. This rate was higher at 4.7% in the subgroup of patients undergoing oesophagogastrectomy. A previous study from the Swedish National Registry identified that 4.2% of patients undergoing oesophagogastrectomy were identified in as outpatients, although this study followed patients up to 2 years after surgery and excluded patients with previous psychiatric morbidity.[Wikman 2015] CPRD data may capture a greater proportion of psychiatric morbidity treated in the primary care setting and not necessarily referred to hospital for outpatient treatment. Interestingly, the proportion of anxiety identified in the Swedish study through medication was much greater than the present analysis.  Of the procedures evaluated, antireflux and bariatric surgery were associated with the highest rates of both preoperative and postoperative psychiatric morbidity, owing to the functional nature of this type of surgery. Higher rates of long-term postoperative psychiatric morbidity have previously been reported in patients undergoing bariatric surgery.[Burgmer 2014] When excluding these patients, patients undergoing oesophagogastrectomy and hepatopancreatobiliary resection had the lowest rate of preoperative psychiatric morbidity and the highest rate of postoperative psychiatric 
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morbidity. This may indicate that the effect of surgery on psychological status is greatest in patients undergoing major upper gastrointestinal cancer resection. Undergoing major resectional surgery may therefore add to the psychological effects of cancer diagnosis. This may be partly attributed to the complexities of management of upper gastrointestinal malignancy. Taking the example of oesophagogastrectomy, the gravity of diagnosis, invasive surgical resection and impairment and disability from harm may all contribute to poor QOL and psychological well-being. Whether cancer diagnosis is independently associated with psychiatric morbidity will be evaluated in detail by logistic regression analysis in a subsequent Chapter.  CPRD data identified that 16.9% of procedures were associated with at least one recording of postoperative symptoms. When procedures were considered separately, the highest rate of postoperative symptoms was observed following oesophagogastrectomy where almost 40% of patients were affected. Most patients presented to primary care once to seek treatment for postoperative symptoms. The overall incidence of symptoms including those that do not trigger a visit to primary care may actually be greater than what was observed in the present analysis. Prospective studies confirm a higher incidence of symptoms such as postoperative reflux following oesophagogastrectomy in studies that routinely question patients during prospective follow-up.[Bonavina 1992, Shibuya 2003] However, recordings in primary care are likely to represent more severe symptoms for which patients seek medical attention. They are informative of the pattern of symptoms that develop after different types of gastrointestinal surgery that present to healthcare. The recording of postoperative psychiatric morbidity and symptoms was greatest in the first three months after surgery, and decreased over time. These data demonstrate that most patients develop poor health status early after surgery. Oesophagogastrectomy was associated with high rates of postoperative symptoms during early follow-up, followed by antireflux surgery. Oesophagogastric surgery for both benign and malignant 
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7. CHAPTER SEVEN – PREDICTING OUTCOME  
Introduction 
Population-level analyses using routine data can help evaluate quality of healthcare services. Case-mix adjustment allows for the derivation of observed-to-expected ratios to demonstrate variability in institutional performance.[Cohen 2013] Previous Chapters have demonstrated that linked databases offer a large number of predictor covariates that can be incorporated into prediction models. Multiple covariates from different databases offer a wide range of risk factors that can be studied in detail. Whether linked routine databases can improve the prediction of surgical outcome and therefore facilitate better risk adjustment has not previously been evaluated.  In the UK, evaluating institutional performance using HES may be challenging as some comorbidity data may overlap with postoperative systemic SAEs given the lack of present on arrival flags.[Spencer 2012] Primary care data may add more information on the severity of chronic illnesses prevalent in the community. While the Michigan database demonstrates that BMI should be incorporated into regression models for morbidity and mortality in general surgery, HES doesn’t have these data and are limited to diagnosis coding for obesity.[Yanquez 2013] Smoking has also been demonstrated to significantly impact on outcome but this type of lifestyle factor is not represented in ICD-10 coding.[Baucom 2015] Health status is also not recorded in HES, but is recorded in CPRD data as demonstrated in the previous Chapter. Socioeconomic status and cancer stage from the IMD and NCIN databases respectively may also lead to better prediction models. Combining information from multiple databases may lead to greater granularity of information, revealing important insights into risk of surgical harm.  
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Aims 
• To present the figures for mortality, readmission and prolonged stay for patients undergoing gastrointestinal surgery 
• To evaluate the impact of predictor covariates derived from linked databases on outcome by regression analysis 
• To assess the effect of incorporating linked database predictor covariates in addition to HES data on the performance of regression models for outcome 
Methods 
The outcome measures that will serve as the dependent variables for regression models will be described. This will include outcome commonly evaluated in the literature, as well as SAEs and poor postoperative health status. Whether patient and surgery characteristics derived from linked databases predict outcome will be tested for each of the outcome measures described.  
Outcome measures  Short-term outcome will include 30-day technical and systemic SAEs, prolonged hospital stay, 30-day readmission and 30-day mortality. SAEs will be evaluated according to database of capture and whether they occurred as in-hospital or post-discharge events. Prolonged hospital stay will be defined as the 4th quartile of procedures with the longest length of hospital stay as previously described.[T. C. Collins 1999] Long-term outcome (within one year of surgery) will include one-year mortality, postoperative psychiatric morbidity and postoperative symptoms.  
Binary logistic regression analysis Patient and surgery characteristics will model the risk of short and long-term outcome. This will quantify the odds ratios for each of the predictor covariates included in regression analyses. For postoperative psychiatric morbidity, separate regression 
188  
models will evaluate the effect of cancer stage with and without adjustment for surgical procedure. This was done to clarify the effect cancer specific variables, as there is growing interest in the effect of psychiatric morbidity on outcome in patients diagnosed with cancer.[Satin 2009] Collinearity will be examined as there is potential for overlap of information in the databases evaluated. Collinearity will be assessed by the VIF. The same covariates will be entered for all regression analyses in this Chapter, making their interaction uniform across all analyses. The odds ratio for risk of a binary outcome will be presented in tables together with 95% confidence intervals for all of the predictor covariates. The overall effects of multiple predictor covariates on outcome will be visualised by tabulating all positive odds ratios for significant risk factors against each of the outcome measures described.  The predictive performance of regression models incorporating linked database covariates will be assessed for each outcome variable by splitting the cohort into two. The ROC will be calculated for all regression models by developing the models using data from patients in the South of England and obtaining predictive probabilities for patients in the North of England. Separate models will be used to derive the ROC when using HES data only, to allow for comparison between linked data and HES. From the HES database, regression analyses will include age, gender, comorbidity, emergency surgery, surgical approach, year of surgery, surgical procedure and cancer diagnosis as predictor covariates. Linked database covariates will additionally include BMI, smoking, socioeconomic status, comorbidities not captured in HES, frailty, preoperative psychiatric morbidity and cancer stage. Percentage change in ROC for each model when incorporating all linked database covariates in addition to HES will be presented and improvements beyond 0.8 will be considered as the threshold for discriminating ability.   
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Missing data When there were missing data for discharge date making it not possible to calculate length of stay, the median length of stay for the procedure was imputed in each of the missing fields.  
 
Results 
Collinearity of linked database covariates Overall, there were 13 predictor covariates for patient and surgery characteristics identified in four separate databases (Table 7-1).  Collinearity diagnostics revealed that interaction between predictor covariates was low.  
 
Table 7-1. Collinearity assessment of predictor covariates derived from linked databases  
Predictor variable 
 
Database (s)  
 
VIF 
    
 
Age HES 1.42 
Female gender HES 1.13 
BMI CPRD 1.11 
Smoking CPRD 1.08 
Low socioeconomic status  IMD 1.04 
One or more recorded comorbidity HES/CPRD 1.14 
Emergency surgery HES 1.12 
Open surgical approach HES 1.31 
Year of surgery HES 1.06 
Frailty CPRD 1.08 
Preoperative psychiatric morbidity HES/CPRD 1.06 
Surgical procedure HES 2.36 
Cancer diagnosis/stage NCIN 2.51 
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Short term outcome Data for mortality and readmission were available for all patients (Table 7-2). In 33 patients, it was not possible to derive length of hospital stay due to missing discharge dates. Length of hospital stay according to surgical procedure was shortest (1 day) in haemorrhoidectomy and longest (16 days) in oesophagogastrectomy. Readmission was least frequent after haemorrhoidectomy (5.5%) and most frequent after oesophagogastrectomy (12.4%). Thirty-day mortality rates were lowest in antireflux surgery (0%) and highest in small bowel resection (11.9%). The overall rate of 30-day SAEs in CPRD or HES was 10.7%   
 Table 7-2. Short-term outcome in patients who underwent gastrointestinal surgery 
Procedure n 











      
Antireflux surgery 1003 3 (2-4) 88 (8.7) 0 (0.0) 59 (5.9) 
Appendicectomy 10814 4 (3-6) 853 (7.8) 26 (0.2) 1119 (10.3) 
Bariatric surgery 1130 3 (2-5) 3113 (10.0) 4 (0.4) 105 (9.3) 
Cholecystectomy 29596 2 (2-4) 2200 (7.4) 68 (0.2) 2282 (7.7) 
Colorectal resection 15257 13 (9-20) 1697 (11.1) 788 (5.2) 3246 (21.3) 
Haemorrhoidectomy 13778 1 (1-2) 754 (5.5) 10 (0.1) 280 (2.0) 
Hepatopancreatobiliary resection 1210 12 (9-19) 133 (10.9) 39 (3.2) 233 (19.3) 
Oesophagogastric resection 1684 16 (12-22) 209 (12.4) 71 (4.2) 415 (24.6) 
Small bowel resection 1382 15 (9-26) 155 (11.2) 165 (11.9) 367 (26.6) 
Total 75854 2 (1-6) 7814 (6.9) 1265 (1.1) 8106 (10.7) 
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Table 7-3. Logistic regression analysis for 30-day mortality in patients who underwent 
gastrointestinal surgery 
Dependent variable = 30-day mortality Odds ratio (95% CI) p value for comparison 
   
PATIENT CHARACTERISTICS 
  
Age 1.07 (1.07-1.08) <0.001 
Female gender 0.93 (0.82-1.06) 0.257 
BMI 0.99 (0.98-1.00) 0.154 
Smoking 1.48 (1.27-1.73) <0.001 
Low socioeconomic status 1.04 (0.99-1.08) 0.149 
At least one recorded comorbidity 2.23 (1.95-2.54) <0.001 
   
SURGERY CHARACTERISTICS 
  
Emergency surgery 3.67 (3.17-4.25) <0.001 
Open approach 2.00 (1.51-2.66) <0.001 
Year of surgery 0.95 (0.93-0.97) <0.001 
   
PREOPERATIVE HEALTH STATUS 
 
More than one recorded frailty 1.03 (0.90-1.19) 0.637 
Preoperative psychiatric morbidity 1.20 (1.01-1.42) 0.036 




Appendicectomy 2.75 (1.35-5.60) <0.001 
Cholecystectomy 4.55 (3.20-6.49) <0.001 
Bariatric surgery 27.80 (8.30-93.13) <0.001 
Small bowel resection 31.98 (16.58-61.67) <0.001 
Colorectal resection 25.95 (13.64-49.35) <0.001 
Oesophagogastrectomy 26.01 (12.92-52.36) <0.001 
Hepatopancreatobiliary resection 30.62 (14.70-63.79) <0.001 
   
CANCER STAGE 
  
No cancer Reference 
Cancer stage I 0.75 (0.56-1.02) 0.067 
Cancer stage II 0.71 (0.57-0.89) 0.003 
Cancer stage III 0.83 (0.67-1.02) 0.078 
Cancer stage IV 0.88 (0.60-1.27) 0.491 
Cancer stage unknown 1.16 (0.92-1.47) 0.212 
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Regression analysis for thirty-day readmission Age, male gender, poor socioeceonomic status, comorbidities, emergency surgery, open surgical approach, year of surgery, frailty, psychiatric morbidity, surgical procedure, cancer stage I and unknown cancer stage were independent predictors of readmission (Table 7-4). Increasing trends in readmission were observed over the years. Type of surgical procedure was less strongly correlated with readmission than was seen in the model for mortality. Haemorrhoidectomy was associated with the lowest risk of readmission while colorectal resection was associated with the highest risk. In this model, patient characteristics had a greater role in predicting readmission. Of the patient factors evaluated, preoperative psychiatric morbidity was associated with the greatest risk of readmission.  The C-statistic (ROC) for this regression model was 0.597. When the analysis was repeated by using HES covariates alone, the C-statistic was 0.580. The incorporation of linked database covariates therefore improved the prediction of readmission when compared with HES data alone. All non-HES covariates independently predicted readmission. Of these, preoperative psychiatric morbidity had the greatest impact on readmission.    
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Table 7-4. Logistic regression analysis for 30-day readmission in patients who underwent 
gastrointestinal surgery 
Dependent variable = 30-day readmission Odds ratio (95% CI) p value for comparison 
   
PATIENT CHARACTERISTICS 
  
Age 1.00 (1.00-1.01) 0.006 
Female gender 0.93 (0.88-0.98) 0.009 
BMI 1.00 (0.99-1.00) 0.508 
Smoking 1.06 (1.00-1.13) 0.058 
Low socioeconomic status 1.02 (1.00-1.04) 0.031 






Emergency surgery 1.11 (1.03-1.20) 0.013 
Open approach 1.14 (1.09-1.19) 0.004 
Year of surgery 1.04 (1.03-1.04) <0.001 
  
  
PREOPERATIVE HEALTH STATUS 
 
More than one recorded frailty 1.11 (1.08-1.15) 0.002 
Preoperative psychiatric morbidity 1.30 (1.22-1.39)  <0.001 





Appendicectomy 1.47 (1.29-1.68) <0.001 
Cholecystectomy 1.55 (1.38-1.74) <0.001 
Antireflux surgery 1.82 (1.61-2.05) <0.001 
Bariatric surgery 1.86 (1.46-2.38) <0.001 
Small bowel resection 1.85 (1.52-2.26) <0.001 
Colorectal resection 1.90 (1.66-2.18) <0.001 
Oesophagogastrectomy 1.88 (1.52-2.34) <0.001 






No cancer Reference 
Cancer stage I 1.20 (1.01-1.44) 0.044 
Cancer stage II 0.95 (0.82-1.11) 0.529 
Cancer stage III 1.11 (0.96-1.29) 0.144 
Cancer stage IV 1.24 (0.97-1.58) 0.084 
Cancer stage unknown 1.28 (1.09-1.51) 0.003 
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Regression analysis for prolonged hospital stay Age, female gender, BMI, poor socioeceonomic status, comorbidities, emergency surgery, open surgical approach, frailty, psychiatric morbidity, cancer stage I and cancer stage III were independent predictors of prolonged hospital stay (Table 7-5). There were decreasing trends in the proportion of patients who had prolonged hospital stay over time. Oesophagogastrectomy was associated with the lowest risk of prolonged hospital stay while small bowel resection was associated with the highest risk. For covariates other than surgical procedure, emergency surgery was the strongest independent predictor of prolonged hospital stay. Year of surgery and stage IV cancer were negative predictors of prolonged hospital stay.  The C-statistic (ROC) for this regression model was 0.771. When the analysis was repeated by using HES covariates alone, the C-statistic was 0.764. The incorporation of linked dataset covariates therefore improved the prediction of prolonged hospital stay when compared with HES data alone. Of the non-HES covariates evaluated, all risk factors were independent predictors of prolonged hospital stay, except for cancer stage, which demonstrated a variable effect.      
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Table 7-5. Logistic regression analysis for prolonged hospital stay in patients who underwent 
gastrointestinal surgery 







Age 1.03 (1.03-1.03) <0.001 
Female gender 0.89 (0.86-0.93) <0.001 
BMI 1.01 (1.00-1.01) <0.001 
Smoking 0.99 (0.94-1.04) 0.667 
Low socioeconomic status 1.07 (1.06-1.09) <0.001 







Emergency surgery 11.36 (10.69-12.06) <0.001 
Open approach 2.78 (2.59-2.98) <0.001 




PREOPERATIVE HEALTH STATUS 
 
More than one recorded frailty 1.14 (1.09-1.20) <0.001 
Preoperative psychiatric morbidity  1.14 (1.09-1.20) <0.001 





Appendicectomy 1.14 (1.09-1.20) <0.001 
Cholecystectomy 1.14 (1.09-1.20) <0.001 
Antireflux surgery 0.30 (0.28-0.33) <0.001 
Bariatric surgery 3.82 (3.51-4.16) <0.001 
Small bowel resection 6.03 (5.09-7.15) <0.001 
Colorectal resection 4.93 (4.08-5.95) <0.001 
Oesophagogastrectomy 0.19 (0.16-0.22) 0.005 







No cancer Reference 
Cancer stage I 1.30 (1.08-1.55) 0.001 
Cancer stage II 2.45 (2.00-2.99) 0.216 
Cancer stage III 1.31 (1.12-1.53) 0.001 
Cancer stage IV 0.92 (0.82-1.05) 0.001 
Cancer stage unknown 0.77 (0.68-0.87) 0.663 
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Regression analysis for technical surgical adverse events Age, male gender, BMI, smoking, poor socioeconomic status, comorbidities, emergency surgery, open surgical approach, psychiatric morbidity and surgical procedure were independent predictors of 30-day technical SAEs (Table 7-6). Frailty was a negative predictor of technical SAEs. Overall, surgical procedure was the strongest determinant of technical SAEs. Haemorrhoidectomy was associated with the lowest risk of technical SAEs while hepatopancreatobiliary resection was associated with the highest risk. Cancer diagnosis was negatively correlated with technical SAEs.  The C-statistic (ROC) for this regression model was 0.715. When the analysis was repeated by using HES covariates alone, the C-statistic was 0.705. The incorporation of linked dataset covariates improved the prediction of 30-day technical SAEs when compared with HES data alone. Of the non-HES predictors evaluated, while all risk factors had an independent impact on technical SAEs, BMI, smoking and preoperative psychiatric morbidity were positive predictors, frailty and cancer stage were negative predictors of technical SAEs.        
198  
Table 7-6. Logistic regression analysis for 30-day technical SAE in patients who underwent 
gastrointestinal surgery 
Dependent variable = 30-day technical SAE Odds ratio (95% CI) p value for comparison 
   
PATIENT CHARACTERISTICS 
  
Age 1.00 (1.00-1.01) <0.001 
Female gender 0.82 (0.77-0.86) <0.001 
BMI 1.02 (1.02-1.03) <0.001 
Smoking 1.12 (1.05-1.19) 0.012 
Low socioeconomic status 1.03 (1.01-1.05) <0.001 
More than one recorded comorbidity 1.18 (1.11-1.25) 0.024 
   SURGERY CHARACTERISTICS 
  
Emergency surgery 1.10 (1.01-1.18) <0.001 
Open approach 1.26 (1.15-1.37) <0.001 
Year of surgery 1.04 (1.03-1.05) 0.774 
   PREOPERATIVE HEALTH STATUS 
 
More than one recorded frailty 0.99 (0.92-1.06) <0.001 
Preoperative psychiatric morbidity 1.16 (1.08-1.24) <0.001 




Appendicectomy 5.90 (4.98-6.98) <0.001 
Cholecystectomy 4.99 (4.26-5.84) <0.001 
Antireflux surgery 3.18 (2.27-4.45) <0.001 
Bariatric surgery 3.59 (2.71-4.76) <0.001 
Small bowel resection 12.79 (10.46-15.64) <0.001 
Colorectal resection 14.70 (12.53-17.25) <0.001 
Oesophagogastrectomy 14.90 (11.95-18.57) <0.001 
Hepatopancreatobiliary resection 16.06 (12.52-20.61) <0.001 
   CANCER STAGE 
  
No cancer Reference 
Cancer stage I 0.73 (0.62-0.85) <0.001 
Cancer stage II 0.69 (0.61-0.78) <0.001 
Cancer stage III 0.64 (0.57-0.72) <0.001 
Cancer stage IV 0.51 (0.41-0.64) <0.001 
Cancer stage unknown 0.73 (0.63-0.85) <0.001 
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Regression analysis for systemic surgical adverse events Age, smoking, comorbidities, emergency surgery, open surgical approach, year of surgery, psychiatric morbidity and surgical procedure were independent predictors of 30-day systemic SAEs (Table 7-7). Overall, surgical procedure was the strongest determinant of systemic SAEs. Haemorrhoidectomy was associated with the lowest risk of technical SAEs while oesophagogastrectomy was associated with the highest risk. Cancer diagnosis did not influence risk of 30-day systemic SAEs.  The C-statistic (ROC) for this regression model was 0.787. When the analysis was repeated by using HES covariates alone, the C-statistic was 0.776. The incorporation of linked dataset covariates improved the prediction of 30-day systemic SAEs when compared with HES data alone. Of all the non-HES covariates evaluated smoking and preoperative psychiatric morbidity were independent predictors of systemic SAEs.  
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Table 7-7. Logistic regression analysis for 30-day systemic SAE in patients who underwent 
gastrointestinal surgery 
Dependent variable = 30-day systemic SAE Odds ratio (95% CI) p value for comparison 
   PATIENT CHARACTERISTICS 
  
Age 1.02 (1.01-1.02) <0.001 
Female gender 1.03 (0.94-1.13) 0.497 
BMI 1.00 (0.98-1.01) 0.441 
Smoking 1.28 (1.15-1.41) <0.001 
Low socioeconomic status 1.03 (1.00-1.06) 0.095 
More than one recorded comorbidity 1.80 (1.64-1.98) <0.001 
   
SURGERY CHARACTERISTICS 
  
Emergency surgery 2.04 (1.82-2.28) <0.001 
Open approach 1.21 (1.12-1.30) 0.010 
Year of surgery 1.06 (1.04-1.07) <0.001 
   PREOPERATIVE HEALTH STATUS 
 
More than one recorded frailty 1.09 (0.98-1.21) 0.097 
Preoperative psychiatric morbidity 1.14 (1.02-1.28) 0.024 




Appendicectomy 3.50 (2.54-4.81) <0.001 
Cholecystectomy 3.97 (2.93-5.40) <0.001 
Antireflux surgery 5.23 (3.93-6.95) <0.001 
Bariatric surgery 3.49 (1.88-6.48) <0.001 
Small bowel resection 13.37 (9.63-18.56) <0.001 
Colorectal resection 10.63 (7.87-14.35) <0.001 
Oesophagogastrectomy 19.66 (13.87-27.87) <0.001 
Hepatopancreatobiliary resection 11.99 (8.00-17.97) <0.001 
   
CANCER STAGE 
  
No cancer Reference 
Cancer stage I 1.14 (0.91-1.43) 0.269 
Cancer stage II 1.07 (0.89-1.29) 0.469 
Cancer stage III 1.15 (0.96-1.37) 0.139 
Cancer stage IV 0.90 (0.66-1.22) 0.512 
Cancer stage unknown 1.19 (0.97-1.46) 0.090 
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Antireflux surgery 1003 2 (0.2) 243 (24.2) 288 (28.7) 
Appendicectomy 10814 69 (0.6) 1718 (15.9) 859 (7.9) 
Bariatric surgery 1130 8 (0.7) 464 (41.1) 133 (11.8) 
Cholecystectomy 29596 247 (0.8) 6197 (20.9) 4035 (13.6) 
Colorectal resection 15257 2029 (13.3) 2212 (14.5) 2402 (15.7) 
Haemorrhoidectomy 13778 120 (0.9) 2636 (19.1) 1180 (8.6) 
Hepatopancreatobiliary resection 1210 252 (20.8) 168 (13.9) 245 (20.2) 
Oesophagogastric resection 1684 390 (23.2) 240 (14.3) 554 (32.9) 
Small bowel resection 1382 292 (21.1) 262 (19.0) 232 (16.8) 
Total 75854 3409 (4.5) 14140 (18.6) 9928 (13.1)     
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Regression analysis for one-year mortality Age, smoking, comorbidities, emergency surgery, open surgical approach, frailty, preoperative psychiatric morbidity and advanced cancer (stages III and IV) were independent predictors of one-year mortality (Table 7-9). BMI and year of surgery were independent negative predictors of one-year mortality. Antireflux surgery was associated with the lowest adjusted risk of one-year mortality while oesophagogastrectomy was associated with the highest adjusted risk. For covariates other than surgical procedure, stage IV cancer and emergency surgery were the strongest predictors of one-year mortality.  The C-statistic (ROC) for this regression model was 0.905. When the analysis was repeated by using HES covariates alone, the C-statistic was 0.898. The incorporation of linked dataset covariates improved the prediction of one-year mortality when compared with HES data alone. Of the non-HES covariates evaluated, all risk factors had an independent impact on one-year mortality. Smoking, preoperative psychiatric morbidity and frailty significantly increased the risk of one-year mortality.     
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Table 7-9. Logistic regression analysis for one-year mortality in patients who underwent 
gastrointestinal surgery 







Age 1.06 (1.05-1.06) <0.001 
Female gender 0.92 (0.85-1.00) 0.054 
BMI 0.99 (0.98-1.00) 0.004 
Smoking 1.38 (1.26-1.53) <0.001 
Low socioeconomic status 1.02 (0.99-1.05) 0.233 







Emergency surgery 3.25 (2.96-3.57) <0.001 
Open approach 1.57 (1.35-1.83) <0.001 




PREOPERATIVE HEALTH STATUS 
 
More than one recorded frailty 1.16 (1.06-1.27) 0.001 
Preoperative psychiatric morbidity  1.16 (1.04-1.29) 0.008 





Appendicectomy 0.56 (0.41-0.76) <0.001 
Cholecystectomy 1.22 (0.95-1.57) 0.113 
Antireflux surgery 0.53 (0.26-1.09) 0.376 
Bariatric surgery 3.04 (1.45-6.42) 0.003 
Small bowel resection 6.35 (4.97-8.11) <0.001 
Colorectal resection 4.14 (3.31-5.19) <0.001 
Oesophagogastrectomy 8.42 (6.48-10.95) <0.001 







No cancer Reference 
Cancer stage I 1.12 (0.91-1.39) 0.283 
Cancer stage II 1.13 (0.96-1.34) 0.135 
Cancer stage III 2.44 (2.10-2.84) <0.001 
Cancer stage IV 3.87 (3.12-4.81) <0.001 
Cancer stage unknown 2.59 (2.20-3.06) <0.001 
204  
Regression analysis for postoperative psychiatric morbidity Female gender, BMI, smoking, low socioeconomic status, comorbidities, frailty and preoperative psychiatric morbidity were independent predictors of postoperative psychiatric morbidity (Table 7-10). Of the predictors, preoperative psychiatric morbidity was associated with the greatest risk of postoperative psychiatric morbidity. Age and year of surgery were negative independent predictors of postoperative psychiatric morbidity. Of the surgical procedures, appendicectomy was associated with the lowest risk of postoperative psychiatric morbidity. Major upper gastrointestinal organ resections were associated with the highest risk of postoperative psychiatric morbidity. When compared with the reference procedure of haemorrhoidectomy, the odds ratio for oesophagogastrectomy was 1.73 (95%CI 1.38-2.17) and hepatopancreatobiliary resection was 1.82 (95%CI 1.40-2.36). In this model, when compared with patients without cancer, advanced cancer stage did not influence postoperative psychiatric morbidity as risk was more strongly correlated with type of surgical procedure. However, in a separate model that did not adjust for surgical procedure, cancer diagnosis and advanced stage were independent predictors of postoperative psychiatric morbidity (Table 7-11). Compared with patients without cancer, cancer stage III OR=1.19 95%CI 1.06-1.37, cancer stage IV OR=1.29 95%CI 1.04-1.60 and unknown cancer stage OR=1.48 95%CI=1.31-1.68 were independent predictors of postoperative psychiatric morbidity.  The C-statistic (ROC) for the regression model when adjusting for all predictor covariates including surgical procedure and cancer stage was 0.796. When surgical procedure was not adjusted for, the C-statistic was slightly less at 0.790. When the analysis was repeated by using HES covariates alone, the C-statistic was 0.602. The incorporation of linked dataset covariates improved the prediction of postoperative psychiatric morbidity when compared with HES data alone. Of the evaluated non-HES covariates, smoking, preoperative psychiatric morbidity, frailty and BMI were independent predictors of postoperative psychiatric morbidity.  
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Table 7-10. Logistic regression analysis for postoperative psychiatric morbidity in patients 
who underwent gastrointestinal surgery when adjusted for surgical procedure and cancer 
stage 
Dependent variable = postoperative 
psychiatric morbidity Odds ratio (95% CI) 








Age 0.99 (0.99-1.00) <0.001 
Female gender 1.32 (1.25-1.40) <0.001 
BMI 1.01 (1.00-1.01) 0.003 
Smoking 1.26 (1.19-1.33) <0.001 
Low socioeconomic status 1.05 (1.03-1.07) <0.001 







Emergency surgery 1.14 (1.06-1.24) 0.001 
Open approach 1.00 (0.92-1.09) 0.988 




PREOPERATIVE HEALTH STATUS 
 
More than one recorded frailty 1.24 (1.17-1.32) <0.001 
Preoperative psychiatric morbidity  10.63 (10.11-11.19) <0.001 





Appendicectomy 0.68 (0.60-0.76) <0.001 
Cholecystectomy 0.88 (0.79-0.98) 0.020 
Antireflux surgery 1.08 (0.87-1.34) 0.489 
Bariatric surgery 0.93 (0.76-1.13) 0.454 
Small bowel resection 0.70 (0.56-0.86) 0.001 
Colorectal resection 1.09 (0.96-1.24) 0.191 
Oesophagogastrectomy 1.73 (1.38-2.17) <0.001 







No cancer Reference 
Cancer stage I 0.91 (0.74-1.11) 0.360 
Cancer stage II 0.88 (0.75-1.03) 0.116 
Cancer stage III 0.97 (0.83-1.13) 0.683 
Cancer stage IV 0.82 (0.62-1.08) 0.163 
Cancer stage unknown 1.00 (0.83-1.21) 0.973 
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Table 7-11. Logistic regression analysis for postoperative psychiatric morbidity in patients 
who underwent gastrointestinal surgery without adjustment for surgical procedure 
Dependent variable = postoperative 
psychiatric morbidity Odds ratio (95% CI) 
p value for 
comparison 
   PATIENT CHARACTERISTICS 
  
Age 1.00 (0.99-1.00) <0.001 
Female gender 1.32 (1.24-1.39) <0.001 
BMI 1.01 (1.00-1.01) 0.001 
Smoking 1.27 (1.20-1.35) <0.001 
Low socioeconomic status 1.05 (1.03-1.07) <0.001 
More than one recorded comorbidity 1.20 (1.14-1.27) <0.001 
   SURGERY CHARACTERISTICS 
  
Emergency surgery 0.95 (0.90-1.01) 0.098 
Open approach 1.07 (1.01-1.13) 0.029 
Year of surgery 0.99 (0.98-1.00) 0.040 
   PREOPERATIVE HEALTH STATUS 
 
More than one recorded frailty 1.24 (1.17-1.32) <0.001 
Preoperative psychiatric morbidity 10.65 (10.12-11.21) <0.001 
   
CANCER STAGE 
  
No cancer Reference 
Cancer stage I 1.09 (0.92-1.30) 0.326 
Cancer stage II 1.04 (0.92-1.18) 0.512 
Cancer stage III 1.19 (1.06-1.34) 0.005 
Cancer stage IV 1.29 (1.04-1.60) 0.022 
Cancer stage unknown 1.48 (1.31-1.68) <0.001   
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Regression analysis for postoperative symptoms Age, female gender, smoking, comorbidities, frailty and preoperative psychiatric morbidity were independent predictors of postoperative symptoms (Table 7-12). Emergency surgery was an independent negative predictor of postoperative symptoms. Of the procedures evaluated, oesophagogastrecotmy and antireflux surgery were associated with the greatest risk of postoperative symptoms when compared with haemorrhoidectomy, which was associated with the lowest risk of postoperative symptoms. Of the patients with cancer, only those with stage III cancer had a significantly increased risk of postoperative symptoms.  The C-statistic (ROC) for this regression model was 0.640. When the analysis was repeated by using HES covariates alone, the C-statistic was 0.612. The incorporation of linked dataset covariates improved the prediction of postoperative symptoms when compared with HES data alone. Of the non-HES variables evaluated, smoking, frailty and preoperative psychiatric morbidity predicted the occurrence of postoperative symptoms.       
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Table 7-12. Logistic regression analysis for postoperative symptoms in patients who 
underwent gastrointestinal surgery 







Age 1.00 (1.00-1.00) <0.001 
Female gender 1.35 (1.29-1.41) <0.001 
BMI 1.00 (1.00-1.01) 0.511 
Smoking 1.10 (1.05-1.15) <0.001 
Low socioeconomic status 1.01 (1.00-1.03) 0.134 







Emergency surgery 0.91 (0.85-0.97) 0.003 
Open approach 0.98 (0.94-1.01) 0.461 




PREOPERATIVE HEALTH STATUS 
 
More than one recorded frailty 1.51 (1.47-1.55) <0.001 
Preoperative psychiatric morbidity  1.55 (1.48-1.62) <0.001 





Appendicectomy 1.16 (1.04-1.29) 0.006 
Cholecystectomy 1.48 (1.35-1.61) <0.001 
Antireflux surgery 3.19 (2.74-3.71) <0.001 
Bariatric surgery 1.32 (1.09-1.59) 0.004 
Small bowel resection 1.79 (1.54-2.09) <0.001 
Colorectal resection 1.84 (1.66-2.04) <0.001 
Oesophagogastrectomy 4.57 (3.90-5.35) <0.001 







No cancer Reference 
Cancer stage I 1.01 (0.87-1.16) 0.944 
Cancer stage II 0.90 (0.80-1.01) 0.078 
Cancer stage III 1.14 (1.02-1.28) 0.020 
Cancer stage IV 1.10 (0.91-1.33) 0.313 
Cancer stage unknown 1.09 (0.96-1.25) 0.183 
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Overview of risk associated with predictor covariates 
As multiple prediction models were evaluated, this section provides an overview of the risks associated with each of the predictor covariates for outcome. Only those predictors that were independently associated with an increased risk of poor outcome are discussed in this part of the analysis (Table 7-13). Of the demographic factors, age was associated with all types of poor outcome except for postoperative psychiatric morbidity. Male gender was associated with all types of poor outcome except for the two measures of health status, which was more likely in women. BMI was associated with prolonged hospital stay, technical SAEs and psychiatric morbidity. Smoking was associated with all types of poor outcome except for readmission and prolonged hospital stay. Low socioeconomic status was associated with all types of poor outcome except for mortality, systemic SAEs and postoperative symptoms. Emergency surgery predicted all types of poor outcome except for postoperative symptoms. Open surgery was associated with all types of poor outcome except for the two measures of health status. Year of surgery was a negative predictor of mortality, hospital stay and postoperative psychiatric morbidity. Year of surgery independently predicted readmission and systemic SAEs. Frailty was associated with all types of poor outcome except for 30-day mortality and SAEs. Preoperative psychiatric morbidity and comorbidity were the only covariates that were associated with all types of poor outcome. Type of surgical procedure was an important determinant of outcome although the odds ratios were low for the outcomes measures of readmission and prolonged hospital stay. Oesophagogastrectomy and hepatopancreatobiliary resection were the only two procedures associated with significantly increased risk of postoperative psychiatric morbidity compared with other procedures. The only significant effect of advanced cancer stage was for the prediction of one-year mortality. This part of the analysis revealed that all predictor covariates had some influence on outcome.  
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Table 7-13. Overview of regression analyses of linked database covariates predicting outcome in patients who underwent gastrointestinal surgery 














         Age 1.07 (1.07-1.08) 1.00 (1.00-1.01) 1.03 (1.03-1.03) 1.00 (1.00-1.01) 1.02 (1.01-1.02) 1.06 (1.05-1.06) - 1.00 (1.00-1.00) 
Female gender - 0.93 (0.88-0.98) 0.89 (0.86-0.93) 0.82 (0.77-0.86) - - 1.32 (1.25-1.40) 1.35 (1.29-1.41) 
BMI - - 1.01 (1.00-1.01) 1.02 (1.02-1.03) - - 1.01 (1.00-1.01) - 
Smoking 1.48 (1.27-1.73) - - 1.12 (1.05-1.19) 1.28 (1.15-1.41) 1.38 (1.26-1.53) 1.26 (1.19-1.33) 1.10 (1.05-1.15) 
Low socioeconomic status - 1.02 (1.00-1.04) 1.07 (1.06-1.09) 1.03 (1.01-1.05) - - 1.05 (1.03-1.07) - 
More than one recorded comorbidity 2.23 (1.95-2.54) 1.17 (1.10-1.24) 1.46 (1.39-1.52) 1.18 (1.11-1.25) 1.80 (1.64-1.98) 1.73 (1.59-1.87) 1.19 (1.12-1.26) 1.16 (1.11-1.22) 
Emergency surgery 3.67 (3.17-4.25) 1.11 (1.03-1.20) 11.36 (10.69-12.06) 1.10 (1.01-1.18) 2.04 (1.82-2.28) 3.25 (2.96-3.57) 1.14 (1.06-1.24) - 
Open approach 2.00 (1.51-2.66) 1.14 (1.09-1.19) 2.78 (2.59-2.98) 1.26 (1.15-1.37) 1.21 (1.12-1.30) 1.57 (1.35-1.83) - - 
Year of surgery 0.95 (0.93-0.97) 1.04 (1.03-1.04) 0.90 (0.90-0.91) - 1.06 (1.04-1.07) 0.95 (0.94-0.97) 0.99 (0.98-1.00) - 
More than one recorded frailty - 1.11 (1.08-1.15) 1.14 (1.09-1.20) - - 1.16 (1.06-1.27) 1.24 (1.17-1.32) 1.51 (1.47-1.55) 
Preoperative psychiatric morbidity 1.20 (1.01-1.42) 1.30 (1.22-1.39) 1.14 (1.09-1.20) 1.16 (1.08-1.24) 1.14 (1.02-1.28) 1.16 (1.04-1.29) 10.63 (10.11-11.19) 1.55 (1.48-1.62) 
Appendicectomy 2.75 (1.35-5.60) 1.47 (1.29-1.68) 1.14 (1.09-1.20) 5.90 (4.98-6.98) 3.50 (2.54-4.81) 0.56 (0.41-0.76) - 1.16 (1.04-1.29) 
Cholecystectomy 4.55 (3.20-6.49) 1.55 (1.38-1.74) 1.14 (1.09-1.20) 4.99 (4.26-5.84) 3.97 (2.93-5.40) - - 1.48 (1.35-1.61) 
Antireflux surgery - 1.82 (1.61-2.05) 0.30 (0.28-0.33) 3.18 (2.27-4.45) 5.23 (3.93-6.95) - - 3.19 (2.74-3.71) 
Bariatric surgery 27.80 (8.30-93.13) 1.86 (1.46-2.38) 3.82 (3.51-4.16) 3.59 (2.71-4.76) 3.49 (1.88-6.48) 3.04 (1.45-6.42) - 1.32 (1.09-1.59) 
Small bowel resection 31.98 (16.58-61.67) 1.85 (1.52-2.26) 6.03 (5.09-7.15) 12.79 (10.46-15.64) 13.37 (9.63-18.56) 6.35 (4.97-8.11) - 1.79 (1.54-2.09) 
Colorectal resection 25.95 (13.64-49.35) 1.90 (1.66-2.18) 4.93 (4.08-5.95) 14.70 (12.53-17.25) 10.63 (7.87-14.35) 4.14 (3.31-5.19) - 1.84 (1.66-2.04) 
Oesophagogastrectomy 26.01 (12.92-52.36) 1.88 (1.52-2.34) 0.19 (0.16-0.22) 14.90 (11.95-18.57) 19.66 (13.87-27.87) 8.42 (6.48-10.95) 1.73 (1.38-2.17) 4.57 (3.90-5.35) 
Hepatopancreatobiliary resection 30.62 (14.70-63.79) 1.64 (1.27-2.11) 0.62 (0.55-0.69) 16.06 (12.52-20.61) 11.99 (8.00-17.97) 7.40 (5.57-9.83) 1.82 (1.40-2.36) 2.40 (1.98-2.90) 
Cancer stage I - 1.20 (1.01-1.44) 1.30 (1.08-1.55) - - - - - 
Cancer stage II - - - - - - - - 
Cancer stage III - - 1.31 (1.12-1.53) - - 2.44 (2.10-2.84) - 1.14 (1.02-1.28) 
Cancer stage IV - - - - - 3.87 (3.12-4.81) - - 
Cancer stage unknown - 1.28 (1.09-1.51) - - - 2.59 (2.20-3.06) - - 
          
Only independent predictors that are positively associated with outcome are presented, except for gender where negative associations signify significant risk with 
male gender and year of surgery where negative associations signify decreasing trends over time
211  
The performance of regression models using linked data 
For each of the outcome measures described, regression analyses incorporated all linked database covariates to predict outcome. Separate analyses evaluated the performance of  regression models using HES data only (Table 7-14). This allowed for the comparison of performance of regression models between the two types of data. The ROC method was used for comparison of predictive performance as previously described.[Dimick 2010] When deriving the ROC, prediction models were first trained on patients from the South of England and the discriminating ability of the model tested on patients from the North of England. Overall, the predictive ability of regression models were similar between the two types of data (Table 7-15). The ROC score from regression models using HES predictor covariates was lowest for readmission (0.580) and highest for 30-day mortality (0.928). The ROC score derived using linked database predictor covariates for patient characteristics was lowest for readmission (0.597) and highest for 30-day mortality (0.934). The inclusion of linked database covariates in addition to HES covariates increased the ROC for all outcome evaluated. The percentage improvement in ROC after including linked database covariates was lowest for 30-day mortality (1.2%) and highest for postoperative psychiatric morbidity (38.8%). Of the outcome measures evaluated, 30-day mortality and one-year mortality demonstrated ROC higher than the threshold of 0.8 using HES data only. All other outcome including readmission, prolonged stay, SAEs, postoperative psychiatric morbidity and postoperative symptoms showed ROC less than 0.8 even with linked database predictor covariates included in the analysis. The addition of linked database covariates did not increase the ROC from below threshold of 0.8 to above 0.8 for any of the outcome variables evaluated. The addition of linked database covariates to HES covariates therefore did not significantly improve the performance of prediction models for outcome.  
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Table 7-14. Regression analyses of linked database covariates predicting outcome using HES predictor covariates only in patients who underwent 
gastrointestinal surgery 












         Age 1.07 (1.06-1.08) 1.00 (1.00-1.00) 1.03 (1.03-1.03) *1.00 (1.00-1.00) 1.02 (1.01-1.02) 1.06 (1.05-1.06) 0.99 (0.99-0.99) 1.00 (1.00-1.01) 
Female gender *0.96 (0.85-1.09) *0.96 (0.91-1.02) 0.94 (0.90-0.98) 0.85 (0.81-0.90) *1.06 (0.97-1.16) 0.90 (0.83-0.97) 1.82 (1.73-1.91) 1.46 (1.40-1.52) 
More than one recorded comorbidity 2.56 (2.25-2.90) 1.26 (1.18-1.34) 1.71 (1.63-1.79) 1.31 (1.24-1.40) 2.02 (1.85-2.21) 1.88 (1.74-2.03) 1.48 (1.40-1.56) 1.19 (1.14-1.25) 
Emergency surgery 3.97 (3.45-4.56) 1.11 (1.02-1.20) 11.21 (10.57-11.88) 1.16 (1.08-1.26) 2.02 (1.81-2.25) 3.08 (2.81-3.36) 1.18 (1.10-1.27) 0.92 (0.87-0.98) 
Open approach 2.03 (1.53-2.69) 1.14 (1.04-1.24) 2.79 (2.60-2.99) 1.27 (1.17-1.38) 1.21 (1.05-1.40) 1.58 (1.36-1.84) *1.03 (0.95-1.11) *0.99 (0.93-1.05) 
Year of surgery 0.95 (0.93-0.97) 1.04 (1.03-1.05) 0.90 (0.89-0.91) 1.04 (1.03-1.05) 1.06 (1.04-1.08) 0.95 (0.94-0.97) *1.00 (1.00-1.01) *1.00 (1.00-1.01) 
Appendicectomy 2.50 (1.19-5.25) 1.44 (1.27-1.64) 0.30 (0.27-0.32) 5.26 (4.45-6.21) 3.44 (2.51-4.72) 0.58 (0.42-0.79) 0.55 (0.49-0.61) 1.11 (1.00-1.23) 
Cholecystectomy 4.41 (2.21-8.80) 1.53 (1.37-1.72) 3.76 (3.45-4.09) 5.13 (4.38-6.01) 3.94 (2.90-5.35) *1.22 (0.95-1.57) 0.87 (0.79-0.96) 1.47 (1.35-1.60) 
Antireflux surgery - 1.81 (1.42-2.30) 5.94 (5.01-7.05) 3.17 (2.26-4.43) 5.17 (2.96-9.05) *0.53 (0.13-2.15) *1.19 (0.98-1.45) 3.24 (2.77-3.78) 
Bariatric surgery 22.51 (6.88-73.61) 1.87 (1.50-2.33) 5.57 (4.68-6.64) 5.61 (4.33-7.26) 3.18 (1.77-5.72) 2.52 (1.21-5.23) 1.48 (1.26-1.74) 1.52 (1.28-1.80) 
Small bowel resection 31.11 (16.17-59.86) 1.90 (1.57-2.31) 0.18 (0.16-0.21) 11.34 (9.30-13.84) 13.60 (9.82-18.83) 7.69 (6.04-9.78) 0.69 (0.57-0.84) 1.82 (1.57-2.12) 
Colorectal resection 21.56 (11.50-40.43) 2.01 (1.83-2.21) 0.55 (0.51-0.59) 10.80 (9.37-12.44) 11.34 (8.61-14.94) 6.70 (5.53-8.11) 0.90 (0.83-0.97) 1.84 (1.71-1.97) 
Oesophagogastrectomy 27.01 (13.82-52.78) 2.28 (1.94-2.69) 1.24 (1.08-1.41) 10.50 (8.71-12.66) 22.49 (16.54-30.58) 19.43 (15.61-24.17) 1.43 (1.23-1.67) 4.80 (4.28-5.37) 
Hepatopanreaticobiliary resection 29.99 (14.86-60.50) 1.97 (1.62-2.40) 1.59 (1.37-1.85) 9.79 (7.96-12.03) 12.15 (8.53-17.31) 21.83 (17.29-27.54) 1.28 (1.07-1.52) 2.49 (2.17-2.87) 
          
*p=not significant   
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Table 7-15. C-statistic (area under the receiver operating characteristic curve) for regression models predicting short and long-term outcome in patients who underwent gastrointestinal surgery according to database from which predictor covariates were derived, and percentage change when linked database covariates were combined with HES predictor covariates  


















         
All linked databases  0.934 0.597 0.771 0.715 0.787 0.905 0.796 0.640 
         
HES only 0.928 0.580 0.764 0.705 0.776 0.898 0.602 0.612 
Change in ROC when linked 
databases were combined with HES 
1.2% 3.4% 1.4% 2.0% 2.2% 1.4% 38.8% 5.6% 
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Discussion 
To study the impact of predictor covariates derived from linked databases, short and long-term outcome that served as the dependent variables for regression analyses were described. Thirty-day mortality and SAEs were highest for small bowel resection, owing to the high proportion of emergency surgery (80.2%) and bowel ischaemia (28.1%) in this group. Although it was not possible to evaluate 30-day mortality for anti-reflux surgery, all other outcome were evaluated for this procedure. As the method of deriving short-term outcome other than SAEs have previously been described in HES, the results of this analysis were expected to be similar to previous studies using this database. Munasinghe et al reported median length of hospital stay of 15 day in oesophagogastrecotmy, similar to the 16 days found in the presented analysis.[Munasinghe 2015] Short-term mortality in this study was also similar at 4.2% for oesophagogastrectomy patients. In colorectal surgery Burns et al reported one-year mortality rates for a mixed cohort of emergency and elective procedures to be 13.9%, similar to the present analysis of 13.3%.[EM Burns 2011] Overall, short-term outcome including 30-day mortality, prolonged stay and SAEs were worse for major organ resection for cancer (colorectal resection, oesophagogastrectomy, hepatopancreatobiliary resection) compared with surgery for benign disease. For readmission, risk was evenly distributed across all procedures meaning that less invasive procedures may still have a significant risk of readmission. Age was an independent predictor of readmission, similar to what was previously reported in abdominal aortic surgery.[Holt 2010] While cancer diagnosis and stage had no impact on short-term mortality, one-year mortality was significantly higher for advanced cancer. Using HES data, Mamidanna et al found one-year mortality to be 42.9% in patients undergoing emergency colorectal resection, higher than in the present analysis due to the inclusion of patients undergoing emergency surgery only.[Mamidanna 2012] 
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Regression analysis for one-year mortality revealed that emergency surgery, advanced cancer stage and surgical procedure were the strongest predictors of this outcome.  Regression models for long-term outcome in surgery are less frequently reported than short-term outcome. Evaluation of all predictor covariates together revealed that patient characteristics including female gender, comorbidities, frailty and preoperative psychiatric morbidity independently predicted postoperative psychiatric morbidity and postoperative symptoms. Hepatopancreatobiliary resection and oesophagogastrectomy were both associated with high adjusted risks for poor postoperative health status. These findings should inform survivorship programs for upper gastrointestinal malignancy aimed at improving long-term outcome in cancer patients. Surgeons and GPs should be aware of the risk of psychiatric morbidity and adverse symptoms in this type of surgery as early treatment is likely to lead to better outcome. Furthermore, these endpoints should be included in prospective studies and clinical trials of new and emerging strategies for treating gastrointestinal cancer.  Predictors of harm identified in this analysis may be potential targets for strategies aimed at reducing surgical risk. For example, as smoking was correlated most strongly with mortality and systemic SAEs, efforts must focus on reducing smoking preoperatively to reduce the rate of systemic SAEs. CPRD data also allowed for new insights to be gained on the effect of preoperative health status in regression analyses for poor outcome. All outcome measures except for 30-day mortality and SAEs were predicted by both preoperative psychiatric morbidity and frailty. These parameters must therefore be included in risk prediction models in future population-level analyses of healthcare performance. This Chapter has demonstrated that longer-term factors associated with day-to-day living must be taken into account when considering risk in patients undergoing gastrointestinal surgery. One limitation of primary care data was that only 522/75854 (0.69%) patients had more than one recorded frailty component, making evaluation of the effect of multiple frailty components challenging. Instead, 
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future analysis could be designed to focus on deriving weightings for individual aspects of frailty. Overall, the presented analysis demonstrates that health status measured in primary care can identify patients at risk of surgical harm.  While insights into preoperative risk factors were gained through linked primary care and hospital data, the challenges in using this dataset when predicting outcome must be acknowledge. For 30-dy mortality, BMI was not found to be an independent predictor unlike other studies (Table 7-13). One study identified that the risk of short-term mortality increased by 40% in patients with BMI less than 23 using NSQIP data.[Turrentine 2012] In this study BMI was considered as a categorical variable. Differences in analytical methods to previous studies may therefore play a part in some of the discrepancies in the presented findings. The high proportion of missing BMI values may also have influenced the lack of significance of this covariate. In the present analysis, socioeconomic status did not predict mortality. Previous studies have demonstrated lower socioeconomic status to be an independent predictor of mortality in gastrointestinal surgery. [Wu 2014] While linked data helped identify a wide range of predictor covariates, socioeconomic status was not a significant risk factor for death. Developing analytical methods to define the threshold for what is considered as low socioeconomic status as threshold may help demonstrate the impact of this important variable in future analyses.  Risk factors derived from linked population data also predict postoperative health status. Understandably, those with poor preoperative health status are at greatest risk of poor postoperative health status. Patients with preoperative frailty and psychiatric morbidity should therefore be counseled appropriately and offered additional support in the postoperative setting.  Odds ratios derived in this analysis may form the bases of a weighted preoperative functional index using primary care data, which would benefit those referring patients for hospital care. Such a tool may facilitate wide scale audit as well as individual risk assessment before surgery. 
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Overall, all of the predictor covariates evaluated in this Chapter had some influence on outcome in regression models. Based on these findings, all of these variables should be included in risk prediction models of outcome in gastrointestinal surgery.  The predictive performance of regression models improved after the incorporation of all linked database covariates in addition to HES. However, improvements were modest for all outcome except for postoperative psychiatric morbidity. Furthermore, the inclusion of linked database predictor covariates did not increase the ROC above the 0.8 threshold for any of the outcome measures evaluated. Predictive performance was already above this value for 30-day mortality and one-year mortality when using HES data only. For readmission, prolonged stay, SAEs, postoperative psychiatric morbidity and postoperative symptoms, the inclusion of linked database covariates did not significantly increase the ROC. However, for postoperative psychiatric morbidity, the inclusion of linked database covariates increased the ROC by almost 40%, taking it close to 0.8. The benefit of including linked database covariates was therefore only observed for this outcome, owing to the predictive ability of preoperative psychiatric morbidity. For the remaining measures of outcome, linked database covariates increased the performance of regression models by between 1.2% and 5.6%. These findings suggest that further exploration of linked data for other predictors of harm and health status may be worthwhile as discriminating ability of prediction models are likely to improve further. However, based on the presented data, the inclusion of linked database patient characteristics did not improve the performance of prediction models to a level that would be useful from a clinical and policy perspective.  In this Chapter, granular information obtained from multiple routine national databases helped improve understanding of predictors of surgical outcome. Risks incurred by covariates from multiple databases were quantified. The inclusion of linked database covariates in addition to HES increased the predictive performance of regression models for all outcome. While these data offer the potential for detailed evaluation of integrated 
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health systems, the findings of this Chapter do not support the use of linked data to inform policy. Nevertheless, insights into the effect of risk factors on poor short and long-term outcome were gained through these analyses.  
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8. CHAPTER EIGHT – EVALUATING THE IMPACT OF HARM 
Introduction 
Linked databases have so far identified a wide range of predictor covariates derived from multiple databases that have helped model surgical outcome. The identification of SAEs and poor long-term health status has allowed for the quantification of risk incurred by a wide range of predictor covariates. In surgery, different measures of poor outcome can interact with each other leading to a negative spiral of harm events. For example, technical SAEs such as anastomotic leakage can lead to localized problems of fistula formation and collection, or in severe cases systemic sepsis and organ failure. It is probable that these patterns of harm may culminate in poor physical, physiological and psychological function. Due to the inherent structure of individual healthcare databases, it has often not been possible to evaluate both short and long-term outcome on one platform, to study such spirals of harm in detail.  Studies using NSQIP data have demonstrated how short-term harm can impact on outcome. Failure-to-rescue, which is mortality from SAEs has previously been shown to reflect hospital performance better than mortality or SAEs alone.[Ghaferi 2011] There are many examples of how poor outcome can act synergistically to affect patients from studies using the NSQIP database. In general surgery, readmission rates have been shown to be associated with post-discharge harm such as wound infection.[Kassin 2012] In colorectal surgery, length of hospital stay has been shown to significantly increased in patients who suffered SAEs.[Ricciardi 2013] In this context, reoperation has also been demonstrated to increase VTE rates, which implies that multiple harm events can impact on the same patient.[Shapiro 2011] Based on these observations, NSQIP data have been used to develop composite measures of harm, which demonstrate variation in performance better than single measures of harm.[Dimick 2013] 
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NSQIP only captures short-term harm so population level analyses of longer-term outcome are less frequently reported. The Patient Reported Outcome program offers QOL data at three months after surgery by the EQD5 method offering some information on health status.[HSCIC 2015] However, only four surgical procedures are included in this database. Some clinical registries record symptoms as part of preoperative evaluation but not as part of outcome.[National Bariatric Surgery Registry 2010] Registry data have also been used to evaluate other aspects of health status such as psychiatric morbidity.[Wikman 2015] Smaller prospective studies are able to go into greater detail, for example, symptoms related to conduit dysfunction following oesophagectomy.[Bonavina 1992] Whether changes in health status correlate with other measures of short-term harm and outcome has not previously been explored using population-level data.  Large-scale analyses of harm in the UK have often been limited to the confines of what covariates can be derived from HES. Using this database, how preoperative variables can be used to assess risk has been extensively studied.[Bottle 2014] In previous studies, poor outcome is often considered as single endpoints. How harm can synergistically impact on outcome is less frequently reported. While patient and surgery characteristics were demonstrated to predict outcome in the previous Chapter, this Chapter will explore how harm can predict other types of outcome. Greater understanding of harm interactions may facilitate the development of strategies to mitigate spiraling negative trends.  To explore this, predictive models of harm will be formulated using multiple predictor covariates from linked databases including those describing short-term harm and long-term poor health status. The predictive performance of regression models will be tested to quantify the value of incorporating these variables as predictors of outcome. Using predictive models, time trends in risk-adjusted rates of harm within an integrated health system will be assessed, together with risk factors in individual surgical procedures.  
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Aims 
• To evaluate the impact of harm and poor health status on outcome 
• To demonstrate interactions between short-term harm and long-term health status 
• To evaluate the performance of regression models when adjusted for harm and poor health status 
• To analyze trends in risk-adjusted rates of poor outcome over time 
• To evaluate risk factors for poor outcome in individual surgical procedures 
Methods 
While measures of harm and poor health status were evaluated as endpoints in the previous Chapter, in this Chapter, they will be considered as predictors of other outcome. It would be logical to evaluate the predictive ability these variables by building on prediction models for outcome developed so far. This will be done to help understand the relationship between different aspects of poor outcome. Short-term harm (30-day SAEs) will be incorporated into regression models of short-term outcome (30-day mortality, 30-day readmission and prolonged hospital stay) and long-term outcome (mortality, psychiatric morbidity and symptoms within one year of surgery). Poor long-term health status (psychiatric morbidity and symptoms within one year of surgery) will be incorporated into regression models for long-term outcome (mortality and psychiatric morbidity within one year of surgery). How the inclusion of new variables affect the risk incurred by existing predictor covariates will be assessed.  
Adjusting for short-term harm SAEs will be incorporated into regression models of outcome. Regression analyses will adjust for individual components of SAEs. The impact of each type of SAE will be evaluated, meaning that some procedures were associated with multiple types of SAEs. 
222  
As an overview, odds ratios for SAEs that are independent predictors of poor outcome will be tabulated after categorizing SAEs as technical or systemic, captured in CPRD or HES and in-hospital or post-discharge.  
Adjusting for long-term poor health status For the regression analysis for one-year mortality, individual symptoms will be evaluated separately, meaning that some procedures were associated with multiple postoperative symptoms. Psychiatric morbidity will be categorized as preoperative psychiatric morbidity or new onset postoperative psychiatric morbidity (postoperative psychiatric morbidity without preoperative psychiatric morbidity). Whether symptoms can predict psychiatric morbidity will also be assessed in a separate regression model. For this procedures will be categorized as those with one type of symptom recorded and those with multiple symptoms recorded. These models will be adjusting for short-term harm. 
Evaluating the performance of regression models The ROC will be calculated by splitting the cohort into two datasets as previously described. Comparisons will be made between models with and without the incorporation new variables. The percentage change in ROC will be calculated and ROC values of 0.8 and above will be considered as a clinically acceptable model.  
Evaluating trends in poor outcome over time A separate analysis will evaluate time trends by converting year of surgery into a categorical variable. Using the procedures undertaken in the first year as the reference point, odds ratios will be calculated for each two-year period thereafter. The significance of time associations will be assessed. This may lead to insights into patterns of poor outcome observed from multiple perspectives within the NHS.  
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Individual procedure analysis Colorectal resection, cholecystectomy, appendicectomy and haemorrhoidectomy were the most commonly performed procedures in the study cohort. These procedures accounted for the majority (91.6%, 69445/75854) of procedures undertaken. Linked database covariates were used to assess risk in each of the four procedures based on prediction models developed so far. The variable for cancer stage was excluded from the analysis for cholecystectomy, appendicectomy and haemorrhoidectomy. The numbers of elective appendicectomies and minimally invasive haemorrhoidectomies were negligible and excluded from respective analyses.  
 
The effect of surgical adverse events on outcome 
Regression analysis for thirty-day mortality When compared to the regression model for thirty-day mortality without SAEs included as a predictor covariate (Table 7-3), the inclusion of SAE did not affect the significance of other predictor covariates except for surgical procedure (Table 8-1). Although appendicectomy was an independent predictor of 30-day mortality when not adjusted for SAEs, appendicectomy was not an independent predictor when adjusted for SAEs. All SAEs except for wound dehiscence were independent predictors of 30-day mortality. Patients with wound dehiscence had an almost two-fold increase in mortality risk, however this effect was not statistically significant. Overall, systemic SAEs predicted 30-day mortality more than technical SAEs, reflected by the odds ratios. Of the technical SAEs, wound infection was associated with significantly reduced risk of 30-day mortality. Reoperation was associated with the greatest adjusted mortality risk. The ROC for the prediction model for 30-day mortality when adjusting for SAEs was 0.952, greater than  compared with the model without SAEs where the ROC was 0.934 
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(Table 7-15). There was no significant interaction between SAEs and other predictor covariates signified by a VIF of 1.07 for SAEs.   
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Table 8-1. Logistic regression analysis for 30-day mortality adjusted for SAEs in patients who 
underwent gastrointestinal surgery 
Dependent variable = 30-day mortality Odds ratio (95% CI) p value for comparison VIF 
     
 
PATIENT CHARACTERISTICS    
 
Age 1.07 (1.06-1.08) <0.001 1.42 
Female gender 1.07 (0.93-1.23) 0.351 1.13 
BMI 0.99 (0.98-1.00) 0.189 1.11 
Smoking 1.35 (1.15-1.60) <0.001 1.08 
Low socioeconomic status 1.03 (0.98-1.09) 0.194 1.04 
More than one recorded comorbidity 2.00 (1.74-2.30) <0.001 1.15 




   
Emergency surgery 3.61 (3.09-4.23) <0.001 1.12 
Open approach 1.75 (1.51-2.03) <0.001 1.31 
Year of surgery 0.91 (0.89-0.93) <0.001 1.06 
      PREOPERATIVE HEALTH STATUS   More than one recorded frailty 1.05 (0.91-1.22) 0.514 1.08 
Preoperative psychiatric morbidity  1.13 (0.94-1.35) 0.192 1.06 
    
SURGERY TYPE     Haemorrhoidectomy Reference  
Appendicectomy 2.08 (1.08-4.00) 0.056 
2.41 
Cholecystectomy 3.28 (2.30-4.68) 0.001 
Bariatric surgery 22.47 (6.64-76.08) <0.001 
Small bowel resection 17.65 (9.06-34.38) <0.001 
Colorectal resection 15.55 (8.17-29.62) <0.001 
Oesophagogastrectomy 14.84 (7.30-30.16) <0.001 
Hepatopancreatobiliary resection 17.35 (8.48-35.47) <0.001 
     
 
CANCER STAGE    
2.51 
No cancer Reference 
Cancer stage I 0.77 (0.56-1.07) 0.121 
Cancer stage II 0.77 (0.61-0.98) 0.034 
Cancer stage III 0.93 (0.74-1.17) 0.541 
Cancer stage IV 1.16 (0.78-1.71) 0.476 
Cancer stage unknown 1.27 (0.98-1.64) 0.068 
    
SAEs    
No SAE Reference  
1.07 
Wound infection only 0.55 (0.33-0.91) 0.020 
Wound dehiscence only 1.96 (0.83-4.66) 0.126 
Bleeding only 2.69 (2.02-3.58) <0.001 
Organ injury only 2.17 (1.11-4.25) 0.025 
 Reoperation only 4.21 (2.29-7.72) <0.001 
VTE only 2.96 (1.76-5.00) <0.001 
Pneumonia only 13.80 (11.06-17.21) <0.001 
Myocardial infarction only 11.99 (8.28-17.35) <0.001 
Cerebrovascular accident only 4.60 (1.58-13.40) 0.005 
Acute renal failure only 13.09 (8.88-19.31)  <0.001 
 Multiple SAEs 11.00 (9.03-13.40)  <0.001 
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Regression analysis for thirty-day readmission Compared to when not adjusted for SAEs (Table 7-4), the inclusion of SAE as a predictor covariate for readmission influenced the significance of other predictor covariates (Table 8-2). Age and female gender were no longer predictors of readmission while BMI was a negative predictor when adjusted for SAEs. While other demographic factors were still significant when adjusted for SAEs, surgical characteristics including emergency surgery and open surgical approach were no longer significant predictors. Year of surgery, frailty and preoperative psychiatric morbidity were all significantly associated with readmission with or without adjustment for SAEs. Organ resections for malignancy were less significantly associated with readmission when adjusted for SAEs. Cancer diagnosis and advanced stage were also predictors of readmission when adjusted for SAEs. All SAEs were independent predictors of readmission and demonstrated the highest adjusted risks for readmission than any of the other predictor covariates. The recording of multiple SAEs was associated with a ten-fold increase in risk of readmission when compared with patients with no SAEs.  The ROC for the regression model adjusting for SAEs was 0.670, while the ROC when not adjusting for SAEs was 0.597 (Table 7-15). Collinearity between predictor covariates was the same for the regression analysis for 30-day mortality, as the entered predictor covariates were the same.     
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Table 8-2. Logistic regression analysis for 30-day readmission adjusted for SAEs in patients 
who underwent gastrointestinal surgery 
Dependent variable = 30-day readmission Odds ratio (95% CI) p value for comparison 
     
PATIENT CHARACTERISTICS    
Age 1.00 (1.00-1.00) 0.542 
Female gender 0.98 (0.92-1.04) 0.452 
BMI 0.99 (0.99-1.00) 0.036 
Smoking 1.03 (0.97-1.10) 0.318 
Low socioeconomic status 1.01 (0.99-1.04) 0.166 
More than one recorded comorbidity 1.08 (1.02-1.15) 0.015 
     SURGERY CHARACTERISTICS 
 
  
Emergency surgery 1.02 (0.93-1.11) 0.671 
Open approach 1.09 (0.99-1.19) 0.073 
Year of surgery 1.03 (1.02-1.03) <0.001 
     PREOPERATIVE HEALTH STATUS  More than one recorded frailty 1.12 (1.05-1.20) 0.001 
Preoperative psychiatric morbidity  1.27 (1.19-1.36) <0.001 
   
SURGERY TYPE    Haemorrhoidectomy Reference 
Appendicectomy 1.23 (1.07-1.41) 0.004 
Cholecystectomy 1.30 (1.16-1.47) <0.001 
Antireflux surgery 1.61 (1.26-2.06) <0.001 
Bariatric surgery 1.65 (1.28-2.13) <0.001 
Small bowel resection 1.02 (0.83-1.26) 0.838 
Colorectal resection 1.09 (0.94-1.26) 0.242 
Oesophagogastrectomy 1.02 (0.81-1.28) 0.870 
Hepatopancreatobiliary resection 0.89 (0.68-1.16) 0.371 
     CANCER STAGE    No cancer Reference 
Cancer stage I 1.35 (1.12-1.63) 0.002 
Cancer stage II 1.07 (0.91-1.25) 0.440 
Cancer stage III 1.29 (1.10-1.50) 0.001 
Cancer stage IV 1.59 (1.24-2.05) <0.001 
Cancer stage unknown 1.40 (1.18-1.67) <0.001 
   
SAEs   
No SAE Reference  
Wound infection only 3.96 (3.60-4.36) <0.001 
Wound dehiscence only 9.05 (6.64-12.35) <0.001 
Bleeding only 5.11 (4.43-5.89) <0.001 
Organ injury only 1.95 (1.39-2.73) <0.001 
 Reoperation only 10.94 (8.95-13.37) <0.001 
VTE only 7.97 (6.08-10.45) <0.001 
Pneumonia only 3.91 (3.27-4.69) <0.001 
Myocardial infarction only 1.58 (1.13-2.19) 0.007 
Cerebrovascular accident only 10.44 (5.46-19.98) <0.001 
Acute renal failure only 5.88 (4.20-8.25)  <0.001 
 Multiple SAEs 10.34 (9.24-11.59)  <0.001 
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Regression model for prolonged hospital stay The incorporation of SAEs into regression models for prolonged hospital meant that the risk associated with surgical procedure and cancer stage III were different when compared with the model not adjusted for SAEs (Table 7-5). For surgical procedures, while small bowel resection was associated with the highest risk of prolonged hospital stay when not adjusted for SAEs, antireflux surgery was associated with the highest risk when adjusted for SAEs (Table 8-3). Oesophagogastrecotmy was associated with the lowest risk of prolonged hospital stay when not adjusted for SAEs while small bowel resection was associated with the lowest risk when adjusted for SAEs. Cancer stage III, similar to cancer stage IV, was a negative predictor of prolonged hospital stay when SAEs were incorporated into regression models.  Overall, technical SAEs were associated with greater risk of prolonged hospital stay compared with systemic SAEs. In particular, the recording of postoperative bleeding was associated with the highest risk of prolonged hospital stay. Other than this variable, recording of multiple SAEs was associated with the highest risk of prolonged hospital stay.  The ROC of this regression model was 0.787, greater than when not adjusting for SAEs where the ROC was 0.771 (Table 7-15). Collinearity between predictor covariates was the same as previous regression analyses in this Chapter as the entered predictor covariates were the same.    
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Table 8-3. Logistic regression analysis for prolonged hospital stay adjusted for SAEs in 
patients who underwent gastrointestinal surgery 
Dependent variable = prolonged hospital 
stay Odds ratio (95% CI) 
p value for 
comparison 
     
PATIENT CHARACTERISTICS    
Age 1.03 (1.03-1.03) <0.001 
Female gender 0.92 (0.88-0.96) <0.001 
BMI 1.01 (1.00-1.01) 0.009 
Smoking 0.97 (0.92-1.02) 0.201 
Low socioeconomic status 1.07 (1.06-1.09) <0.001 
More than one recorded comorbidity 1.42 (1.36-1.49) <0.001 
     SURGERY CHARACTERISTICS 
 
  
Emergency surgery 12.17 (11.43-12.95) <0.001 
Open approach 2.82 (2.63-3.02) <0.001 
Year of surgery 0.89 (0.89-0.90) <0.001 
     PREOPERATIVE HEALTH STATUS  More than one recorded frailty 1.16 (1.10-1.22) <0.001 
Preoperative psychiatric morbidity  1.12 (1.07-1.18) <0.001 
   
SURGERY TYPE    Haemorrhoidectomy Reference 
Appendicectomy 0.26 (0.24-0.29) <0.001 
Cholecystectomy 3.65 (3.35-3.98) <0.001 
Antireflux surgery 5.95 (5.00-7.07) <0.001 
Bariatric surgery 4.77 (3.93-5.80) <0.001 
Small bowel resection 0.12 (0.10-0.14) <0.001 
Colorectal resection 0.43 (0.39-0.48) <0.001 
Oesophagogastrectomy 0.89 (0.74-1.07) 0.215 
Hepatopancreatobiliary resection 1.83 (1.48-2.26) <0.001 
     CANCER STAGE    No cancer Reference 
Cancer stage I 1.35 (1.19-1.52) <0.001 
Cancer stage II 0.95 (0.83-1.08) 0.413 
Cancer stage III 0.81 (0.71-0.92) 0.001 
Cancer stage IV 0.44 (0.35-0.54) <0.001 
Cancer stage unknown 1.05 (0.91-1.21) <0.537 
   
SAEs   
No SAE Reference  
Wound infection only 1.91 (1.74-2.10) <0.001 
Wound dehiscence only 2.72 (1.90-3.89) <0.001 
Bleeding only 14.61 (12.61-16.94) <0.001 
Organ injury only 2.61 (2.02-3.37) <0.001 
 Reoperation only 3.39 (2.72-4.23) <0.001 
VTE only 2.85 (2.11-3.85) <0.001 
Pneumonia only 2.55 (2.14-3.05) <0.001 
Myocardial infarction only 0.99 (0.74-1.31) 0.923 
Cerebrovascular accident only 1.19 (0.54-2.63) 0.666 
Acute renal failure only 1.56 (1.08-2.26) 0.021 
 Multiple SAEs 4.80 (4.24-5.43)  <0.001 
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Regression analysis for one-year mortality  The inclusion of SAEs in to regression models for one-year mortality did not influence the significance of most of other predictor covariates when compared with regression models not adjusted for SAEs (Table 7-9). Only the significance of stage II cancer changed and this factor was an independent predictor of one-year mortality when adjusted for SAEs (Table 8-4). This meant that all cancer stages except for stage I disease were independent predictors of one-year mortality when adjusted for SAEs.  Of the technical SAEs evaluated, bleeding and reoperation were independent predictors of one-year mortality. All systemic SAEs except for VTE were predictors of one-year mortality. While VTE was associated with increased odds of death, this effect did not reach statistical significance. Of the SAEs evaluated, cerebrovascular accident was associated with the highest adjusted risk of one-year mortality. When adjusted for SAEs, the strongest predictors of one-year mortality were emergency surgery, cancer resection and cancer stage. The ROC for this model was 0.909, greater than when not adjusted for SAEs where the ROC was 0.905 (Table 7-15). Collinearity between predictor covariates was the same as previous regression analyses in this Chapter as the entered predictor covariates were the same.   
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Table 8-4. Logistic regression analysis for one-year mortality when adjusted for SAEs in 
patients who underwent gastrointestinal surgery 
Dependent variable = one-year mortality Odds ratio (95% CI) p value for comparison 
     
PATIENT CHARACTERISTICS    
Age 1.05 (1.05-1.06) <0.001 
Female gender 0.97 (0.90-1.06) 0.501 
BMI 0.99 (0.98-1.00) 0.004 
Smoking 1.33 (1.21-1.47) <0.001 
Low socioeconomic status 1.01 (0.98-1.04) 0.411 
More than one recorded comorbidity 1.63 (1.50-1.77) <0.001 
     SURGERY CHARACTERISTICS 
 
  
Emergency surgery 3.15 (2.86-3.47) <0.001 
Open approach 1.52 (1.31-1.77) <0.001 
Year of surgery 0.94 (0.93-0.95) <0.001 
     PREOPERATIVE HEALTH STATUS  More than one recorded frailty 1.17 (1.07-1.28) 0.001 
Preoperative psychiatric morbidity  1.13 (1.01-1.26) 0.033 
   
SURGERY TYPE    Haemorrhoidectomy Reference 
Appendicectomy 0.51 (0.37-0.70) <0.001 
Cholecystectomy 1.11 (0.87-1.43) 0.404 
Antireflux surgery 0.49 (0.15-1.60) 0.323 
Bariatric surgery 2.86 (1.35-6.03) 0.006 
Small bowel resection 4.77 (3.71-6.13) <0.001 
Colorectal resection 3.20 (2.54-4.03) <0.001 
Oesophagogastrectomy 6.34 (4.84-8.29) <0.001 
Hepatopancreatobiliary resection 5.72 (4.28-7.64) <0.001 
     CANCER STAGE    No cancer Reference 
Cancer stage I 1.16 (0.94-1.44) 0.175 
Cancer stage II 1.20 (1.02-1.43) 0.033 
Cancer stage III 2.70 (2.31-3.16) <0.001 
Cancer stage IV 4.59 (3.68-5.72) <0.001 
Cancer stage unknown 2.80 (2.36-3.32) <0.001 
   
SAEs   
No SAE Reference  
Wound infection only 0.88 (0.71-1.08) 0.222 
Wound dehiscence only 0.88 (0.46-1.69) 0.696 
Bleeding only 2.68 (2.25-3.20) <0.001 
Organ injury only 1.07 (0.66-1.74) 0.708 
 Reoperation only 1.64 (1.05-2.58) 0.031 
VTE only 1.44 (0.98-2.13) 0.065 
Pneumonia only 4.71 (3.92-5.67) <0.001 
Myocardial infarction only 4.38 (3.13-6.14) <0.001 
Cerebrovascular accident only 4.99 (2.27-11.00) <0.001 
Acute renal failure only 4.71 (3.30-6.72) <0.001 
 Multiple SAEs 3.89 (3.33-4.55)  <0.001 
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Regression analysis for postoperative psychiatric morbidity The inclusion of SAEs in regression models for postoperative psychiatric morbidity did not influence the significance of other predictor covariates (Table 8-5). This meant that all patient and surgery characteristics excluding open surgical approach, cancer stage and some types of surgical procedures were associated with increased risk of postoperative psychiatric morbidity, as was the case for the regression model not adjusted for SAEs (Table 7-10). While cancer diagnosis and stage were not independent predictors of postoperative psychiatric morbidity, patients undergoing major upper gastrointestinal cancer resection (oesophagogastrectomy and hepatopancreatobiliary resection) were the only procedures in which there was significant increase in risk of postoperative psychiatric morbidity when adjusted for all other predictor covariates.  Of the SAEs evaluated, all technical SAEs had a positive association with postoperative psychiatric morbidity. However, this correlation was statistically significant for bleeding only. All systemic SAEs were negatively associated with postoperative psychiatric morbidity, however none of the systemic SAEs demonstrated a statistically significant association. The ROC for this model was 0.799, which was greater than the model not adjusted for SAEs where the ROC was 0.796 (Table 7-15). Collinearity between predictor covariates was the same as previous regression analyses in this Chapter as the entered predictor covariates were the same.       
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Table 8-5. Logistic regression analysis for postoperative psychiatric morbidity adjusted for 
SAEs in patients who underwent gastrointestinal surgery 
Dependent variable = postoperative 
psychiatric morbidity Odds ratio (95% CI) 
p value for 
comparison 
     
PATIENT CHARACTERISTICS    
Age 0.99 (0.99-1.00) <0.001 
Female gender 1.33 (1.25-1.40) <0.001 
BMI 1.01 (1.00-1.01) 0.005 
Smoking 1.26 (1.19-1.33) <0.001 
Low socioeconomic status 1.05 (1.03-1.07) <0.001 
More than one recorded comorbidity 1.19 (1.12-1.26) <0.001 
     SURGERY CHARACTERISTICS 
 
  
Emergency surgery 1.14 (1.05-1.24) 0.002 
Open approach 1.00 (0.92-1.09) 0.956 
Year of surgery 0.99 (0.98-1.00) 0.015 
     PREOPERATIVE HEALTH STATUS  More than one recorded frailty 1.24 (1.17-1.32) <0.001 
Preoperative psychiatric morbidity  10.63 (10.10-11.19) <0.001 
   
SURGERY TYPE    Haemorrhoidectomy Reference 
Appendicectomy 0.67 (0.59-0.76) <0.001 
Cholecystectomy 0.87 (0.79-0.97) 0.013 
Antireflux surgery 1.07 (0.86-1.33) 0.528 
Bariatric surgery 0.92 (0.75-1.13) 0.418 
Small bowel resection 0.67 (0.54-0.83) <0.001 
Colorectal resection 1.05 (0.92-1.20) 0.438 
Oesophagogastrectomy 1.67 (1.33-2.10) <0.001 
Hepatopancreatobiliary resection 1.75 (1.34-2.28) <0.001 
     CANCER STAGE    No cancer Reference 
Cancer stage I 0.91 (0.75-1.12) 0.388 
Cancer stage II 0.89 (0.76-1.04) 0.147 
Cancer stage III 0.98 (0.84-1.15) 0.816 
Cancer stage IV 0.84 (0.63-1.10) 0.203 
Cancer stage unknown 1.01 (0.84-1.22) 0.911 
   
SAEs   
No SAE Reference  
Wound infection only 1.12 (0.99-1.27) 0.074 
Wound dehiscence only 1.36 (0.86-2.17) 0.192 
Bleeding only 1.35 (1.22-1.49) 0.002 
Organ injury only 1.11 (0.77-1.59) 0.581 
 Reoperation only 1.06 (0.76-1.48) 0.752 
VTE only 0.76 (0.46-1.23) 0.257 
Pneumonia only 0.96 (0.75-1.23) 0.748 
Myocardial infarction only 0.79 (0.67-0.94) 0.178 
Cerebrovascular accident only 2.15 (0.89-5.21) 0.095 
Acute renal failure only 0.87 (0.50-1.51) 0.624 
 Multiple SAEs 1.25 (1.05-1.48) 0.014 
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Regression analysis for postoperative symptoms Adjusting the prediction model for postoperative symptoms for SAEs had no influence on the significance of other predictor covariates . This meant that most patient and surgery characteristics were predictors of postoperative symptoms whether SAEs were adjusted for (Table 8-6) or not (Table 7-11).  Of the individual SAEs evaluated, bleeding, pneumonia, myocardial infarction and multiple SAEs were negatively associated with postoperative symptoms. All other SAEs were positively associated with postoperative symptoms. Wound infection and reoperation were independent predictors of postoperative symptoms, while pneumonia was an independent negative predictor of postoperative symptoms. The adjustment of the model for SAEs did not alter the fact that the two upper gastrointestinal procedures, oesophagogastrectomy and antireflux surgery were associated with the highest adjusted risk of postoperative symptoms.  The ROC for this prediction model was 0.641, greater than when not adjusted for SAEs where the ROC was 0.640 (Table 7-15). Collinearity between predictor covariates was the same as previous regression analyses in this Chapter as the entered predictor covariates were the same.       
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Table 8-6. Logistic regression analysis for postoperative symptoms adjusted for SAEs in 
patients who underwent gastrointestinal surgery 
Dependent variable = postoperative 
symptoms Odds ratio (95% CI) 
p value for 
comparison 
     
PATIENT CHARACTERISTICS    
Age 1.00 (1.00-1.00) <0.001 
Female gender 1.35 (1.30-1.41) <0.001 
BMI 1.00 (1.00-1.01) 0.689 
Smoking 1.10 (1.05-1.15) <0.001 
Low socioeconomic status 1.01 (1.00-1.03) 0.130 
More than one recorded comorbidity 1.17 (1.11-1.22) <0.001 
     SURGERY CHARACTERISTICS 
 
  
Emergency surgery 0.91 (0.86-0.97) 0.006 
Open approach 0.97 (0.94-1.00) 0.383 
Year of surgery 1.00 (0.99-1.01) 0.484 
     PREOPERATIVE HEALTH STATUS  More than one recorded frailty 1.51 (1.48-1.55) <0.001 
Preoperative psychiatric morbidity  1.55 (1.48-1.62) <0.001 
   
SURGERY TYPE    Haemorrhoidectomy Reference 
Appendicectomy 1.13 (1.02-1.26) 0.019 
Cholecystectomy 1.46 (1.34-1.59) <0.001 
Antireflux surgery 3.18 (2.73-3.70) <0.001 
Bariatric surgery 1.31 (1.09-1.58) 0.005 
Small bowel resection 1.78 (1.52-2.08) <0.001 
Colorectal resection 1.80 (1.62-2.00) <0.001 
Oesophagogastrectomy 4.58 (3.91-5.37) <0.001 
Hepatopancreatobiliary resection 2.35 (1.94-2.85) <0.001 
     CANCER STAGE    No cancer Reference 
Cancer stage I 1.02 (0.88-1.17) 0.840 
Cancer stage II 0.91 (0.81-1.02) 0.119 
Cancer stage III 1.16 (1.03-1.29) 0.011 
Cancer stage IV 1.11 (0.92-1.34) 0.273 
Cancer stage unknown 1.11 (0.97-1.26) 0.131 
   
SAEs   
No SAE Reference  
Wound infection only 1.40 (1.28-1.53) <0.001 
Wound dehiscence only 1.27 (0.88-1.82) 0.199 
Bleeding only 0.97 (0.84-1.13) 0.716 
Organ injury only 1.01 (0.79-1.30) 0.951 
 Reoperation only 1.37 (1.22-1.55) 0.009 
VTE only 1.04 (0.77-1.42) 0.790 
Pneumonia only 0.63 (0.57-0.70) <0.001 
Myocardial infarction only 0.86 (0.66-1.11) 0.248 
Cerebrovascular accident only 1.09 (0.57-2.10) 0.824 
Acute renal failure only 1.17 (0.97-1.41) 0.403 
 Multiple SAEs 0.92 (0.80-1.06) 0.238 
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Overall impact of surgical adverse events on outcome To assess the overall impact of SAEs on outcome, SAEs categorized in different ways were evaluated in separate regression models. When evaluating the impact on outcome according to type of SAE, technical SAEs were found to independently predict all outcome (Table 8-7). Systemic SAEs independently predicted all outcome except for the two measures of health status. Systemic SAEs were strongly correlated with mortality, while technical SAEs were strongly correlated with processes such as readmission and prolonged hospital stay.  When evaluating SAEs according to database of capture, SAEs identified in CPRD were significantly associated with poor outcome. They were more strongly correlated with poor health status than SAEs identified in HES. SAEs identified in HES predicted all poor outcome except for postoperative symptoms. SAEs identified in HES were strongly correlated with mortality, readmission and hospital stay. When evaluating the effects of SAEs according to whether SAEs occurred during or after hospital stay, all post-discharge SAEs were significantly associated with poor outcome. In-hospital SAEs were also significantly associated with poor outcome except for postoperative psychiatric morbidity and postoperative symptoms. In-hospital SAEs were strongly correlated with mortality and prolonged hospital stay, while post-discharge SAEs were strongly correlated with readmission and poor health status.     
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Table 8-7. Outcome according to technical or systemic SAE, database of capture of SAE and in-hospital or post-discharge SAE in patients who 
underwent gastrointestinal surgery 
  30-day mortality 30-day readmission Prolonged hospital stay One-year mortality Postoperative psychiatric morbidity Postoperative symptoms 
  OR (95%CI) *p value  OR (95%CI) 
*p 
value OR (95%CI) 
*p 
value  OR (95%CI) 
*p 
value  OR (95%CI) 
*p 
value OR (95%CI) 
*p 
value  
              
  
        
Type of SAE       
  
     
Technical SAE 1.85 (1.57-2.17) <0.001 4.95 (4.63-5.29) <0.001 3.41 (3.20-3.63) <0.001 1.57 (1.42-1.75) <0.001 1.20 (1.10-1.31) <0.001 1.23 (1.15-1.31) <0.001 
Systemic SAE 9.72 (8.34-11.26) <0.001 2.76 (2.48-3.08) <0.001 1.78 (1.60-1.99) <0.001 3.80 (3.38-4.28) <0.001 0.92 (.84-1.15) 0.242 0.73 (0.65-0.82) <0.001 
  
      
  
   
  
Captured database              
SAE captured in HES 6.10 (5.31-6.99) <0.001 6.92 (6.43-7.44) <0.001 4.87 (4.54-5.23) <0.001 2.79 (2.53-3.06) <0.001 1.11 (1.00-1.23) <0.001 0.92 (0.85-0.99) 0.024 
SAE captured in CPRD 3.65 (2.84-4.70) <0.001 3.12 (2.81-3.46) <0.001 1.41 (1.23-1.56) <0.001 1.58 (1.31-1.89) <0.001 1.14 (1.01-1.29) <0.001 1.46 (1.34-1.60) <0.001 
             
Timing of SAE              
In-hospital SAE 6.91 (6.02-7.92) <0.001 1.26 (1.13-1.41) <0.001 7.04 (6.50-7.63) <0.001 2.91 (2.64-3.21) <0.001 1.03 (0.92-1.15) 0.606 0.83 (0.77-0.91) <0.001 
Post-discharge SAE 2.06 (1.54-2.77) <0.001 12.22 (11.36-13.14) <0.001 1.35 (1.24-1.47) <0.001 1.56 (1.32-1.85) <0.001 1.21 (1.09-1.34) <0.001 1.42 (1.31-1.54) <0.001 
                         
*comparison with procedures with no SAE
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The effect of postoperative health status on outcome 
Regression analysis for one-year mortality The inclusion of postoperative psychiatric morbidity and postoperative symptoms as predictor covariates for one-year mortality did not affect the significance of other predictor variables when compared with models that were not adjusted for postoperative health status (Table 8-8). Both technical and systemic SAEs impacted on one-year mortality whether regression models were adjusted postoperative health status or not. When including psychiatric morbidity as a predictor, both preoperative psychiatric morbidity and new onset postoperative psychiatric morbidity were independent predictors of one-year mortality. When evaluating the effects of postoperative symptoms individually, faecal incontinence, dumping and steatorrhoea were excluded form the analysis as there were no deaths associated with any of these symptoms recorded in isolation. Overall, recording of vomit and nausea in isolation, as well as the recording of two different symptoms were associated with significantly increased risk of one-year mortality. Reflux, dyspepsia, diarrhea postoperative pain and fatigue were independent negative predictors of mortality. A separate regression model assessed postoperative symptoms as a single binary variable to evaluate the overall impact of all postoperative symptoms on one-year mortality. This demonstrated that the presence of at least one postoperative symptom was overall a negative predictor of one-year mortality.  
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Table 8-8. Logistic regression model of one-year mortality adjusted for postoperative health 
status in patients who underwent gastrointestinal surgery 
Dependent variable = one-year mortality Odds ratio (95% CI) p value for comparison VIF 
      
PATIENT CHARACTERISTICS    
 
Age 1.06 (1.05-1.06) <0.001 1.42 
Female gender 0.94 (0.87-1.02) 0.151 1.13 
BMI 0.99 (0.98-1.00) 0.009 1.11 
Smoking 1.33 (1.21-1.47) <0.001 1.08 
Low socioeconomic status 1.02 (0.99-1.05) 0.304 1.04 
More than one recorded comorbidity 1.62 (1.49-1.76) <0.001 1.15 
      
SURGERY CHARACTERISTICS 
 
   
Emergency surgery 3.09 (2.80-3.40) <0.001 1.12 
Open approach 1.53 (1.31-1.78) <0.001 1.31 
Year of surgery 0.94 (0.93-0.95) <0.001 1.06 
      
PREOPERATIVE HEALTH STATUS   
More than one recorded frailty 1.19 (1.08-1.30) <0.001 1.08 
    
SURGERY TYPE     
Haemorrhoidectomy Reference  
Appendicectomy 0.51 (0.37-0.70) <0.001 
2.41 
Cholecystectomy 1.11 (0.87-1.43) 0.411 
Antireflux surgery 0.50 (0.12-2.13) 0.327 
Bariatric surgery 2.88 (1.36-6.09) 0.006 
Small bowel resection 4.93 (3.84-6.35) <0.001 
Colorectal resection 3.27 (2.60-4.12) <0.001 
Oesophagogastrectomy 6.16 (4.70-8.08) <0.001 
Hepatopancreatobiliary resection 5.83 (4.36-7.79) <0.001 
      CANCER STAGE    
 
2.51 
No cancer Reference 
Cancer stage I 1.15 (0.93-1.43) 0.205 
Cancer stage II 1.17 (0.99-1.39) 0.067 
Cancer stage III 2.61 (2.23-3.05) <0.001 
Cancer stage IV 4.36 (3.50-5.44) <0.001 
Cancer stage unknown 2.73 (2.30-3.24) <0.001 
    




No SAE Reference 
Technical SAE only 1.63 (1.46-1.83) <0.001 
Systemic SAE only 4.06 (3.54-4.65) <0.001 
Technical and systemic SAEs 4.95 (3.95-6.20) <0.001 
    
PSYCHIATRIC MORBIDITY    
No psychiatric morbidity Reference   
Preoperative psychiatric morbidity 1.16 (1.04-1.30) 0.009 1.24 
Postoperative psychiatric morbidity only 1.48 (1.25-1.75) <0.001 
    
POSTOPERATIVE SYMPTOMS    
No symptoms Reference   
Reflux only 0.43 (0.26-0.72) 0.001  
Dysphagia only 1.00 (0.53-1.90) 0.997  
Dyspepsia only 0.44 (0.29-0.65) <0.001  
Vomit only 1.85 (1.48-2.32) <0.001  
Diarrhoea only 0.41 (0.33-0.51) <0.001 1.02 
Nausea only 1.49 (1.18-1.87) 0.001  
Postoperative pain only 0.39 (0.16-0.97) 0.042  
Fatigue only 0.38 (0.25-0.56) <0.001  
Two recorded symptoms 1.29 (1.06-1.55) 0.009  
Three or more recorded symptoms 1.43 (1.00-2.05) 0.053  
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The ROC for the regression model for one-year mortality when adjusted for postoperative health status was 0.910, greater than the model not adjusted for SAEs and postoperative health status where the ROC was 0.905 (Table 7-15).  The incorporation of postoperative health status as predictor covariates meant that the VIF for each variable was calculated. As with previous regression analyses, the greatest interaction between predictor covariates was for cancer stage and surgical procedure. SAEs, postoperative psychiatric morbidity and postoperative symptoms did not interact with other predictor variables.  




Table 8-9. Logistic regression analysis of postoperative psychiatric morbidity adjusted for 
SAEs and postoperative symptoms in patients who underwent gastrointestinal surgery 
Dependent variable = postoperative psychiatric 
morbidity Odds ratio (95% CI) p value for comparison VIF 
      
PATIENT CHARACTERISTICS    
 
Age 0.99 (0.99-1.00) <0.001 1.42 
Female gender 1.29 (1.22-1.37) <0.001 1.13 
BMI 1.01 (1.00-1.01) 0.007 1.11 
Smoking 1.26 (1.19-1.33) <0.001 1.08 
Low socioeconomic status 1.05 (1.03-1.07) <0.001 1.04 
More than one recorded comorbidity 1.18 (1.11-1.24) <0.001 1.15 
      
SURGERY CHARACTERISTICS 
 
   
Emergency surgery 1.15 (1.06-1.25) 0.001 1.12 
Open approach 1.00 (0.92-1.09) 0.988 1.31 
Year of surgery 0.99 (0.98-1.00) 0.023 1.06 
      
PREOPERATIVE HEALTH STATUS   
More than one recorded frailty 1.19 (1.12-1.27) <0.001 1.08 
Preoperative psychiatric morbidity 10.40 (9.88-10.94) <0.001 1.06 
    
SURGERY TYPE     
Haemorrhoidectomy Reference  
Appendicectomy 0.66 (0.58-0.75) <0.001 
2.41 
Cholecystectomy 0.85 (0.76-0.94) 0.002 
Antireflux surgery 0.97 (0.78-1.20) 0.748 
Bariatric surgery 0.89 (0.73-1.10) 0.276 
Small bowel resection 0.65 (0.52-0.80) <0.001 
Colorectal resection 1.01 (0.88-1.15) 0.933 
Oesophagogastrectomy 1.40 (1.12-1.76) 0.004 
Hepatopancreatobiliary resection 1.60 (1.23-2.08) 0.001 
      CANCER STAGE    
 
2.51 
No cancer Reference 
Cancer stage I 0.92 (0.75-1.12) 0.396 
Cancer stage II 0.89 (0.76-1.05) 0.166 
Cancer stage III 0.96 (0.82-1.12) 0.605 
Cancer stage IV 0.83 (0.63-1.09) 0.180 
Cancer stage unknown 1.00 (0.83-1.21) 0.980 
    




No SAE Reference 
Technical SAE only 1.16 (1.06-1.27) 0.001 
Systemic SAE only 0.92 (0.78-1.09) 0.345 
Technical and systemic SAEs 1.24 (0.92-1.67) 0.161 
    
POSTOPERATIVE SYMPTOMS    
No symptoms Reference   
Reflux only 1.53 (1.27-1.85) <0.001  
Dysphagia only 1.59 (0.97-2.62) 0.071  
Dyspepsia only 1.37 (1.17-1.60) <0.001  
Vomit only 1.54 (1.28-1.86) <0.001  
Dumping only 3.71 (0.95-14.49) 0.061 1.02 
Diarrhoea only 1.58 (1.42-1.77) <0.001  
Faecal incontinence only 2.08 (0.80-5.43) 0.133  
Nausea only 1.92 (1.62-2.26) <0.001  
Postoperative pain only 1.31 (0.97-1.78) 0.077  
Fatigue only 1.69 (1.47-1.94) <0.001  
Two recorded symptoms 2.00 (1.87-2.13) <0.001  
Three or more recorded symptoms 2.53 (1.96-3.26) <0.001  
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The ROC for this model was C=0.804, greater than when not adjusted for SAEs or postoperative symptoms where the ROC was 0.796 (Table 7-15). The greatest interaction between predictor covariates was for cancer stage and surgical procedure as in previous regression models.  
The performance of regression models when adjusting for harm and 
poor health status 
The ROC for all analyses in this Chapter are presented below (Table 8-10). Comparisons were made to regression models using all linked database covariates but without the inclusion of harm or poor health status as predictor covariates.  The predictive performance of regression models for all evaluated outcome measures increased following the inclusion of new predictor covariates (Table 8-10). The percentage increase in performance of regression models was lowest for postoperative symptoms (0.2%) and highest for readmission (14%). While the ROC was already above the 0.8 threshold for 30-day and one-year mortality without the inclusion of harm and poor health status as predictor covariates, their inclusion did not increase the ROC to above this value for any of the other outcome measures except for postoperative psychiatric morbidity. For this outcome, inclusion of SAEs and postoperative symptoms as predictros increased the ROC from below the threshold (0.796) to above the threshold (0.804).  
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With harm variables as predictors 0.952 0.670 0.787 0.910 0.804 0.641 
       
Without harm variables as predictors 0.934 0.597 0.771 0.905 0.796 0.640 
Change in ROC when  harm variables were 
combined with other linked database covariates 
3.6% 14.6% 3.2% 1.0% 1.6% 0.2% 
 
 
*includes both SAEs and postoperative symptoms as predictors of outcome 
** includes SAEs, postoperative symptoms and postoperative psychiatric morbidity as predictors of outcome 
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Time trends in surgical harm  
Using these highly granular data, patterns of poor outcome observed in data derived from integrated health systems within the NHS were observed over period of about a decade. When adjusted for all linked database covariates, there were significantly decreasing trends in mortality, hospital stay, systemic SAEs and postoperative psychiatric morbidity over time. This was paralleled by significantly increasing trends in hospital readmission rates. As for trends in short-term harm, systemic SAEs were observed to have significantly reduced over time. However, there has been no significant change in the adjusted risk of technical SAEs. For longer-term outcome, while the risk of postoperative psychiatric morbidity significantly reduced, there has been little improvement in the latter years covered by the presented dataset. The risk of postoperative symptoms did not change significantly over time.      
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*p<0.05 for significant time trend in regression analyses 
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Individual procedure analysis 
Colorectal resection This cohort represented the only group out of the four most commonly performed procedures that included patients who underwent surgery for both benign and malignant conditions. The influence of cancer-specific variables was assessed in this group of patients. Cancer stage was not associated with poor outcome except for one-year mortality. Overall, logistic regression analysis revealed that age was the only covariate that independently predicted all poor outcome (Table 8-11). Emergency surgery was associated with all poor outcome except for postoperative symptoms. Laparoscopic surgery was associated with shorter hospital stay. Of the measures of health status, preoperative frailty and postoperative psychiatric morbidity increased the risk of one-year mortality. SAEs were found to increase all types of poor outcome except for long-term health status. This meant that patients did not suffer long-term consequences of short-term harm if they survived.  
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Table 8-11. Logistic regression analyses for short and long term outcome in patients who underwent colorectal resection 
               30-day mortality 30-day readmission Prolonged hospital stay One-year mortality Postoperative psychiatric morbidity Postoperative symptoms  OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p Age 1.07 (1.06-1.08) <0.001 1.00 (0.99-1.00) 0.028 1.03 (1.02-1.03) <0.001 1.05 (1.04-1.06) <0.001 0.99 (0.99-1.00) 0.001 0.99 (0.99-1.00) 0.001 Female gender 0.98 (0.83-1.16) 0.856 1.06 (0.95-1.17) 0.311 1.05 (0.96-1.14) 0.277 1.03 (0.93-1.15) 0.537 1.34 (1.27-1.43) <0.001 1.32 (1.22-1.43) <0.001 BMI 1.00 (0.98-1.01) 0.610 1.00 (0.99-1.01) 0.955 1.00 (0.99-1.01) 0.513 0.99 (0.98-1.00) 0.039 1.00 (0.99-1.01) 0.501 1.00 (1.00-1.01) 0.227 Smoking 1.34 (1.08-1.65) 0.007 1.02 (0.89-1.16) 0.792 0.93 (0.83-1.03) 0.166 1.25 (1.09-1.43) 0.002 1.26 (1.09-1.45) 0.001 1.11 (1.00-1.23) 0.047 Low socioeconomic status 1.04 (0.98-1.10) 0.231 0.99 (0.95-1.03) 0.642 1.07 (1.03-1.10) <0.001 1.01 (0.97-1.05) 0.493 1.04 (0.99-1.08) 0.088 0.99 (0.96-1.02) 0.669 More than one recorded comorbidity 1.93 (1.63-2.28) <0.001 0.95 (0.85-1.07) 0.418 1.46 (1.34-1.59) <0.001 1.73 (1.55-1.93) <0.001 1.05 (0.92-1.18) 0.484 1.06 (0.97-1.15) 0.211 Emergency surgery 3.43 (2.88-4.08) <0.001 0.72 (0.63-0.82) <0.001 4.27 (3.90-4.68) <0.001 2.98 (2.66-3.33) <0.001 1.17 (1.03-1.34) 0.019 0.80 (0.72-0.88) <0.001 Open approach 1.56 (1.10-2.21) 0.025 1.07 (0.91-1.27) 0.395 1.57 (1.32-1.86) <0.001 1.34 (1.08-1.65) 0.007 0.91 (0.82-1.00) 0.304 1.01 (0.89-1.15) 0.885 Year of surgery 0.91 (0.89-0.94) <0.001 1.03 (1.01-1.05) 0.003 0.94 (0.92-0.95) <0.001 0.93 (0.92-0.95) <0.001 1.00 (0.98-1.02) 0.862 1.01 (0.99-1.02) 0.463 More than one recorded frailty 1.12 (0.94-1.34) 0.206 1.01 (0.89-1.14) 0.929 1.15 (1.04-1.27) 0.005 1.13 (1.01-1.27) 0.038 1.03 (0.90-1.18) 0.687 1.45 (1.33-1.57) <0.001 Preoperative psychiatric morbidity 1.16 (0.93-1.45) 0.185 1.17 (1.02-1.35) 0.026 1.22 (1.09-1.37) 0.001 1.13 (0.98-1.32) 0.097 9.61 (8.54-10.82) <0.001 1.41 (1.26-1.56) <0.001 Cancer stage I 0.71 (0.51-0.99) 0.046 1.19 (0.98-1.45) 0.087 0.79 (0.67-0.93) 0.005 1.15 (0.92-1.45) 0.222 0.95 (0.76-1.18) 0.625 1.02 (0.87-1.19) 0.841 Cancer stage II 0.69 (0.54-0.88) 0.003 1.00 (0.85-1.19) 0.961 0.70 (0.62-0.80) <0.001 1.12 (0.93-1.34) 0.223 0.92 (0.77-1.10) 0.362 0.97 (0.85-1.10) 0.605 Cancer stage III 0.82 (0.65-1.04) 0.106 1.20 (1.01-1.41) 0.033 0.63 (0.56-0.72) <0.001 2.46 (2.08-2.90) <0.001 0.96 (0.81-1.14) 0.651 1.25 (1.10-1.41) 0.001 Cancer stage IV 1.37 (0.91-2.08) 0.134 1.43 (1.06-1.94) 0.020 0.58 (0.45-0.75) <0.001 8.39 (6.52-10.78) <0.001 1.07 (0.76-1.51) 0.703 1.59 (1.26-2.00) <0.001 Cancer stage unknown 0.96 (0.71-1.31) 0.799 1.29 (1.05-1.58) 0.013 0.75 (0.64-0.88) 0.001 2.06 (1.68-2.54) <0.001 1.07 (0.85-1.34) 0.562 1.10 (0.93-1.29) 0.255 Technical SAE only 1.95 (1.54-2.47) <0.001 2.85 (2.52-3.23) <0.001 3.39 (3.04-3.78) <0.001 1.60 (1.39-1.86) <0.001 1.09 (0.93-1.28) 0.294 1.07 (0.95-1.19) 0.274 Systemic SAE only 10.91 (8.92-13.35) <0.001 3.17 (2.63-3.82) <0.001 1.43 (1.22-1.69) <0.001 4.44 (3.74-5.26) <0.001 0.92 (0.72-1.18) 0.547 0.77 (0.64-0.93) 0.010 Technical and systemic SAE 13.45 (9.65-18.73) <0.001 4.12 (3.11-5.45) <0.001 4.10 (3.57-4.71) <0.001 5.21 (3.92-6.91) <0.001 1.00 (0.64-1.57) 0.991 0.78 (0.57-1.07) 0.138 Postoperative psychiatric morbidity - - - - - - 1.49 (1.18-1.87) 0.001 - - - - All symptoms - - - - - - 0.73 (0.63-0.83) <0.001 1.94 (1.71-2.20) <0.001 - - 
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Cholecystectomy Overall, emergency surgery, open surgical approach and SAEs were important predictor covariates as they were associated with the highest odds of poor outcome (Table 8-12). Short-term technical SAEs were not only significantly associated with mortality, but also associated with postoperative psychiatric morbidity and symptoms. Readmission was significantly associated with comorbidity, emergency surgery, open approach, frailty, preoperative psychiatric morbidity and SAEs. Postoperative psychiatric morbidity was significantly associated with young age, female gender, smoking, comorbidity, frailty, low socioeconomic status, emergency surgery, open approach, preoperative psychiatric morbidity, technical SAEs and postoperative symptoms. Older age, female gender, smoking, comorbidity, frailty, preoperative psychiatric morbidity and technical SAEs significantly increased the risk of postoperative symptoms. Unlike in colorectal resection, technical SAEs significantly increased the risk of poor health status.   
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Table 8-12. Logistic regression analyses for short and long term outcome in patients who underwent cholecystectomy 
              30-day mortality 30-day readmission Prolonged hospital stay One-year mortality Postoperative psychiatric morbidity Postoperative symptoms  OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p Age 1.07 (1.04-1.09) <0.001 1.00 (1.00-1.00) 0.800 1.04 (1.03-1.04) <0.001 1.08 (1.07-1.10) <0.001 0.99 (0.99-1.00) <0.001 1.01 (1.00-1.01) <0.001 Female gender 0.72 (0.42-1.22) 0.225 0.90 (0.81-1.00) 0.054 0.70 (0.64-0.75) <0.001 0.86 (0.65-1.14) 0.289 1.21 (1.09-1.35) <0.001 1.39 (1.29-1.51) <0.001 BMI 1.01 (0.95-1.06) 0.803 1.00 (0.99-1.01) 0.495 1.01 (1.00-1.02) 0.021 1.00 (0.97-1.03) 0.986 1.00 (1.00-1.01) 0.256 1.00 (0.99-1.01) 0.882 Smoking 0.85 (0.43-1.69) 0.643 1.03 (0.93-1.15) 0.573 0.89 (0.82-0.98) 0.012 1.31 (0.94-1.82) 0.109 1.25 (1.14-1.36) <0.001 1.11 (1.04-1.19) 0.003 Low socioeconomic status 1.02 (0.84-1.25) 0.829 1.02 (0.99-1.06) 0.251 1.15 (1.12-1.18) <0.001 0.97 (0.87-1.07) 0.492 1.05 (1.02-1.08) 0.003 1.01 (0.99-1.03) 0.390 More than one recorded comorbidity 2.81 (1.57-5.03) 0.001 1.19 (1.08-1.32) 0.001 1.52 (1.41-1.65) <0.001 2.26 (1.71-3.00) <0.001 1.20 (1.10-1.31) <0.001 1.19 (1.11-1.28) <0.001 Emergency surgery 3.94 (2.96-5.24) <0.001 1.41 (1.32-1.50) <0.001 47.82 (42.52-53.78) <0.001 2.61 (2.24-3.04) <0.001 1.15 (1.02-1.30) 0.026 1.07 (0.98-1.17) 0.172 Open approach 2.14 (1.21-3.79) 0.010 1.18 (1.02-1.36) 0.022 5.51 (5.01-6.07) <0.001 2.04 (1.50-2.78) <0.001 1.02 (0.90-1.17) 0.737 0.92 (0.88-0.98) 0.143 Year of surgery 0.93 (0.86-1.02) 0.113 1.01 (1.00-1.03) 0.128 0.86 (0.85-0.87) <0.001 0.97 (0.93-1.01) 0.139 0.99 (0.98-1.00) 0.152 1.00 (0.99-1.01) 0.789 More than one recorded frailty 1.43 (0.84-2.42) 0.203 1.20 (1.07-1.34) 0.002 1.15 (1.05-1.25) 0.002 1.48 (1.28-1.71) 0.006 1.29 (1.17-1.42) <0.001 1.54 (1.43-1.65) <0.001 Preoperative psychiatric morbidity 1.29 (0.68-2.44) 0.441 1.26 (1.14-1.41) <0.001 1.14 (1.05-1.25) 0.003 1.31 (0.95-1.80) 0.109 11.01 (10.16-11.93) <0.001 1.64 (1.53-1.75) <0.001 Technical SAE only 4.40 (2.16-8.95) <0.001 6.19 (5.51-6.95) <0.001 2.84 (2.51-3.21) <0.001 2.15 (1.44-3.20) <0.001 1.24 (1.07-1.44) 0.004 1.47 (1.31-1.65) <0.001 Systemic SAE only 24.98 (13.12-47.53) <0.001 5.23 (4.10-6.66) <0.001 3.85 (2.89-5.12) <0.001 5.18 (3.17-8.48) <0.001 0.85 (0.60-1.21) 0.376 0.93 (0.81-1.07) 0.614 Technical and systemic SAE 19.35 (6.53-57.35) <0.001 12.61 (8.10-19.62) <0.001 8.09 (4.70-13.90) <0.001 8.34 (3.89-17.86) <0.001 1.72 (0.90-3.30) 0.101 1.04 (0.78-1.38) 0.893 Postoperative psychiatric morbidity - - - - - - 0.80 (0.36-1.76) 0.574 - - - - All symptoms - - - - - - 1.20 (0.88-1.65) 0.251 1.68 (1.53-1.83) <0.001 - - 
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Appendicectomy  Outcome in appendicectomy has improved over recent years as 30-day mortality, prolonged hospital stay and one-year mortality have shown decreased trends over time (Table 8-13). However, readmission significantly increased over time. Readmission was significantly associated with all types of SAEs although the strongest correlation was seen with technical SAEs. Age, low socioeconomic status, comorbidity, emergency surgery, open surgical approach and SAEs significantly increased the risk of prolonged stay. Of the measures of health status, frailty was significantly associated with postoperative psychiatric morbidity and postoperative symptoms. Preoperative psychiatric morbidity was significantly associated with readmission, one-year mortality, postoperative psychiatric morbidity and postoperative symptoms. Systemic SAEs predicted mortality while technical SAEs predicted readmission and postoperative symptoms. Both types of SAEs predicted prolonged stay.  Laparoscopic appendicectomy was associated with significantly shorter hospital stay. 
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Table 8-13. Logistic regression analyses for short and long term outcome in patients who underwent appendicectomy 
               30-day mortality 30-day readmission Prolonged hospital stay One-year mortality Postoperative psychiatric morbidity Postoperative symptoms  OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p Age 1.12 (1.08-1.16) <0.001 1.00 (1.00-1.01) 0.278 1.05 (1.05-1.05) <0.001 1.09 (1.07-1.11) <0.001 1.00 (0.99-1.00) 0.519 1.01 (1.00-1.01) 0.002 Female gender 2.32 (0.91-5.91) 0.077 1.11 (0.95-1.30) 0.205 1.08 (0.97-1.20) 0.178 1.10 (0.67-1.83) 0.705 1.47 (1.26-1.71) <0.001 1.58 (1.39-1.79) <0.001 BMI 1.00 (0.88-1.14) 0.977 0.99 (0.97-1.00) 0.054 1.00 (0.99-1.01) 0.627 1.00 (0.95-1.05) 0.888 1.00 (0.98-1.02) 0.841 0.99 (0.98-1.01) 0.394 Smoking 1.96 (0.72-5.35) 0.190 1.07 (0.90-1.28) 0.459 0.96 (0.85-1.09) 0.556 1.51 (0.85-2.70) 0.166 1.31 (1.11-1.53) 0.001 1.08 (0.94-1.24) 0.299 Low socioeconomic status 1.16 (0.83-1.62) 0.398 1.02 (0.97-1.08) 0.451 1.07 (1.03-1.12) <0.001 1.05 (0.87-1.27) 0.626 1.03 (0.98-1.09) 0.214 1.01 (0.97-1.06) 0.552 More than one recorded comorbidity 2.83 (1.12-7.19) 0.028 0.98 (0.80-1.21) 0.883 1.33 (1.16-1.52) <0.001 2.02 (1.19-3.45) 0.010 1.34 (1.12-1.61) 0.002 1.30 (1.11-1.52) 0.001 Open approach 1.74 (0.35-8.53) 0.499 0.84 (0.70-1.02) 0.078 1.38 (1.21-1.58) <0.001 1.41 (0.64-3.13) 0.398 1.01 (0.84-1.22) 0.898 0.95 (0.88-1.03) 0.557 Year of surgery 0.83 (0.72-0.97) 0.015 1.06 (1.03-1.09) <0.001 0.97 (0.95-0.99) 0.001 0.92 (0.85-1.00) 0.043 0.98 (0.96-1.01) 0.184 0.99 (0.97-1.01) 0.280 More than one recorded frailty 1.87 (0.76-4.60) 0.173 1.04 (0.82-1.33) 0.743 1.18 (1.00-1.38) 0.050 1.38 (0.79-2.44) 0.262 1.27 (1.15-1.41) 0.020 1.80 (1.52-2.13) <0.001 Preoperative psychiatric morbidity 1.67 (0.60-4.62) 0.327 1.25 (1.02-1.52) 0.031 1.00 (0.86-1.15) 0.946 2.45 (1.84-3.25) 0.002 10.17 (8.78-11.78) <0.001 1.50 (1.29-1.74) <0.001 Technical SAE only 0.48 (0.06-3.85) 0.490 14.44 (12.20-17.09) <0.001 4.11 (3.53-4.80) <0.001 0.96 (0.40-2.30) 0.925 1.04 (0.80-1.34) 0.791 1.31 (1.07-1.61) 0.009 Systemic SAE only 13.82 (4.76-40.08) <0.001 5.70 (3.89-8.36) <0.001 4.05 (2.86-5.72) <0.001 4.71 (2.07-10.75) <0.001 0.80 (0.46-1.40) 0.440 1.32 (0.87-2.01) 0.191 Technical and systemic SAE 8.99 (0.95-84.84) 0.055 15.95 (8.61-29.55) <0.001 14.67 (7.00-30.72) <0.001 5.15 (1.10-23.99) 0.037 2.26 (0.94-5.47) 0.070 1.14 (0.47-2.76) 0.767 Postoperative psychiatric morbidity - - - - - - 0.57 (0.08-4.35) 0.591 - - - - All symptoms - - - - - - 0.71 (0.33-1.49) 0.362 1.42 (1.18-1.71) <0.001 - - 
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Haemorrhoidectomy Prolonged hospital stay significantly decreased over time while readmissions significantly increased (Table 8-14).  Prolonged stay was significantly associated with age, comorbidity, emergency surgery, frailty and SAEs. Readmission was significantly associated with age, male gender, lower BMI, lower socioeconomic status, comorbidity, emergency surgery, frailty, preoperative psychiatric morbidity and SAEs. Technical SAEs were the strongest predictors of readmission. In this group of patients, postoperative symptoms were significantly associated with both postoperative psychiatric morbidity and one-year mortality. However, SAEs did not predict symptoms in these patients. Based on these findings, short-term harm did not lead to long-term poor health status in patients undergoing haemorrhoidectomy. Instead, age, female gender, low socioeconomic status, frailty and preoperative psychiatric morbidity were significantly associated postoperative symptoms.    
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Table 8-14. Logistic regression analyses for short and long term outcome in patients who underwent haemorrhoidectomy 
               30-day mortality 30-day readmission Prolonged hospital stay One-year mortality Postoperative psychiatric morbidity Postoperative symptoms  OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p Age 1.07 (1.01-1.13) 0.019 1.01 (1.01-1.02) <0.001 1.02 (1.02-1.03) <0.001 1.08 (1.07-1.10) <0.001 1.00 (0.99-1.00) 0.257 1.01 (1.00-1.01) 0.006 Female gender 0.80 (0.16-3.99) 0.785 0.75 (0.64-0.89) 0.001 1.07 (0.96-1.19) 0.206 0.73 (0.49-1.08) 0.117 1.29 (1.21-1.37) <0.001 1.49 (1.33-1.66) <0.001 BMI 0.81 (0.59-1.12) 0.182 0.98 (0.97-1.00) 0.027 1.00 (0.99-1.02) 0.780 0.98 (0.92-1.04) 0.473 1.01 (1.00-1.02) 0.032 1.00 (0.99-1.01) 0.743 Smoking 2.00 (0.31-13.03) 0.467 1.07 (0.89-1.29) 0.468 1.07 (0.93-1.23) 0.327 1.82 (1.14-2.88) 0.011 1.23 (1.07-1.40) 0.003 0.98 (0.86-1.12) 0.763 Low socioeconomic status 0.94 (0.52-1.69) 0.827 1.06 (1.00-1.12) 0.043 0.98 (0.94-1.02) 0.249 1.18 (1.02-1.36) 0.022 1.05 (1.01-1.10) 0.019 1.05 (1.01-1.09) 0.026 More than one recorded comorbidity 2.00 (0.32-12.38) 0.456 1.52 (1.27-1.82) <0.001 1.47 (1.30-1.67) <0.001 2.06 (1.37-3.10) <0.001 1.22 (1.07-1.41) 0.004 1.32 (1.17-1.50) <0.001 Emergency surgery 92.17 (9.53-891.7) <0.001 2.12 (1.62-2.77) <0.001 14.83 (12.43-17.68) <0.001 6.06 (3.88-9.49) <0.001 1.18 (0.92-1.51) 0.203 1.06 (0.84-1.34) 0.641 Year of surgery 1.12 (0.85-1.48) 0.424 1.04 (1.01-1.06) 0.005 0.77 (0.76-0.79) <0.001 0.99 (0.93-1.05) 0.678 0.97 (0.96-0.99) 0.006 1.01 (0.99-1.02) 0.518 More than one recorded frailty 1.05 (0.19-5.66) 0.957 1.36 (1.12-1.65) 0.002 1.20 (1.06-1.36) 0.009 1.48 (0.98-2.24) 0.064 1.17 (1.01-1.36) 0.035 1.76 (1.65-1.87) <0.001 Preoperative psychiatric morbidity 1.85 (0.25-13.67) 0.545 1.35 (1.11-1.63) 0.002 1.01 (0.88-1.17) 0.847 2.09 (1.32-3.32) 0.002 12.16 (10.78-13.73) <0.001 1.56 (1.38-1.77) <0.001 Technical SAE only 0.00 (0.00-0.00) <0.001 30.17 (22.66-40.18) <0.001 4.09 (3.01-5.55) <0.001 0.94 (0.22-3.97) 0.931 1.36 (0.92-2.02) 0.123 0.82 (0.53-1.28) 0.381 Systemic SAE only 39.80 (5.73-276.5) <0.001 3.62 (1.72-7.63) 0.001 2.42 (1.68-3.49) 0.016 7.17 (2.59-19.85) <0.001 0.62 (0.24-1.58) 0.313 1.10 (0.74-1.63) 0.814 Technical and systemic SAE 4872. (113.9-20836) <0.001 31.60 (5.02-198.7) <0.001 4.25 (0.46-39.70) 0.204 142.4 (13.22-1534.) <0.001 - - - - Postoperative psychiatric morbidity - - - - - - 3.82 (1.99-7.32) <0.001 - - - - All symptoms - - - - - - 1.88 (1.19-2.96) 0.007 1.35 (1.15-1.59) <0.001 - - 
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Discussion  
In this Chapter, harm and poor health status following surgery were evaluated as predictors of outcome by building on regression models developed so far in this thesis. The adjusted risks incurred by these new predictor covariates were calculated, and the performance of prediction models compared with previous models. For most analyses, the inclusion of these new variables did not influence the effect of other covariates (patient and surgery characteristics).  Incorporation of SAEs into regression models affected how the type of surgical procedure influenced outcome. When referenced against the lowest mortality procedure (haemorrhoidectomy), appendecectomy independently predicted 30-day mortality when not adjusted for SAEs (Table 7-3). However when adjusted for SAEs, appendicectomy was not an independent predictor of 30-day mortality (Table 8-1). This subtle difference explains how the increase in overall mortality from appendicectomy was reflective of the higher rate of SAEs when compared with haemorrhoidectomy. SAEs by definition are modifiable, so reducing their rates are likely to lead to improvements in mortality figures.  The inclusion of SAE as predictors of outcome also increased the predictive significance of cancer-specific variables. Advanced cancer predicted readmission only when adjusted for SAEs, implying that there was a propensity to developing SAEs associated with readmission in patients with advanced cancer. Overall, SAEs were associated with the greatest risk of readmission than any of the other predictor variables. The inclusion of this predictor covariate improved the predictive performance of regression models (Table 8-10). Further studies are needed to evaluate whether other types of harm may be implicated in hospital readmission and improve the performance of prediction models.  Technical SAEs predicted short-term outcome including readmission and prolonged hospital stay. But wound infection was a negative predictor of 30-day mortality. This suggests that wound infection is unlikely to present in primary care if patients were ill in hospital and perished within 30 days of surgery. Instead, systemic SAEs were stronger 
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predictors of both short and long-term mortality. In the long-term, technical SAEs had greater influence on health status including psychiatric morbidity and postoperative symptoms than systemic SAEs. Overall, SAEs were important determinants of long-term outcome, as demonstrated by the cumulative impact of multiple recordings of different types of SAEs in the same procedure.  When evaluating SAEs according to database of capture, SAEs identified in HES and CPRD were both associated with poor outcome. SAEs identified in HES were associated with outcome recorded in HES (readmission and prolonged stay), while SAEs identified in CPRD were associated with outcome recorded in primary care (psychiatric morbidity and symptoms) (Table 8-7). Mortality was predicted most strongly by SAEs identified in HES, but was also predicted by SAEs identified in CPRD, demonstrating the importance of this database in capturing significant harm. In some instances however, there was a negative correlation between SAEs identified in CPRD and outcome. Wound infection was an independent negative predictor of 30-day mortality. Patients who die after surgery were presumably not well enough to present to primary care where half of wound infections were recorded. SAEs captured in CPRD were also strong predictors of health status, demonstrating how this database uniquely captures both short and longer-term harm. Combining HES and CPRD may therefore be a way of evaluating overall rates of poor outcome that impact on patients.  With reference to the discharge date, in-hospital SAEs predicted outcome better than post-discharge SAEs. However, the impact of post-discharge SAEs cannot be ignored as there were significant associations with poor outcome, in particular, readmission and poor health status.  What is unique about the present analysis is that it revealed how short-term harm influenced health status. Technical SAEs had a significant impact on postoperative psychiatric morbidity and symptoms. As technical SAEs are by definition modifiable and akin to error in the delivery of care, efforts must focus on reducing technical SAEs to 
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improve long-term functional outcome. New onset postoperative psychiatric morbidity was associated with an increased risk of one-year mortality by 48%. While psychiatric morbidity was associated with increased mortality in one previous study of oesophagogastrectomy,[Wikman 2015] this has not been demonstrated across different gastrointestinal surgical procedures in any healthcare database. This allowed the appreciation of psychiatric illness in those with no history as a significant predictor of survival. The effect size was similar to that of technical SAEs, highlighting the importance of psychological well being in patients undergoing surgery. Of the procedures evaluated, major upper gastrointestinal resection for cancer was associated with the greatest risk of postoperative psychiatric morbidity, making these findings important from a survivorship perspective in this group of patients. Patients with preoperative psychiatric morbidity may benefit from additional support, while greater awareness is needed to recognize and treat new onset postoperative psychiatric morbidity early. Symptoms on the other hand did not influence mortality. This may be because patients who die do not have as much opportunity to present to primary care than those who survive. In these patients, symptoms significantly increased the rates of postoperative psychiatric morbidity. This is the first time that postoperative symptoms have been shown to impact on outcome. Different types of postoperative symptoms were independent predictors of psychiatric morbidity. For most symptoms, the risk incurred by postoperative symptoms was greater than other predictors such as comorbidity and type of surgery. Postoperative symptoms are likely to impact on patients’ QOL. These endpoints deserve careful consideration when evaluating the effectiveness of new treatments of surgical disease. Recent randomized controlled trials evaluating the efficacy of laparoscopic colorectal surgery (COLOR II) have assessed symptoms such as genitourinary dysfunction as important endpoints.[Andersson 2014] Improving gastrointestinal function following surgery may therefore help convey the maximum benefits of surgery to patients.  Overall, the predictive performance of regression models increased after including harm and health status variables as predictors of outcome. The incorporation of harm variables 
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increased the predictive performance of the regression model for readmission. However, this increase did not make the overall performance of this regression model to above the 0.8 threshold. For postoperative psychiatric morbidity, the inclusion of linked database covariates increased the ROC to above 0.8.  When considering the overall improvement in ROC from adding in all linked database covariates to HES data (Table 7-15), the increase in ROC was modest for one-year mortality (2.4%), prolonged stay (4.6%), 30-day mortality (4.8%) and postoperative symptoms (5.8%). The increase in ROC was high for the outcome of readmission (18%) and postoperative psychiatric morbidity (40.4%). However, these increases did not increase the predictive performance of regression models to above the 0.8 threshold for any of the outcome variables except for postoperative psychiatric morbidity. Overall, linked databases increased our understanding of risk factors that impact on outcome, and revealed important interactions between health status and harm. While predictive ability only improved for postoperative psychiatric morbidity, this outcome represented an important aspect of health status that was significantly associated with mortality. As prediction models for health status were achieved using linked database covariates in this Chapter, further population linkage of data may be worthy of consideration to inform surgical practice and policy.  Evaluation of time trends revealed decreasing adjusted risk for most types of outcome, reflecting improvements in patient selection and perioperative care driving better outcome over recent years. However, increasing drives towards shorter hospital stay and minimizing unexpected prolonged stay have been paralleled by an associated increase in risk of readmission. As post-discharge SAEs were one of the strongest predictors of readmission, this may be a suitable target for quality improvement and minimizing the burden from readmission on healthcare resources.[Stitzenberg 2015] Future focus must be placed on reducing post-discharge SAEs while maintaining decreasing trends in hospital stay.  
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Trends in SAEs were different for technical and systemic SAEs. While great strides have been made in reducing mortality rates by preventing and treating systemic SAEs through better patient selection and preoperative optimisation, there has been no improvement in rates of technical SAEs demonstrated over time. Further research and investment is necessary if technical SAEs are to be reduced to parallel decreasing trends as demonstrated in NSQIP.[Hall 2009] Postoperative psychiatric morbidity demonstrated decreasing adjusted trends over time. This is despite previously reported increasing trends in psychiatric morbidity in the primary care population.[Frisher 2004] This may reflect better counseling and patient involvement during perioperative care over the last decade or so.  The risk of postoperative symptoms did not change over time, suggesting that there has been little progress in minimizing the impact of surgery on patients. Postoperative symptoms were the least predictable outcome in regression suggesting that there is lack of understanding of risk factors for this outcome. Symptoms were predominantly determined by surgical procedure, which strictly speaking is not modifiable. Emphasis must therefore be placed on managing symptoms effectively in the postoperative setting to minimize their impact on patients.  Subgroup analysis of individual surgical procedures revealed important insights into patterns of harm. Significant associations between emergency cholecystectomy and harmful outcome were observed. The evaluation of prolonged hospital stay was more meaningful when evaluating individual surgical procedures. Laparoscopic appendicectomy resulted in significantly shorter hospital stay compared with open surgery when adjusted for short-term surgical harm. In the analysis of all procedures together, technical SAEs were found to predict postoperative psychiatric morbidity. In subgroup analysis, cholecystectomy was the only procedures to demonstrate this association. Rates of technical SAE in cholecystectomy were relatively low (Table 5-11). However, when rare but important technical SAEs occurred in this group of patients, there was a significant associated increase in psychiatric morbidity. Interestingly, technical SAEs 
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increased the risk of postoperative symptoms in cholecystectomy and appendicectomy only. In these procedures, reducing short-term harm may benefit patients and help them achieve better health status. Further population coverage of linked data will most likely allow for detailed evaluations of surgical risk in less frequently performed surgical procedures. Subgroup analysis also revealed insights into the effects of cancer-specific variables in colorectal resection. It was demonstrated that there was a negative association between cancer diagnosis and mortality, so patients with colitis and diverticular disease had a poorer prognosis in comparison. This may be related to the level of sepsis associated with inflammatory conditions of the lower gastrointestinal tract. These findings are likely to also be reflected in other procedures such as small bowel resection and oesophagogastrectomy where surgery for benign conditions such as bleeding, ischaemia and perforation are often associated poorer perioperative outcome when compared with cancer surgery.  Overall, regression analyses in this Chapter demonstrated that linked databases offer important insights into the impact of harm and health status on outcome. Primary care data were valuable in identifying risk factors for short and long-term outcome. These findings suggest that SAEs and functional outcome significantly impact on patients, and deserve careful consideration in future surgical trials.    
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9. CHAPTER NINE – DISCUSSION 
Main findings  
Summary of background This thesis sought to evaluate harm in gastrointestinal surgery using linked routine databases derived from integrated health systems in England. To justify the proposed investigation, the association between surgical harm and well-being was explored by systematic review of the literature. QOL instruments assessed in the systematic review also assessed other aspects of health status including symptoms and poor function (disability) in both physical and mental domains. Health status is increasingly incorporated into economical analysis of healthcare outcome. As SAEs were found to be associated with poor health status, the literature suggests that reducing SAEs may lead to better longer-term outcome in gastrointestinal surgery.  To do this, harm must first be measured. When evaluating the ways in which harm can be quantified, the available healthcare data vary in their extent of population coverage and depth of information. Routinely collected data includes a large number of patients and is accessible, updated in real time and linked to other routine databases. Population-level outcome in the UK have been studied most extensively using HES data. While HES have the advantage of covering the entire population, disadvantages include the lack of data on out-of-hospital clinical events and limitations in assessing health status. Previous studies have demonstrated low rates of VTE and wound infection in HES when compared to other sources of information.[Jen 2008, Dyer 2013, El-Dhuwaib 2013] Primary care data are increasingly being used to evaluate out-of-hospital harm in surgical patients.[Tsang 2013, Walker 2014] Growing emphasis on shorter hospital stay has meant that GPs are likely to be increasingly identifying hospital care-related harm. HES data also do not capture important information including lifestyle factors, cancer-specific variables, frailty, psychiatric morbidity and postoperative symptoms. To explore this further, linked routine databases that included both hospital and primary care data were selected as a platform to 
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assess short and long-term harm together. Linked data have not previously been used to evaluate the impact of surgery on health status on a large scale. The analysis was designed to identify interactions between different aspects of measurable harm within an increasingly integrated health system in the UK. By doing so, this investigation aimed to assess whether further investment in better linkage of hospital and primary care data would be worthwhile.  
Database analysis In patients with complete linkage of the five evaluated databases, HES was used to derive surgery covariates (procedure type, emergency surgery, surgical approach) and process (reoperation, readmission, prolonged stay). CPRD data were used to assess lifestyle factors (smoking and BMI), out-of-hospital SAEs and aspects related to health status (frailty, psychiatric morbidity, symptoms). Additional variables from ONS, NCIN and IMD meant that there were nine more covariates in addition to HES covariates making a total of 22 variables in the presented linked databases analysis. This enabled the evaluation of regression models for a greater range of outcome measures using multiple predictor covariates derived from different sources of information.  Linked database analysis increased the number of harm outcome recorded in surgery. For short-term harm, just over a tenth of patients were affected by either technical or systemic SAEs. Overall, technical SAEs were more frequently recorded than systemic SAEs. Certain SAEs were captured preferentially in primary care data. A significant proportion (28%) of all SAEs were captured in primary care data only. For technical SAEs, the incorporation of CPRD data led to over a two-fold increase in the wound infection rate. For systemic SAEs, the incorporation of CPRD data led to over a two-fold increase in postoperative myocardial infarction rates. When evaluating post-discharge SAEs, of all procedures associated with recording of SAEs in either HES or CPRD databases, 48.5% (3936/8106) were associated with a recording of at least one post-discharge SAE. This equated over 40% of the total number of SAEs recorded in the post-discharge setting. Two-thirds (2193/3936) of procedures that were associated with post-discharge SAEs were identified 
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through coding in CPRD data. These findings indicate that primary care data are an important source of information on post-discharge surgical harm that is not captured by HES.  For long-term outcome, linked databases allowed for the assessment of health status. The systematic review identified that a decrease in both physical and mental domains of well-being were associated with surgical harm. Building on these findings, aspects of health status that were reflective of poor physical and mental function were evaluated. Psychiatric morbidity was evaluated before and after surgery, and preoperative rates were higher than postoperative rates. The decrease in rates of psychiatric morbidity after surgery was greater in patients undergoing surgery for benign conditions (Table 6-3 and Table 6-5). Overall, over a tenth of patients who underwent surgery were affected by postoperative psychiatric morbidity. Patients undergoing major upper gastrointestinal cancer resection were at significant risk of this type of harm (Table 8-8). These findings indicate that primary care data are an important resource to determine postoperative health status that is not captured by HES.  Linked databases also allowed for the evaluation of symptoms across different surgical procedures. Overall, 16.9% of patients had at least one recorded postoperative symptom in primary care. Postoperative symptoms were most frequent in three upper gastrointestinal surgical procedures including oesophagogastrectomy, antireflux surgery and hepatopancreaticobiliary resection. The proportion of procedures associated with adverse postoperative symptoms was substantially below figures reported from prospective studies. These data suggest that only those with severe symptoms that warrant medical attention present in primary care and are recorded in CPRD. Other patients with symptoms may not be seeking medical attention, or are assessed in the hospital clinic setting.  
Regression modelling Binary logistic regression analyses were used to evaluate the risk of harm incurred through covariates derived from linked databases. Overall, seven endpoints were 
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evaluated including measures of short-term harm and long-term health status. Risk factors for poor outcome were identified. All evaluated predictors had significant correlations with at least one of the measures of outcome. Overall, SAEs were found to predict mortality, readmission and prolonged hospital stay up to 30 days after surgery. Analysis according to type of SAEs revealed that systemic SAEs were strongly correlated with mortality while technical SAEs were strongly correlated with outcome of process and health status (Table 8-7). There was a significant association between technical SAEs and long-term outcome including postoperative psychiatric morbidity and postoperative symptoms. Analysis of time trends revealed that risk-adjusted rates of technical SAEs have not improved over the duration of this investigation. Initiatives to actively reduce SAE rates may lead to improvements in overall outcome as seen with systemic SAEs in this analysis (Figure 8-1). A strong correlation was also observed between out-of-hospital harm and readmission, demonstrating that the same patterns of harm can be observed from both the hospital and primary care perspectives.  For long-term health status, preoperative psychiatric morbidity was associated with significantly increased one-year mortality risk. Postoperative psychiatric morbidity in the absence of preoperative psychiatric morbidity incurred an increase in adjusted odds of death of 48% (Table 8-8). This was significant considering technical SAEs incurred a mortality risk of 61%. Postoperative symptoms were significantly associated with postoperative psychiatric morbidity but not mortality. Patients presenting to primary care with psychiatric symptoms are therefore more likely to present with other types of symptoms. This association was cumulative as risk of psychiatric morbidity increased with the number of symptoms recorded (Table 8-9). Recordings of symptoms in primary care, including those of a psychiatric nature therefore reflect on poor physical and mental health status, significantly increasing the risk of other types of harm and overall poor outcome.  
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Predictive performance of regression models When evaluating the performance of regression models, the ROC increased with the inclusion of a linked database predictor covariates for all outcome. Prediction models incorporated a greater number of covariates making the analysis more granular. Greater understanding of risk factors that are not represented in hospital data was achieved. However, for most outcome, the improvement in ROC following the inclusion of linked database covariates was modest. While greater knowledge was gained about predictors of risk, efforts to refine analytical methods and identify other markers of health status are immediate goals for development. This may pave the way for greater population coverage leading to wider-scale healthcare evaluation in the future.  When evaluating the prediction models for 30-day and one-year mortality, ROC values were high before additional linked database predictor covariates (Table 7-15 and Table 8-10). For the prediction models for prolonged hospital stay and postoperative symptoms, the ROC remained below the threshold of 0.8 set a priori even after the inclusion of linked database predictor covariates. These data demonstrate that for the outcome measures of mortality, hospital stay and postoperative symptoms, the inclusion of linked database covariates did not significantly improve the performance of prediction models. For two of the outcome measures, there was a substantial increase in ROC following the inclusion of linked database covariates. For models predicting readmission, the addition of harm variables increased the ROC by 15% (Table 8-10). However, even with the inclusion of all predictor variables, the highest ROC achieved for this model was 0.670, which remained below the threshold of 0.8. For models predicting postoperative psychiatric morbidity, the inclusion of linked database covariates, in particular, preoperative psychiatric morbidity increased the ROC by 39% (Table 7-15). However, it was only when harm and health status variables were also included that the ROC increased to 0.804, above the threshold. These data demonstrate that for the outcome measures of readmission and postoperative psychiatric morbidity, the inclusion of linked database covariates substantially increased the predictive performance of regression models. 
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However, the predictive performance of regression models for readmission remained poor even after the inclusion of linked database predictor covariates.  Out of the evaluated outcome measures, the predictive performance of regression models for postoperative psychiatric morbidity were significantly improved by the inclusion of linked database predictor covariates. The main reason for this was the ability of preoperative psychiatric morbidity to predict postoperative psychiatric morbidity. However, this aspect of health status remains an important determinant of outcome in surgery as demonstrated by its significant association with mortality. Patients who developed postoperative psychiatric morbidity without the history of preoperative psychiatric morbidity were at greatest risk of adverse outcome. Based on these findings, further data linkage to increase population coverage may be worthy of consideration as linked data can assess aspects of health status that correlate with outcome. For the remaining outcome measures evaluated, linked data allowed for greater depth in knowledge about risk factors. This thesis is just a starting point. Further research is likely to lead to the identification of other markers of health status that may be important determinants of outcome. As the number of predictors increase, refinement in covariate selection and analytical methods will lead to better prediction of outcome and the potential to inform policy on a national scale using database linkage. .  
Addressing the hypothesis The incorporation of linked database covariates to predict outcome in gastrointestinal surgery improved our understanding of poor outcome in the following ways:  1. A greater number of SAEs were identified in linked data compared with using HES data only, thereby offering a comprehensive overview of rates of short-term harm. 2. A greater number of preoperative risk factor covariates were identified in linked data compared with HES data only. 3. It was feasible to identify domains of health status in linked data, offering greater granularity of information on preoperative risk and long-term outcome. 
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4. Multiple linked database covariates lead to greater understanding of risk incurred through regression analyses 5. Multiple linked database covariates for lead to better performance of regression models for poor outcome compared with using HES data only. 6. The improvement in predictive performance of regression models was significant for postoperative psychiatric morbidity Based on these findings, the hypothesis was addressed as patient-level linkage of multiple routine population-level databases improved our understanding, measurement and risk adjustment of harm in gastrointestinal surgery. HES data was the reference method, as most studies evaluating harm have used this database in the past. HES offers high numbers of patients for statistical analysis using prospectively maintained data that has lower running costs than other healthcare databases.[Raftery 2005] However, limitations in HES were highlighted in the presented analysis. There are a growing number of efforts to link routine population-level data with each other. This thesis explored the potential of one such dataset to enhance our understanding of harm in gastrointestinal surgery. It was demonstrated that linked databases, particularly primary care data, led to the detection of more harm and greater understanding of interactions with health status.  
Gaining new insights Using this model of harm, novel insights were gained into the risk and impact of long-term surgical harm. It was only possible to achieve such insight by taking each step described in this thesis to develop sophisticated regression models for outcome. For example, without all of the patient covariates from linked databases, it would not have been possible to adjust for important predictors of harm such as preoperative psychiatric morbidity, frailty and cancer stage. It would also have been meaningless to evaluate long-term health status without adjusting for short-term harm as the former had a tendency to carry greater weight of risk. By incorporating a higher number of predictor covariates compared with conventional methods of using hospital data only, greater granularity and analytical power 
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were achieved for regression analyses of outcome. This lead to insights into the patterns of harm in gastrointestinal surgery as follows:  1. Technical SAEs significantly increased the risk of postoperative psychiatric morbidity and postoperative symptoms.  2. The average time to recording of postoperative symptoms was shorter than the average time to recording of postoperative psychiatric morbidity.  3. Postoperative symptoms significantly increased the risk of postoperative psychiatric morbidity.  4. In patients with psychiatric morbidity, new onset postoperative psychiatric morbidity (postoperative psychiatric morbidity without preoperative psychiatric morbidity) incurred the greatest risk of one-year mortality.  5. The increase in risk of mortality incurred by psychiatric morbidity was significantly greater in patients undergoing surgery for upper gastrointestinal malignancy.  Based on prediction models for surgical outcome using linked data, novel insights were gained into patterns of harm in gastrointestinal surgery not previously reported in the literature.  
Novelty of presented research 
The findings of this thesis increased knowledge in two ways. Firstly, this is the first time overall rates of harm have been quantified in any surgical specialty using routine national databases. Secondly, these data have lead to new insights into the long-term impact of surgical harm. 
New knowledge in England Many retrospective single-centre studies have reported on harm in patients undergoing gastrointestinal surgery.[Sutcliffe 2008, Alkhaffaf 2010, Owers 2013, Ang 2015] These small series offer detailed accounts of specific types of harm. However, data offering an overview of all harm is lacking, due to the difficulties in undertaking studies of such scale. 
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HES data have previously been used to quantify harm.[Pal 2008, E. M. Burns 2010, E. M. Burns 2011, Sinha 2013] This is limited by the diagnosis coding system used in HES. Nevertheless, HES data cover the entire population and offer an overview of harm nationally allowing for comparison of hospital performance within the English NHS. Due to the way HES data is collected, only short-term harm is often examined. This is because HES records diagnoses and procedures associated with hospital admission, so there is a lack of clinical information when patients are discharged from hospital unless they are readmitted to hospital. However, HES remains an excellent source of information on in-hospital clinical processes. As such, the method described in this thesis of using HES data to accurately identify surgical procedures, followed by using primary care data to identify harm seem appropriate, and should be the model for future analyses of healthcare services in England. Information on harm at population-level is also available in disease-specific clinical registries. Clinical registries have the advantage of offering long-term information on harm that have led to important insights not gained through the use of other healthcare databases.[E. Morris 2008, Padwal 2013] For example, the only previous account of the impact of postoperative psychiatric morbidity in cancer surgery came from the Swedish National Registry for oesophagogastric cancer.[Wikman 2015]  No such studies have previously been reported in the UK. Generally, there have not been as many published studies that have used clinical registry data compared with hospital administrative data.[Palser 2013, Codd 2014] This may be because clinical registries have high running costs and are less accessible to those wishing to undertake research or evaluate services. They have also been developed relatively recently so there are some concerns about data quality.[Almoudaris 2011] As each specialty has its own registry, aggregate analyses of risk factors across different types of gastrointestinal procedures are not possible unless multiple clinical registries are linked. As it was not feasible to link data from multiple disease-specific clinical registries, this type of data were not used in the presented analysis. However, the greater clinical depth and quality of data offered by clinical 
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registries make them attractive targets for database linkage and evaluation of harm in the future.  For these reasons, this thesis examines the use of linked routine databases, to measure harm and health status across different surgical procedures using data that overarch integrated health systems. Although currently database coverage is only 8% of the UK population, this is sufficiently greater than what can be achieved by individual studies with prospective follow-up. The potential for further population coverage makes this method attractive for the purposes of quality evaluation in the future. While the majority of primary care practices in the UK use electronic health records, the aggregation of this information is currently not coordinated centrally. This thesis explored the use of this resource to specifically evaluate harm, which was the first of its kind in any medical or surgical discipline. The methodology has been built upon a grounding of previous accounts of harm reported in isolation.[Humes 2013, Tsang 2013, Walker 2014] In light of the closely integrated structure of primary and secondary care services within the English NHS, it was demonstrated that the burden harm, in particular out-of-hospital harm, had a significant impact on overall outcome. Out-of-hospital harm is seldom discussed in the literature due to the lack of availability of this data in hospital databases. The Health Protection Agency (HPA) have been collecting data on wound infections prospectively since 2006, while PROMs follows patients up to three months after surgery to evaluate satisfaction and adverse events after patients are discharged from hospital.[Health Protection Agency 2011, HSCIC 2015] While these resources offer important information, they are separate pieces of the puzzle that cannot be evaluated on one platform, nor can the effect of one type of harm on another be evaluated by regression analysis. This thesis offers an alternative way of using routinely collected information to evaluate both short and long-term harm in one database. Through these data, the interface between primary and secondary care services can be evaluated in detail. This part of the patient journey has previously been highlighted as an area where harm can impact on patients.[Kripalani 2007]   
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This unique approach has lead to new knowledge in patients undergoing gastrointestinal surgery in England. While the HPA monitors wound infection rates in some procedures, linked data can offer knowledge on wound infections in all surgical procedures identifiable in HES. When comparing linked data with the HPA database, observed wound infection rates were comparable in cholecystectomy, colorectal, hepatopancreatobiliary and small bowel resections between the two databases (Table 9-1). This demonstrated that linked database analysis achieve similar wound infection rates to what has previously been reported from dedicated audits. Wound infection rates for appendicectomy, bariatric surgery, antireflux surgery, haemorrhoidectomy and oesophagogastrectomy have not previously been reported by the HPA. Linked routine database analysis offers one approach to measuring wound infection rates in these procedures, which have lower running costs than prospective projects such as the HPA.   Table 9-1. Comparison  of wound infection rates (% of procedures affected) between linked 
data analysis and national audit.[Health Protection Agency 2013]  
   
 
HPA Linked database 
   
Cholecystectomy 2.8 4.3 
Colorectal resection 10.3 8 
Small bowel resection 7.4 6.8 
Hepatopancreatobiliary resection 7 8.3  
HPA = Health Protection Agency 
 Linked data also offered new insights into the incidence of other types of post-discharge harm. Data on post-discharge VTE have been previously reported from NSQIP in the US but no such database exists in the UK. In light of the recommendation from NICE that primary care data should be used to develop policy on outpatient thromboprophylaxis, linked data should inform guidelines. When compared with reported VTE rates from 
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NSQIP, the proportion of post-discharge VTE was higher in linked databases for major cancer resection (Table 9-2). This may be because in-patient VTE is not captured well in HES leading to lower VTE rates compared with NSQIP.[Merkow 2011] For the evaluation of ambulatory procedures such as laparoscopic cholecystectomy, overall VTE rates observed in the present investigation (0.17%) were similar to what has been previously reported from NSQIP  (0.19%), highlighting the reliability of these data for procedures with short hospital stay.[Gangireddy 2007]   Table 9-2. Proportion of post-discharge VTE recorded in NSQIP and linked data [Merkow 2011] 
   
 
NSQIP Linked database 
   
Colorectal resection 32.1 40.7 
Oesophagogastrecotmy 17.9 46.7 
Hepatopancreatobiliary resection 32.5 36.4  
NSQIP=National Surgical Quality Improvement Programme 
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Additionally, aspects of health status such as frailty were observed to be similar to previous population-level analyses (Table 9-3). Frailty recording in primary care may therefore be adequate to offer risk stratification for surgical patients.   Table 9-3. Proportion of patients with at least one recording of frailty in linked database 
analysis compared with other studies 
   
Other studies (%) Linked database (%) 
   
All procedures [Makary 2010] 10.4 18.1 
Colorectal resection [Robinson 2013] 33.3 24.2 
Upper GI surgery [C. C. Chen 2015]  32.2 18.9-26.0 
Oesophagogastrectomy  [Hodari 2013]  28.3 20.8   Overall, linked databases increased our knowledge of levels of SAEs in England, given that observed rates were comparable with previous studies from within and outside of the UK. The strength of this database is in the assessment of post-discharge harm, particularly for ambulatory surgery. Further validation is necessary to determine the accuracy of recording of harm in linked data. While knew insights were also gained for long-term outcome, these findings will be discussed in the next section as part of new knowledge gained in the international setting, as no previous population-level data have offered the opportunity to gain these insights.  
New knowledge internationally Long-term outcome from surgery is less frequently reported than short-term outcome.  When it is, it often reports on mortality.[Mamidanna 2012] While short-term harm reflects on the quality of perioperative care, measures of long-term non-mortality outcome are lacking. The systematic review of the literature identified that long-term health status may be significantly impaired in surgical patients especially in the context of short-term harm.  Such adverse long-term impact may manifest in the form of physical or mental 
   
 273 
compromise. The study from the Swedish National Registry identified postoperative psychiatric morbidity as a predictor of mortality in patients undergoing oesophagogastric resection, but this study excluded patients with preoperative psychiatric morbidity.[Wikman 2015] In the present analysis, when adjusted for all other determinants of one-year mortality, both preoperative and postoperative psychiatric morbidity were found to independently increase mortality in all types of gastrointestinal surgical procedures. There have been no previous evaluations of psychiatric morbidity in primary care in surgical patients. The presented analyses add depth to current knowledge of psychiatric morbidity associated with surgery (Table 9-4). This thesis demonstrated that the majority of psychiatric morbidity is diagnosed and treated in primary care, without referral to hospitals. The regression model for one-year mortality is unique in that it offers adjustment for other harm variables making the assessment of impact of long-term harm meaningful. While psychiatric morbidity deserves further attention in prehabilitation and survivorship programmes, the present analysis suggests for the first time that minimizing SAEs and postoperative symptoms may reduce psychiatric morbidity and subsequent mortality.     
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Table 9-4. Studies reporting on significant associations between psychiatric morbidity and poor surgical 
outcome 





Evaluated outcome  
Risk of poor 
outcome 
 






















Oesophagectomy [Wikman 2015] Postoperative Mortality 1.65-2.77 
Intensive Care Unit [Abrams 2010] Preoperative Mortality 1.21 
Coronary bypass [J. B. Williams 2013] Preoperative Major morbidity/mortality 1.28-5.1 




Risk of needing surgery 
 
1.28 
   To date, it has not been possible to incorporate data for symptoms in regression analyses due to the lack of coding for such variables in population-level databases. Primary care data has allowed, for the first time, the assessment of the incidence and impact of postoperative symptoms on a large scale. While the rate of symptoms presenting to primary care is likely to represent only a fraction of those who develop symptoms, this adds to the specificity of regression analysis as the presenting symptoms are likely to be those that are severe and considered important enough for patients to seek treatment. The patterns observed are relevant to. Healthcare as correlations were seen with other outcome such as psychiatric morbidity. This sequence of long-term harm from symptoms, to psychiatric morbidity to mortality has not previously been reported in the literature, and deserves further attention in prospective studies. Developing strategies to detect and treat postoperative symptoms early may improve outcome, particularly in upper 
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gastrointestinal surgery where the risk was greatest. As they are at risk of developing psychiatric morbidity, these patients may benefit from wider psychosocial support.  Population level analyses of surgical outcome have allowed for outcome between different countries to be compared. Clinical registry data from England, Sweden, Denmark and the Netherlands have previously been used to demonstrate differences in risk-adjusted mortality rates following oesophagogastrectomy within Europe.[Dikken 2013] Similarly, outcome have been compared between the US and UK using hospital administrative data focusing on assessing volume-outcome relationships.[Munasinghe 2015] These studies report on mortality as primary endpoints, but further studies are needed to compare non-mortality harm across different health systems. This thesis aimed to gain further knowledge of non-mortality harm within a single nation’s health service. The English NHS is uniquely placed as it has clear referral pathways from primary care to hospitals, and availability of primary care data linked to hospital data making it a suitable platform to evaluate risk and harm across integrated health systems. By quantifying overall rates of harm, this database offers insight into harm that can affect patients during the entirety of their health journeys. No such database exists anywhere else in the world. Routine primary care and hospital data allow for analyses to be carried out longitudinally making it a suitable platform for epidemiological studies and evaluation of care pathways and processes. In the current economic climate where resources are limited within the NHS, focus must be placed on gaining knowledge using available resources without inventing new ways expending resource. Linkage of routine databases is without a doubt the future of large-scale analyses of health systems where there are increasing numbers of databases and granularity of information. This thesis offers the grounding for the use of linked routine data for detailed evaluations of quality and safety in the setting of sub-specialist surgical services. 
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Limitations 
While linked data offer a versatile platform upon which large-scale evaluation of healthcare could be undertaken, there are limitations inherent to the use of routine data for this type of analysis. This thesis was developed based on the notion that harm must be measured. However, it is also acknowledged that not all aspects of quality of healthcare can be measured by conventional means. While population-level linkage of multiple routine databases increased the granularity of information on outcome, finer detail in other aspects of quality such as patient satisfaction could not be fully assessed. A recent survey in the US revealed that a good doctor-patient relationship was more important to a patient than outcome statistics.[The Associated Press-NORC Center for Public Affairs Research 2014] Clinical decision-making is another area where methods for measurement are lacking, but treatment decisions have previously been demonstrated to significantly impact on outcome. [Dowding 2003, Ko 2008] These finer aspects of care are often under-represented in routine databases, but are important to both users and providers of healthcare. It is therefore acknowledged that this thesis does not address all aspects of quality relevant to healthcare.  Other than limitations of routine data, the main limitations of the presented analysis are inherent in the methods used to obtain, process and evaluate the data. Database linkage of five routinely collected databases led to a rich collection of patient, surgery and harm covariates. However, linkage of data led to a decrease in the overall number of patients. HES data was central to the presented analysis as patients were selected based on diagnosis and operation coding in this database. However, only half of practices registered with CPRD had agreed to database linkage meaning that a significant number of patients undergoing surgery would have been missed.  There is also lack of validity of the data in its current format for use in identifying harm. Apart from for VTE, there has been no studies reporting on the accuracy of diagnosis coding for harm in primary care. However, as the software systems used to generate the data are used in real-time by GPs during consultations, it is difficult to imagine a more 
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direct route to entering clinical data relevant to healthcare. Further validation is necessary to establish whether harm observed in primary care data are accurately recorded through comparison with other records such as discharge summaries and hospital correspondence. As the database is dynamic and gets regularly updated with new patients, it would be necessary to sample the accuracy of coding continuously to ensure high quality of the generated data. One of the aims of this thesis was to evaluate whether linked databases, in particular primary care data, can facilitate the evaluation of harm and health status in surgery when compared with currently available methods. Consequently, this thesis demonstrated the short-comings of HES data, which is central to the presented methodology and analysis. While HES data has been validated as a suitable means of identifying case-mix,[E. M. Burns 2012] evidence for using HES data to identify harm is limited. This thesis demonstrates that out-of-hospital harm is increasingly relevant in the context of ambulatory care and early hospital discharge, and that HES data are limited in the capture of important adverse events such as wound infection. Furthermore, there are not many variables representative of health status coded in HES making this database unsuitable for the purposes of assessing longer-term impact of harm. To overcome these limitations, an algorithm was developed to quantify the overall rate of poor outcome measured by both HES and primary care data. However, there were limitations in the analytical methods themselves. Regression models incorporated a high number of predictor covariates, however failed to demonstrate key correlations between BMI and socioeconomic status on mortality. This may be due to the high proportion of missing BMI values in CPRD data. CPRD was useful in assessing different domains of health status, however, these were a mixture of impairments, poor function (disability) and symptoms.  Some aspects such as lifestyle factors including exercise, activity levels and surrogates of healthcare expenditure like the number of visits to GPs remain unexplored. There is a general lack of validation of using linked databases for these 
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purposes, and linkage to clinical registry data must be considered a priority to validate and improve the accuracy of routine data.  During the development of this thesis, it had become apparent that there is a limitation in the way CPRD data is captured. In CPRD, it is not possible to flag patients who have moved practices and combine their data from previous practices that they were registered with. Patients are therefore registered as new patients each time they move practices, and are assigned a new unique identifier number. This may increase the significance of some analyses. For example, the significance of impact of harm may increase due to double counting of the same patients who is coded for poor outcome. To improve the accuracy of the data, an identifier code is needed for patients who were previously registered with another practice. These findings must be fed back to industry where this data is generated.   The present analysis is also reliant on the accuracy of coding in general practice. There may be significant variations in the quality of coding amongst primary care practices using the Vision software system. Some practices may record diagnoses more comprehensively than others, leading to strong associations in patients coming from those practices. For example, if frailty is recorded in primary care data only, in a practice that records diagnoses well, postoperative diagnoses such as psychiatric morbidity and symptoms will also be recorded more frequently. This may increase the likelihood of correlations between variables recorded in primary care. Further research and quality control may ensure that this unique way of obtaining data can be put to full use to observe and improve the quality of healthcare services in the UK. Another limitation was the way in which time from surgery to SAE was measured in HES. While the date of recording of SAE was specified in primary care data, the exact date when SAEs occurred was only known in HES if an SAE lead to reoperation or readmission. For SAEs recorded during the index hospital admission, it was not possible to determine the date of SAE. For these SAEs, the discharge date was considered as the date of SAE. As these SAEs may have been recorded in HES later than when they actually occurred, care must be taken when interpreting the results. 
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While these limitations highlight challenges faced while developing the presented methodology, they offer a framework for future research. Further refinement and development of analytical methods in linked database analysis may pave the way for improved data quality and population coverage of this unique healthcare resource.  
Implications for practice, policy and research 
This thesis demonstrated that primary care data are an important source of information pertaining to short-term harm and longer-term health status in gastrointestinal surgery. By informing practice on levels and timings of harmful outcome, these data offer a framework for developing strategies for community and hospital-based post-discharge care. Based on the presented findings, certain high-risk groups may require more community-based support than others particularly in patients who undergo major cancer resection. The goal for developing methods in multiple healthcare database analysis would be to use this information to compare performance amongst healthcare providers. The database evaluated in this thesis offers the ability to assess healthcare systems at multiple levels  across a range of different parameters. While the currently available population coverage of linked data offers substantial numbers for regression, there weren’t enough patients to perform meaningful provider level comparisons. Greater population coverage will enable the calculation of institution-based observed-to-expected ratios for harm. Further database linkage is currently underway with MHRA planning to expand the CPRD database to incorporate primary care electronic health records from EMIS, in addition to the data that is already available. This would offer a sufficient platform to evaluate provider-based performance at local and national levels. No other healthcare system in the world is placed as uniquely as the NHS to undertake detailed analysis of increasingly complex care pathways. Further database linkage is a matter of time needed to overcome technical and governance obstacles to unify healthcare information in a way that is acceptable to patients and purchasers of services. If linked primary and secondary care data were available for the entire population of the UK, the depth of information gained 
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from these resources will be comparable to world-leading quality programs such as NSQIP. Exactly how long it will take to make full use of such potential is difficult to guess.  The inclusion of primary care data to HES increased the number of predictor covariates for regression analyses including variables of harm and health status. For some covariates such as comorbidity and psychiatric morbidity, although HES identified some patients, CPRD helped identify more patients at risk. This meant that database linkage lead to a dataset that was more informative and had higher granularity than using HES data alone. When evaluating predictive performances of regression models, inclusion of linked database covariates led to higher ROC for all of the evaluated outcome measures. Improvement in ROC was seen at two levels - after the inclusion of linked database patient characteristics, and after the inclusion of harm and health status variables as predictors of outcome. The overall improvement in ROC was considered clinically meaningful for the outcome of postoperative psychiatric morbidity only. For all other outcome, inclusion of linked database covariates lead to an increase in predictive performance that was not considered sufficient to inform clinical practice and policy. Based on these findings, further linkage of population-level data should be driven by the need to identify different types of harm and aspects of health status that may further improve the performance of prediction models. The importance of psychiatric morbidity has implications in the delivery of cancer care. Given that the risk of postoperative psychiatric morbidity was highest for major upper cancer resection, its significant effect on mortality must be noted. When adjusted for all covariates including surgical harm and cancer stage, postoperative psychiatric morbidity in patients without a history of preoperative psychiatric morbidity significantly increased the risk of death up to one year after surgery. Reasons for this may include the adoption of maladaptive behaviours such as smoking and poor nutrition, and the effect of psychological stress on the immune system. [Sluzewska 1996]   When predicting postoperative psychiatric morbidity, as technical SAEs and postoperative symptoms were significantly correlated with postoperative psychiatric morbidity, patients 
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who suffer SAEs are at increased risk of presenting in primary care with symptoms including those of a psychiatric nature. This reflects the burden of surgical harm on primary care resources. The data suggest that psychological effect of the gravity of diagnosis was augmented in patients who suffered harm from surgery. Efforts to reduce SAE rates may therefore help improve longer-term mental health status following cancer surgery. Earlier and better management of adverse postoperative symptoms may also lead to mental well-being. These findings have significant implications on survivorship programs in which psychosocial support should be routinely offered. The results of this analysis should be further evaluated in a prospective setting to assess whether harm can be identified early and if intervention can improve health status. Better management of psychiatric morbidity may lead to better overall outcome including survival.  Further research could build on the grounding laid by this thesis to improve our understanding of other types of poor outcome. As health status was preferentially recorded in primary care, focus should be placed on other aspects of health status that are measurable and may be informative to policy makers. Longer-term health status must be considered together with short-term harm when evaluating performance in surgery. These parameters will become increasingly recognized as important endpoints for clinical trials. While interactions between psychiatric morbidity, symptoms and mortality were identified as particularly relevant to those undergoing cancer surgery, health status and functionality may also be important in other areas such as orthopedic and vascular surgery. Wider application of the presented protocol to other surgical procedures may reveal new insights into interactions of harm.  This thesis provides evidence to support database linkage as a platform to explore healthcare performance at multiple levels. From a technical point of view, greater processing power is needed to deal with ever-increasing numbers of variables with adequate processing power to manage multiple databases of increasing complexity. However, there is significant public awareness on the dangers of wide-scale availability of patient information, as demonstrated by the postponement of the Care.data program.[BBC 
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2014] Careful consideration of implications to all stakeholders is needed to achieve greater availability of data that is capable of assessing quality on a wider scale. For this, high granularity of information at patient-level is necessary. This must be paralleled by closer regulation to ensure that data is only available to those with genuine intent on benefiting patients. Further database linkage may lead to data-driven development of interventions. A common observational tool, which fulfils the needs of patients, healthcare providers, purchasers and policy makers is best placed to drive improvements in quality from multiple perspectives. For these purposes, linked routine data are ideally placed as they are accessible, available at national level and consider all patients within a health system together rather than focusing on disease-specific groups as seen with clinical registries. National-level linkage of primary care and hospital databases may lead to an explosion of knowledge on quality and safety within the NHS. For this to happen, software systems used to generate primary care electronic health records must be standardized across the UK.  This thesis identified aspects of health status including symptoms and psychiatric morbidity that were useful indicators of surgical outcome. Future research should explore how improvement in health status can lead to better patient satisfaction. In light of the transfer of skills and resources out of hospitals and towards community-based care with shorter hospital stay, the interface between primary and secondary care may be an increasingly important aspect of healthcare where quality could be improved.[Darzi 2008] This thesis explored how data can also be integrated to model health systems in their entirety.  
Concluding remarks 
This thesis explored the use of data that were not purpose-built for evaluating clinical processes. These resources increased the detection of harm and helped gain novel insights into the longer-term effects of surgery on patients. HES remains an important source of information on hospital performance. However, the present analysis has provided 
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sufficient evidence to suggest that the addition of variables from primary care and other routine databases increases our knowledge of poor outcome. Overall, this thesis demonstrated that: 1. Linkage of multiple healthcare databases offered a platform for the comprehensive evaluation of poor outcome. 2. Quality of surgery is reflected in long-term health status.  3. Greater population linkage between primary care and hospital data would allow for the use of these important resources to evaluate services across integrated health systems within the UK.   
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APPENDICES 
Appendix 1. Application for approval of investigation by Independent Scientific Advisory Committee   
ISAC APPLICATION FORM 
PROTOCOLS FOR RESEARCH USING THE CLINICAL PRACTICE RESEARCH DATALINK 
(CPRD) 
 







If you have any queries, please contact ISAC 
Secretariat: ISAC@cprd.com 
 
 Study Title  
Modelling surgical risk and harm from linked primary and secondary care data  
 Principal Investigator (full name, job title, organisation & e-mail address for correspondence regarding this 
protocol) 
Ms Elaine Burns, Clinical Lecturer, Imperial College London, e.burns@imperial.ac.uk 
 Affiliation (full address) 
Department of Surgery and Cancer, 10th Floor, QEQM building, St Mary's Hospital, London, W2 1NY  
 
 Protocol’s Author (if different from the principal investigator) 
Mr George Bouras, Clinical Research Fellow, Department of Surgery and Cancer, Imperial College London  
 Type of Institution (please tick one box below) 
 
Academia  Research Service Provider  Pharmaceutical Industry  
NHS   Government Departments  Others    
 
 Financial Sponsor of study 
 
Pharmaceutical Industry (please specify)         Academia(please specify)  
Government / NHS (please specify)          None    
Other (please specify)           
 
Funded through the National Reporting and Learning System Development Program, Imperial College 
London 
 
 Data source  (please tick one box below) 
 
      
 
Sponsor has on-line access   Purchase of ad hoc dataset     
Commissioned study     
Other      (please specify)        
 
 Has this protocol been peer reviewed by another Committee? 
 
Yes*    No   
 
* Please state in your protocol the name of the reviewing Committee(s) and provide an outline of the 
review process and outcome. 
 
 Type of Study (please tick all the relevant boxes which apply) 
 
Adverse Drug Reaction/Drug Safety    Drug Use     Disease Epidemiology
   
Drug Effectiveness   Pharmacoeconomic          Other  
  
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 This study is intended for: 
 
Publication in peer reviewed journals   Presentation at scientific conference 
  
Presentation at company/institutional meetings  Other    
       
  
 
 Does this protocol also seek access to data held under the CPRD Data Linkage Scheme? 
 
    No   
 
12. If you are seeking access to data held under the CPRD Data Linkage Scheme, please select 
the source(s) of linked data being requested. 
 
 Hospital Episode Statistics   Cancer Registry Data*   MINAP                                                       
 ONS Mortality Data    Index of Multiple Deprivation/ Townsend Score  
 Mother Baby Link    Other: (please specify)   
 
*P lease note that applicants seeking access to cancer registry data must provide consent for 
publication of their study title and study institution on the UK Cancer Registry website. P lease 
contact the CPRD Research Team on +44 (20) 3080 6383 or email kc@cprd.com to discuss 
this requirement further. 
 
13. If you are seeking access to data held under the CPRD Data Linkage Scheme, have you 
already discussed your request with a member of the Research team?  
 
Yes    No*   
 
*P lease contact the CPRD Research Team on +44 (20) 3080 6383 or email kc@cprd.com to 
discuss your requirements before submitting your application. 
 





14. Does this protocol involve requesting any additional information from GPs?  
 
Yes*   No   
 
 * Please indicate what will be required:  
   Completion of questionnaires by the GPψ       Yes      No   
 Provision of anonymised records (e.g.  hospital discharge summaries) Yes     No   
 Other (please describe)             
 
ψ Any questionnaire for completion by GPs or other health care professional must be approved 
by ISAC before circulation for completion.   
15. Does this protocol describe a purely observational study using CPRD data (this may 
include the review of anonymised free text)? 
 
Yes*   No**   
 
* Yes: I f you w ill be using data obtained from the CPRD Group, this study does not require 
separate ethics approval from an NHS Research Ethics Committee. 
** No: You may need to seek separate ethics approval from an NHS Research Ethics 
Committee for this study. The ISAC w ill provide advice on whether this may be needed. 
 
16. Does this study involve linking to patient identifiable data from other sources? 
 
Yes    No   
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17. Does this study require contact with patients in order for them to complete a 
questionnaire? 
 
Yes    No   
N.B. Any questionnaire for completion by patients must be approved by ISAC before 
circulation for completion.   
18. Does this study require contact with patients in order to collect a sample? 
 
Yes*   No   
 
* P lease state what w ill be collected         
 
 Experience/expertise available  
 
Please complete the following questions to indicate the experience/expertise available within the team of 
researchers actively involved in the proposed research, including  analysis of data and interpretation of 
results 
 Previous GPRD/CPRD Studies  Publications using GPRD/CPRD data 
 
None                   
1-3       
> 3       
          Yes                             
 No 
Is statistical expertise available within the research team?     
  
                           If yes, please outline level of experience             
 
Dr Alex Bottle is a Senior Lecturer in Medical Statistics (non-clinical) with a specialist interest in database 
analysis. Thanos Athanasiou is the Professor of Cardiovascular Sciences and Cardiac Surgery at the 
Department of Surgery and Cancer who specialises in evidence synthesis, meta-analysis and medical 
statistics. Ms Elaine Burns is a clinical lecturer in the same department with experience in database analysis 
and medical statistics. These members have extensive knowledge and skill in the evaluation of hospital 
administrative databases and using statistical software including SAS, SPSS, Revman and STATA.  
 
Is experience of handling large data sets (>1 million records)  
available within the research team?        
  
                           If yes, please outline level of experience           
 
Dr Alex Bottle has extensive experience in the evaluation of large databases, in particular using hospital 
administrative data as part of his previous work with the Dr Foster Unit. His most recent work includes the 
Global Comparators Projects which aims to synthesize data internationally on an unprecedented scale. Ms 
Elaine Burns has expertise in the analysis of Hospital Episodes Statistics in bariatric and colorectal surgery 
and these works have been published in high-impact journals such as the BMJ. She is also a member of the 
UK Ileal Pouch Registry for which she oversees aspects of database analysis.  
 
Is UK primary care experience available within the research team?     
  
                           If yes, please outline level of experience                        
 
Dr Alex Bottle has previous experience in using the General Practice Research Database (GPRD) and has 
co-authored an article from this work which has recently been accepted for publication. This experience 
also encompasses the use of linked primary and secondary care databases. The proposal forms a part of a 
PhD thesis for Mr George Bouras, which was formally reviewed by Professor A Majeed who has previously 
published extensively using primary care data. On-going advice will also be given by Michael Soljak and 
Daniel Gibbons from the Primary Care School within the college who are currently using GPRD data for 
research. 
 List of all investigators/collaborators (please list the names, affiliations and e-mail addresses* of all 
collaborators, other than the principal investigator) 
 
Mr George Bouras, Clinical Research Fellow, Imperial College London, g.bouras@imperial.ac.uk 
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Professor Thanos Athanasiou, Imperial College London, t.athanasiou@imperial.ac.uk 
Dr Alex Bottle, Senior Lecturer, Imperial College London, a.bottle@imperial.ac.uk 
Professor Ara Darzi, Imperial College London, a.darzi@imperial.ac.uk 
 
*Please note that your ISAC application form and protocol must be copied to all e-mail addresses listed above at the 
time of submission of your application to the ISAC mailbox. Failure to do so will result in delays in the processing of your 
application. 
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PROTOCOL CONTENT CHECKLIST 
In order to help ensure that protocols submitted for review contain adequate information for 
protocol evaluation, ISAC have produced instructions on the content of protocols for research using 
CPRD data. These instructions are available on the CPRD website (www.cprd.com/ISAC). All 
protocols using CPRD data which are submitted for review by ISAC must contain information on the 
areas detailed in the instructions.  IF you do not feel that a specific area required by ISAC is 
relevant for your protocol, you will need to justify this decision to ISAC.  
 
Applicants must complete the checklist below to confirm that the protocol being submitted includes 
all the areas required by ISAC, or to provide justification where a required area is not considered to 
be relevant for a specific protocol.  Protocols will not be circulated to ISAC for review until the 
checklist has been completed by the applicant.  
 
Please note, your protocol will be returned to you if you do not complete this checklist, 
or if you answer ‘no’ and fail to include justification for the omission of any required 
area. 
 
 Included in 
protocol? 
 
Required area Yes No If no, reason for 
omission 
Lay Summary (max.200 
words) 
        
Background         
Objective, specific aims and 
rationale 















      
      
      
Study Design  
 
       
Sample size/ power 
calculation  
(P lease provide 
justification of  
sample size in the protocol) 
        
Study population  
(including estimate of 
expected number of  







      
Selection of comparison 
group(s) or controls 
        
Exposures, outcomes and 
covariates 
Exposures are clearly 
described  








      
      
Data/  Statistical Analysis 
P lan 
There is plan for addressing 
confounding  
There is a plan for 







      
      
                      
 
 
Patient/  user group 
involvement † 
  N/A 
Limitations of the study 
design, data sources  
and analytic methods 
        
Plans for disseminating and 
communicating study 
results 
        
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[PLEASE INSERT THE STUDY PROTOCOL DOCUMENT HERE] 
  
LAY SUMMARY 
Recent publicity of unsafe practice has reiterated the importance of monitoring and improving hospital safety. 
Adverse events are failures in healthcare intervention that cause harm. Adverse events are under-reported 
and no single method of detection captures all harm. SAEs (SAEs) may be measured from hospital 
administrative data. Trends towards early discharge mean that SAEs are increasingly encountered by General 
Practitioners in the community. Primary care databases contain patient information for each consultation that 
may record harm related to hospital care. Coding in primary care databases may also help assess preoperative 
risk status of patients referred for surgery. Recent linkage of primary and secondary care databases offers a 
novel platform to measure risk-adjusted surgical outcomes from the referrer’s perspective. Rates of SAEs will 
be determined using both types of data. Clinical and socioeconomic characteristics will be compared between 
patients who have and have not suffered SAEs. The burden of SAEs on primary care resources will be 
evaluated by assessing their influence on the number of consultations following hospital discharge, 
emergency consultations and referral back to the original surgical team or other specialties. Date and cause of 
out-of-hospital death will be determined from population statistics allowing for survival analysis for serious 
SAEs. Measuring surgical harm by this approach may help us monitor hospital safety from a service user’s 
perspective, and drive further linkage of primary and secondary care databases.  
 
BACKGROUND 
Recent publicity of unsafe practice has reiterated the importance of monitoring and improving hospital safety. 
Harm related to healthcare intervention is caused by adverse events that are difficult to measure and often 
underestimated. No single method of detection captures all harm. Case notes review by experienced clinicians 
is costly to perform on a large scale. The use of existing databases is recommended to negate difficulties 
associated with developing new datasets. Using routinely collected data for such analyses is on average 60 
times less expensive than maintaining prospective clinical registries. Hospital administrative databases such as 
the Hospital Episodes Statistics (HES) can measure SAEs on a large scale using operative coding for 
reoperations and diagnostic coding for postoperative adverse events. However, this measurable harm is 
limited to what happens during in-hospital stay. Trends towards enhanced recovery, early discharge, day-case 
surgery and reduced follow-up mean that SAEs may be increasingly encountered in by General Practitioners in 
the community. Such out-of-hospital SAEs occur in up to 30% of patients and may not be detected by 
hospitals unless patients are readmitted. Longitudinal evaluation of hospitalized patients using primary care 
data has previously shown correlation between primary and secondary care coding for upper gastrointestinal 
bleeding. SAEs such as wound infection and postoperative pain are coded for in primary care databases but 
evaluation specifically in surgical patients has not previously been performed. Primary care data may be an 
important source of information on SAEs that are recognised following hospital discharge. Clinical coding may 
also facilitate preoperative risk assessment of patients referred for surgery. Accurate case-mix adjustment is 
necessary to interpret rates of morbidity and mortality and allow for comparisons between healthcare 
providers. Risk-adjustment for deriving observed to expected ratios using hospital administrative data is 
challenging.  It is difficult to distinguish SAEs that occur following surgery from pre-existing conditions using 
ICD-10 codes given the lack of present on arrival flags. The General Practice Research Database (GPRD) linked 
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to other databases contains important information on preoperative risk such as comorbidity, smoking, BMI, 
cancer stage and socioeconomic status. Whether these factors correlate with outcomes has not previously 
been investigated using linked data. SAEs measured in hospitals and in the community may impact on 
processes such as readmission, emergency admission, number of primary care consultations and specialist 
referral. The GPRD offers a novel platform to evaluate the risk and harm from SAEs longitudinally through 
linkage with HES, Office of National Statistics (ONS) and Cancer Registries. Combining information from these 
databases may help evaluate hospital safety from a service user’s perspective. This approach may drive 
further linkage of primary and secondary care databases to facilitate the research of surgical outcomes on a 
national scale.   
 
HYPOTHESIS 
The detection of adverse events related to hospital surgical care can be augmented by using primary linked to 
secondary care data 
  
OBJECTIVE 
To measure the risk, rate and harm from SAEs using linked primary and secondary care data 
 
AIMS 
1. To use coding in GPRD to detect SAEs related to hospital care  
2. To improve risk prediction scoring for surgical outcomes using coding in GPRD 
3. To determine the burden of SAEs on primary care resources 
 
RATIONALE 
There is increasing focus on researching the economic impact of healthcare outcomes particularly from a 
commissioners’ perspective. The GPRD is one of the largest electronic databases in the world. Linkage with 
HES represents a pioneering opportunity to study increasingly relevant processes that transcend in-hospital 
and out-of-hospital surgical care. It is unknown whether primary care databases can enhance the detection of 
SAEs beyond what is currently measurable using hospital administrative data. Linkage of primary and 
secondary care databases offers a novel approach to monitoring surgical safety at patient level. This research 
is hypothesis generating as it explores for the first time whether indicators that reflect hospital safety can be 
derived from primary care databases. Based on our results, we hope to stimulate further research into the use 
of coding in primary care databases as indicators of safety in secondary care. 
 
STUDY DESIGN 
This is a population-based observational study that will quantify the recorded incidences of SAEs following 
hospital surgical admissions. The occurrence of SAEs following surgery will be analysed using a time-to-event 
framework by correlating the date of surgery in HES to recording of SAE in GPRD. For major SAEs, survival 
analysis will be performed by calculating the time from SAE in HES or GPRD to the date and cause of death in 
ONS. Database linkage will allow for all analyses to be performed at patient level, and extrapolated to practice 
level using the practice identifier (pracid) codes in GPRD. This will help determine practices that are recording 
high levels of SAEs following referral of patients to their local hospitals.  
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Study population: 300000 consecutive patients undergoing index procedures of interest up to January 2012. 
The minimum follow-up length required is 1 year to assess the impact of SAEs on survival. Data will therefore 
be obtained for patients undergoing index procedures at least 1 year prior to the latest available data (August 
2013 according to feasibility count). The feasibility count revealed a surgical cohort of 444548 patients since 
January 1998 (Kendal Chidwick 24th August 2013). Sample calculations reveal that at least 100000 patients will 
be needed for meaningful comparisons. We would like to obtain the maximum number of patients to allow 
for subgroup analyses. Data on the most recent 300000 patients with 1-year follow-up will be requested to 
cover all potential needs and to comply with CPRD policy. We are keen to obtain consecutive cases rather 
than a random sample of surgical patients to allow for meaningful multi-level hierarchical modelling.  
Definition of SAEs: An SAE is an adverse event related to surgical intervention that causes harm. A recent 
review has concluded that when assessing safety in healthcare, the cause of harm must be modifiable. In 
surgery, complications are traditionally used to benchmark performance but not all complications are 
avoidable and indicative of harm. Surgical harm that is not intended must therefore be differentiated from 
unavoidable sequelae of disease and treatment. For example, conversion and stoma formation are intended, 
in contrast, wound complications, anastomotic leakage and venous thromboembolism may have acceptable 
rates as they cannot be entirely mitigated, however they may be surrogates of unintended harm. SAEs are 
therefore complications that are potentially avoidable that are indicators of unsafe surgical practice.  
Selection of index procedures: We are interested in evaluating SAEs that are both common to different 
procedures such as wound infection, venous thromboembolism and pain, as well as procedure-specific SAEs 
such as anastomotic leakage, organ injury and device errors. We have chosen to study general, 
gastrointestinal, breast and endocrine surgery as these procedures are routinely performed in high numbers 
and may be associated with a wide range of SAEs that are commonly encountered by the general surgeon. 
They represent a significant proportion of patients undergoing surgical treatment in English hospitals. The 
selected procedures are in line with our unit’s interests and we have a track-record of publishing surgical 
outcomes research in gastrointestinal surgery. Vascular surgery is excluded due to the changing nature of this 
specialty in recent years related to centralisation, increased utilisation of interventional radiology and training. 
The Joint Commission for Surgical Training now recognises vascular surgery as well as urology as separate 
specialties with specific training needs that are different to general surgery. Limiting to general surgery will 
help keep the number of patients (and therefore initial costs) for data extraction down. Only patients from 
practices that have agreed to linkage with HES and have undergone surgery after their up-to-standard date 
(uts) for data quality will be evaluated to ensure that the data is of research quality in all patients. The Office 
of Population Census and Survey (OPCS) coding (version 4.2-4.6) for index procedures will be used to identify 
relevant patients from HES. International Classification of Diseases version 10 (ICD-10) diagnostic coding will 
be used to distinguish between some types of patients, for example, obesity and gastric cancer will 
differentiate between bariatric and oncological surgery in patients coded for gastric surgery. Surgical patients 
will also be identified from primary care database using READ coding. This will include oesophagogastric 
surgery (READ 76….), colorectal surgery (READ 77….), hepatopancreatobiliary surgery (READ 78….), hernia 
repair (READ 7H….) and breast and endocrine surgery (READ 71….). The corresponding Medcodes will be 
translated using the Clinical Practice Research Datalink (CPRD) Medical Dictionary to identify patients in GPRD. 
The coding for operative procedures in primary and secondary care data will be compared. 
Censoring for patients leaving the practice: Patients who have left the practice will be identified using the 
‘transfer out date’ code (tod) in GPRD. Out of these patients, those who have died will be identified using the 
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transfer out reason code (toreason) and included in the analysis. The rest of the patients will be excluded if 
they have transferred from their practice within 30 days of hospital discharge following their index operation.  
Measuring SAEs in HES: SAEs will be measured using OPCS coding for reoperation, endoscopic intervention 
and radiological intervention. Other SAEs will be coded by diagnostic coding for example organ failure, 
transfusion reaction and device errors amongst others.  
Measuring SAEs in GPRD: The incidence of SAEs has not previously been quantified in surgical patients using 
primary care data. ICD-10 codes for adverse events have previously been translated to READ coding for 
primary care data. The NHS Information Authority Clinical Terminology Browser will be used to specify READ 
coding for adverse events in surgery.  
Risk factors for developing SAEs: Primary care data may be an important source of information on surgical risk 
and facilitate the allocation of resources to areas of need.  We aim to improve risk prediction scoring for 
surgical outcomes using linked data to measure comorbidity, socioeconomic status, smoking, cancer stage and 
BMI. We have previously used the Charlson index to perform risk-adjustment for reoperation in colorectal and 
bariatric surgery at national level using HES. The Charlson index has previously been adapted to derive 
utilisation costs in primary care. The index has been translated for use with READ coding with a number of 
established ICD-10 translations demonstrating good performance. BMI is recorded in 48-65% of patients in 
GPRD and at least 10 measurements are performed in each patient longitudinally. The recording of BMI seems 
to be better in diabetic patients. The Michigan database has shown that BMI significantly influences both 
morbidity and mortality in general surgery. Whether this is the case has not previously been demonstrated in 
England. The Townsend score will help us refine the assessment of socioeconomic status and its influence on 
surgical outcomes.  
Measuring the burden of SAEs on primary care resources: Survival analysis will be performed using 
information from linked data. Mortality will be measured in HES (in-hospital mortality) and ONS (out-of-
hospital mortality) that records date and cause of death accurately. In surgery, recognized surrogates of 
adverse outcomes include ITU admission, length of stay, readmission and emergency admission. These 
parameters will be measured in HES. Similarly, the burden of SAEs on primary care resources can be reflected 
in primary care data. The impact of SAEs on the number of consultations following hospital admission (event 
dates) and re-r referral to the original surgical team or other specialties (NHS specialty codes – Textfile Look-
up DEP) will be evaluated. Comparisons will be made between patients who have and have not suffered SAEs 




- HES data for all hospital episodes of patients with index procedure 
- GPRD data linked to HES data for all patients with index procedure 
- Linked ONS data, cancer registry data and Townsend score 
 
SAMPLE SIZE 
Previous studies have shown that mortality in surgical patients ranges between 0.55 and 0.74%. Although the 
incidence of SAEs from primary care records is unknown, one study has shown that adverse events may be 
recorded in up to 0.072% of consultations. Sample calculations were based on these figures to demonstrate 
the smallest difference in outcomes from the available data. To detect a 0.1% difference in survival between 
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case and control groups for SAEs occurring at 0.072%, 137412 patients will be needed to allow for a 
comparison between 99 patients in each group at 80% power and p<0.05. For preoperative factors, 154580 
patients will be needed to demonstrate a 0.1% (SD 2.5) difference in wound infection rates between obese 
and non-obese individuals taking into consideration a morbid obesity rate of approximately 10% in the 
general surgical cohort and the recording of BMI in only 40% of GPRD patients. A clinical study with 20000 
patients has previously demonstrated a difference in wound infection rates between obese and non-obese 
patients. As individual SAEs are relatively rare, we are requesting the maximum available dataset (<300000) to 
allow for subgroup analyses according to index procedure. Our initial feasibility count was 444584 patients 
since the start of ONS linkage in 1998. In order to comply with CPRD policy, we are seeking to obtain data 
from the most recent 300000 patients with at least 1 year follow-up for survival evaluation.  
 
STATISTICAL ANALYSIS 
All analyses will be performed on SPSS (version 20.0 for Window, SPSS Inc.) and Stata (Stata Corporation). 
Descriptive analyses of the study population will include the number of GP practices, years that the practices 
have participated in GPRD, deprivation, and geographical location of the practices. The incidence of SAEs will 
be calculated for specific procedures using Medcodes. SAEs that occur within 30 days and within 1 year after 
surgery will be evaluated in separate analyses. The precision of incidence calculations will be indicated by the 
reporting of 95% confidence intervals. The rate of SAEs per patient will be correlated against risk factors (age, 
sex, socioeconomic status, BMI, cancer stage and Charlson score), mortality and process measures (number of 
consultations, re-referral to original team, referral to other specialty). Univariate analysis will be performed 
using t-tests, chi-squared tests, Wilcoxon sum-rank tests as appropriate and multivariate regression modelling 
will be applied. Odds ratios and c-statistics will be reported where appropriate. The reliability and robustness 
of created regression models will be examined through sensitivity analyses. Multilevel hierarchical modelling 
will cluster patients, practices and secondary care providers. Risk factors will be assessed by the generalized 
estimating equation with random intercepts and random effects. Survival analysis will be performed by 
multilevel Cox regression modelling of time from SAE to death. These analyses will identify practices that 
record high risk-adjusted levels of SAEs that reflect the care provided by their local hospitals. 
Handling of missing data: Patients with missing data will be excluded as we will take a complete case analysis 
approach without any imputation of missing fields. We assume that most data will be missing completely at 
random and that this percentage will be small. For BMI, previous studies have shown that data may be 
missing in up to 50% of non-diabetes individuals and therefore this data is missing at random and the 
missingness is dependent on whether the patient is diabetic. In this circumstance, as the missing data rate is 
high, multiple imputation by chained equations will be used to model the association between BMI and SAEs .    
 
STUDY LIMITATIONS 
• The GPRD contains limited clinical detail and data are derived from an existing coding system that was not 
designed specifically to measure patient safety.  
• The overall incidence of SAEs for the entire surgical cohort will be calculated, but it is impossible to predict 
whether individual SAEs in specific procedures will yield sufficient numbers. 
• Handling of missing data by complete case analysis assumes that the data is missing completely at 
random. 
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PLANS FOR DISSEMINATION 
The results of this research will be disseminated through peer-review publications, conference abstracts, 
presentations and media release.   
 
INFORMATION GOVERNANCE 
The College’s institutinal Data Protection Number is Z5940050. Data will be accessed in a secure locked room 
on a personal computer that is not connected to the internet. There will be encrypting software, password 
protection log-in, Caldicott Guardian and Care Record Guarantee in place. To protect confidentiality, all 
person identifiable data processed will comply with the Data Protection Act 1998 and Department of Health 
guidelines. Annual reporting of information security will be in line with BS7799 Information Security 
Management Code of Practice. Data will be destroyed with data decrypting software.   
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Appendix 2. Confirmation of ethical approval for research project 
 
 
30 September 2013 
 
Dear Mr Bouras 
 
Study title:   
Measuring the burden of patient harm from multiple national databases and case 
notes review  
REC reference: 13/LO/1374  S TD A 3106 
Protocol number: IRAS project ID: 133513  
 
The Research Ethics Committee reviewed the above application at the meeting 
held on 24 September 2013. Thank you for attending to discuss the application 
with Dr Elaine Burns. 
We plan to publish your research summary wording for the above study on the 
NRES website, together with your contact details, unless you expressly withhold 
permission to do so. Publication will be no earlier than three months from the date 
of this favourable opinion letter. Should you wish to provide a substitute contact 
point, require further information, or wish to withhold permission to publish, please 
contact the REC Manager Mr Atul Patel, nrescommittee.london-
westminster@nhs.net. 
Ethical opinion 
The members of the Committee present gave a favourable ethical opinion of the 
above research on the basis described in the application form, protocol and 
supporting documentation, subject to the conditions specified below. 
Ethical review of research sites 
The favourable opinion applies to all NHS sites taking part in the study, subject to 
management permission being obtained from the NHS/HSC R&D office prior to the 
start of the study (see “Conditions of the favourable opinion” below). 
Conditions of the favourable opinion 
The favourable opinion is subject to the following conditions being met prior to the 
start of the study. Management permission or approval must be obtained from 
each host organisation prior to the start of the study at the site concerned. 
Management permission (“R&D approval”) should be sought from all NHS 
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organisations involved in the study in accordance with NHS research governance 
arrangements. Guidance on applying for NHS permission for research is available 
in the Integrated Research Application System or at http://www.rdforum.nhs.uk. 
Where a NHS organisation’s role in the study is limited to identifying and referring 
potential participants to research sites (“participant identification centre”), guidance 
should be sought from the R&D office on the information it requires to give 
permission for this activity. For non-NHS sites, site management permission 
should be obtained in accordance with the procedures of the relevant host 
organisation. Sponsors are not required to notify the Committee of approvals from 
host organisations 
The documents reviewed and approved at the meeting were: 
Document Version Date 
Covering Letter  19 August 2013 
Evidence of insurance or indemnity  29 July 2013 
Investigator CV   
Letter from Sponsor  07 August 2013 
Other: Student CV   
Protocol 2 01 July 2013 
REC application 133513/4991 13/1/915 09 September 2013 
 
With the Committee’s best wishes for the success of this project. Yours sincerely 
 
Dr Alan Ruben Chair 
Email: nrescommittee.london-westminster@nhs.net 
NRES Committee London - Westminster 
Research Health Authority Ground Floor, Skipton House 80 London Road SE1 
6LH 
Telephone: 020 797 22561 Facsimile: 020 797 22592 
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Appendix 3. Full list of variables for linked databases analysis 
Database Category Field name Description 
CPRD 
Patient 
patid Encrypted unique identifier given to a patient in CPRD GOLD gender Patient’s gender yob Patient’s year of birth mob Patient’s month of birth (for those aged under 16). 0 indicates no month set marital Patient’s current martial status ses Patient’s socio-economic status. Currently 0; to be populated in future builds 
frd Date the patient first registered with the practice. If patient only has ‘temporary’ records, the date is the first encounter with the practice; if patient has ‘permanent’ records it is the date of the first ‘permanent’ record (excluding preceding temporary records) 
crd Date the patient’s current period of registration with the practice began (date of the first ‘permanent’ record after the latest transferred out period). If there are no ‘transferred out periods’, the date is equal to ‘frd’ regstat Status of registration detailing gaps and temporary patients reggap Number of days missing in the patients registration details internal Number of internal transfer out periods, in the patient’s registration details tod Date the patient transferred out of the practice, if relevant. Empty for patients who have not transferred out toreason Reason the patient transferred out of the practice. Includes 'Death' as an option accept Flag to indicate whether the patient has met certain quality standards: 1 = acceptable, 0 = unacceptable 
Practice 
pracid Encrypted unique identifier given to a specific practice in CPRD GOLD 
region Value to indicate where in the UK the practice is based. The region denotes the Strategic Health Authority for practices within England, and the country i.e. Wales, Scotland, or Northern Ireland for the rest lcd Date of the last collection for the practice 
uts Date at which the practice data is deemed to be of research quality. Derived using a CPRD algorithm that primarily looks at practice death recording and gaps in the data 
Staff staffid Encrypted unique identifier given to the practice staff member entering the data gender Staff’s gender role Role of the member of staff who created the event 
Consultation constype 
Type of consultation (e.g. Surgery Consultation, Night Visit, Emergency etc) consid The consultation identifier linking events at the same consultation, when used in combination with pracid duration The length of time (minutes) between the opening, and closing of the consultation record 
Clinical 
eventdate Date associated with the event, as entered by the GP sysdate Date the event was entered into Vision medcode CPRD unique code for the medical term selected by the GP 
textid Identifier that allows freetext information on the event to be retrieved, when used in combination with pracid and event type ‘Clinical’. A value of 0 indicates that there is no freetext information for this event episode Episode type for a specific clinical event enttype Identifier that represents the structured data area in Vision where the data was entered Additional clinical adid Identifier that allows additional information to be retrieved for this event, when used in combination with 
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pracid. A value of 0 signifies that there is no additional information associated with the event. data1  Depends on Entity Type ¨ data2 Depends on Entity Type ¨ data3 Depends on Entity Type ¨ data4 Depends on Entity Type ¨ data5 Depends on Entity Type ¨ data6 Depends on Entity Type ¨ data7 Depends on Entity Type ¨ 
Referral 
source Classification of the source of the referral e.g. GP, Self nhsspec Referral speciality according to the National Health Service (NHS) classification fhsaspec Referral speciality according to the Family Health Services Authority (FHSA) classification inpatient Classification of the type of referral, e.g. Day case, In patient attendance Category describing whether the referral event is the first visit, a follow-up etc urgency Classification of the urgency of the referral e.g. Routine, Urgent 
Immunisation 
immstype Individual components of an immunisation, e.g. Mumps, Rubella, Measles stage Stage of the immunisation given, e.g. 1, 2, B2 status Status of the immunisation e.g. Advised, Given, Refusal compound Immunisation compound administered – may be a single or multi-component preparation, e.g. MMR source Location where the immunisation was administered, e.g. In this practice reason Reason for administering the immunisation, e.g. Routine measure method Route of administration for the immunisation, e.g. Oral, Intramuscular 
Test 
enttype Identifier that represents the structured data area in Vision where the data was entered data1 Qualifier data2 Normal range from  data3 Normal range to  data4 Normal range basis 
Therapy 
bnfcode Code representing the chapter & section from the British National Formulary for the product selected by GP qty Total quantity entered by the GP for the prescribed product 
ndd Numeric daily dose prescribed for the event. Derived using a CPRD algorithm on common dosage strings (represented by textid < 100,000). Value is set to 0 for all dosage strings represented by textid > 100,000 numdays Number of treatment days prescribed for a specific therapy event numpacks Number of individual product packs prescribed for a specific therapy event packtype Pack size or type of the prescribed product 
issueseq Number to indicate whether the event is associated with a repeat schedule. Value of 0 implies the event is not part of a repeat prescription. A value ³ 1 denotes the issue number for the prescription within a repeat schedule  
HES 
Patient 
ethnos Patient’s ethnicity derived from HES records gen_HESid A generated unique identifier assigned to a patient in the HES data. An individual that has contributed data to more than one GOLD practice has the same gen_HESid n_patid_hes Number of individuals in GOLD assigned the same gen_HESid (unique patient identifier generated in HES) 
Hospitalisation 
spno Spell number uniquely identifying a hospitalisation admidate Date of admission discharged Date of discharge admimeth Method of admission admisorc Source of admission 
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disdest Destination on discharge dismeth Method of discharge duration Duration of hospitalisation spell in days elecdate Date of decision to admit patient elecdur Waiting time (difference in days between elecdate and admidate) 
Episodes 
epikey Episode key uniquely identifying an episode of care epistart Date of start of episode epiend Date of end of episode eorder Order of episode within spell epidur Duration of episode in days epitype Type of episode (general, delivery, birth, psychiatric etc.) mainspef Speciality under which consultant is contracted tretspef Speciality under which consultant is working in period of care pconsult Consultant code (pseudonymised) intmanig Intended management 
classpat Patient classification: (Actual Management) 1=Ordinary admission; 2=Day case admission; 3=Regular day attendee; 4=Regular night attendee; 5=Mothers and babies using only delivery facilities; 8=Not applicable (other maternity event) firstreg First regular day or night admission? 
Diagnoses ICD An ICD10 diagnosis code in XXX or XXX.X format ICDx 5th/6th characters of the ICD code (if available) d_order Ordering of diagnosis code in episode, within range 1-20 Procedures OPCS An OPCS 4 procedure code evdate Date of operation / procedure p_order Ordering of OPCS code in episode, within range 1-24 
ONS 
Date of death DOD Date associated with the event, as additional number of days after the patient's CRD registration date 
Cause of death 
Cause An ICD10 diagnosis code in XXX or XXX.X format Cause1 An ICD10 diagnosis code in XXX or XXX.X format Cause2 An ICD10 diagnosis code in XXX or XXX.X format Cause3 An ICD10 diagnosis code in XXX or XXX.X format Cause4 An ICD10 diagnosis code in XXX or XXX.X format Cause5 An ICD10 diagnosis code in XXX or XXX.X format Cause6 An ICD10 diagnosis code in XXX or XXX.X format Cause7 An ICD10 diagnosis code in XXX or XXX.X format Cause8 An ICD10 diagnosis code in XXX or XXX.X format Cause9 An ICD10 diagnosis code in XXX or XXX.X format Cause10 An ICD10 diagnosis code in XXX or XXX.X format Cause11 An ICD10 diagnosis code in XXX or XXX.X format Cause12 An ICD10 diagnosis code in XXX or XXX.X format Cause13 An ICD10 diagnosis code in XXX or XXX.X format Cause14 An ICD10 diagnosis code in XXX or XXX.X format Cause15 An ICD10 diagnosis code in XXX or XXX.X format 
NCIN 
Diagnosis diag_date_month Month portion of diagnosis date, where available diag_date_year Year portion of diagnosis date, where available site4_icd10_recoded Tumour site recoded into ICD10 
Stage 
stage Available from 1993 onwards reg_uicc_version_clin Version of the TNM classification of malignant cancers was used to stage the tumour for the clinical TNM values 
reg_tnm_clin 
Combination of clinical T, N and M in “t_clin”, “n_clin” and “m_clin”. Includes Ann Arbor staging for lymphomas. NB: It is not guaranteed that data from the individual reg_t_clin, reg_n_clin and reg_m_clin variables have been combined into this variable, so they should be used in parallel. reg_t_clin TNM staging is dependent on tumour site and should be investigated prior to use 
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reg_n_clin TNM staging is dependent on tumour site and should be investigated prior to use reg_m_clin TNM staging is dependent on tumour site and should be investigated prior to use reg_uicc_version_path Version of the TNM classification of malignant cancers was used to stage the tumour for the pathalogical TNM values 
reg_tnm_path 
Combination of clinical T, N and M in “t_path”, “n_path” and “m_path”. Includes Ann Arbor staging for lymphomas. NB: It is not guaranteed that data from the individual reg_t_path, reg_n_path and reg_m_path variables have been combined into this variable, so they should be used in parallel. reg_t_path TNM staging is dependent on tumour site and should be investigated prior to use reg_n_path TNM staging is dependent on tumour site and should be investigated prior to use reg_m_path TNM staging is dependent on tumour site and should be investigated prior to use reg_uicc_version_int Version of the TNM classification of malignant cancers was used to stage the tumour for the integrated TNM values 
reg_tnm_int 
Combination of clinical T, N and M in “t_int”, “n_int” and “m_int”. Includes Ann Arbor staging for lymphomas. NB: It is not guaranteed that data from the individual reg_t_int, reg_n_int and reg_m_int variables have been combined into this variable, so they should be used in parallel. reg_t_int TNM staging is dependent on tumour site and should be investigated prior to use reg_n_int TNM staging is dependent on tumour site and should be investigated prior to use reg_m_int TNM staging is dependent on tumour site and should be investigated prior to use reg_duke_stage Used for colorectal cancer reg_mets Metastases reg_tumour_size Diameter of a lesion in mm, largest if more than one, if the histology proves to be invasive reg_nodes_examined Number of examined lymph nodes reg_nodes_positive Number of nodes found positive 
Adjuvant therapy 
reg_rt All treatments within 6 months of diagnosis should be included. reg_ct All treatments within 6 months of diagnosis should be included. reg_hormonetherapy All treatments within 6 months of diagnosis should be included. Includes immunotherapy. trtother All treatments within 6 months of diagnosis should be included. reg_neoadjuvant_flag_path Indicates whether staging occurred following prior tumour-shrinking treatment 
Area-based depravation Socioeconomic status 
imd2010_5 IMD 2010 quintile (1=LEAST deprived,…, 5=MOSTdeprived) imd2010_10 IMD 2010 decile (1=LEAST deprived,…, 10=MOSTdeprived) imd2010_20 IMD 2010 ‘twentile’ (1=LEAST deprived,…, 20=MOSTdeprived)   
